1	Articles	NNPS	O	Articles	_	0	SENT_1	[p1l101t169r251b205],

1	3	CD	NUMBER	3	nsubj	15	SENT_2	[p1l93t360r241b434],
2	@	SYM	O	@	dep	5	SENT_2	[p1l93t360r241b434],
3	+5	CD	NUMBER	+5	num	5	SENT_2	[p1l256t345r316b430],
4	Genetic	JJ	O	genetic	amod	5	SENT_2	[p1l354t365r579b418],
5	variants	NNS	O	variant	dep	15	SENT_2	[p1l595t365r840b418],
6	in	IN	O	in	_	0	SENT_2	[p1l860t365r911b417],
7	ABCB1	NN	O	abcb1	prep_in	5	SENT_2	[p1l926t367r1120b418],
8	and	CC	O	and	_	0	SENT_2	[p1l1140t363r1252b418],
9	CYP2C19	NN	O	cyp2c19	prep_in	5	SENT_2	[p1l1270t367r1532b426],
10	and	CC	O	and	_	0	SENT_2	[p1l1550t363r1662b418],
11	cardiovascular	JJ	O	cardiovascular	amod	12	SENT_2	[p1l1679t363r2110b418],
12	outcomes	NNS	O	outcome	conj_and	5	SENT_2	[p1l353t463r649b509],
13	after	IN	O	after	_	0	SENT_2	[p1l667t454r811b509],
14	treatment	NN	O	treatment	prep_after	12	SENT_2	[p1l823t463r1136b509],
15	with	IN	O	with	_	0	SENT_2	[p1l1151t454r1289b508],
16	clopidogrel	NN	O	clopidogrel	pobj	15	SENT_2	[p1l1309t454r1642b526],
17	and	CC	O	and	_	0	SENT_2	[p1l1662t454r1774b509],
18	prasugrel	NN	O	prasugrel	pobj	15	SENT_2	[p1l1791t454r2068b526],
19	in	IN	O	in	_	0	SENT_2	[p1l2090t456r2142b508],
20	the	DT	O	the	det	21	SENT_2	[p1l351t545r451b600],
21	TRITON	NNP	ORGANIZATION	TRITON	prep_in	16	SENT_2	[p1l463t550r856b600],
22	.	.	O	.	_	0	SENT_2	[p1l463t550r856b600],

1	—	NN	O	—	_	0	SENT_3	[p1l463t550r856b600],
2	.	.	O	.	_	0	SENT_3	[p1l463t550r856b600],

1	TIMI	NNP	ORGANIZATION	TIMI	nn	3	SENT_4	[p1l463t550r856b600],
2	38	CD	NUMBER	38	num	3	SENT_4	[p1l876t545r950b608],
3	trial	NN	O	trial	_	0	SENT_4	[p1l965t545r1104b600],
4	:	:	O	:	_	0	SENT_4	[p1l965t545r1104b600],
5	a	DT	O	a	det	7	SENT_4	[p1l1123t563r1155b600],
6	pharmacogenetic	JJ	O	pharmacogenetic	amod	7	SENT_4	[p1l1171t545r1698b617],
7	analysis	NN	O	analysis	dep	3	SENT_4	[p1l1715t545r1951b616],

1	Jessica	NNP	PERSON	Jessica	nn	2	SENT_5	[p1l347t667r432b697],
2	L	NNP	PERSON	L	_	0	SENT_5	[p1l441t667r453b691],
3	Mega	JJ	PERSON	mega	amod	4	SENT_5	[p1l461t666r551b699],
4	*	NN	O	*	dep	2	SENT_5	[p1l461t666r551b699],
5	,	,	O	,	_	0	SENT_5	[p1l461t666r551b699],
6	Sandra	NNP	PERSON	Sandra	nn	9	SENT_5	[p1l560t665r648b691],
7	L	NNP	O	L	nn	9	SENT_5	[p1l656t668r669b691],
8	Close	NNP	O	Close	nn	9	SENT_5	[p1l677t665r761b696],
9	*	NN	O	*	appos	4	SENT_5	[p1l677t665r761b696],
10	,	,	O	,	_	0	SENT_5	[p1l677t665r761b696],
11	Stephen	NNP	PERSON	Stephen	nn	13	SENT_5	[p1l770t665r872b699],
12	D	NNP	PERSON	D	nn	13	SENT_5	[p1l881t668r898b691],
13	Wiviott	NNP	PERSON	Wiviott	appos	4	SENT_5	[p1l906t667r1004b696],
14	,	,	O	,	_	0	SENT_5	[p1l906t667r1004b696],
15	Lei	NNP	LOCATION	Lei	nn	16	SENT_5	[p1l1014t667r1047b691],
16	Shen	NNP	LOCATION	Shen	appos	4	SENT_5	[p1l1054t665r1211b699],
17	,	,	O	,	_	0	SENT_5	[p1l1054t665r1211b699],
18	}	CD	NUMBER	}	num	21	SENT_5	[p1l1054t665r1211b699],
19	oseph	NN	O	oseph	nn	21	SENT_5	[p1l1054t665r1211b699],
20	R	NN	O	r	nn	21	SENT_5	[p1l1220t668r1235b691],
21	Walker	NNP	PERSON	Walker	appos	4	SENT_5	[p1l1242t665r1333b696],
22	,	,	O	,	_	0	SENT_5	[p1l1242t665r1333b696],
23	Tabassome	NNP	PERSON	Tabassome	nn	24	SENT_5	[p1l1342t665r1484b691],
24	Simon	NNP	PERSON	Simon	appos	4	SENT_5	[p1l1490t667r1576b696],
25	,	,	O	,	_	0	SENT_5	[p1l1490t667r1576b696],
26	Elliott	NNP	PERSON	Elliott	nn	28	SENT_5	[p1l1586t665r1661b691],
27	M	NNP	PERSON	M	nn	28	SENT_5	[p1l1668t667r1691b691],
28	Antman	NNP	PERSON	Antman	appos	4	SENT_5	[p1l1699t668r1812b696],
29	,	,	O	,	_	0	SENT_5	[p1l1699t668r1812b696],
30	Eugene	NNP	PERSON	Eugene	nn	31	SENT_5	[p1l1821t668r1912b699],
31	Braunwald	NNP	PERSON	Braunwald	appos	4	SENT_5	[p1l1919t665r2062b696],
32	,	,	O	,	_	0	SENT_5	[p1l1919t665r2062b696],
33	MarcSSabatine	NNP	O	MarcSSabatine	appos	4	SENT_5	[p1l352t708r555b734],

1	Summary	NN	O	summary	_	0	SENT_6	[p1l6t795r184b836],

1	Lancet201o	NN	O	lancet201o	_	0	SENT_7	[p1l60t847r345b870],
2	;	:	O	;	_	0	SENT_7	[p1l60t847r345b870],
3	376:1312	CD	NUMBER	376:1312	num	7	SENT_7	[p1l60t847r345b870],
4	—	CD	NUMBER	—	num	7	SENT_7	[p1l60t847r345b870],
5	19	CD	NUMBER	19	num	7	SENT_7	[p1l60t847r345b870],
6	Background	NNP	O	Background	nn	7	SENT_7	[p1l392t843r573b879],
7	Clopidogrel	NNP	O	Clopidogrel	nsubj	11	SENT_7	[p1l593t842r776b880],
8	and	CC	O	and	_	0	SENT_7	[p1l798t842r856b871],
9	prasugrel	NN	O	prasugrel	nsubj	11	SENT_7	[p1l878t842r1026b880],
10	are	VBP	O	be	cop	11	SENT_7	[p1l1049t852r1096b871],
11	subject	JJ	O	subject	dep	1	SENT_7	[p1l1120t842r1230b880],
12	to	TO	O	to	_	0	SENT_7	[p1l1252t848r1281b871],
13	eﬂiux	JJ	O	eﬂiux	prep_to	11	SENT_7	[p1l1304t842r1391b871],
14	via	IN	O	via	_	0	SENT_7	[p1l1412t843r1456b871],
15	P-glycoprotein	NN	O	p-glycoprotein	prep_via	13	SENT_7	[p1l1480t842r1705b880],
16	(	CD	NUMBER	(	num	15	SENT_7	[p1l1729t842r1869b880],
17	encoded	VBN	O	encode	partmod	15	SENT_7	[p1l1729t842r1869b880],
18	by	IN	O	by	_	0	SENT_7	[p1l1891t842r1928b880],
19	ABCB1	NN	O	abcb1	agent	17	SENT_7	[p1l1949t844r2069b875],
20	,	,	O	,	_	0	SENT_7	[p1l1949t844r2069b875],
21	also	RB	O	also	advmod	17	SENT_7	[p1l2093t842r2154b871],
22	known	VBN	O	know	amod	15	SENT_7	[p1l6t888r113b917],
23	as	IN	O	as	dep	22	SENT_7	[p1l128t898r159b917],

1	Published	VBN	O	publish	_	0	SENT_8	[p1l171t941r269b961],
2	Online	JJ	O	online	amod	4	SENT_8	[p1l276t941r346b961],
3	MDR1	NN	O	mdr1	nn	4	SENT_8	[p1l387t936r505b972],
4	)	NN	O	)	dobj	1	SENT_8	[p1l387t936r505b972],
5	.	.	O	.	_	0	SENT_8	[p1l387t936r505b972],

1	ABCB1	NN	O	abcb1	nn	2	SENT_9	[p1l523t936r636b963],
2	polymorphisms	NNS	O	polymorphism	nsubj	11	SENT_9	[p1l651t934r907b972],
3	,	,	O	,	_	0	SENT_9	[p1l651t934r907b972],
4	particularly	RB	O	particularly	advmod	5	SENT_9	[p1l925t934r1104b972],
5	3435C	NN	O	3435c	appos	2	SENT_9	[p1l1120t935r1282b967],
6	—	CD	NUMBER	—	num	8	SENT_9	[p1l1120t935r1282b967],
7	>	JJR	O	>	amod	8	SENT_9	[p1l1120t935r1282b967],
8	T	NN	O	t	dep	5	SENT_9	[p1l1120t935r1282b967],
9	,	,	O	,	_	0	SENT_9	[p1l1120t935r1282b967],
10	may	MD	O	may	aux	11	SENT_9	[p1l1300t944r1367b972],
11	affect	VB	O	affect	_	0	SENT_9	[p1l1383t934r1467b963],
12	drug	NN	O	drug	nn	13	SENT_9	[p1l1483t934r1557b972],
13	transport	NN	O	transport	dobj	11	SENT_9	[p1l1572t940r1717b971],
14	and	CC	O	and	_	0	SENT_9	[p1l1733t934r1791b963],
15	eﬂicacy	NN	O	eﬂicacy	conj_and	13	SENT_9	[p1l1808t934r1927b972],
16	.	.	O	.	_	0	SENT_9	[p1l1808t934r1927b972],

1	We	PRP	O	we	nsubj	2	SENT_10	[p1l1944t937r1995b963],
2	aimed	VBD	O	aim	_	0	SENT_10	[p1l2011t934r2109b963],
3	to	TO	O	to	aux	4	SENT_10	[p1l2125t940r2154b963],
4	assess	VB	O	assess	xcomp	2	SENT_10	[p1l6t989r102b1007],

1	August	NNP	DATE	August	_	0	SENT_11	[p1l175t1014r249b1039],
2	29	CD	DATE	29	num	1	SENT_11	[p1l256t1015r287b1036],
3	,	,	DATE	,	_	0	SENT_11	[p1l256t1015r287b1036],
4	2010	CD	DATE	2010	num	1	SENT_11	[p1l295t1015r346b1032],
5	DO	NNP	O	DO	nsubj	14	SENT_11	[p1l133t1049r346b1072, p1l163t1085r346b1111],
6	|	CD	NUMBER	|	number	7	SENT_11	[p1l133t1049r346b1072, p1l163t1085r346b1111],
7	:10.1016	CD	NUMBER	:10.1016	amod	5	SENT_11	[p1l133t1049r346b1072, p1l163t1085r346b1111],
8	/	:	O	/	punct	10	SENT_11	[p1l133t1049r346b1072, p1l163t1085r346b1111],
9	S01406736	CD	NUMBER	s01406736	number	10	SENT_11	[p1l133t1049r346b1072, p1l163t1085r346b1111],
10	(	CD	NUMBER	(	dep	7	SENT_11	[p1l133t1049r346b1072, p1l163t1085r346b1111],
11	10	CD	NUMBER	10	num	12	SENT_11	[p1l133t1049r346b1072, p1l163t1085r346b1111],
12	)	NN	O	)	dep	10	SENT_11	[p1l133t1049r346b1072, p1l163t1085r346b1111],
13	61273-1	CD	NUMBER	61273-1	dep	10	SENT_11	[p1l133t1049r346b1072, p1l163t1085r346b1111],
14	See	VB	O	see	rcmod	1	SENT_11	[p1l84t1136r118b1154],
15	Comment	NN	O	comment	nn	16	SENT_11	[p1l125t1136r233b1154],
16	page	NN	O	page	dobj	14	SENT_11	[p1l239t1141r289b1160],
17	1278	CD	DATE	1278	num	16	SENT_11	[p1l295t1134r346b1156],

1	the	DT	O	the	det	2	SENT_12	[p1l6t1221r55b1250],
2	eifect	NN	O	eifect	conj_and	2	SENT_12	[p1l67t1221r152b1250],
3	of	IN	O	of	_	0	SENT_12	[p1l163t1221r198b1250],
4	this	DT	O	this	det	5	SENT_12	[p1l204t1221r261b1250],
5	polymorphism	NN	O	polymorphism	prep_of	2	SENT_12	[p1l274t1221r506b1259],
6	by	IN	O	by	_	0	SENT_12	[p1l517t1221r553b1259],
7	itself	PRP	O	itself	prep_by	2	SENT_12	[p1l564t1221r646b1250],
8	and	CC	O	and	_	0	SENT_12	[p1l652t1221r710b1250],
9	alongside	IN	O	alongside	_	0	SENT_12	[p1l721t1221r871b1259],
10	variants	NNS	O	variant	prep_alongside	2	SENT_12	[p1l882t1222r1005b1250],
11	in	IN	O	in	_	0	SENT_12	[p1l1017t1222r1049b1249],
12	CYPZCI9	NN	O	cypzci9	prep_in	2	SENT_12	[p1l1063t1223r1209b1250],
13	on	IN	O	on	_	0	SENT_12	[p1l1219t1231r1258b1250],
14	cardiovascular	JJ	O	cardiovascular	amod	15	SENT_12	[p1l1270t1221r1495b1250],
15	outcomes	NNS	O	outcome	prep_on	2	SENT_12	[p1l1506t1227r1657b1250],
16	in	IN	O	in	_	0	SENT_12	[p1l1669t1222r1700b1249],
17	patients	NNS	O	patient	prep_in	2	SENT_12	[p1l1712t1222r1835b1258],
18	treated	VBN	O	treat	partmod	2	SENT_12	[p1l6t1267r114b1296],
19	with	IN	O	with	_	0	SENT_12	[p1l135t1267r204b1296],
20	clopidogrel	NN	O	clopidogrel	prep_with	18	SENT_12	[p1l225t1267r400b1305],
21	or	CC	O	or	_	0	SENT_12	[p1l421t1277r454b1296],
22	prasugrel	NN	O	prasugrel	conj_or	20	SENT_12	[p1l475t1267r623b1305],
23	in	IN	O	in	_	0	SENT_12	[p1l644t1268r676b1295],
24	TRITON	NNP	ORGANIZATION	TRITON	prep_in	18	SENT_12	[p1l697t1269r937b1296],
25	.	.	O	.	_	0	SENT_12	[p1l697t1269r937b1296],

1	—	NN	O	—	_	0	SENT_13	[p1l697t1269r937b1296],
2	.	.	O	.	_	0	SENT_13	[p1l697t1269r937b1296],

1	TIMI	NNP	ORGANIZATION	TIMI	_	0	SENT_14	[p1l697t1269r937b1296],
2	38	CD	NUMBER	38	dep	1	SENT_14	[p1l960t1270r1004b1296],
3	.	.	O	.	_	0	SENT_14	[p1l960t1270r1004b1296],

1	We	PRP	O	we	nsubj	3	SENT_15	[p1l1026t1270r1076b1296],
2	also	RB	O	also	advmod	3	SENT_15	[p1l1098t1267r1159b1296],
3	assessed	VBD	O	assess	_	0	SENT_15	[p1l1180t1267r1315b1296],
4	the	DT	O	the	det	5	SENT_15	[p1l1335t1267r1385b1296],
5	effect	NN	O	effect	dobj	3	SENT_15	[p1l1406t1267r1491b1296],
6	of	IN	O	of	_	0	SENT_15	[p1l1512t1267r1547b1296],
7	genotype	NN	O	genotype	prep_of	5	SENT_15	[p1l1563t1273r1705b1305],
8	on	IN	O	on	_	0	SENT_15	[p1l1726t1277r1766b1296],
9	the	DT	O	the	det	13	SENT_15	[p1l1787t1267r1836b1296],
10	pharmacodynamic	JJ	O	pharmacodynamic	amod	13	SENT_15	[p1l6t1313r299b1351],
11	and	CC	O	and	_	0	SENT_15	[p1l309t1313r368b1342],
12	pharmacokinetic	JJ	O	pharmacokinetic	amod	13	SENT_15	[p1l377t1313r641b1350],
13	properties	NNS	O	property	prep_on	3	SENT_15	[p1l651t1314r809b1350],
14	of	IN	O	of	_	0	SENT_15	[p1l821t1313r856b1342],
15	these	DT	O	these	det	16	SENT_15	[p1l861t1313r943b1342],
16	drugs	NNS	O	drug	prep_of	13	SENT_15	[p1l954t1313r1042b1351],
17	in	IN	O	in	_	0	SENT_15	[p1l1053t1314r1084b1341],
18	healthy	JJ	O	healthy	amod	19	SENT_15	[p1l1094t1313r1209b1351],
19	individuals	NNS	O	individual	prep_in	16	SENT_15	[p1l1219t1313r1400b1342],
20	.	.	O	.	_	0	SENT_15	[p1l1219t1313r1400b1342],

1	See	VB	O	see	dep	8	SENT_16	[p1l108t1374r142b1392],
2	Am	VBP	O	be	dep	4	SENT_16	[p1l148t1375r199b1392],
3	es	NNS	O	e	nn	4	SENT_16	[p1l206t1379r227b1392],
4	page	NN	O	page	advcl	1	SENT_16	[p1l233t1379r281b1398],
5	1320	CD	NUMBER	1320	num	6	SENT_16	[p1l287t1376r337b1395],
6	Methods	NNS	O	method	dep	4	SENT_16	[p1l374t1390r501b1416],
7	We	PRP	O	we	nsubj	8	SENT_16	[p1l508t1391r556b1416],
8	genotyped	VBD	O	genotype	_	0	SENT_16	[p1l566t1388r721b1425],
9	ABCB1	NN	O	abcb1	dobj	8	SENT_16	[p1l729t1391r838b1416],
10	in	IN	O	in	_	0	SENT_16	[p1l846t1398r877b1416],
11	2932	CD	DATE	2932	num	12	SENT_16	[p1l887t1391r957b1416],
12	patients	NNS	O	patient	prep_in	8	SENT_16	[p1l966t1394r1084b1425],
13	with	IN	O	with	_	0	SENT_16	[p1l1094t1388r1160b1416],
14	acute	JJ	O	acute	amod	16	SENT_16	[p1l1170t1394r1249b1416],
15	coronary	JJ	O	coronary	amod	16	SENT_16	[p1l1258t1398r1390b1425],
16	syndromes	NNS	O	syndrome	prep_with	8	SENT_16	[p1l1399t1388r1563b1425],
17	undergoing	VBG	O	undergo	partmod	16	SENT_16	[p1l1573t1388r1749b1425],
18	percutaneous	JJ	O	percutaneous	amod	19	SENT_16	[p1l1758t1394r1960b1425],
19	intervention	NN	O	intervention	dobj	17	SENT_16	[p1l1970t1394r2154b1416],
20	who	WP	O	who	nsubjpass	22	SENT_16	[p1l372t1433r436b1461],
21	were	VBD	O	be	auxpass	22	SENT_16	[p1l450t1443r522b1461],
22	treated	VBN	O	treat	rcmod	19	SENT_16	[p1l536t1433r640b1461],
23	with	IN	O	with	_	0	SENT_16	[p1l653t1433r720b1461],
24	clopidogrel	NN	O	clopidogrel	nn	26	SENT_16	[p1l734t1433r901b1470],
25	(	CD	NUMBER	(	num	26	SENT_16	[p1l917t1435r1042b1470],
26	n	NN	O	n	prep_with	22	SENT_16	[p1l917t1435r1042b1470],
27	=	JJ	O	=	amod	26	SENT_16	[p1l917t1435r1042b1470],
28	1471	CD	DATE	1471	number	29	SENT_16	[p1l917t1435r1042b1470],
29	)	CD	NUMBER	)	dep	27	SENT_16	[p1l917t1435r1042b1470],
30	or	CC	O	or	_	0	SENT_16	[p1l1059t1443r1090b1461],
31	prasugrel	NN	O	prasugrel	nn	33	SENT_16	[p1l1104t1433r1246b1470],
32	(	NN	O	(	nn	33	SENT_16	[p1l1263t1435r1387b1470],
33	n	NN	O	n	prep_with	22	SENT_16	[p1l1263t1435r1387b1470],
34	=	JJ	O	=	amod	33	SENT_16	[p1l1263t1435r1387b1470],
35	1461	CD	DATE	1461	number	36	SENT_16	[p1l1263t1435r1387b1470],
36	)	CD	NUMBER	)	dep	34	SENT_16	[p1l1263t1435r1387b1470],
37	in	IN	O	in	_	0	SENT_16	[p1l1404t1434r1434b1460],
38	the	DT	O	the	det	39	SENT_16	[p1l1448t1433r1496b1461],
39	TRITON	NNP	ORGANIZATION	TRITON	prep_in	22	SENT_16	[p1l1510t1435r1741b1461],
40	.	.	O	.	_	0	SENT_16	[p1l1510t1435r1741b1461],

1	—	NN	O	—	_	0	SENT_17	[p1l1510t1435r1741b1461],
2	.	.	O	.	_	0	SENT_17	[p1l1510t1435r1741b1461],

1	TIMI	NNP	ORGANIZATION	TIMI	_	0	SENT_18	[p1l1510t1435r1741b1461],
2	38	CD	NUMBER	38	num	3	SENT_18	[p1l1757t1435r1791b1461],
3	trial	NN	O	trial	dep	1	SENT_18	[p1l1806t1433r1873b1461],
4	.	.	O	.	_	0	SENT_18	[p1l1806t1433r1873b1461],

1	We	PRP	O	we	nsubj	2	SENT_19	[p1l1888t1436r1937b1461],
2	evaluated	VBD	O	evaluate	_	0	SENT_19	[p1l1952t1433r2093b1461],
3	the	DT	O	the	det	5	SENT_19	[p1l2106t1433r2154b1461],
4	car	NN	O	car	nn	5	SENT_19	[p1l85t1467r336b1525],
5	association	NN	O	association	dobj	2	SENT_19	[p1l372t1479r538b1529],
6	between	IN	O	between	_	0	SENT_19	[p1l551t1477r677b1505],
7	ABICBI	NNP	O	ABICBI	nn	8	SENT_19	[p1l690t1480r799b1529],
8	3435C	NNP	O	3435C	prep_between	2	SENT_19	[p1l813t1479r965b1505],
9	—	CD	NUMBER	—	num	11	SENT_19	[p1l813t1479r965b1505],
10	>	JJR	O	>	amod	11	SENT_19	[p1l813t1479r965b1505],
11	T	NN	O	t	dep	8	SENT_19	[p1l813t1479r965b1505],
12	and	CC	O	and	_	0	SENT_19	[p1l978t1478r1035b1505],
13	rates	NNS	O	rate	prep_between	2	SENT_19	[p1l1048t1483r1119b1505],
14	of	IN	O	of	_	0	SENT_19	[p1l1133t1477r1168b1505],
15	the	DT	O	the	det	21	SENT_19	[p1l1176t1477r1223b1505],
16	primary	JJ	O	primary	amod	21	SENT_19	[p1l1237t1479r1358b1529],
17	eﬂicacy	NN	O	eﬂicacy	nn	21	SENT_19	[p1l1371t1477r1482b1514],
18	endpoint	NN	O	endpoint	nn	21	SENT_19	[p1l1495t1477r1631b1514],
19	(	CD	NUMBER	(	num	21	SENT_19	[p1l1646t1477r1870b1514],
20	cardiovascular	JJ	O	cardiovascular	amod	21	SENT_19	[p1l1646t1477r1870b1514],
21	death	NN	O	death	prep_of	13	SENT_19	[p1l1883t1477r1973b1510],
22	,	,	O	,	_	0	SENT_19	[p1l1883t1477r1973b1510],
23	myocardial	JJ	O	myocardial	amod	24	SENT_19	[p1l1988t1477r2154b1514],
24	Brigham	NNP	ORGANIZATION	Brigham	prep_of	13	SENT_19	[p1l6t1537r94b1563],
25	and	CC	O	and	_	0	SENT_19	[p1l101t1537r140b1557],
26	women	NNS	O	woman	conj_and	21	SENT_19	[p1l145t1539r243b1557],
27	’	CD	NUMBER	’	num	26	SENT_19	[p1l145t1539r243b1557],
28	;	:	O	;	_	0	SENT_19	[p1l145t1539r243b1557],
29	Hospital	NNP	O	Hospital	nn	30	SENT_19	[p1l250t1537r336b1563],
30	infarction	NN	O	infarction	conj_and	8	SENT_19	[p1l373t1522r527b1554],
31	,	,	O	,	_	0	SENT_19	[p1l373t1522r527b1554],
32	or	CC	O	or	_	0	SENT_19	[p1l536t1532r568b1550],
33	stroke	NN	O	stroke	nn	34	SENT_19	[p1l575t1522r675b1559],
34	)	NN	O	)	prep_between	2	SENT_19	[p1l575t1522r675b1559],
35	until	IN	O	until	_	0	SENT_19	[p1l684t1522r756b1550],
36	15	CD	DURATION	15	num	37	SENT_19	[p1l764t1523r794b1550],
37	months	NNS	NUMBER	month	prep_until	2	SENT_19	[p1l804t1522r927b1550],
38	.	.	O	.	_	0	SENT_19	[p1l804t1522r927b1550],

1	We	PRP	O	we	nsubj	3	SENT_20	[p1l936t1525r985b1550],
2	then	RB	O	then	advmod	3	SENT_20	[p1l992t1522r1060b1550],
3	assessed	VBD	O	assess	_	0	SENT_20	[p1l1068t1522r1196b1550],
4	the	DT	O	the	det	6	SENT_20	[p1l1203t1522r1251b1550],
5	combined	JJ	O	combined	amod	6	SENT_20	[p1l1258t1522r1409b1550],
6	effect	NN	O	effect	iobj	3	SENT_20	[p1l1416t1522r1498b1550],
7	of	IN	O	of	_	0	SENT_20	[p1l1505t1522r1539b1550],
8	ABCB1	NN	O	abcb1	nn	9	SENT_20	[p1l1541t1524r1650b1550],
9	3435C	NN	O	3435c	prep_of	6	SENT_20	[p1l1658t1523r1810b1550],
10	—	CD	NUMBER	—	num	9	SENT_20	[p1l1658t1523r1810b1550],
11	>	JJR	O	>	amod	13	SENT_20	[p1l1658t1523r1810b1550],
12	T	NN	O	t	nn	13	SENT_20	[p1l1658t1523r1810b1550],
13	genotype	NN	O	genotype	dobj	3	SENT_20	[p1l1817t1528r1953b1559],
14	and	CC	O	and	_	0	SENT_20	[p1l1960t1522r2017b1550],
15	reducedand	NN	O	reducedand	nn	18	SENT_20	[p1l2024t1522r2153b1550, p1l38t1573r79b1594],
16	Harvard	NNP	ORGANIZATION	Harvard	nn	18	SENT_20	[p1l86t1573r172b1594],
17	Medical	NNP	ORGANIZATION	Medical	nn	18	SENT_20	[p1l179t1573r261b1594],
18	School	NNP	ORGANIZATION	School	dobj	3	SENT_20	[p1l268t1573r346b1597],
19	,	,	O	,	_	0	SENT_20	[p1l268t1573r346b1597],
20	function	NN	O	function	nn	21	SENT_20	[p1l386t1567r517b1596],
21	alleles	NNS	O	allele	appos	13	SENT_20	[p1l536t1567r630b1596],
22	of	IN	O	of	_	0	SENT_20	[p1l649t1567r684b1596],
23	CYPZCI9	NN	O	cypzci9	prep_of	21	SENT_20	[p1l700t1569r850b1596],
24	.	.	O	.	_	0	SENT_20	[p1l700t1569r850b1596],

1	321	CD	NUMBER	321	num	3	SENT_21	[p1l871t1569r922b1596],
2	healthy	JJ	O	healthy	amod	3	SENT_21	[p1l940t1567r1053b1605],
3	individuals	NNS	O	individual	nsubjpass	6	SENT_21	[p1l1072t1567r1241b1596],
4	were	VBD	O	be	auxpass	6	SENT_21	[p1l1260t1577r1334b1596],
5	also	RB	O	also	advmod	6	SENT_21	[p1l1352t1567r1412b1596],
6	genotyped	VBN	O	genotype	_	0	SENT_21	[p1l1431t1567r1597b1605],
7	,	,	O	,	_	0	SENT_21	[p1l1431t1567r1597b1605],
8	and	CC	O	and	_	0	SENT_21	[p1l1617t1567r1675b1596],
9	we	PRP	O	we	nsubj	10	SENT_21	[p1l1692t1577r1736b1596],
10	tested	VBD	O	test	conj_and	6	SENT_21	[p1l1754t1567r1845b1596],
11	the	DT	O	the	det	12	SENT_21	[p1l1863t1567r1911b1596],
12	association	NN	O	association	dobj	10	SENT_21	[p1l1930t1568r2100b1596],
13	of	IN	O	of	_	0	SENT_21	[p1l2119t1567r2154b1596],
14	genetic	JJ	O	genetic	amod	15	SENT_21	[p1l6t1614r116b1651],
15	Boston	NNP	LOCATION	Boston	prep_of	12	SENT_21	[p1l267t1612r349b1633],
16	,	,	O	,	_	0	SENT_21	[p1l267t1612r349b1633],
17	MA	NNP	LOCATION	MA	appos	15	SENT_21	[p1l356t1611r399b1633],
18	,	,	O	,	_	0	SENT_21	[p1l356t1611r399b1633],
19	USA	NNP	LOCATION	USA	nn	22	SENT_21	[p1l406t1611r451b1630],
20	(	CD	NUMBER	(	num	22	SENT_21	[p1l458t1611r471b1635],
21	J	NNP	O	J	nn	22	SENT_21	[p1l458t1611r471b1635],
22	L	NNP	O	L	appos	17	SENT_21	[p1l479t1612r489b1629],
23	Mega	JJ	O	mega	amod	29	SENT_21	[p1l496t1612r552b1636],
24	MD	NN	O	md	tmod	23	SENT_21	[p1l559t1612r599b1633],
25	,	,	O	,	_	0	SENT_21	[p1l559t1612r599b1633],
26	5	CD	NUMBER	5	number	27	SENT_21	[p1l438t1648r448b1667],
27	D	NN	O	d	amod	24	SENT_21	[p1l456t1648r469b1666],
28	Wiviott	NNP	PERSON	Wiviott	nn	29	SENT_21	[p1l475t1648r552b1667],
29	MD	NNP	O	MD	dep	22	SENT_21	[p1l559t1648r599b1670],
30	,	,	O	,	_	0	SENT_21	[p1l559t1648r599b1670],

1	variants	NNS	O	variant	_	0	SENT_22	[p1l6t1686r127b1714],
2	with	IN	O	with	_	0	SENT_22	[p1l137t1685r205b1714],
3	reduction	NN	O	reduction	prep_with	1	SENT_22	[p1l215t1685r363b1714],
4	in	IN	O	in	_	0	SENT_22	[p1l373t1686r404b1714],
5	maximum	NN	O	maximum	nn	7	SENT_22	[p1l414t1686r576b1714],
6	platelet	NN	O	platelet	nn	7	SENT_22	[p1l585t1685r697b1723],
7	aggregation	NN	O	aggregation	prep_in	1	SENT_22	[p1l706t1686r888b1723],
8	and	CC	O	and	_	0	SENT_22	[p1l897t1685r955b1714],
9	plasma	NN	O	plasma	nn	10	SENT_22	[p1l964t1685r1075b1723],
10	concentrations	NNS	O	concentration	prep_in	1	SENT_22	[p1l1085t1686r1312b1714],
11	of	IN	O	of	_	0	SENT_22	[p1l1323t1685r1358b1714],
12	active	JJ	O	active	amod	14	SENT_22	[p1l1362t1686r1449b1714],
13	drug	NN	O	drug	nn	14	SENT_22	[p1l1459t1685r1532b1723],
14	metabolites	NNS	O	metabolite	prep_of	1	SENT_22	[p1l1541t1685r1727b1714],
15	.	.	O	.	_	0	SENT_22	[p1l1541t1685r1727b1714],

1	Prof	NNP	O	Prof	nn	5	SENT_23	[p1l123t1736r166b1756],
2	E	NNP	O	E	nn	5	SENT_23	[p1l172t1738r182b1756],
3	M	NNP	O	M	nn	5	SENT_23	[p1l189t1738r207b1756],
4	Antman	NNP	PERSON	Antman	nn	5	SENT_23	[p1l214t1738r297b1756],
5	MD	NNP	O	MD	nsubj	14	SENT_23	[p1l306t1738r345b1759],
6	,	,	O	,	_	0	SENT_23	[p1l306t1738r345b1759],
7	Prof	NNP	O	Prof	nn	10	SENT_23	[p1l124t1772r166b1792],
8	E	NNP	O	E	nn	10	SENT_23	[p1l172t1774r182b1792],
9	Braunwald	NNP	PERSON	Braunwald	nn	10	SENT_23	[p1l190t1773r298b1792],
10	MD	NNP	O	MD	appos	5	SENT_23	[p1l306t1774r345b1796],
11	,	,	O	,	_	0	SENT_23	[p1l306t1774r345b1796],
12	*	CD	NUMBER	*	num	13	SENT_23	[p1l45t1420r136b1439],
13	Authors	NNS	O	author	appos	10	SENT_23	[p1l45t1420r136b1439],
14	contributed	VBD	O	contribute	_	0	SENT_23	[p1l142t1420r260b1439],
15	equally	RB	O	equally	advmod	14	SENT_23	[p1l267t1420r337b1445],

1	Findings	NNS	O	finding	_	0	SENT_24	[p1l6t1821r135b1857],
2	In	IN	O	in	dep	1	SENT_24	[p1l146t1823r180b1848],
3	patients	NNS	O	patient	pobj	2	SENT_24	[p1l190t1821r314b1857],
4	treated	VBN	O	treat	partmod	3	SENT_24	[p1l324t1820r432b1849],
5	with	IN	O	with	_	0	SENT_24	[p1l442t1820r511b1849],
6	clopidogrel	NN	O	clopidogrel	prep_with	4	SENT_24	[p1l521t1820r703b1858],
7	,	,	O	,	_	0	SENT_24	[p1l521t1820r703b1858],
8	ABCB1	NN	O	abcb1	nn	9	SENT_24	[p1l714t1822r827b1849],
9	3435C	NN	O	3435c	appos	6	SENT_24	[p1l838t1821r996b1849],
10	—	CD	NUMBER	—	num	12	SENT_24	[p1l838t1821r996b1849],
11	>	JJR	O	>	amod	12	SENT_24	[p1l838t1821r996b1849],
12	T	NN	O	t	tmod	4	SENT_24	[p1l838t1821r996b1849],
13	genotype	NN	O	genotype	nsubjpass	16	SENT_24	[p1l1006t1826r1147b1858],
14	was	VBD	O	be	auxpass	16	SENT_24	[p1l1157t1830r1215b1849],
15	signiﬁcantly	RB	O	signiﬁcantly	advmod	16	SENT_24	[p1l1227t1820r1418b1858],
16	associated	VBN	O	associate	rcmod	12	SENT_24	[p1l1428t1820r1587b1849],
17	with	IN	O	with	_	0	SENT_24	[p1l1596t1820r1665b1849],
18	the	DT	O	the	det	19	SENT_24	[p1l1675t1820r1725b1849],
19	risk	NN	O	risk	prep_with	16	SENT_24	[p1l1735t1820r1794b1849],
20	of	IN	O	of	prep	19	SENT_24	[p1l1804t1820r1839b1849],

1	M	NN	O	m	nn	4	SENT_25	[p1l70t1872r88b1891],
2	5Sabatine	NN	O	5sabatine	nn	4	SENT_25	[p1l98t1871r204b1891],
3	MD	NN	O	md	nn	4	SENT_25	[p1l211t1872r261b1896],
4	)	NN	O	)	_	0	SENT_25	[p1l211t1872r261b1896],
5	;	:	O	;	_	0	SENT_25	[p1l211t1872r261b1896],
6	Indiana	NNP	LOCATION	Indiana	nn	8	SENT_25	[p1l271t1871r352b1891],
7	cardiovascular	JJ	O	cardiovascular	amod	8	SENT_25	[p1l391t1865r616b1894],
8	death	NN	O	death	conj_or	4	SENT_25	[p1l630t1865r724b1899],
9	,	,	O	,	_	0	SENT_25	[p1l630t1865r724b1899],
10	myocardial	JJ	O	myocardial	amod	11	SENT_25	[p1l740t1865r913b1903],
11	infarction	NN	O	infarction	conj_or	4	SENT_25	[p1l928t1865r1089b1899],
12	,	,	O	,	_	0	SENT_25	[p1l928t1865r1089b1899],
13	or	CC	O	or	_	0	SENT_25	[p1l1105t1875r1138b1894],
14	stroke	NN	O	stroke	nn	16	SENT_25	[p1l1153t1865r1248b1894],
15	(	NN	O	(	nn	16	SENT_25	[p1l1265t1868r1445b1903],
16	p	NN	O	p	conj_or	4	SENT_25	[p1l1265t1868r1445b1903],
17	=	JJ	O	=	amod	19	SENT_25	[p1l1265t1868r1445b1903],
18	0-0064	CD	NUMBER	0-0064	tmod	17	SENT_25	[p1l1265t1868r1445b1903],
19	)	NN	O	)	dep	16	SENT_25	[p1l1265t1868r1445b1903],
20	.	.	O	.	_	0	SENT_25	[p1l1265t1868r1445b1903],

1	TT	NN	ORGANIZATION	tt	nn	2	SENT_26	[p1l1461t1867r1507b1894],
2	homozygotes	NNS	O	homozygote	nsubj	3	SENT_26	[p1l1521t1865r1728b1903],
3	had	VBD	O	have	_	0	SENT_26	[p1l1744t1865r1802b1894],
4	a	DT	O	a	det	6	SENT_26	[p1l1816t1875r1832b1894],
5	72	CD	PERCENT	72	num	6	SENT_26	[p1l1849t1867r1915b1895],
6	%	NN	PERCENT	%	dobj	3	SENT_26	[p1l1849t1867r1915b1895],
7	increased	VBD	O	increase	rcmod	6	SENT_26	[p1l1931t1865r2080b1894],
8	risk	NN	O	risk	dobj	7	SENT_26	[p1l2095t1865r2154b1894],
9	of	IN	O	of	_	0	SENT_26	[p1l6t1911r41b1940],
10	the	DT	O	the	det	20	SENT_26	[p1l48t1911r97b1940],
11	University	NNP	O	University	dep	20	SENT_26	[p1l43t1945r159b1970],
12	,	,	O	,	_	0	SENT_26	[p1l43t1945r159b1970],
13	Indianapolis	NNP	LOCATION	Indianapolis	dep	11	SENT_26	[p1l167t1944r306b1970],
14	,	,	O	,	_	0	SENT_26	[p1l167t1944r306b1970],
15	IN	IN	O	in	prep	11	SENT_26	[p1l313t1946r342b1968],
16	,	,	O	,	_	0	SENT_26	[p1l313t1946r342b1968],
17	USA	NNP	LOCATION	USA	dep	20	SENT_26	[p1l6t1982r50b2001],
18	(	CD	NUMBER	(	num	20	SENT_26	[p1l57t1982r76b2006],
19	S	NN	O	s	nn	20	SENT_26	[p1l57t1982r76b2006],
20	L	NN	O	l	prep_of	8	SENT_26	[p1l83t1982r93b2000],
21	Close	JJ	O	close	amod	23	SENT_26	[p1l99t1981r152b2001],
22	PhD	NN	O	phd	nn	23	SENT_26	[p1l160t1981r215b2006],
23	)	NN	O	)	dep	20	SENT_26	[p1l160t1981r215b2006],
24	;	:	O	;	_	0	SENT_26	[p1l160t1981r215b2006],
25	Eli	NNP	ORGANIZATION	Eli	nn	26	SENT_26	[p1l223t1981r246b2000],
26	Lilly	NNP	ORGANIZATION	Lilly	dep	20	SENT_26	[p1l254t1981r297b2007],
27	and	CC	ORGANIZATION	and	_	0	SENT_26	[p1l303t1981r343b2001],
28	Company	NNP	ORGANIZATION	Company	dep	20	SENT_26	[p1l51t2019r159b2043],
29	,	,	O	,	_	0	SENT_26	[p1l51t2019r159b2043],
30	Indianapolis	NNP	LOCATION	Indianapolis	appos	26	SENT_26	[p1l167t2017r306b2043],
31	,	,	O	,	_	0	SENT_26	[p1l167t2017r306b2043],
32	IN	IN	O	in	amod	26	SENT_26	[p1l313t2019r342b2041],
33	,	,	O	,	_	0	SENT_26	[p1l313t2019r342b2041],
34	USA	NNP	LOCATION	USA	nn	36	SENT_26	[p1l6t2055r50b2074],
35	(	CD	NUMBER	(	num	36	SENT_26	[p1l57t2055r76b2079],
36	L	NN	O	l	appos	26	SENT_26	[p1l57t2055r76b2079],
37	Shen	VBN	O	shen	partmod	36	SENT_26	[p1l82t2054r131b2074],
38	PhD	NN	O	phd	nn	45	SENT_26	[p1l140t2054r185b2077],
39	,	,	O	,	_	0	SENT_26	[p1l140t2054r185b2077],
40	S	NN	O	s	dep	45	SENT_26	[p1l193t2055r203b2074],
41	LC	NN	O	lc	nn	45	SENT_26	[p1l211t2054r280b2074],
42	|	CD	NUMBER	|	num	45	SENT_26	[p1l211t2054r280b2074],
43	ose	NN	O	ose	nn	45	SENT_26	[p1l211t2054r280b2074],
44	PhD	NN	O	phd	nn	45	SENT_26	[p1l287t2054r343b2079],
45	)	NN	O	)	dep	37	SENT_26	[p1l287t2054r343b2079],
46	;	:	O	;	_	0	SENT_26	[p1l287t2054r343b2079],

1	primary	JJ	O	primary	amod	2	SENT_27	[p1l6t2155r132b2191],
2	endpoint	NN	O	endpoint	nsubj	9	SENT_27	[p1l141t2154r283b2191],
3	compared	VBN	O	compare	_	0	SENT_27	[p1l293t2154r449b2191],
4	with	IN	O	with	prepc_compared_with	2	SENT_27	[p1l458t2154r527b2183],
5	CT	NN	O	ct	nn	8	SENT_27	[p1l539t2156r594b2191],
6	]	CD	NUMBER	]	num	8	SENT_27	[p1l539t2156r594b2191],
7	CC	NN	O	cc	nn	8	SENT_27	[p1l597t2156r644b2182],
8	individuals	NNS	O	individual	pobj	2	SENT_27	[p1l656t2154r828b2182],
9	(	VBP	O	(	_	0	SENT_27	[p1l841t2154r1064b2192],
10	Kaplan-Meier	JJ	O	kaplan-meier	amod	12	SENT_27	[p1l841t2154r1064b2192],
11	event	NN	O	event	nn	12	SENT_27	[p1l1074t2160r1157b2183],
12	rates	NNS	O	rate	nn	45	SENT_27	[p1l1167t2160r1241b2182],
13	12	CD	NUMBER	12	dep	12	SENT_27	[p1l1253t2157r1298b2182],
14	-	:	O	-	_	0	SENT_27	[p1l1253t2157r1298b2182],
15	9	CD	PERCENT	9	num	16	SENT_27	[p1l1306t2156r1354b2184],
16	%	NN	PERCENT	%	dep	12	SENT_27	[p1l1306t2156r1354b2184],
17	[	CD	NUMBER	[	number	18	SENT_27	[p1l1366t2155r1411b2191],
18	52	CD	NUMBER	52	num	16	SENT_27	[p1l1366t2155r1411b2191],
19	of	IN	O	of	_	0	SENT_27	[p1l1421t2154r1457b2182],
20	414	CD	NUMBER	414	num	21	SENT_27	[p1l1462t2157r1522b2191],
21	]	CD	NUMBER	]	prep_of	16	SENT_27	[p1l1462t2157r1522b2191],
22	vs	CC	O	vs	_	0	SENT_27	[p1l1534t2164r1562b2182],
23	7	CD	NUMBER	7	prep_of	16	SENT_27	[p1l1573t2156r1601b2183],
24	-	:	O	-	_	0	SENT_27	[p1l1573t2156r1601b2183],
25	8	CD	PERCENT	8	num	26	SENT_27	[p1l1609t2156r1657b2184],
26	%	NN	PERCENT	%	dep	12	SENT_27	[p1l1609t2156r1657b2184],
27	[	CD	NUMBER	[	number	28	SENT_27	[p1l1669t2156r1713b2191],
28	80	CD	NUMBER	80	num	26	SENT_27	[p1l1669t2156r1713b2191],
29	of	IN	O	of	_	0	SENT_27	[p1l1724t2154r1760b2182],
30	1057	CD	DATE	1057	num	31	SENT_27	[p1l1766t2155r1836b2183],
31	participants	NNS	O	participant	prep_of	26	SENT_27	[p1l6t2201r208b2237],
32	]	CD	NUMBER	]	dep	26	SENT_27	[p1l6t2201r208b2237],
33	;	:	O	;	_	0	SENT_27	[p1l6t2201r208b2237],
34	HR	NN	DURATION	hr	dep	12	SENT_27	[p1l225t2203r280b2228],
35	1-72	CD	NUMBER	1-72	num	34	SENT_27	[p1l293t2201r370b2233],
36	,	,	O	,	_	0	SENT_27	[p1l293t2201r370b2233],
37	95	CD	PERCENT	95	number	38	SENT_27	[p1l386t2201r454b2230],
38	%	NN	PERCENT	%	amod	39	SENT_27	[p1l386t2201r454b2230],
39	CI	NN	O	ci	appos	34	SENT_27	[p1l469t2202r505b2228],
40	1-22-2-44	CD	NUMBER	1-22-2-44	dep	39	SENT_27	[p1l520t2202r691b2233],
41	,	,	O	,	_	0	SENT_27	[p1l520t2202r691b2233],
42	p	NN	O	p	appos	34	SENT_27	[p1l706t2202r858b2237],
43	=	JJ	O	=	amod	45	SENT_27	[p1l706t2202r858b2237],
44	0-002	CD	NUMBER	0-002	tmod	43	SENT_27	[p1l706t2202r858b2237],
45	)	NN	O	)	dobj	9	SENT_27	[p1l706t2202r858b2237],
46	.	.	O	.	_	0	SENT_27	[p1l706t2202r858b2237],

1	ABCB1	NN	O	abcb1	nn	2	SENT_28	[p1l873t2202r986b2228],
2	3435C	NN	O	3435c	nsubj	13	SENT_28	[p1l999t2201r1158b2228],
3	—	CD	NUMBER	—	num	5	SENT_28	[p1l999t2201r1158b2228],
4	>	JJR	O	>	amod	5	SENT_28	[p1l999t2201r1158b2228],
5	T	NN	O	t	dep	2	SENT_28	[p1l999t2201r1158b2228],
6	and	CC	O	and	_	0	SENT_28	[p1l1171t2200r1229b2228],
7	CYPZCI9	NN	O	cypzci9	nn	8	SENT_28	[p1l1245t2202r1391b2228],
8	genotypes	NNS	O	genotype	dep	2	SENT_28	[p1l1403t2205r1560b2237],
9	were	VBD	O	be	cop	13	SENT_28	[p1l1573t2210r1649b2228],
10	signiﬁcant	JJ	O	signiﬁcant	amod	13	SENT_28	[p1l1663t2200r1835b2237],
11	,	,	O	,	_	0	SENT_28	[p1l1663t2200r1835b2237],
12	independent	JJ	O	independent	amod	13	SENT_28	[p1l6t2246r205b2283],
13	predictors	NNS	O	predictor	_	0	SENT_28	[p1l213t2246r370b2283],
14	of	IN	O	of	_	0	SENT_28	[p1l380t2245r415b2274],
15	the	DT	O	the	det	17	SENT_28	[p1l419t2246r468b2274],
16	primary	JJ	O	primary	amod	17	SENT_28	[p1l477t2247r603b2283],
17	endpoint	NN	O	endpoint	prep_of	13	SENT_28	[p1l611t2246r760b2283],
18	,	,	O	,	_	0	SENT_28	[p1l611t2246r760b2283],
19	and	CC	O	and	_	0	SENT_28	[p1l770t2246r828b2274],
20	681	CD	PERCENT	681	number	21	SENT_28	[p1l838t2248r890b2274],
21	(	CD	PERCENT	(	conj_and	13	SENT_28	[p1l900t2247r988b2283],
22	47	CD	PERCENT	47	num	23	SENT_28	[p1l900t2247r988b2283],
23	%	NN	PERCENT	%	dep	21	SENT_28	[p1l900t2247r988b2283],
24	)	CD	NUMBER	)	dep	13	SENT_28	[p1l900t2247r988b2283],
25	of	IN	O	of	_	0	SENT_28	[p1l999t2245r1035b2274],
26	the	DT	O	the	det	29	SENT_28	[p1l1038t2246r1087b2274],
27	1454	CD	DATE	1454	num	29	SENT_28	[p1l1097t2247r1168b2274],
28	genotyped	JJ	O	genotyped	amod	29	SENT_28	[p1l1177t2246r1338b2283],
29	patients	NNS	O	patient	prep_of	24	SENT_28	[p1l1347t2247r1471b2283],
30	taking	VBG	O	take	partmod	29	SENT_28	[p1l1480t2246r1579b2283],
31	clopidogrel	NN	O	clopidogrel	dobj	30	SENT_28	[p1l1587t2246r1762b2283],
32	who	WP	O	who	dep	35	SENT_28	[p1l1770t2246r1836b2274],
33	Daiichi	NNP	ORGANIZATION	Daiichi	nn	35	SENT_28	[p1l6t2294r78b2315],
34	Sankyo	NNP	ORGANIZATION	Sankyo	nn	35	SENT_28	[p1l88t2294r167b2321],
35	Inc.	NNP	ORGANIZATION	Inc.	rcmod	31	SENT_28	[p1l177t2296r213b2318],
36	.	.	O	.	_	0	SENT_28	[p1l177t2296r213b2318],

1	Edison	NNP	PERSON	Edison	_	0	SENT_29	[p1l225t2294r302b2318],
2	.	.	O	.	_	0	SENT_29	[p1l225t2294r302b2318],

1	NJ	NNP	O	NJ	_	0	SENT_30	[p1l313t2296r342b2320],
2	.	.	O	.	_	0	SENT_30	[p1l313t2296r342b2320],

1	were	VBD	O	be	dep	7	SENT_31	[p1l382t2300r457b2319],
2	either	DT	O	either	det	7	SENT_31	[p1l470t2290r562b2319],
3	C	NN	O	c	nn	7	SENT_31	[p1l576t2292r599b2319],
4	YPZCI9	NN	O	ypzci9	nn	7	SENT_31	[p1l602t2292r722b2319],
5	reduced-function	NN	O	reduced-function	nn	7	SENT_31	[p1l733t2290r1003b2319],
6	allele	NN	O	allele	nn	7	SENT_31	[p1l1016t2290r1096b2319],
7	carriers	NNS	O	carrier	_	0	SENT_31	[p1l1109t2291r1236b2323],
8	,	,	O	,	_	0	SENT_31	[p1l1109t2291r1236b2323],
9	ABCB1	NN	O	abcb1	appos	7	SENT_31	[p1l1250t2292r1362b2319],
10	3435	CD	NUMBER	3435	num	12	SENT_31	[p1l1376t2291r1447b2319],
11	TT	NN	O	tt	nn	12	SENT_31	[p1l1461t2292r1507b2318],
12	homozygotes	NNS	O	homozygote	nsubj	16	SENT_31	[p1l1519t2290r1735b2328],
13	,	,	O	,	_	0	SENT_31	[p1l1519t2290r1735b2328],
14	or	CC	O	or	_	0	SENT_31	[p1l1749t2300r1782b2319],
15	both	DT	O	both	conj_or	12	SENT_31	[p1l1793t2290r1864b2319],
16	were	VBD	O	be	rcmod	9	SENT_31	[p1l1876t2300r1951b2319],
17	at	IN	O	at	_	0	SENT_31	[p1l1964t2296r1992b2319],
18	increased	VBN	O	increase	amod	19	SENT_31	[p1l2005t2290r2154b2319],
19	risk	NN	O	risk	prep_at	16	SENT_31	[p1l6t2336r65b2365],
20	of	IN	O	of	_	0	SENT_31	[p1l74t2336r109b2365],
21	USA	NNP	LOCATION	USA	nn	27	SENT_31	[p1l29t2369r74b2388],
22	(	CD	NUMBER	(	num	21	SENT_31	[p1l81t2369r94b2393],
23	J	NNP	O	J	nn	27	SENT_31	[p1l81t2369r94b2393],
24	R	NNP	O	R	nn	27	SENT_31	[p1l102t2370r114b2388],
25	Walker	NNP	PERSON	Walker	nn	27	SENT_31	[p1l119t2368r190b2388],
26	PharmD	NNP	O	PharmD	nn	27	SENT_31	[p1l196t2368r293b2393],
27	)	NN	O	)	prep_of	19	SENT_31	[p1l196t2368r293b2393],
28	;	:	O	;	_	0	SENT_31	[p1l196t2368r293b2393],
29	and	CC	O	and	_	0	SENT_31	[p1l300t2368r341b2388],
30	Assistance	NNP	ORGANIZATION	Assistance	nn	33	SENT_31	[p1l13t2405r127b2424],
31	Publique-Hépitaux	NNP	ORGANIZATION	Publique-Hépitaux	nn	33	SENT_31	[p1l135t2404r341b2430],
32	de	IN	ORGANIZATION	de	amod	33	SENT_31	[p1l6t2441r31b2461],
33	Paris	NNP	ORGANIZATION	Paris	conj_and	9	SENT_31	[p1l38t2442r95b2464],
34	,	,	O	,	_	0	SENT_31	[p1l38t2442r95b2464],
35	UPMC-Paris06	NN	O	upmc-paris06	appos	33	SENT_31	[p1l102t2441r264b2464],
36	,	,	O	,	_	0	SENT_31	[p1l102t2441r264b2464],
37	France	NNP	LOCATION	France	appos	33	SENT_31	[p1l271t2443r340b2461],
38	(	CD	NUMBER	(	num	42	SENT_31	[p1l150t2477r218b2502],
39	ProfT	NNP	O	ProfT	nn	42	SENT_31	[p1l150t2477r218b2502],
40	Simon	NNP	PERSON	Simon	nn	42	SENT_31	[p1l224t2479r289b2497],
41	MD	NN	O	md	nn	42	SENT_31	[p1l297t2478r340b2502],
42	)	NN	O	)	dep	37	SENT_31	[p1l297t2478r340b2502],

1	the	DT	O	the	det	3	SENT_32	[p1l6t2577r55b2605],
2	primary	JJ	O	primary	amod	3	SENT_32	[p1l65t2578r191b2614],
3	endpoint	NN	O	endpoint	_	0	SENT_32	[p1l199t2577r341b2614],
4	(	CD	NUMBER	(	num	5	SENT_32	[p1l352t2580r417b2614],
5	HR	NN	DURATION	hr	dep	3	SENT_32	[p1l352t2580r417b2614],
6	1	CD	NUMBER	1	dep	5	SENT_32	[p1l427t2580r453b2605],
7	-	:	O	-	_	0	SENT_32	[p1l427t2580r453b2605],
8	97	CD	DATE	97	dep	5	SENT_32	[p1l460t2578r504b2610],
9	,	,	O	,	_	0	SENT_32	[p1l460t2578r504b2610],
10	95	CD	PERCENT	95	number	11	SENT_32	[p1l516t2578r583b2607],
11	%	NN	PERCENT	%	amod	12	SENT_32	[p1l516t2578r583b2607],
12	CI	NN	O	ci	appos	8	SENT_32	[p1l594t2579r630b2605],
13	1	CD	NUMBER	1	dep	12	SENT_32	[p1l641t2579r655b2605],
14	-	:	O	-	_	0	SENT_32	[p1l662t2593r667b2598],
15	38-2	CD	NUMBER	38-2	num	17	SENT_32	[p1l675t2579r748b2605],
16	-	:	O	-	_	0	SENT_32	[p1l755t2593r760b2598],
17	82	CD	DATE	82	dep	5	SENT_32	[p1l768t2579r812b2610],
18	,	,	O	,	_	0	SENT_32	[p1l768t2579r812b2610],
19	p	NN	O	p	nn	21	SENT_32	[p1l822t2579r880b2614],
20	=	JJ	O	=	amod	21	SENT_32	[p1l822t2579r880b2614],
21	o	NN	O	o	appos	17	SENT_32	[p1l822t2579r880b2614],
22	-	:	O	-	_	0	SENT_32	[p1l888t2593r893b2598],
23	0002	CD	DATE	0002	number	24	SENT_32	[p1l900t2579r993b2614],
24	)	CD	NUMBER	)	dep	21	SENT_32	[p1l900t2579r993b2614],
25	.	.	O	.	_	0	SENT_32	[p1l900t2579r993b2614],

1	In	IN	O	in	_	0	SENT_33	[p1l1005t2580r1039b2605],
2	healthy	JJ	O	healthy	amod	3	SENT_33	[p1l1048t2577r1163b2614],
3	participants	NNS	O	participant	prep_in	8	SENT_33	[p1l1172t2578r1365b2614],
4	,	,	O	,	_	0	SENT_33	[p1l1172t2578r1365b2614],
5	3435	CD	NUMBER	3435	num	7	SENT_33	[p1l1377t2578r1449b2605],
6	TT	NN	O	tt	nn	7	SENT_33	[p1l1459t2579r1505b2605],
7	homozygotes	NNS	O	homozygote	nsubj	8	SENT_33	[p1l1514t2577r1721b2614],
8	had	VBD	O	have	_	0	SENT_33	[p1l1731t2577r1789b2605],
9	an	DT	O	a	det	11	SENT_33	[p1l1798t2587r1836b2605],
10	absolute	JJ	O	absolute	amod	11	SENT_33	[p1l6t2622r137b2651],
11	reduction	NN	O	reduction	dobj	8	SENT_33	[p1l150t2622r301b2651],
12	in	IN	O	in	_	0	SENT_33	[p1l314t2624r346b2651],
13	maximum	NN	O	maximum	nn	15	SENT_33	[p1l359t2624r523b2651],
14	platelet	NN	O	platelet	nn	15	SENT_33	[p1l536t2623r650b2660],
15	aggregation	NN	O	aggregation	prep_in	11	SENT_33	[p1l663t2624r847b2660],
16	with	IN	O	with	_	0	SENT_33	[p1l860t2623r929b2651],
17	clopidogrel	NN	O	clopidogrel	prep_with	15	SENT_33	[p1l942t2622r1116b2660],
18	that	WDT	O	that	nsubj	22	SENT_33	[p1l1129t2623r1190b2651],
19	was	VBD	O	be	cop	22	SENT_33	[p1l1202t2633r1260b2651],
20	7-3	CD	NUMBER	7-3	num	22	SENT_33	[p1l1276t2624r1328b2652],
21	percentage	NN	O	percentage	nn	22	SENT_33	[p1l1342t2628r1513b2660],
22	points	NNS	O	point	rcmod	11	SENT_33	[p1l1526t2624r1623b2660],
23	less	JJR	O	less	dep	24	SENT_33	[p1l1637t2623r1694b2651],
24	than	IN	O	than	advmod	22	SENT_33	[p1l1708t2622r1779b2651],
25	for	IN	O	for	_	0	SENT_33	[p1l1792t2622r1837b2651],
26	CT	NNP	O	CT	prep_for	22	SENT_33	[p1l7t2670r63b2706],
27	/	:	O	/	punct	30	SENT_33	[p1l7t2670r63b2706],
28	CC	NN	O	cc	nn	29	SENT_33	[p1l66t2670r113b2697],
29	individuals	NNS	O	individual	nsubj	30	SENT_33	[p1l127t2668r299b2697],
30	(	VBP	O	(	dep	11	SENT_33	[p1l314t2670r492b2706],
31	p	NN	O	p	nsubj	32	SENT_33	[p1l314t2670r492b2706],
32	=	JJ	O	=	xcomp	30	SENT_33	[p1l314t2670r492b2706],
33	0-0127	CD	NUMBER	0-0127	num	34	SENT_33	[p1l314t2670r492b2706],
34	)	NN	O	)	dep	11	SENT_33	[p1l314t2670r492b2706],
35	.	.	O	.	_	0	SENT_33	[p1l314t2670r492b2706],

1	ABCB1	NN	O	abcb1	nn	2	SENT_34	[p1l506t2670r619b2697],
2	genotypes	NNS	O	genotype	nsubjpass	6	SENT_34	[p1l631t2674r787b2706],
3	were	VBD	O	be	auxpass	6	SENT_34	[p1l800t2679r875b2697],
4	not	RB	O	not	neg	6	SENT_34	[p1l888t2674r939b2697],
5	signiﬁcantly	RB	O	signiﬁcantly	advmod	6	SENT_34	[p1l952t2668r1143b2706],
6	associated	VBN	O	associate	_	0	SENT_34	[p1l1155t2668r1315b2697],
7	with	IN	O	with	_	0	SENT_34	[p1l1326t2668r1396b2697],
8	clinical	JJ	O	clinical	prep_with	6	SENT_34	[p1l1409t2668r1520b2697],
9	or	CC	O	or	_	0	SENT_34	[p1l1533t2679r1565b2697],
10	pharmacological	JJ	O	pharmacological	amod	11	SENT_34	[p1l1577t2668r1836b2706],
11	c0	NN	O	c0	prep_with	6	SENT_34	[p1l147t2729r345b2755],
12	,	,	O	,	_	0	SENT_34	[p1l147t2729r345b2755],
13	,	,	O	,	_	0	SENT_34	[p1l147t2729r345b2755],
14	e5p0	NN	O	e5p0	appos	8	SENT_34	[p1l147t2729r345b2755],
15	,	,	O	,	_	0	SENT_34	[p1l147t2729r345b2755],
16	,	,	O	,	_	0	SENT_34	[p1l147t2729r345b2755],
17	de	FW	O	de	appos	8	SENT_34	[p1l147t2729r345b2755],
18	,	,	O	,	_	0	SENT_34	[p1l147t2729r345b2755],
19	,	,	O	,	_	0	SENT_34	[p1l147t2729r345b2755],
20	ceto	NN	O	ceto	appos	8	SENT_34	[p1l147t2729r345b2755],
21	;	:	O	;	_	0	SENT_34	[p1l147t2729r345b2755],
22	outcomes	NNS	O	outcome	dep	8	SENT_34	[p1l397t2720r548b2743],
23	in	IN	O	in	_	0	SENT_34	[p1l573t2715r604b2742],
24	patients	NNS	O	patient	prep_in	22	SENT_34	[p1l628t2715r752b2751],
25	with	IN	O	with	_	0	SENT_34	[p1l776t2714r846b2743],
26	an	DT	O	a	det	29	SENT_34	[p1l870t2724r908b2743],
27	acute	JJ	O	acute	amod	29	SENT_34	[p1l932t2720r1015b2743],
28	coronary	JJ	O	coronary	amod	29	SENT_34	[p1l1039t2724r1177b2752],
29	syndrome	NN	O	syndrome	prep_with	24	SENT_34	[p1l1201t2714r1357b2751],
30	or	CC	O	or	_	0	SENT_34	[p1l1381t2724r1414b2743],
31	healthy	JJ	O	healthy	amod	32	SENT_34	[p1l1437t2714r1552b2751],
32	individuals	NNS	O	individual	conj_or	8	SENT_34	[p1l1576t2714r1749b2743],
33	treated	VBN	O	treat	partmod	32	SENT_34	[p1l1773t2714r1881b2743],
34	with	IN	O	with	_	0	SENT_34	[p1l1904t2714r1974b2743],
35	prasugrel	NN	O	prasugrel	prep_with	33	SENT_34	[p1l1998t2714r2154b2752],
36	,	,	O	,	_	0	SENT_34	[p1l1998t2714r2154b2752],

1	respectively	RB	O	respectively	_	0	SENT_35	[p1l6t2759r193b2797],
2	.	.	O	.	_	0	SENT_35	[p1l6t2759r193b2797],

1	Drjessica	NN	PERSON	drjessica	_	0	SENT_36	[p1l147t2813r240b2836],
2	L	NN	PERSON	l	dep	3	SENT_36	[p1l247t2813r257b2831],
3	Mega	JJ	PERSON	mega	amod	1	SENT_36	[p1l264t2813r320b2838],
4	or	CC	O	or	dep	5	SENT_36	[p1l326t2818r347b2832],
5	Dr	NN	O	dr	dep	3	SENT_36	[p1l6t2850r28b2867],
6	Marc	NNP	PERSON	Marc	nn	8	SENT_36	[p1l35t2850r85b2868],
7	S	NNP	PERSON	S	nn	8	SENT_36	[p1l91t2849r101b2868],
8	Sabatine	NNP	PERSON	Sabatine	dep	5	SENT_36	[p1l108t2848r202b2871],
9	,	,	O	,	_	0	SENT_36	[p1l108t2848r202b2871],
10	Brigham	NNP	ORGANIZATION	Brigham	appos	5	SENT_36	[p1l211t2848r296b2874],
11	and	CC	ORGANIZATION	and	_	0	SENT_36	[p1l304t2848r341b2868],
12	Women	NNP	ORGANIZATION	Women	poss	14	SENT_36	[p1l32t2885r128b2904],
13	's	POS	ORGANIZATION	's	_	0	SENT_36	[p1l32t2885r128b2904],
14	Hospital	NNP	ORGANIZATION	Hospital	conj_and	10	SENT_36	[p1l136t2884r225b2910],
15	,	,	O	,	_	0	SENT_36	[p1l136t2884r225b2910],
16	TIMI	NNP	ORGANIZATION	TIMI	nn	18	SENT_36	[p1l230t2886r275b2904],
17	Study	NNP	ORGANIZATION	Study	nn	18	SENT_36	[p1l283t2884r342b2910],
18	Group	NNP	ORGANIZATION	Group	appos	5	SENT_36	[p1l23t2922r91b2947],
19	,	,	O	,	_	0	SENT_36	[p1l23t2922r91b2947],
20	Cardiovascular	NNP	O	Cardiovascular	nn	21	SENT_36	[p1l98t2921r247b2941],
21	Division	NNP	O	Division	appos	5	SENT_36	[p1l254t2922r341b2944],
22	,	,	O	,	_	0	SENT_36	[p1l254t2922r341b2944],
23	350	CD	NUMBER	350	appos	5	SENT_36	[p1l51t2960r89b2980],
24	Longwood	NNP	ORGANIZATION	Longwood	nn	25	SENT_36	[p1l97t2957r207b2983],
25	Ave	NNP	O	Ave	dep	23	SENT_36	[p1l212t2959r255b2980],
26	,	,	O	,	_	0	SENT_36	[p1l212t2959r255b2980],
27	Boston	NNP	LOCATION	Boston	appos	25	SENT_36	[p1l264t2959r341b2981],
28	,	,	O	,	_	0	SENT_36	[p1l264t2959r341b2981],

1	Interpretation	NN	O	interpretation	nn	2	SENT_37	[p1l8t3059r222b3093],
2	Individuals	NNS	O	individual	nsubj	10	SENT_37	[p1l237t3057r412b3085],
3	with	IN	O	with	_	0	SENT_37	[p1l425t3057r495b3085],
4	the	DT	O	the	det	5	SENT_37	[p1l508t3057r557b3085],
5	ABCB1	NN	O	abcb1	prep_with	2	SENT_37	[p1l570t3059r683b3085],
6	3435	CD	NUMBER	3435	num	8	SENT_37	[p1l696t3058r768b3085],
7	TT	NN	O	tt	nn	8	SENT_37	[p1l782t3059r828b3085],
8	genotype	NN	O	genotype	dep	5	SENT_37	[p1l841t3063r982b3095],
9	have	VBP	O	have	aux	10	SENT_37	[p1l995t3057r1067b3086],
10	reduced	VBN	O	reduce	_	0	SENT_37	[p1l1080t3057r1206b3085],
11	platelet	NN	O	platelet	nn	12	SENT_37	[p1l1219t3057r1333b3094],
12	inhibition	NN	O	inhibition	dobj	10	SENT_37	[p1l1346t3057r1501b3085],
13	and	CC	O	and	_	0	SENT_37	[p1l1515t3057r1573b3085],
14	are	VBP	O	be	conj_and	10	SENT_37	[p1l1586t3067r1634b3085],
15	at	IN	O	at	_	0	SENT_37	[p1l1647t3063r1675b3085],
16	increased	VBN	O	increase	amod	17	SENT_37	[p1l1688t3057r1837b3085],
17	risk	NN	O	risk	prep_at	14	SENT_37	[p1l7t3103r66b3131],
18	of	IN	O	of	_	0	SENT_37	[p1l75t3103r110b3131],
19	recurrent	JJ	O	recurrent	amod	21	SENT_37	[p1l114t3108r261b3131],
20	ischaemic	JJ	O	ischaemic	amod	21	SENT_37	[p1l270t3103r427b3131],
21	events	NNS	O	event	prep_of	17	SENT_37	[p1l436t3108r534b3131],
22	during	IN	O	during	_	0	SENT_37	[p1l545t3103r651b3140],
23	clopidogrel	NN	O	clopidogrel	nn	24	SENT_37	[p1l660t3103r834b3140],
24	treatment	NN	O	treatment	prep_during	21	SENT_37	[p1l843t3108r1005b3131],
25	.	.	O	.	_	0	SENT_37	[p1l843t3108r1005b3131],

1	In	IN	O	in	_	0	SENT_38	[p1l1016t3106r1050b3131],
2	patients	NNS	O	patient	pobj	1	SENT_38	[p1l1059t3104r1183b3140],
3	with	IN	O	with	_	0	SENT_38	[p1l1192t3103r1262b3131],
4	acute	JJ	O	acute	amod	6	SENT_38	[p1l1271t3108r1353b3131],
5	coronary	JJ	O	coronary	amod	6	SENT_38	[p1l1363t3113r1500b3140],
6	syndromes	NNS	O	syndrome	prep_with	2	SENT_38	[p1l1509t3103r1680b3140],
7	who	WP	O	who	nsubj	9	SENT_38	[p1l1690t3103r1756b3131],
8	have	VBP	O	have	aux	9	SENT_38	[p1l1765t3103r1837b3131],
9	undergone	VBN	O	undergo	rcmod	6	SENT_38	[p1l6t3148r177b3186],
10	percutaneous	JJ	O	percutaneous	amod	11	SENT_38	[p1l191t3154r402b3186],
11	intervention	NN	O	intervention	dobj	9	SENT_38	[p1l417t3150r617b3182],
12	,	,	O	,	_	0	SENT_38	[p1l417t3150r617b3182],
13	when	WRB	O	when	advmod	19	SENT_38	[p1l632t3149r719b3177],
14	both	CC	O	both	preconj	15	SENT_38	[p1l733t3149r803b3177],
15	ABCB1	NN	O	abcb1	nsubjpass	19	SENT_38	[p1l817t3151r930b3177],
16	and	CC	O	and	_	0	SENT_38	[p1l943t3149r1002b3177],
17	CYPZCI9	NN	O	cypzci9	conj_and	15	SENT_38	[p1l1019t3151r1165b3177],
18	are	VBP	O	be	auxpass	19	SENT_38	[p1l1177t3159r1224b3177],
19	taken	VBN	O	take	dep	11	SENT_38	[p1l1238t3149r1324b3177],
20	into	IN	O	into	_	0	SENT_38	[p1l1338t3150r1400b3177],
21	account	NN	O	account	prep_into	19	SENT_38	[p1l1414t3154r1544b3182],
22	,	,	O	,	_	0	SENT_38	[p1l1414t3154r1544b3182],
23	nearly	RB	O	nearly	quantmod	24	SENT_38	[p1l1559t3149r1656b3186],
24	half	NN	O	half	appos	21	SENT_38	[p1l1669t3148r1735b3177],
25	of	IN	O	of	_	0	SENT_38	[p1l1744t3148r1779b3177],
26	the	DT	O	the	prep_of	24	SENT_38	[p1l1788t3148r1837b3177],

1	MA	NNP	O	MA	_	0	SENT_39	[p1l186t3198r221b3217],
2	02115	CD	DATE	02115	dep	1	SENT_39	[p1l233t3199r301b3220],
3	.	.	O	.	_	0	SENT_39	[p1l233t3199r301b3220],

1	USA	NNP	LOCATION	USA	nn	2	SENT_40	[p1l314t3198r356b3217],
2	population	NN	O	population	nsubj	3	SENT_40	[p1l398t3192r568b3230],
3	carries	VBZ	O	carry	_	0	SENT_40	[p1l583t3193r686b3221],
4	a	DT	O	a	det	5	SENT_40	[p1l702t3202r718b3221],
5	genotype	NN	O	genotype	dobj	3	SENT_40	[p1l733t3198r874b3230],
6	associated	VBN	O	associate	partmod	5	SENT_40	[p1l889t3192r1048b3221],
7	with	IN	O	with	_	0	SENT_40	[p1l1062t3192r1131b3221],
8	increased	VBN	O	increase	amod	9	SENT_40	[p1l1146t3192r1295b3221],
9	risk	NN	O	risk	prep_with	6	SENT_40	[p1l1310t3192r1369b3221],
10	of	IN	O	of	_	0	SENT_40	[p1l1383t3192r1419b3221],
11	major	JJ	O	major	amod	14	SENT_40	[p1l1422t3193r1516b3230],
12	adverse	JJ	O	adverse	amod	14	SENT_40	[p1l1530t3192r1647b3221],
13	cardiovascular	JJ	O	cardiovascular	amod	14	SENT_40	[p1l1662t3192r1887b3221],
14	events	NNS	O	event	prep_of	9	SENT_40	[p1l1901t3198r1999b3221],
15	while	IN	O	while	mark	16	SENT_40	[p1l2014t3192r2099b3221],
16	on	IN	O	on	dep	14	SENT_40	[p1l2114t3202r2154b3221],
17	standard	NN	O	standard	pobj	16	SENT_40	[p1l6t3238r142b3267],

1	5	CD	NUMBER	5	_	0	SENT_41	[p1l118t3271r345b3296],
2	'	''	O	'	_	0	SENT_41	[p1l118t3271r345b3296],
3	“	CD	NUMBER	“	dep	1	SENT_41	[p1l118t3271r345b3296],
4	°	CD	NUMBER	°	dep	1	SENT_41	[p1l118t3271r345b3296],
5	9	CD	NUMBER	9	rcmod	4	SENT_41	[p1l118t3271r345b3296],
6	"	``	O	"	punct	5	SENT_41	[p1l118t3271r345b3296],
7	‘	NN	O	‘	nn	8	SENT_41	[p1l118t3271r345b3296],
8	@P	NN	O	@p	dep	5	SENT_41	[p1l118t3271r345b3296],
9	"	''	O	"	punct	5	SENT_41	[p1l118t3271r345b3296],
10	t	NN	O	t	nn	12	SENT_41	[p1l118t3271r345b3296],
11	'	''	O	'	_	0	SENT_41	[p1l118t3271r345b3296],
12	“	NN	O	“	dep	5	SENT_41	[p1l118t3271r345b3296],
13	'	''	O	'	_	0	SENT_41	[p1l118t3271r345b3296],
14	5	CD	NUMBER	5	dep	12	SENT_41	[p1l118t3271r345b3296],
15	'	''	O	'	_	0	SENT_41	[p1l118t3271r345b3296],
16	°	NN	O	°	dep	4	SENT_41	[p1l118t3271r345b3296],
17	'	''	O	'	_	0	SENT_41	[p1l118t3271r345b3296],
18	9	CD	NUMBER	9	num	19	SENT_41	[p1l118t3271r345b3296],
19	doses	NNS	O	dose	dep	16	SENT_41	[p1l383t3275r468b3304],
20	of	IN	O	of	_	0	SENT_41	[p1l480t3275r515b3304],
21	clopidogrel	NN	O	clopidogrel	prep_of	19	SENT_41	[p1l520t3275r702b3313],
22	.	.	O	.	_	0	SENT_41	[p1l520t3275r702b3313],

1	msabatine@partners.org	NN	O	msabatine@partners.org	_	0	SENT_42	[p1l73t3307r345b3333],

1	Funding	NNP	O	Funding	nn	2	SENT_43	[p1l354t3368r477b3404],
2	Daiichi	NNP	ORGANIZATION	Daiichi	_	0	SENT_43	[p1l490t3367r602b3396],
3	Sankyo	NNP	ORGANIZATION	Sankyo	nn	5	SENT_43	[p1l615t3367r725b3405],
4	Company	NNP	ORGANIZATION	Company	nn	5	SENT_43	[p1l736t3369r887b3405],
5	Ltd	NNP	ORGANIZATION	Ltd	dep	2	SENT_43	[p1l898t3367r946b3396],
6	and	CC	O	and	_	0	SENT_43	[p1l956t3367r1014b3396],
7	Eli	NNP	PERSON	Eli	nn	8	SENT_43	[p1l1025t3367r1066b3395],
8	Lilly	NNP	PERSON	Lilly	dep	2	SENT_43	[p1l1077t3367r1143b3405],
9	and	CC	O	and	_	0	SENT_43	[p1l1152t3367r1211b3396],
10	Company	NNP	O	Company	conj_and	5	SENT_43	[p1l1221t3369r1376b3405],
11	.	.	O	.	_	0	SENT_43	[p1l1221t3369r1376b3405],

1	Introduction	NN	O	introduction	_	0	SENT_44	[p1l646t3488r1036b3544],

1	In	IN	O	in	_	0	SENT_45	[p1l645t3579r700b3621],
2	patients	NNS	O	patient	prep_in	30	SENT_45	[p1l730t3577r937b3636],
3	presenting	VBG	O	present	conj_and	3	SENT_45	[p1l968t3577r1252b3637],
4	with	IN	O	with	_	0	SENT_45	[p1l1280t3574r1397b3622],
5	acute	JJ	O	acute	amod	7	SENT_45	[p1l1427t3584r1563b3622],
6	coronary	JJ	O	coronary	amod	7	SENT_45	[p1l1594t3591r1825b3637],
7	syndromes	NNS	O	syndrome	prep_with	3	SENT_45	[p1l1856t3574r2142b3637],
8	and	CC	O	and	_	0	SENT_45	[p2l643t25r740b72],
9	in	IN	O	in	_	0	SENT_45	[p2l803t28r855b72],
10	those	DT	O	those	nsubj	11	SENT_45	[p2l918t25r1059b72],
11	undergoing	VBG	O	undergo	prepc_in	3	SENT_45	[p2l1122t25r1430b88],
12	percutaneous	JJ	O	percutaneous	amod	14	SENT_45	[p2l1493t34r1848b87],
13	coronary	JJ	O	coronary	amod	14	SENT_45	[p2l1914t42r2146b87],
14	interventions	NNS	O	intervention	dobj	11	SENT_45	[p2l642t103r990b148],
15	with	IN	O	with	_	0	SENT_45	[p2l1019t100r1136b148],
16	stenting	NN	O	stenting	prep_with	11	SENT_45	[p2l1166t103r1392b163],
17	,	,	O	,	_	0	SENT_45	[p2l1166t103r1392b163],
18	dual	JJ	O	dual	amod	20	SENT_45	[p2l1423t100r1536b148],
19	antiplatelet	JJ	O	antiplatelet	amod	20	SENT_45	[p2l1565t100r1858b162],
20	treatment	NN	O	treatment	nsubj	30	SENT_45	[p2l1885t110r2145b148],
21	with	IN	O	with	_	0	SENT_45	[p2l641t176r757b224],
22	aspirin	NN	O	aspirin	prep_with	20	SENT_45	[p2l789t179r972b238],
23	and	CC	O	and	_	0	SENT_45	[p2l1004t176r1101b224],
24	the	DT	O	the	det	26	SENT_45	[p2l1130t176r1212b224],
25	thienopyridine	NN	O	thienopyridine	nn	26	SENT_45	[p2l1243t176r1633b239],
26	clopidogrel	NN	O	clopidogrel	conj_and	22	SENT_45	[p2l1665t176r1958b239],
27	is	VBZ	O	be	cop	30	SENT_45	[p2l1989t179r2029b224],
28	the	DT	O	the	det	30	SENT_45	[p2l2061t176r2143b224],
29	guideline-approved	JJ	O	guideline-approved	amod	30	SENT_45	[p2l643t253r1151b316],
30	standard	NN	O	standard	_	0	SENT_45	[p2l1222t253r1450b300],
31	of	IN	O	of	_	0	SENT_45	[p2l1520t253r1578b300],
32	care	NN	O	care	prep_of	30	SENT_45	[p2l1639t256r1798b300],
33	.	.	O	.	_	0	SENT_45	[p2l1639t256r1798b300],

1	”	RB	O	”	advmod	7	SENT_46	[p2l1639t256r1798b300],
2	As	IN	O	as	_	0	SENT_46	[p2l1867t256r1933b300],
3	such	JJ	O	such	prep_such_as	7	SENT_46	[p2l2006t253r2141b308],
4	,	,	O	,	_	0	SENT_46	[p2l2006t253r2141b308],
5	clopidogrel	NN	O	clopidogrel	nsubj	7	SENT_46	[p2l643t328r935b391],
6	is	VBZ	O	be	cop	7	SENT_46	[p2l973t331r1013b376],
7	one	CD	NUMBER	one	_	0	SENT_46	[p2l1053t345r1147b376],
8	of	IN	O	of	_	0	SENT_46	[p2l1186t328r1244b376],
9	the	DT	O	the	det	13	SENT_46	[p2l1272t328r1354b376],
10	most	RBS	O	most	advmod	11	SENT_46	[p2l1392t338r1524b376],
11	frequently	RB	O	frequently	advmod	12	SENT_46	[p2l1560t328r1832b391],
12	prescribed	VBN	O	prescribe	amod	13	SENT_46	[p2l1867t328r2145b390],
13	drugs	NNS	O	drug	prep_of	7	SENT_46	[p2l643t404r790b467],
14	worldwide	RB	O	worldwide	advmod	13	SENT_46	[p2l851t404r1139b452],
15	.	.	O	.	_	0	SENT_46	[p2l851t404r1139b452],

1	However	RB	O	however	advmod	8	SENT_47	[p2l1205t409r1447b459],
2	,	,	O	,	_	0	SENT_47	[p2l1205t409r1447b459],
3	the	DT	O	the	det	5	SENT_47	[p2l1509t404r1591b452],
4	pharmacodynamic	JJ	O	pharmacodynamic	amod	5	SENT_47	[p2l1651t404r2144b467],
5	response	NN	O	response	nsubj	8	SENT_47	[p2l642t498r877b543],
6	to	TO	O	to	_	0	SENT_47	[p2l921t490r970b528],
7	clopidogrel	NN	O	clopidogrel	prep_to	5	SENT_47	[p2l1016t481r1308b544],
8	varies	VBZ	O	vary	_	0	SENT_47	[p2l1351t484r1503b528],
9	substantially	RB	O	substantially	advmod	8	SENT_47	[p2l1550t481r1882b543],
10	between	IN	O	between	_	0	SENT_47	[p2l1924t481r2144b528],
11	patients	NNS	O	patient	prep_between	8	SENT_47	[p2l642t559r882b618],
12	}	CD	NUMBER	}	nsubj	23	SENT_47	[p2l642t559r882b618],
13	and	CC	O	and	_	0	SENT_47	[p2l919t556r1016b604],
14	individuals	NNS	O	individual	nsubj	23	SENT_47	[p2l1051t556r1340b604],
15	with	IN	O	with	_	0	SENT_47	[p2l1376t556r1493b604],
16	low	JJ	O	low	amod	18	SENT_47	[p2l1528t556r1621b604],
17	platelet	NN	O	platelet	nn	18	SENT_47	[p2l1655t556r1847b618],
18	inhibition	NN	O	inhibition	prep_with	14	SENT_47	[p2l1881t556r2144b604],
19	during	IN	O	during	_	0	SENT_47	[p2l643t632r820b695],
20	treatment	NN	O	treatment	prep_during	18	SENT_47	[p2l836t642r1096b680],
21	with	IN	O	with	_	0	SENT_47	[p2l1110t632r1227b680],
22	clopidogrel	NN	O	clopidogrel	prep_with	20	SENT_47	[p2l1244t632r1536b695],
23	are	VBP	O	be	rcmod	11	SENT_47	[p2l1554t649r1632b680],
24	at	IN	O	at	_	0	SENT_47	[p2l1650t642r1696b680],
25	increased	VBN	O	increase	amod	26	SENT_47	[p2l1712t632r1963b680],
26	risk	NN	O	risk	prep_at	23	SENT_47	[p2l1979t632r2079b680],
27	of	IN	O	of	_	0	SENT_47	[p2l2095t632r2153b680],
28	cardiovascular	JJ	O	cardiovascular	amod	29	SENT_47	[p2l643t709r1021b756],
29	events	NNS	O	event	prep_of	26	SENT_47	[p2l1055t712r1253b756],
30	.	.	O	.	_	0	SENT_47	[p2l1055t712r1253b756],

1	‘	NN	O	‘	nsubj	19	SENT_48	[p2l1055t712r1253b756],
2	*	CD	NUMBER	*	num	1	SENT_48	[p2l1055t712r1253b756],
3	Prasugrel	NNP	O	Prasugrel	nsubj	7	SENT_48	[p2l1289t709r1539b772],
4	is	VBZ	O	be	cop	7	SENT_48	[p2l1574t712r1615b756],
5	a	DT	O	a	det	7	SENT_48	[p2l1652t726r1678b756],
6	third-generation	JJ	O	third-generation	amod	7	SENT_48	[p2l1712t709r2144b772],
7	thienopyridine	NN	O	thienopyridine	rcmod	1	SENT_48	[p2l641t784r1031b847],
8	that	WDT	O	that	nsubj	9	SENT_48	[p2l1062t784r1164b832],
9	achieves	VBZ	O	achieve	rcmod	7	SENT_48	[p2l1195t784r1413b832],
10	greater	JJR	O	greater	amod	12	SENT_48	[p2l1446t794r1630b847],
11	platelet	NN	O	platelet	nn	12	SENT_48	[p2l1659t784r1851b846],
12	inhibition	NN	O	inhibition	dobj	9	SENT_48	[p2l1881t784r2144b832],
13	with	IN	O	with	_	0	SENT_48	[p2l641t860r757b908],
14	less	JJR	O	less	amod	15	SENT_48	[p2l817t860r914b908],
15	variability	NN	O	variability	prep_with	9	SENT_48	[p2l975t860r1236b923],
16	between	IN	O	between	_	0	SENT_48	[p2l1294t860r1515b908],
17	patients	NNS	O	patient	prep_between	15	SENT_48	[p2l1575t863r1782b922],
18	than	IN	O	than	advmod	19	SENT_48	[p2l1845t860r1964b908],
19	does	VBZ	O	do	_	0	SENT_48	[p2l2025t860r2142b908],
20	clopidogrel	NN	O	clopidogrel	dobj	19	SENT_48	[p2l643t937r966b1000],
21	?	.	O	?	_	0	SENT_48	[p2l643t937r966b1000],

1	In	IN	O	in	_	0	SENT_49	[p2l1009t942r1065b984],
2	the	DT	O	the	det	3	SENT_49	[p2l1104t937r1186b984],
3	Trial	NN	O	trial	pobj	1	SENT_49	[p2l1225t937r1343b984],
4	to	TO	O	to	aux	5	SENT_49	[p2l1382t946r1431b984],
5	Assess	VB	O	assess	infmod	3	SENT_49	[p2l1470t940r1645b984],
6	Improvement	NN	O	improvement	dobj	5	SENT_49	[p2l1690t941r2053b999],
7	in	IN	O	in	prep	5	SENT_49	[p2l2091t940r2144b984],

1	Therapeutic	JJ	O	therapeutic	amod	2	SENT_50	[p2l7t1343r458b1431],
2	Outcomes	NNS	O	outcome	_	0	SENT_50	[p2l486t1348r864b1411],
3	by	IN	O	by	_	0	SENT_50	[p2l890t1343r977b1432],
4	Optimizing	VBG	O	optimize	prepc_by	2	SENT_50	[p2l1003t1347r1434b1432],
5	Platelet	NN	O	platelet	nn	6	SENT_50	[p2l1462t1342r1736b1411],
6	Inhibition	NN	O	inhibition	dobj	4	SENT_50	[p2l1763t1342r2140b1411],
7	with	IN	O	with	_	0	SENT_50	[p2l7t1451r172b1519],
8	Prasugrel	NN	O	prasugrel	prep_with	4	SENT_50	[p2l221t1451r1139b1541],
9	.	.	O	.	_	0	SENT_50	[p2l221t1451r1139b1541],

1	—	NN	O	—	_	0	SENT_51	[p2l221t1451r1139b1541],
2	.	.	O	.	_	0	SENT_51	[p2l221t1451r1139b1541],

1	Thrombolysis	NNP	O	Thrombolysis	_	0	SENT_52	[p2l221t1451r1139b1541],
2	in	IN	O	in	_	0	SENT_52	[p2l1187t1456r1261b1518],
3	Myocardial	JJ	O	myocardial	amod	4	SENT_52	[p2l1309t1451r1720b1541],
4	Infarction	NN	O	infarction	prep_in	1	SENT_52	[p2l1770t1451r2140b1519],
5	(	CD	NUMBER	(	dep	1	SENT_52	[p2l14t1565r634b1651],
6	TRITON	NNP	ORGANIZATION	TRITON	dep	5	SENT_52	[p2l14t1565r634b1651],
7	.	.	O	.	_	0	SENT_52	[p2l14t1565r634b1651],

1	—	NN	O	—	_	0	SENT_53	[p2l14t1565r634b1651],
2	.	.	O	.	_	0	SENT_53	[p2l14t1565r634b1651],

1	TIMI	NNP	ORGANIZATION	TIMI	dep	11	SENT_54	[p2l14t1565r634b1651],
2	)	CD	NUMBER	)	num	3	SENT_54	[p2l14t1565r634b1651],
3	38	CD	NUMBER	38	dep	1	SENT_54	[p2l671t1567r772b1639],
4	,	,	O	,	_	0	SENT_54	[p2l671t1567r772b1639],
5	treatment	NN	O	treatment	nsubj	11	SENT_54	[p2l802t1574r1171b1629],
6	with	IN	O	with	_	0	SENT_54	[p2l1194t1561r1360b1629],
7	prasugrel	NN	O	prasugrel	prep_with	5	SENT_54	[p2l1387t1561r1741b1651],
8	compared	VBN	O	compare	_	0	SENT_54	[p2l1769t1561r2141b1650],
9	with	IN	O	with	prepc_compared_with	7	SENT_54	[p2l7t1669r172b1738],
10	clopidogrel	NN	O	clopidogrel	pobj	7	SENT_54	[p2l206t1669r621b1759],
11	resulted	VBD	O	result	_	0	SENT_54	[p2l654t1669r956b1738],
12	in	IN	O	in	_	0	SENT_54	[p2l988t1674r1063b1736],
13	a	DT	O	a	det	16	SENT_54	[p2l1097t1694r1134b1738],
14	signiﬁcantly	RB	O	signiﬁcantly	advmod	15	SENT_54	[p2l1170t1669r1627b1759],
15	lower	JJR	O	lower	amod	16	SENT_54	[p2l1656t1669r1864b1738],
16	rate	NN	O	rate	prep_in	11	SENT_54	[p2l1895t1683r2035b1738],
17	of	IN	O	of	_	0	SENT_54	[p2l2070t1669r2153b1738],
18	ischaemic	JJ	O	ischaemic	amod	19	SENT_54	[p2l8t1778r384b1846],
19	events	NNS	O	event	prep_of	16	SENT_54	[p2l410t1792r643b1847],
20	and	CC	O	and	_	0	SENT_54	[p2l672t1778r810b1846],
21	more	JJR	O	more	amod	22	SENT_54	[p2l834t1803r1030b1846],
22	bleeding	NN	O	bleeding	conj_and	19	SENT_54	[p2l1055t1778r1423b1868],
23	?	.	O	?	_	0	SENT_54	[p2l1055t1778r1423b1868],

1	Both	DT	O	both	preconj	2	SENT_55	[p2l83t1888r259b1956],
2	clopidogrel	NN	O	clopidogrel	nsubj	6	SENT_55	[p2l283t1888r708b1978],
3	and	CC	O	and	_	0	SENT_55	[p2l733t1888r872b1955],
4	prasugrel	NN	O	prasugrel	conj_and	2	SENT_55	[p2l895t1888r1256b1978],
5	are	VBP	O	be	cop	6	SENT_55	[p2l1281t1912r1393b1955],
6	prodrugs	NNS	O	prodrug	_	0	SENT_55	[p2l1418t1888r1763b1978],
7	that	WDT	O	that	nsubj	8	SENT_55	[p2l1788t1888r1935b1956],
8	need	VBP	O	need	rcmod	6	SENT_55	[p2l1958t1888r2141b1956],
9	intestinal	JJ	O	intestinal	amod	10	SENT_55	[p2l8t1997r366b2066],
10	absorption	NN	O	absorption	dobj	8	SENT_55	[p2l390t1997r797b2086],
11	and	CC	O	and	_	0	SENT_55	[p2l820t1997r960b2066],
12	subsequent	JJ	O	subsequent	amod	13	SENT_55	[p2l983t1997r1421b2086],
13	biotransformation	NN	O	biotransformation	conj_and	10	SENT_55	[p2l1440t1997r2140b2066],
14	to	TO	O	to	_	0	SENT_55	[p2l7t2120r78b2174],
15	active	JJ	O	active	amod	16	SENT_55	[p2l115t2111r328b2174],
16	metabolites	NNS	O	metabolite	prep_to	10	SENT_55	[p2l364t2106r803b2174],
17	by	IN	O	by	_	0	SENT_55	[p2l840t2106r929b2196],
18	cytochrome	NN	O	cytochrome	nn	20	SENT_55	[p2l963t2106r1406b2196],
19	P450	NN	O	p450	nn	20	SENT_55	[p2l1447t2111r1625b2174],
20	enzymes	NNS	O	enzyme	prep_by	8	SENT_55	[p2l1663t2130r2017b2196],
21	.	.	O	.	_	0	SENT_55	[p2l1663t2130r2017b2196],

1	In	IN	O	in	_	0	SENT_56	[p2l2061t2113r2140b2173],
2	several	JJ	O	several	amod	3	SENT_56	[p2l11t2216r270b2284],
3	studies	NNS	O	study	prep_in	18	SENT_56	[p2l326t2216r614b2294],
4	,	,	O	,	_	0	SENT_56	[p2l326t2216r614b2294],
5	reduced-function	JJ	O	reduced-function	amod	7	SENT_56	[p2l671t2216r1329b2284],
6	genetic	JJ	O	genetic	amod	7	SENT_56	[p2l1384t2220r1657b2306],
7	variants	NNS	O	variant	nsubjpass	18	SENT_56	[p2l1708t2220r2008b2284],
8	in	IN	O	in	_	0	SENT_56	[p2l2065t2220r2140b2282],
9	CYPZCI9	NN	O	cypzci9	prep_in	7	SENT_56	[p2l15t2330r369b2393],
10	(	CD	NUMBER	(	num	9	SENT_56	[p2l440t2324r731b2414],
11	located	JJ	O	located	amod	9	SENT_56	[p2l440t2324r731b2414],
12	on	IN	O	on	_	0	SENT_56	[p2l802t2349r896b2393],
13	chromosome	NN	O	chromosome	nn	15	SENT_56	[p2l967t2324r1467b2393],
14	10	CD	NUMBER	10	num	15	SENT_56	[p2l1541t2330r1640b2414],
15	)	NN	O	)	prep_on	11	SENT_56	[p2l1541t2330r1640b2414],
16	have	VBP	O	have	aux	18	SENT_56	[p2l1715t2324r1887b2393],
17	been	VBN	O	be	auxpass	18	SENT_56	[p2l1957t2324r2140b2393],
18	associated	VBN	O	associate	ccomp	27	SENT_56	[p2l9t2433r397b2501],
19	with	IN	O	with	_	0	SENT_56	[p2l435t2433r603b2501],
20	reduced	VBN	O	reduce	amod	21	SENT_56	[p2l644t2433r949b2501],
21	concentrations	NNS	O	concentration	prep_with	18	SENT_56	[p2l989t2438r1551b2501],
22	of	IN	O	of	_	0	SENT_56	[p2l1596t2433r1680b2501],
23	active	JJ	O	active	amod	25	SENT_56	[p2l1709t2438r1921b2501],
24	drug	NN	O	drug	nn	25	SENT_56	[p2l1964t2433r2140b2523],
25	metabolite	NN	O	metabolite	prep_of	21	SENT_56	[p2l8t2543r432b2621],
26	,	,	O	,	_	0	SENT_56	[p2l8t2543r432b2621],
27	diminished	VBD	O	diminish	_	0	SENT_56	[p2l476t2543r914b2611],
28	platelet	NN	O	platelet	nn	29	SENT_56	[p2l952t2543r1230b2632],
29	inhibition	NN	O	inhibition	nsubj	27	SENT_56	[p2l1268t2543r1669b2621],
30	,	,	O	,	_	0	SENT_56	[p2l1268t2543r1669b2621],
31	and	CC	O	and	_	0	SENT_56	[p2l1713t2543r1853b2610],
32	higher	JJR	O	higher	amod	33	SENT_56	[p2l1890t2543r2141b2633],
33	rates	NNS	O	rate	nsubj	27	SENT_56	[p2l8t2665r188b2720],
34	of	IN	O	of	_	0	SENT_56	[p2l226t2651r310b2720],
35	adverse	JJ	O	adverse	amod	37	SENT_56	[p2l334t2651r616b2720],
36	cardiovascular	JJ	O	cardiovascular	amod	37	SENT_56	[p2l654t2651r1202b2720],
37	events	NNS	O	event	prep_of	33	SENT_56	[p2l1236t2665r1473b2720],
38	in	IN	O	in	_	0	SENT_56	[p2l1511t2656r1587b2718],
39	the	DT	O	the	det	40	SENT_56	[p2l1620t2651r1739b2720],
40	setting	NN	O	setting	prep_in	37	SENT_56	[p2l1777t2656r2033b2741],
41	of	IN	O	of	_	0	SENT_56	[p2l2069t2651r2153b2720],
42	treatment	NN	O	treatment	prep_of	40	SENT_56	[p2l7t2773r384b2828],
43	with	IN	O	with	_	0	SENT_56	[p2l408t2760r576b2828],
44	clopidogrel	NN	O	clopidogrel	prep_with	42	SENT_56	[p2l605t2760r1049b2850],
45	,	,	O	,	_	0	SENT_56	[p2l605t2760r1049b2850],
46	but	CC	O	but	_	0	SENT_56	[p2l1079t2760r1206b2828],
47	not	RB	O	not	_	0	SENT_56	[p2l1232t2773r1356b2828],
48	prasugrel	NN	O	prasugrel	conj_negcc	42	SENT_56	[p2l1382t2760r1850b2850],
49	.	.	O	.	_	0	SENT_56	[p2l1382t2760r1850b2850],

1	”	NN	O	”	nsubj	12	SENT_57	[p2l1382t2760r1850b2850],
2	To	TO	O	to	_	0	SENT_57	[p2l1878t2765r1966b2828],
3	that	DT	O	that	det	4	SENT_57	[p2l1994t2760r2141b2828],
4	end	NN	O	end	prep_to	1	SENT_57	[p2l9t2870r168b2948],
5	,	,	O	,	_	0	SENT_57	[p2l9t2870r168b2948],
6	the	DT	O	the	det	8	SENT_57	[p2l241t2870r360b2937],
7	US	NNP	ORGANIZATION	US	nn	8	SENT_57	[p2l435t2875r545b2938],
8	Food	NNP	ORGANIZATION	Food	prep_to	1	SENT_57	[p2l624t2870r807b2938],
9	and	CC	ORGANIZATION	and	_	0	SENT_57	[p2l878t2870r1017b2937],
10	Drug	NNP	ORGANIZATION	Drug	nn	11	SENT_57	[p2l1091t2876r1284b2960],
11	Administration	NNP	ORGANIZATION	Administration	conj_and	4	SENT_57	[p2l1353t2870r1941b2938],
12	has	VBZ	O	have	_	0	SENT_57	[p2l2010t2870r2138b2938],

1	Articles	NNPS	O	Articles	_	0	SENT_58	[p2l6t3439r156b3475],
2	I	PRP	O	I	dep	1	SENT_58	[p2l204t3276r252b3474],

1	vwvw	NN	O	vwvw	_	0	SENT_59	[p2l794t3141r1327b3192],
2	.	.	O	.	_	0	SENT_59	[p2l794t3141r1327b3192],

1	the	DT	O	the	det	2	SENT_60	[p2l794t3141r1327b3192],
2	|	NN	O	|	_	0	SENT_60	[p2l794t3141r1327b3192],
3	ancet.com	NNP	O	ancet.com	nn	4	SENT_60	[p2l794t3141r1327b3192],
4	Vol	NNP	O	Vol	dep	2	SENT_60	[p2l1370t3141r1457b3192],
5	376	CD	NUMBER	376	num	6	SENT_60	[p2l1477t3140r1580b3199],
6	October	NNP	DATE	October	dep	2	SENT_60	[p2l1626t3141r1850b3192],
7	16,2010	CD	DATE	16,2010	num	6	SENT_60	[p2l1867t3140r2111b3201],

1	incorporated	JJ	O	incorporated	_	0	SENT_61	[p3l8t97r496b186],
2	CYPZCI9	NN	O	cypzci9	nn	4	SENT_61	[p3l560t103r912b166],
3	genetic	JJ	O	genetic	amod	4	SENT_61	[p3l967t102r1240b187],
4	information	NN	O	information	dobj	1	SENT_61	[p3l1297t97r1758b166],
5	into	IN	O	into	_	0	SENT_61	[p3l1815t102r1964b166],
6	the	DT	O	the	det	9	SENT_61	[p3l2021t97r2139b166],
7	updated	VBN	O	update	amod	9	SENT_61	[p3l7t206r316b295],
8	clopidogrel	NN	O	clopidogrel	nn	9	SENT_61	[p3l338t206r762b296],
9	label	NN	O	label	prep_into	4	SENT_61	[p3l782t206r961b274],
10	in	IN	O	in	_	0	SENT_61	[p3l983t211r1058b273],
11	the	DT	O	the	det	12	SENT_61	[p3l1079t206r1197b274],
12	form	NN	O	form	prep_in	9	SENT_61	[p3l1219t206r1406b274],
13	of	IN	O	of	_	0	SENT_61	[p3l1429t206r1513b274],
14	a	DT	O	a	det	16	SENT_61	[p3l1523t231r1560b274],
15	boxed	JJ	O	boxed	amod	16	SENT_61	[p3l1580t206r1804b274],
16	warning	NN	O	warning	prep_of	12	SENT_61	[p3l1822t211r2140b296],
17	noting	VBG	O	note	partmod	16	SENT_61	[p3l8t320r257b406],
18	that	IN	O	that	complm	25	SENT_61	[p3l294t316r442b383],
19	carriers	NNS	O	carrier	nsubj	25	SENT_61	[p3l480t320r765b384],
20	of	IN	O	of	_	0	SENT_61	[p3l807t316r891b383],
21	two	CD	NUMBER	two	num	24	SENT_61	[p3l915t329r1049b384],
22	reduced-function	JJ	O	reduced-function	amod	24	SENT_61	[p3l1089t316r1746b384],
23	CYPZCI9	NN	O	cypzci9	nn	24	SENT_61	[p3l1791t321r2144b384],
24	alleles	NNS	O	allele	prep_of	19	SENT_61	[p3l9t425r242b494],
25	have	VBP	O	have	ccomp	17	SENT_61	[p3l271t425r444b494],
26	a	DT	O	a	det	28	SENT_61	[p3l474t450r511b494],
27	diminished	JJ	O	diminished	amod	28	SENT_61	[p3l539t425r978b494],
28	response	NN	O	response	dobj	25	SENT_61	[p3l1004t450r1344b514],
29	to	TO	O	to	_	0	SENT_61	[p3l1371t439r1441b494],
30	standard	JJ	O	standard	amod	31	SENT_61	[p3l1473t425r1803b494],
31	doses	NNS	O	dose	prep_to	1	SENT_61	[p3l1831t425r2037b494],
32	of	IN	O	of	_	0	SENT_61	[p3l2069t425r2153b494],
33	clopidogrel	NN	O	clopidogrel	prep_of	31	SENT_61	[p3l9t534r453b624],
34	.	.	O	.	_	0	SENT_61	[p3l9t534r453b624],

1	Additionally	RB	O	additionally	advmod	14	SENT_62	[p3l78t645r541b734],
2	,	,	O	,	_	0	SENT_62	[p3l78t645r541b734],
3	a	DT	O	a	det	5	SENT_62	[p3l585t669r622b713],
4	key	JJ	O	key	amod	5	SENT_62	[p3l660t645r786b734],
5	protein	NN	O	protein	nsubj	14	SENT_62	[p3l823t649r1091b734],
6	involved	VBN	O	involve	partmod	5	SENT_62	[p3l1131t645r1441b713],
7	in	IN	O	in	_	0	SENT_62	[p3l1479t649r1554b712],
8	thienopyridine	NN	O	thienopyridine	nn	9	SENT_62	[p3l1591t645r2140b734],
9	absorption	NN	O	absorption	prep_in	6	SENT_62	[p3l9t753r406b842],
10	is	VBZ	O	be	cop	14	SENT_62	[p3l446t758r504b822],
11	the	DT	O	the	det	14	SENT_62	[p3l546t753r662b822],
12	eiﬁux	NN	O	eiﬁux	nn	14	SENT_62	[p3l705t753r912b822],
13	pump	NN	O	pump	nn	14	SENT_62	[p3l951t778r1173b842],
14	P-glycoprotein	NN	O	p-glycoprotein	_	0	SENT_62	[p3l1219t753r1770b843],
15	,	,	O	,	_	0	SENT_62	[p3l1219t753r1770b843],
16	which	WDT	O	which	nsubjpass	18	SENT_62	[p3l1813t753r2040b822],
17	is	VBZ	O	be	auxpass	18	SENT_62	[p3l2081t758r2138b822],
18	encoded	VBN	O	encode	rcmod	14	SENT_62	[p3l9t862r319b930],
19	by	IN	O	by	_	0	SENT_62	[p3l361t862r448b951],
20	ABCB1	NN	O	abcb1	nn	21	SENT_62	[p3l490t867r758b930],
21	(	NN	O	(	agent	18	SENT_62	[p3l807t862r972b952],
22	also	RB	O	also	advmod	23	SENT_62	[p3l807t862r972b952],
23	known	VBN	O	know	partmod	21	SENT_62	[p3l1016t862r1272b930],
24	as	IN	O	as	_	0	SENT_62	[p3l1317t886r1389b930],
25	MDR1	NN	O	mdr1	prep_as	23	SENT_62	[p3l1440t868r1693b940],
26	,	,	O	,	_	0	SENT_62	[p3l1440t868r1693b940],
27	located	JJ	O	located	amod	31	SENT_62	[p3l1740t862r2002b930],
28	on	IN	O	on	_	0	SENT_62	[p3l2047t886r2140b930],
29	chromosome	NN	O	chromosome	prep_on	27	SENT_62	[p3l9t972r499b1040],
30	7	CD	NUMBER	7	num	29	SENT_62	[p3l557t976r638b1061],
31	)	NN	O	)	appos	25	SENT_62	[p3l557t976r638b1061],
32	.	.	O	.	_	0	SENT_62	[p3l557t976r638b1061],

1	P-glycoprotein	NN	O	p-glycoprotein	nsubj	6	SENT_63	[p3l705t972r1238b1061],
2	is	VBZ	O	be	cop	6	SENT_63	[p3l1296t976r1354b1040],
3	an	DT	O	a	det	6	SENT_63	[p3l1415t996r1504b1040],
4	ATP-dependent	JJ	O	atp-dependent	amod	6	SENT_63	[p3l1561t971r2142b1060],
5	eiﬁux	NN	O	eiﬁux	nn	6	SENT_63	[p3l9t1081r217b1150],
6	pump	NN	O	pump	_	0	SENT_63	[p3l266t1106r488b1170],
7	that	WDT	O	that	nsubj	8	SENT_63	[p3l539t1081r684b1150],
8	transports	VBZ	O	transport	rcmod	6	SENT_63	[p3l732t1095r1108b1170],
9	various	JJ	O	various	amod	10	SENT_63	[p3l1161t1086r1429b1150],
10	molecules	NNS	O	molecule	dobj	8	SENT_63	[p3l1483t1081r1857b1150],
11	across	IN	O	across	_	0	SENT_63	[p3l1912t1106r2138b1150],
12	extracellular	JJ	O	extracellular	amod	15	SENT_63	[p3l9t1191r463b1259],
13	and	CC	O	and	_	0	SENT_63	[p3l483t1191r620b1259],
14	intracellular	JJ	O	intracellular	conj_and	12	SENT_63	[p3l639t1191r1090b1259],
15	membranes	NNS	O	membrane	prep_across	8	SENT_63	[p3l1109t1191r1574b1259],
16	.	.	O	.	_	0	SENT_63	[p3l1109t1191r1574b1259],

1	It	PRP	O	it	nsubjpass	3	SENT_64	[p3l1603t1198r1657b1259],
2	is	VBZ	O	be	auxpass	3	SENT_64	[p3l1675t1196r1733b1259],
3	expressed	VBN	O	express	_	0	SENT_64	[p3l1757t1191r2137b1280],
4	,	,	O	,	_	0	SENT_64	[p3l1757t1191r2137b1280],
5	among	IN	O	among	_	0	SENT_64	[p3l9t1325r268b1390],
6	other	JJ	O	other	amod	7	SENT_64	[p3l302t1300r497b1369],
7	places	NNS	O	place	prep_among	3	SENT_64	[p3l529t1300r774b1389],
8	,	,	O	,	_	0	SENT_64	[p3l529t1300r774b1389],
9	on	IN	O	on	_	0	SENT_64	[p3l813t1325r906b1369],
10	intestinal	JJ	O	intestinal	amod	12	SENT_64	[p3l940t1300r1287b1369],
11	epithelial	JJ	O	epithelial	amod	12	SENT_64	[p3l1321t1300r1663b1389],
12	cells	NNS	O	cell	prep_on	3	SENT_64	[p3l1698t1300r1877b1379],
13	,	,	O	,	_	0	SENT_64	[p3l1698t1300r1877b1379],
14	where	WRB	O	where	advmod	20	SENT_64	[p3l1912t1300r2140b1369],
15	increased	VBN	O	increase	amod	16	SENT_64	[p3l8t1409r363b1477],
16	expression	NN	O	expression	nsubj	20	SENT_64	[p3l389t1414r784b1498],
17	or	CC	O	or	_	0	SENT_64	[p3l810t1434r887b1477],
18	function	NN	O	function	nsubj	20	SENT_64	[p3l910t1409r1226b1477],
19	can	MD	O	can	aux	20	SENT_64	[p3l1252t1434r1379b1477],
20	affect	VB	O	affect	rcmod	12	SENT_64	[p3l1405t1410r1606b1477],
21	bioavailability	NN	O	bioavailability	dobj	20	SENT_64	[p3l1629t1409r2142b1499],
22	of	IN	O	of	_	0	SENT_64	[p3l9t1518r92b1586],
23	drugs	NNS	O	drug	prep_of	21	SENT_64	[p3l116t1518r323b1608],
24	that	WDT	O	that	nsubj	26	SENT_64	[p3l360t1518r504b1586],
25	are	VBP	O	be	cop	26	SENT_64	[p3l538t1542r649b1586],
26	substrates	NNS	O	substrate	rcmod	23	SENT_64	[p3l687t1518r1077b1586],
27	.	.	O	.	_	0	SENT_64	[p3l687t1518r1077b1586],

1	Previous	JJ	O	previous	amod	2	SENT_65	[p3l1121t1523r1437b1586],
2	research	NN	O	research	nsubj	42	SENT_65	[p3l1474t1518r1788b1586],
3	suggests	VBZ	O	suggest	_	0	SENT_65	[p3l1825t1531r2138b1608],
4	that	IN	O	that	complm	33	SENT_65	[p3l7t1627r152b1696],
5	when	WRB	O	when	advmod	6	SENT_65	[p3l209t1627r414b1696],
6	treated	VBN	O	treat	advcl	33	SENT_65	[p3l474t1628r730b1696],
7	with	IN	O	with	_	0	SENT_65	[p3l787t1628r952b1696],
8	clopidogrel	NN	O	clopidogrel	prep_with	6	SENT_65	[p3l1013t1627r1443b1717],
9	,	,	O	,	_	0	SENT_65	[p3l1013t1627r1443b1717],
10	individuals	NNS	O	individual	nsubj	33	SENT_65	[p3l1508t1627r1915b1696],
11	with	IN	O	with	_	0	SENT_65	[p3l1977t1628r2141b1696],
12	genetic	JJ	O	genetic	amod	13	SENT_65	[p3l10t1741r275b1826],
13	variants	NNS	O	variant	prep_with	10	SENT_65	[p3l301t1741r592b1804],
14	in	IN	O	in	_	0	SENT_65	[p3l624t1741r698b1803],
15	AB	NNP	O	AB	nn	17	SENT_65	[p3l726t1741r840b1803],
16	CB1	NN	O	cb1	nn	17	SENT_65	[p3l851t1741r993b1804],
17	(	NN	O	(	prep_in	13	SENT_65	[p3l1027t1736r1454b1826],
18	speciﬁcally	RB	O	speciﬁcally	advmod	13	SENT_65	[p3l1027t1736r1454b1826],
19	those	DT	O	those	dep	13	SENT_65	[p3l1480t1736r1678b1804],
20	who	WP	O	who	nsubj	23	SENT_65	[p3l1706t1736r1862b1804],
21	are	VBP	O	be	cop	23	SENT_65	[p3l1893t1761r2004b1804],
22	TT	NN	O	tt	nn	23	SENT_65	[p3l2032t1741r2141b1803],
23	homozygotes	NNS	O	homozygote	rcmod	19	SENT_65	[p3l7t1846r499b1936],
24	for	IN	O	for	_	0	SENT_65	[p3l551t1846r657b1913],
25	the	DT	O	the	det	31	SENT_65	[p3l705t1846r820b1914],
26	3435C	NN	O	3435c	npadvmod	28	SENT_65	[p3l875t1850r1244b1914],
27	—	CD	NUMBER	—	num	26	SENT_65	[p3l875t1850r1244b1914],
28	>	JJR	O	>	amod	31	SENT_65	[p3l875t1850r1244b1914],
29	T	NN	O	t	nn	31	SENT_65	[p3l875t1850r1244b1914],
30	variant	JJ	O	variant	amod	31	SENT_65	[p3l1291t1850r1569b1936],
31	)	NN	O	)	prep_for	23	SENT_65	[p3l1291t1850r1569b1936],
32	have	VBP	O	have	aux	33	SENT_65	[p3l1624t1846r1793b1914],
33	reduced	VBN	O	reduce	ccomp	3	SENT_65	[p3l1844t1846r2141b1914],
34	concentrations	NNS	O	concentration	dobj	33	SENT_65	[p3l9t1959r555b2023],
35	of	IN	O	of	_	0	SENT_65	[p3l633t1954r716b2023],
36	the	DT	O	the	det	40	SENT_65	[p3l776t1954r892b2023],
37	active	JJ	O	active	amod	40	SENT_65	[p3l967t1959r1173b2023],
38	drug	NN	O	drug	nn	40	SENT_65	[p3l1249t1955r1423b2044],
39	metabolite	NN	O	metabolite	nn	40	SENT_65	[p3l1497t1954r1929b2023],
40	“	NN	O	“	prep_of	34	SENT_65	[p3l1497t1954r1929b2023],
41	and	CC	O	and	_	0	SENT_65	[p3l2004t1955r2141b2023],
42	increased	VBD	O	increase	conj_and	3	SENT_65	[p3l8t2063r363b2131],
43	rates	NNS	O	rate	dobj	42	SENT_65	[p3l410t2077r584b2131],
44	of	IN	O	of	_	0	SENT_65	[p3l635t2063r718b2131],
45	adverse	JJ	O	adverse	amod	47	SENT_65	[p3l754t2063r1030b2131],
46	clinical	JJ	O	clinical	amod	47	SENT_65	[p3l1079t2063r1342b2131],
47	outcomes	NNS	O	outcome	prep_of	43	SENT_65	[p3l1391t2068r1813b2131],
48	.	.	O	.	_	0	SENT_65	[p3l1391t2068r1813b2131],

1	”	NN	O	”	nn	3	SENT_66	[p3l1391t2068r1813b2131],
2	Further	JJ	O	further	amod	3	SENT_66	[p3l1864t2063r2142b2131],
3	investigation	NN	O	investigation	nsubjpass	41	SENT_66	[p3l8t2177r486b2262],
4	into	IN	O	into	_	0	SENT_66	[p3l535t2177r679b2240],
5	the	DT	O	the	det	6	SENT_66	[p3l727t2172r844b2240],
6	effect	NN	O	effect	prep_into	3	SENT_66	[p3l894t2172r1095b2240],
7	of	IN	O	of	_	0	SENT_66	[p3l1143t2172r1226b2240],
8	this	DT	O	this	det	9	SENT_66	[p3l1260t2172r1396b2240],
9	polymorphism	NN	O	polymorphism	prep_of	6	SENT_66	[p3l1447t2172r1998b2262],
10	on	IN	O	on	_	0	SENT_66	[p3l2047t2197r2140b2240],
11	outcomes	NNS	O	outcome	prep_on	9	SENT_66	[p3l9t2295r366b2350],
12	in	IN	O	in	_	0	SENT_66	[p3l403t2286r476b2348],
13	patients	NNS	O	patient	prep_in	11	SENT_66	[p3l510t2286r802b2371],
14	treated	VBN	O	treat	partmod	13	SENT_66	[p3l837t2282r1093b2350],
15	with	IN	O	with	_	0	SENT_66	[p3l1124t2282r1289b2350],
16	clopidogrel	NN	O	clopidogrel	prep_with	14	SENT_66	[p3l1323t2282r1753b2372],
17	,	,	O	,	_	0	SENT_66	[p3l1323t2282r1753b2372],
18	the	DT	O	the	det	19	SENT_66	[p3l1789t2282r1905b2349],
19	effect	NN	O	effect	prep_on	9	SENT_66	[p3l1941t2282r2141b2349],
20	in	IN	O	in	_	0	SENT_66	[p3l8t2395r83b2457],
21	relation	NN	O	relation	prep_in	19	SENT_66	[p3l104t2390r389b2458],
22	to	TO	O	to	_	0	SENT_66	[p3l409t2404r477b2458],
23	C	NN	O	c	nn	27	SENT_66	[p3l507t2396r561b2458],
24	YPZC	NN	O	ypzc	nn	27	SENT_66	[p3l567t2396r773b2458],
25	19	CD	NUMBER	19	num	27	SENT_66	[p3l778t2397r852b2458],
26	reduced-function	NN	O	reduced-function	nn	27	SENT_66	[p3l870t2390r1509b2458],
27	variants	NNS	O	variant	prep_to	21	SENT_66	[p3l1528t2395r1841b2469],
28	,	,	O	,	_	0	SENT_66	[p3l1528t2395r1841b2469],
29	and	CC	O	and	_	0	SENT_66	[p3l1867t2390r2005b2458],
30	the	DT	O	the	det	31	SENT_66	[p3l2024t2390r2140b2458],
31	effect	NN	O	effect	prep_on	9	SENT_66	[p3l9t2499r211b2567],
32	in	IN	O	in	_	0	SENT_66	[p3l296t2504r370b2566],
33	those	DT	O	those	prep_in	31	SENT_66	[p3l456t2499r654b2567],
34	treated	VBN	O	treat	partmod	33	SENT_66	[p3l741t2499r997b2567],
35	with	IN	O	with	_	0	SENT_66	[p3l1081t2499r1245b2567],
36	the	DT	O	the	det	39	SENT_66	[p3l1331t2499r1447b2567],
37	third-generation	JJ	O	third-generation	amod	39	SENT_66	[p3l1533t2499r2140b2589],
38	thienopyridine	NN	O	thienopyridine	nn	39	SENT_66	[p3l7t2609r556b2698],
39	prasugrel	NN	O	prasugrel	prep_with	34	SENT_66	[p3l581t2609r932b2699],
40	is	VBZ	O	be	auxpass	41	SENT_66	[p3l957t2613r1014b2677],
41	needed	VBN	O	need	_	0	SENT_66	[p3l1042t2609r1326b2677],
42	.	.	O	.	_	0	SENT_66	[p3l1042t2609r1326b2677],

1	We	PRP	O	we	nsubj	2	SENT_67	[p3l78t2724r196b2786],
2	genotyped	VBD	O	genotype	_	0	SENT_67	[p3l241t2717r627b2807],
3	a	DT	O	a	det	4	SENT_67	[p3l670t2742r707b2786],
4	subset	NN	O	subset	dobj	2	SENT_67	[p3l753t2717r991b2786],
5	of	IN	O	of	_	0	SENT_67	[p3l1034t2717r1118b2786],
6	patients	NNS	O	patient	prep_of	4	SENT_67	[p3l1147t2722r1442b2806],
7	in	IN	O	in	_	0	SENT_67	[p3l1488t2722r1562b2784],
8	the	DT	O	the	det	11	SENT_67	[p3l1605t2717r1721b2786],
9	TRITONTIMI	NN	O	tritontimus	nn	11	SENT_67	[p3l1764t2722r2142b2786, p3l7t2830r203b2893],
10	38	CD	NUMBER	38	num	11	SENT_67	[p3l241t2832r323b2894],
11	trial	NN	O	trial	prep_in	2	SENT_67	[p3l353t2826r502b2894],
12	who	WP	O	who	nsubj	13	SENT_67	[p3l530t2826r687b2894],
13	provided	VBD	O	provide	rcmod	11	SENT_67	[p3l718t2826r1046b2915],
14	samples	NNS	O	sample	dobj	13	SENT_67	[p3l1077t2826r1379b2915],
15	for	IN	O	for	_	0	SENT_67	[p3l1411t2826r1518b2894],
16	genetic	JJ	O	genetic	amod	17	SENT_67	[p3l1547t2831r1814b2916],
17	analysis	NN	O	analysis	prep_for	13	SENT_67	[p3l1845t2826r2138b2915],
18	with	IN	O	with	_	0	SENT_67	[p3l7t2936r172b3004],
19	the	DT	O	the	det	20	SENT_67	[p3l212t2936r328b3004],
20	aim	NN	O	aim	prep_with	13	SENT_67	[p3l371t2940r513b3004],
21	of	IN	O	of	_	0	SENT_67	[p3l555t2935r638b3004],
22	assessing	VBG	O	assess	prepc_of	20	SENT_67	[p3l667t2940r1020b3025],
23	the	DT	O	the	det	24	SENT_67	[p3l1059t2935r1176b3004],
24	association	NN	O	association	dep	32	SENT_67	[p3l1219t2940r1631b3004],
25	between	IN	O	between	_	0	SENT_67	[p3l1671t2935r1983b3004],
26	the	DT	O	the	det	27	SENT_67	[p3l2023t2936r2139b3004],
27	ABCB1	NN	O	abcb1	prep_between	24	SENT_67	[p3l7t3050r276b3113],
28	3435C	NN	O	3435c	dep	32	SENT_67	[p3l332t3049r704b3113],
29	—	CD	NUMBER	—	num	28	SENT_67	[p3l332t3049r704b3113],
30	>	JJR	O	>	amod	32	SENT_67	[p3l332t3049r704b3113],
31	T	NN	O	t	nn	32	SENT_67	[p3l332t3049r704b3113],
32	polymorphism	NN	O	polymorphism	dep	22	SENT_67	[p3l755t3044r1310b3134],
33	and	CC	O	and	_	0	SENT_67	[p3l1364t3044r1502b3113],
34	adverse	JJ	O	adverse	amod	36	SENT_67	[p3l1555t3044r1832b3113],
35	cardiovascular	JJ	O	cardiovascular	amod	36	SENT_67	[p3l1888t3044r2138b3113, p3l7t3153r314b3221],
36	outcomes	NNS	O	outcome	dep	22	SENT_67	[p3l345t3166r704b3221],
37	during	IN	O	during	_	0	SENT_67	[p3l740t3153r991b3243],
38	treatment	NN	O	treatment	prep_during	22	SENT_67	[p3l1022t3166r1391b3221],
39	with	IN	O	with	_	0	SENT_67	[p3l1419t3153r1585b3221],
40	clopidogrel	NN	O	clopidogrel	prep_with	38	SENT_67	[p3l1617t3153r2032b3243],
41	or	CC	O	or	_	0	SENT_67	[p3l2065t3177r2141b3221],
42	prasugrel	NN	O	prasugrel	prep_with	38	SENT_67	[p3l8t3262r381b3352],
43	.	.	O	.	_	0	SENT_67	[p3l8t3262r381b3352],

1	To	TO	O	to	aux	2	SENT_68	[p3l429t3267r516b3331],
2	obtain	VB	O	obtain	purpcl	11	SENT_68	[p3l564t3262r798b3331],
3	supporting	VBG	O	support	xcomp	2	SENT_68	[p3l846t3267r1254b3352],
4	pharmacological	JJ	O	pharmacological	amod	5	SENT_68	[p3l1299t3262r1919b3352],
5	data	NNS	O	datum	dobj	3	SENT_68	[p3l1965t3262r2136b3341],
6	,	,	O	,	_	0	SENT_68	[p3l1965t3262r2136b3341],
7	ABCB1	NN	O	abcb1	nn	8	SENT_68	[p3l7t3376r276b3439],
8	genotyping	NN	O	genotyping	nsubjpass	11	SENT_68	[p3l308t3376r725b3461],
9	was	VBD	O	be	auxpass	11	SENT_68	[p3l755t3395r893b3439],
10	also	RB	O	also	advmod	11	SENT_68	[p3l928t3371r1071b3439],
11	done	VBN	O	do	_	0	SENT_68	[p3l1104t3371r1285b3439],
12	in	IN	O	in	_	0	SENT_68	[p3l1317t3376r1392b3438],
13	healthy	JJ	O	healthy	amod	14	SENT_68	[p3l1422t3371r1697b3461],
14	individuals	NNS	O	individual	prep_in	11	SENT_68	[p3l1726t3371r2138b3439],
15	in	IN	O	in	_	0	SENT_68	[p3l8t3485r83b3547],
16	whom	WP	O	whom	rel	23	SENT_68	[p3l133t3480r371b3548],
17	platelet	NN	O	platelet	nn	18	SENT_68	[p3l422t3480r694b3569],
18	inhibition	NN	O	inhibition	nsubjpass	23	SENT_68	[p3l744t3480r1118b3548],
19	and	CC	O	and	_	0	SENT_68	[p3l1170t3480r1308b3548],
20	drug	NN	O	drug	nn	21	SENT_68	[p3l1360t3480r1534b3570],
21	concentrations	NNS	O	concentration	conj_and	18	SENT_68	[p3l1587t3485r2138b3548],
22	were	VBD	O	be	auxpass	23	SENT_68	[p3l7t3614r184b3658],
23	measured	VBN	O	measure	rcmod	14	SENT_68	[p3l220t3590r591b3658],
24	in	IN	O	in	_	0	SENT_68	[p3l624t3594r698b3656],
25	response	NN	O	response	prep_in	23	SENT_68	[p3l732t3614r1066b3678],
26	to	TO	O	to	_	0	SENT_68	[p3l1100t3603r1168b3658],
27	clopidogrel	NN	O	clopidogrel	prep_to	23	SENT_68	[p3l1205t3589r1620b3679],
28	or	CC	O	or	_	0	SENT_68	[p3l1655t3614r1732b3658],
29	prasugrel	NN	O	prasugrel	conj_or	27	SENT_68	[p3l1764t3590r2136b3679],
30	.	.	O	.	_	0	SENT_68	[p3l1764t3590r2136b3679],

1	We	PRP	O	we	nsubj	3	SENT_69	[p3l7t3705r125b3766],
2	also	RB	O	also	advmod	3	SENT_69	[p3l144t3698r287b3766],
3	assessed	VBD	O	assess	_	0	SENT_69	[p3l307t3698r626b3766],
4	the	DT	O	the	det	5	SENT_69	[p3l641t3698r758b3766],
5	contribution	NN	O	contribution	dobj	3	SENT_69	[p3l777t3698r1243b3766],
6	of	IN	O	of	_	0	SENT_69	[p3l1261t3698r1344b3766],
7	the	DT	O	the	det	10	SENT_69	[p3l1347t3698r1464b3766],
8	AB	NNP	O	AB	nn	10	SENT_69	[p3l1481t3703r1596b3765],
9	CB1	NN	O	cb1	nn	10	SENT_69	[p3l1606t3703r1750b3766],
10	3435C	NN	O	3435c	prep_of	5	SENT_69	[p3l1770t3703r2141b3766],
11	—	CD	NUMBER	—	num	13	SENT_69	[p3l1770t3703r2141b3766],
12	>	JJR	O	>	amod	13	SENT_69	[p3l1770t3703r2141b3766],
13	T	NN	O	t	dep	10	SENT_69	[p3l1770t3703r2141b3766],

1	polymorphism	NN	O	polymorphism	_	0	SENT_70	[p4l8t28r563b117],
2	in	IN	O	in	_	0	SENT_70	[p4l622t32r696b95],
3	the	DT	O	the	det	4	SENT_70	[p4l754t28r870b96],
4	context	NN	O	context	prep_in	1	SENT_70	[p4l930t41r1198b96],
5	of	IN	O	of	_	0	SENT_70	[p4l1256t28r1339b96],
6	CYPZCI9	NN	O	cypzci9	nn	7	SENT_70	[p4l1392t33r1739b96],
7	status	NN	O	status	prep_of	4	SENT_70	[p4l1797t41r2010b96],
8	to	TO	O	to	aux	9	SENT_70	[p4l2070t41r2139b96],
9	elucidate	VB	O	elucidate	infmod	1	SENT_70	[p4l9t137r342b206],
10	the	DT	O	the	det	12	SENT_70	[p4l392t137r508b206],
11	independent	JJ	O	independent	amod	12	SENT_70	[p4l559t138r1034b226],
12	contribution	NN	O	contribution	dobj	9	SENT_70	[p4l1084t138r1550b206],
13	of	IN	O	of	_	0	SENT_70	[p4l1601t137r1684b206],
14	variants	NNS	O	variant	prep_of	12	SENT_70	[p4l1719t142r2013b206],
15	in	IN	O	in	_	0	SENT_70	[p4l2066t142r2140b205],
16	these	DT	O	these	det	18	SENT_70	[p4l7t246r203b314],
17	two	CD	NUMBER	two	num	18	SENT_70	[p4l228t260r360b314],
18	genes	NNS	O	gene	prep_in	14	SENT_70	[p4l389t270r621b336],
19	.	.	O	.	_	0	SENT_70	[p4l389t270r621b336],

1	Methods	NNS	O	method	nn	2	SENT_71	[p4l13t454r401b533],
2	Patients	NNS	O	patient	_	0	SENT_71	[p4l13t576r322b642],
3	The	DT	O	the	det	4	SENT_71	[p4l7t683r151b751],
4	design	NN	O	design	dep	2	SENT_71	[p4l178t683r424b773],
5	and	CC	O	and	_	0	SENT_71	[p4l451t683r589b751],
6	primary	JJ	O	primary	amod	7	SENT_71	[p4l613t688r913b773],
7	results	NNS	O	result	dep	2	SENT_71	[p4l938t683r1185b751],
8	of	IN	O	of	_	0	SENT_71	[p4l1214t683r1297b751],
9	the	DT	O	the	det	10	SENT_71	[p4l1309t683r1425b751],
10	TRITON	NNP	ORGANIZATION	TRITON	prep_of	2	SENT_71	[p4l1450t688r2024b751],
11	.	.	O	.	_	0	SENT_71	[p4l1450t688r2024b751],

1	—	NN	O	—	_	0	SENT_72	[p4l1450t688r2024b751],
2	.	.	O	.	_	0	SENT_72	[p4l1450t688r2024b751],

1	TIMI	NNP	ORGANIZATION	TIMI	nsubjpass	21	SENT_73	[p4l1450t688r2024b751],
2	38	CD	NUMBER	38	num	3	SENT_73	[p4l2057t689r2139b751],
3	trial	NN	O	trial	nsubjpass	6	SENT_73	[p4l7t794r157b862],
4	have	VBP	O	have	aux	6	SENT_73	[p4l183t794r353b862],
5	been	VBN	O	be	auxpass	6	SENT_73	[p4l381t794r562b862],
6	described	VBN	O	describe	rcmod	1	SENT_73	[p4l591t794r949b862],
7	previously	RB	DATE	previously	advmod	14	SENT_73	[p4l975t794r1397b883],
8	.6	CD	NUMBER	.6	num	9	SENT_73	[p4l975t794r1397b883],
9	Patients	NNS	O	patient	pobj	7	SENT_73	[p4l1429t798r1722b862],
10	with	IN	O	with	_	0	SENT_73	[p4l1751t794r1916b862],
11	acute	JJ	O	acute	amod	13	SENT_73	[p4l1945t807r2139b862],
12	coronary	JJ	O	coronary	amod	13	SENT_73	[p4l9t928r337b993],
13	syndromes	NNS	O	syndrome	prep_with	7	SENT_73	[p4l374t903r781b993],
14	undergoing	VBG	O	undergo	ccomp	6	SENT_73	[p4l819t903r1258b993],
15	planned	VBN	O	plan	dep	14	SENT_73	[p4l1294t903r1599b992],
16	percutaneous	JJ	O	percutaneous	amod	18	SENT_73	[p4l1634t917r2138b992],
17	coronary	JJ	O	coronary	amod	18	SENT_73	[p4l9t1037r337b1102],
18	interventions	NNS	O	intervention	dobj	15	SENT_73	[p4l410t1017r905b1080],
19	were	VBD	O	be	auxpass	21	SENT_73	[p4l980t1037r1158b1080],
20	randomly	RB	O	randomly	advmod	21	SENT_73	[p4l1234t1012r1596b1102],
21	allocated	VBN	O	allocate	_	0	SENT_73	[p4l1670t1012r1997b1080],
22	to	TO	O	to	_	0	SENT_73	[p4l2070t1026r2139b1080],
23	treatment	NN	O	treatment	prep_to	21	SENT_73	[p4l7t1135r377b1190],
24	with	IN	O	with	_	0	SENT_73	[p4l393t1122r559b1190],
25	clopidogrel	NN	O	clopidogrel	nn	26	SENT_73	[p4l579t1122r995b1212],
26	(	NN	O	(	prep_with	23	SENT_73	[p4l1021t1128r1173b1212],
27	300	CD	NUMBER	300	num	30	SENT_73	[p4l1021t1128r1173b1212],
28	mg	NN	O	mg	nn	30	SENT_73	[p4l1194t1146r1316b1212],
29	loading	NN	O	loading	nn	30	SENT_73	[p4l1334t1122r1614b1212],
30	dose	NN	O	dose	dobj	21	SENT_73	[p4l1635t1122r1802b1189],
31	followed	VBN	O	follow	partmod	30	SENT_73	[p4l1823t1122r2141b1190],
32	by	IN	O	by	_	0	SENT_73	[p4l7t1230r94b1320],
33	75	CD	NUMBER	75	num	34	SENT_73	[p4l113t1235r190b1301],
34	mg	NN	O	mg	agent	31	SENT_73	[p4l215t1255r337b1320],
35	daily	JJ	SET	daily	amod	36	SENT_73	[p4l359t1230r555b1320],
36	)	NN	O	)	dep	34	SENT_73	[p4l359t1230r555b1320],
37	or	CC	O	or	_	0	SENT_73	[p4l583t1255r660b1299],
38	prasugrel	NN	O	prasugrel	agent	31	SENT_73	[p4l679t1230r1033b1320],
39	(	CD	NUMBER	(	num	38	SENT_73	[p4l1060t1236r1168b1320],
40	60	CD	NUMBER	60	num	43	SENT_73	[p4l1060t1236r1168b1320],
41	mg	NN	O	mg	nn	43	SENT_73	[p4l1190t1255r1312b1320],
42	loading	NN	O	loading	nn	43	SENT_73	[p4l1332t1230r1611b1320],
43	dose	NN	O	dose	dep	38	SENT_73	[p4l1634t1230r1801b1299],
44	followed	VBN	O	follow	_	0	SENT_73	[p4l1823t1230r2141b1299],
45	by	IN	O	by	prepc_followed_by	21	SENT_73	[p4l7t1339r94b1429],
46	10	CD	NUMBER	10	num	47	SENT_73	[p4l127t1345r201b1407],
47	mg	NN	O	mg	nn	49	SENT_73	[p4l233t1363r355b1429],
48	daily	JJ	SET	daily	amod	49	SENT_73	[p4l387t1339r583b1429],
49	)	NN	O	)	pobj	21	SENT_73	[p4l387t1339r583b1429],
50	for	IN	O	for	_	0	SENT_73	[p4l620t1339r726b1407],
51	up	RB	DURATION	up	quantmod	53	SENT_73	[p4l755t1363r851b1428],
52	to	TO	DURATION	to	dep	53	SENT_73	[p4l882t1352r951b1407],
53	15	CD	DURATION	15	num	54	SENT_73	[p4l987t1343r1058b1407],
54	months	NNS	NUMBER	month	prep_for	49	SENT_73	[p4l1093t1339r1400b1407],
55	.	.	O	.	_	0	SENT_73	[p4l1093t1339r1400b1407],

1	We	PRP	O	we	nsubj	2	SENT_74	[p4l1435t1346r1552b1408],
2	undertook	VBD	O	undertake	_	0	SENT_74	[p4l1583t1339r1973b1407],
3	this	DT	O	this	det	5	SENT_74	[p4l2001t1339r2138b1407],
4	pharmacogenetic	JJ	O	pharmacogenetic	amod	5	SENT_74	[p4l8t1449r655b1539],
5	analysis	NN	O	analysis	dobj	2	SENT_74	[p4l681t1449r973b1538],
6	in	IN	O	in	_	0	SENT_74	[p4l999t1453r1074b1515],
7	a	DT	O	a	det	8	SENT_74	[p4l1099t1473r1136b1516],
8	TRITON	NNP	ORGANIZATION	TRITON	prep_in	2	SENT_74	[p4l1159t1453r1732b1517],
9	.	.	O	.	_	0	SENT_74	[p4l1159t1453r1732b1517],

1	—	NN	O	—	_	0	SENT_75	[p4l1159t1453r1732b1517],
2	.	.	O	.	_	0	SENT_75	[p4l1159t1453r1732b1517],

1	TIMI	NNP	ORGANIZATION	TIMI	nn	4	SENT_76	[p4l1159t1453r1732b1517],
2	38	CD	NUMBER	38	num	1	SENT_76	[p4l1765t1455r1847b1517],
3	genetic	JJ	O	genetic	amod	4	SENT_76	[p4l1873t1453r2140b1539],
4	substudy	NN	O	substudy	nsubj	18	SENT_76	[p4l11t1557r347b1647],
5	that	WDT	O	that	nsubj	6	SENT_76	[p4l373t1557r518b1626],
6	included	VBD	O	include	rcmod	4	SENT_76	[p4l546t1557r872b1626],
7	2932	CD	NUMBER	2932	num	8	SENT_76	[p4l903t1564r1074b1626],
8	patients	NNS	O	patient	dobj	6	SENT_76	[p4l1106t1562r1400b1646],
9	who	WP	O	who	nsubj	16	SENT_76	[p4l1430t1557r1587b1626],
10	both	DT	O	both	dep	11	SENT_76	[p4l1616t1557r1785b1626],
11	provided	VBD	O	provide	rcmod	8	SENT_76	[p4l1814t1557r2141b1646],
12	a	DT	O	a	det	14	SENT_76	[p4l9t1690r47b1734],
13	genetic	JJ	O	genetic	amod	14	SENT_76	[p4l79t1671r346b1756],
14	sample	NN	O	sample	dobj	11	SENT_76	[p4l379t1666r644b1755],
15	and	CC	O	and	_	0	SENT_76	[p4l677t1666r815b1734],
16	had	VBD	O	have	rcmod	8	SENT_76	[p4l843t1666r983b1734],
17	ABCB1	NN	O	abcb1	dobj	16	SENT_76	[p4l1011t1671r1281b1734],
18	genotyped	VBD	O	genotype	_	0	SENT_76	[p4l1311t1666r1696b1756],
19	(	CD	NUMBER	(	num	20	SENT_76	[p4l1732t1670r2004b1756],
20	n	NN	O	n	dobj	18	SENT_76	[p4l1732t1670r2004b1756],
21	=	JJ	O	=	amod	20	SENT_76	[p4l1732t1670r2004b1756],
22	1471	CD	DATE	1471	tmod	21	SENT_76	[p4l1732t1670r2004b1756],
23	for	IN	O	for	_	0	SENT_76	[p4l2035t1666r2141b1734],
24	clopidogrel	NN	O	clopidogrel	prep_for	21	SENT_76	[p4l9t1775r425b1865],
25	and	CC	O	and	_	0	SENT_76	[p4l470t1775r608b1844],
26	n	NN	O	n	prep_for	21	SENT_76	[p4l651t1782r907b1844],
27	=	JJ	O	=	amod	20	SENT_76	[p4l651t1782r907b1844],
28	1461	CD	DATE	1461	tmod	27	SENT_76	[p4l651t1782r907b1844],
29	for	IN	O	for	_	0	SENT_76	[p4l951t1775r1058b1844],
30	prasugrel	NN	O	prasugrel	nn	31	SENT_76	[p4l1100t1776r1500b1865],
31	)	NN	O	)	prep_for	18	SENT_76	[p4l1100t1776r1500b1865],
32	.	.	O	.	_	0	SENT_76	[p4l1100t1776r1500b1865],

1	This	DT	O	this	det	2	SENT_77	[p4l1547t1776r1710b1844],
2	study	NN	O	study	nsubjpass	4	SENT_77	[p4l1759t1775r1959b1865],
3	was	VBD	O	be	auxpass	4	SENT_77	[p4l1999t1800r2138b1844],
4	approved	VBN	O	approve	_	0	SENT_77	[p4l9t1884r352b1973],
5	by	IN	O	by	_	0	SENT_77	[p4l404t1884r492b1974],
6	institutional	JJ	O	institutional	amod	8	SENT_77	[p4l545t1884r1002b1953],
7	review	NN	O	review	nn	8	SENT_77	[p4l1056t1889r1301b1953],
8	boards	NNS	O	board	agent	4	SENT_77	[p4l1352t1884r1622b1962],
9	,	,	O	,	_	0	SENT_77	[p4l1352t1884r1622b1962],
10	and	CC	O	and	_	0	SENT_77	[p4l1681t1884r1819b1953],
11	written	VBN	O	write	amod	13	SENT_77	[p4l1872t1889r2140b1953],
12	informed	JJ	O	informed	amod	13	SENT_77	[p4l8t1994r360b2062],
13	consent	NN	O	consent	nsubjpass	15	SENT_77	[p4l386t2007r678b2062],
14	was	VBD	O	be	auxpass	15	SENT_77	[p4l700t2018r838b2062],
15	obtained	VBN	O	obtain	conj_and	4	SENT_77	[p4l867t1994r1191b2062],
16	from	IN	O	from	_	0	SENT_77	[p4l1216t1994r1400b2062],
17	all	DT	O	all	det	18	SENT_77	[p4l1427t1994r1512b2062],
18	participants	NNS	O	participant	prep_from	15	SENT_77	[p4l1536t1999r1998b2083],
19	.	.	O	.	_	0	SENT_77	[p4l1536t1999r1998b2083],

1	I-Iealthy	NN	O	i-iealthy	nn	2	SENT_78	[p4l83t2103r382b2193],
2	participants	NNS	O	participant	nsubj	6	SENT_78	[p4l471t2108r923b2192],
3	in	IN	O	in	_	0	SENT_78	[p4l1017t2108r1093b2170],
4	seven	CD	NUMBER	seven	num	5	SENT_78	[p4l1187t2128r1399b2172],
5	studies	NNS	O	study	prep_in	2	SENT_78	[p4l1493t2104r1759b2172],
6	(	VBP	O	(	_	0	SENT_78	[p4l1859t2110r2134b2193],
7	n	NN	O	n	nsubjpass	22	SENT_78	[p4l1859t2110r2134b2193],
8	=	JJ	O	=	dep	22	SENT_78	[p4l1859t2110r2134b2193],
9	321	CD	NUMBER	321	num	10	SENT_78	[p4l1859t2110r2134b2193],
10	)	NN	O	)	nsubjpass	22	SENT_78	[p4l1859t2110r2134b2193],
11	involving	VBG	O	involve	partmod	10	SENT_78	[p4l8t2212r363b2302],
12	treatment	NN	O	treatment	dobj	11	SENT_78	[p4l407t2226r784b2280],
13	with	IN	O	with	_	0	SENT_78	[p4l826t2212r995b2280],
14	clopidogrel	NN	O	clopidogrel	prep_with	11	SENT_78	[p4l1040t2212r1466b2302],
15	or	CC	O	or	_	0	SENT_78	[p4l1512t2237r1589b2280],
16	prasugrel	NN	O	prasugrel	conj_or	14	SENT_78	[p4l1632t2212r2015b2302],
17	,	,	O	,	_	0	SENT_78	[p4l1632t2212r2015b2302],
18	or	CC	O	or	_	0	SENT_78	[p4l2064t2237r2141b2280],
19	both	DT	O	both	conj_or	14	SENT_78	[p4l7t2322r199b2400],
20	,	,	O	,	_	0	SENT_78	[p4l7t2322r199b2400],
21	were	VBD	O	be	auxpass	22	SENT_78	[p4l263t2346r444b2390],
22	included	VBN	O	include	xcomp	6	SENT_78	[p4l508t2322r842b2390],
23	in	IN	O	in	_	0	SENT_78	[p4l903t2327r979b2389],
24	the	DT	O	the	det	25	SENT_78	[p4l1041t2322r1160b2390],
25	pharmacodynamic	JJ	O	pharmacodynamic	prep_in	22	SENT_78	[p4l1223t2322r1938b2411],
26	and	CC	O	and	_	0	SENT_78	[p4l2001t2322r2141b2390],
27	pharmacokinetic	JJ	O	pharmacokinetic	conj_and	25	SENT_78	[p4l8t2431r654b2520],
28	analyses	NNS	O	analysis	nsubj	29	SENT_78	[p4l698t2431r1013b2521],
29	(	VBP	O	(	ccomp	27	SENT_78	[p4l1064t2432r1592b2521],
30	webappendix	JJ	O	webappendix	amod	31	SENT_78	[p4l1064t2432r1592b2521],
31	pp	NN	O	pp	dobj	29	SENT_78	[p4l1632t2456r1726b2520],
32	1	CD	NUMBER	1	number	36	SENT_78	[p4l1772t2438r1803b2498],
33	and	CC	O	and	_	0	SENT_78	[p4l1846t2431r1986b2500],
34	4	CD	NUMBER	4	num	25	SENT_78	[p4l2026t2437r2140b2521],
35	)	CD	NUMBER	)	number	36	SENT_78	[p4l2026t2437r2140b2521],
36	.8	CD	NUMBER	.8	num	25	SENT_78	[p4l2026t2437r2140b2521],

1	www	NN	O	www	_	0	SENT_79	[p4l7t2702r540b2753],
2	.	.	O	.	_	0	SENT_79	[p4l7t2702r540b2753],

1	the	DT	O	the	det	2	SENT_80	[p4l7t2702r540b2753],
2	|	NN	O	|	_	0	SENT_80	[p4l7t2702r540b2753],
3	ancet.com	NNP	O	ancet.com	nn	4	SENT_80	[p4l7t2702r540b2753],
4	Vol	NNP	O	Vol	dep	2	SENT_80	[p4l583t2702r670b2753],
5	376	CD	NUMBER	376	num	6	SENT_80	[p4l689t2701r793b2760],
6	October	NNP	DATE	October	dep	2	SENT_80	[p4l839t2702r1063b2753],
7	16,2010	CD	DATE	16,2010	num	6	SENT_80	[p4l1080t2701r1324b2762],

1	These	DT	O	these	det	2	SENT_81	[p4l8t2890r170b2939],
2	studies	NNS	O	study	nsubjpass	4	SENT_81	[p4l208t2890r398b2939],
3	were	VBD	O	be	auxpass	4	SENT_81	[p4l434t2908r563b2939],
4	approved	VBN	O	approve	_	0	SENT_81	[p4l601t2890r850b2954],
5	by	IN	O	by	_	0	SENT_81	[p4l884t2890r947b2954],
6	institutional	JJ	O	institutional	amod	8	SENT_81	[p4l981t2890r1316b2939],
7	review	NN	O	review	nn	8	SENT_81	[p4l1352t2894r1530b2939],
8	boards	NNS	O	board	agent	4	SENT_81	[p4l8t2967r205b3022],
9	,	,	O	,	_	0	SENT_81	[p4l8t2967r205b3022],
10	and	CC	O	and	_	0	SENT_81	[p4l246t2967r345b3015],
11	written	VBN	O	write	amod	13	SENT_81	[p4l380t2970r576b3015],
12	informed	JJ	O	informed	amod	13	SENT_81	[p4l613t2967r869b3015],
13	consent	NN	O	consent	nsubjpass	15	SENT_81	[p4l906t2977r1119b3015],
14	was	VBD	O	be	auxpass	15	SENT_81	[p4l1153t2984r1253b3015],
15	obtained	VBN	O	obtain	conj_and	4	SENT_81	[p4l1293t2967r1529b3015],
16	from	IN	O	from	_	0	SENT_81	[p4l9t3045r143b3093],
17	all	DT	O	all	det	18	SENT_81	[p4l163t3045r225b3093],
18	participants	NNS	O	participant	prep_from	15	SENT_81	[p4l245t3048r582b3108],
19	.	.	O	.	_	0	SENT_81	[p4l245t3048r582b3108],

1	Procedures	NNS	O	procedure	_	0	SENT_82	[p4l12t3200r309b3249],

1	In	IN	O	in	_	0	SENT_83	[p5l12t26r68b68],
2	the	DT	O	the	det	3	SENT_83	[p5l85t21r168b69],
3	TRITON	NNP	ORGANIZATION	TRITON	pobj	1	SENT_83	[p5l185t24r597b69],
4	.	.	O	.	_	0	SENT_83	[p5l185t24r597b69],

1	—	NN	O	—	_	0	SENT_84	[p5l185t24r597b69],
2	.	.	O	.	_	0	SENT_84	[p5l185t24r597b69],

1	TIMI	NNP	ORGANIZATION	TIMI	nn	3	SENT_85	[p5l185t24r597b69],
2	38	CD	NUMBER	38	num	3	SENT_85	[p5l620t25r679b69],
3	study	NN	O	study	nsubj	12	SENT_85	[p5l699t21r850b84],
4	,	,	O	,	_	0	SENT_85	[p5l699t21r850b84],
5	the	DT	O	the	det	9	SENT_85	[p5l869t21r952b69],
6	prespeciﬁed	JJ	O	prespeciﬁed	amod	9	SENT_85	[p5l970t21r1297b84],
7	primary	JJ	O	primary	amod	9	SENT_85	[p5l1314t24r1530b84],
8	efﬁcacy	NN	O	efﬁcacy	nn	9	SENT_85	[p5l10t98r209b162],
9	endpoint	NN	O	endpoint	appos	3	SENT_85	[p5l248t98r490b161],
10	was	VBD	O	be	cop	12	SENT_85	[p5l527t115r627b147],
11	a	DT	O	a	det	12	SENT_85	[p5l669t116r695b147],
12	composite	NN	O	composite	_	0	SENT_85	[p5l736t101r1011b161],
13	of	IN	O	of	_	0	SENT_85	[p5l1052t98r1112b147],
14	cardiovascular	JJ	O	cardiovascular	amod	15	SENT_85	[p5l1143t98r1530b147],
15	death	NN	O	death	prep_of	12	SENT_85	[p5l10t176r170b232],
16	,	,	O	,	_	0	SENT_85	[p5l10t176r170b232],
17	myocardial	JJ	O	myocardial	amod	18	SENT_85	[p5l209t176r506b240],
18	infarction	NN	O	infarction	prep_of	12	SENT_85	[p5l542t176r820b232],
19	,	,	O	,	_	0	SENT_85	[p5l542t176r820b232],
20	or	CC	O	or	_	0	SENT_85	[p5l859t194r914b225],
21	stroke	NN	O	stroke	prep_of	12	SENT_85	[p5l951t176r1146b225],
22	.	.	O	.	_	0	SENT_85	[p5l951t176r1146b225],

1	“	NN	O	“	nn	2	SENT_86	[p5l951t176r1146b225],
2	A	NN	O	a	nsubj	10	SENT_86	[p5l1181t179r1223b224],
3	secondary	JJ	O	secondary	amod	4	SENT_86	[p5l1261t176r1529b240],
4	endpoint	NN	O	endpoint	dep	2	SENT_86	[p5l10t254r252b317],
5	was	VBD	O	be	cop	10	SENT_86	[p5l277t271r376b302],
6	deﬁnite	JJ	O	deﬁnite	amod	10	SENT_86	[p5l406t254r610b302],
7	or	CC	O	or	_	0	SENT_86	[p5l638t271r693b302],
8	probable	JJ	O	probable	amod	10	SENT_86	[p5l719t254r953b317],
9	stent	NN	O	stent	nn	10	SENT_86	[p5l983t263r1113b302],
10	thrombosis	NN	O	thrombosis	_	0	SENT_86	[p5l1139t254r1445b302],
11	as	IN	O	as	_	0	SENT_86	[p5l1475t271r1527b302],
12	deﬁned	VBN	O	deﬁned	prepc_as	10	SENT_86	[p5l10t331r211b380],
13	by	IN	O	by	_	0	SENT_86	[p5l232t331r295b395],
14	the	DT	O	the	det	17	SENT_86	[p5l315t331r399b380],
15	Academic	NNP	ORGANIZATION	Academic	nn	17	SENT_86	[p5l422t331r687b380],
16	Research	NNP	ORGANIZATION	Research	nn	17	SENT_86	[p5l713t331r953b380],
17	Consortium	NNP	ORGANIZATION	Consortium	prep_by	12	SENT_86	[p5l978t334r1346b380],
18	.	.	O	.	_	0	SENT_86	[p5l978t334r1346b380],

1	”	NNP	O	”	nn	3	SENT_87	[p5l978t334r1346b380],
2	Safety	NNP	O	Safety	nn	3	SENT_87	[p5l1372t331r1529b395],
3	endpoints	NNS	O	endpoint	nsubj	4	SENT_87	[p5l10t409r276b472],
4	included	VBD	O	include	_	0	SENT_87	[p5l303t409r538b458],
5	TIMI	NNP	ORGANIZATION	TIMI	amod	6	SENT_87	[p5l561t412r702b457],
6	major	JJ	O	major	nsubj	11	SENT_87	[p5l729t412r889b473],
7	or	CC	O	or	_	0	SENT_87	[p5l914t427r969b458],
8	minor	JJ	O	minor	amod	9	SENT_87	[p5l993t412r1161b458],
9	bleeding	NN	O	bleeding	nsubj	11	SENT_87	[p5l1184t409r1416b473],
10	not	RB	O	not	neg	11	SENT_87	[p5l1441t419r1529b458],
11	related	JJ	O	related	xcomp	4	SENT_87	[p5l9t488r192b536],
12	to	TO	O	to	_	0	SENT_87	[p5l246t497r295b536],
13	coronary	JJ	O	coronary	amod	16	SENT_87	[p5l352t505r588b551],
14	artery	NN	O	artery	nn	16	SENT_87	[p5l642t497r797b551],
15	bypass	NN	O	bypass	nn	16	SENT_87	[p5l850t488r1028b551],
16	grafting	NN	O	grafting	prep_to	11	SENT_87	[p5l1086t488r1310b552],
17	.	.	O	.	_	0	SENT_87	[p5l1086t488r1310b552],

1	These	DT	O	these	det	2	SENT_88	[p5l1368t488r1528b536],
2	outcomes	NNS	O	outcome	nsubjpass	4	SENT_88	[p5l10t575r268b614],
3	were	VBD	O	be	auxpass	4	SENT_88	[p5l280t583r408b614],
4	adjudicated	VBN	O	adjudicate	_	0	SENT_88	[p5l422t565r732b629],
5	by	IN	O	by	_	0	SENT_88	[p5l742t565r804b629],
6	a	DT	O	a	det	9	SENT_88	[p5l816t583r842b614],
7	clinical	JJ	O	clinical	amod	9	SENT_88	[p5l855t565r1046b614],
8	events	NNS	O	event	nn	9	SENT_88	[p5l1059t575r1226b614],
9	committee	NN	O	committee	agent	4	SENT_88	[p5l1240t568r1528b614],
10	unaware	JJ	O	unaware	amod	9	SENT_88	[p5l8t661r239b692],
11	of	IN	O	of	_	0	SENT_88	[p5l259t644r319b692],
12	treatment	NN	O	treatment	nn	13	SENT_88	[p5l328t654r593b692],
13	assignment	NN	O	assignment	prep_of	9	SENT_88	[p5l612t647r938b708],
14	.	.	O	.	_	0	SENT_88	[p5l612t647r938b708],

1	Among	IN	O	among	_	0	SENT_89	[p5l58t749r260b810],
2	the	DT	O	the	det	4	SENT_89	[p5l297t746r380b794],
3	healthy	JJ	O	healthy	amod	4	SENT_89	[p5l418t746r616b809],
4	participants	NNS	O	participant	prep_among	9	SENT_89	[p5l652t749r985b809],
5	,	,	O	,	_	0	SENT_89	[p5l652t749r985b809],
6	pharmacodynamic	JJ	O	pharmacodynamic	amod	7	SENT_89	[p5l1025t746r1528b809],
7	response	NN	O	response	nsubjpass	9	SENT_89	[p5l9t840r250b886],
8	was	VBD	O	be	auxpass	9	SENT_89	[p5l287t840r386b872],
9	assessed	VBN	O	assess	_	0	SENT_89	[p5l428t823r658b872],
10	by	IN	O	by	_	0	SENT_89	[p5l694t823r757b887],
11	use	NN	O	use	agent	9	SENT_89	[p5l793t840r885b872],
12	of	IN	O	of	_	0	SENT_89	[p5l925t823r984b872],
13	light	JJ	O	light	amod	15	SENT_89	[p5l1013t823r1137b887],
14	transmission	NN	O	transmission	nn	15	SENT_89	[p5l1173t826r1528b872],
15	aggregometry	NN	O	aggregometry	prep_of	11	SENT_89	[p5l10t911r382b965],
16	in	IN	O	in	_	0	SENT_89	[p5l405t904r459b949],
17	response	NN	O	response	prep_in	15	SENT_89	[p5l483t918r723b964],
18	to	TO	O	to	_	0	SENT_89	[p5l748t911r797b949],
19	20	CD	NUMBER	20	num	20	SENT_89	[p5l825t905r885b949],
20	umol	NN	O	umol	prep_to	9	SENT_89	[p5l909t901r1076b964],
21	/	:	O	/	punct	23	SENT_89	[p5l909t901r1076b964],
22	L	NN	O	l	nn	23	SENT_89	[p5l1083t906r1113b949],
23	ADP	NN	O	adp	dep	20	SENT_89	[p5l1136t904r1278b957],
24	,	,	O	,	_	0	SENT_89	[p5l1136t904r1278b957],
25	and	CC	O	and	_	0	SENT_89	[p5l1305t901r1404b949],
26	was	VBD	O	be	auxpass	27	SENT_89	[p5l1427t918r1526b949],
27	expressed	VBN	O	express	conj_and	9	SENT_89	[p5l10t978r273b1041],
28	as	IN	O	as	_	0	SENT_89	[p5l305t996r356b1027],
29	absolute	JJ	O	absolute	amod	30	SENT_89	[p5l390t978r613b1027],
30	reduction	NN	O	reduction	prep_as	27	SENT_89	[p5l646t978r904b1027],
31	in	IN	O	in	_	0	SENT_89	[p5l936t982r989b1026],
32	maximum	NN	O	maximum	nn	34	SENT_89	[p5l1021t982r1302b1027],
33	platelet	NN	O	platelet	nn	34	SENT_89	[p5l1333t978r1529b1041],
34	aggregation	NN	O	aggregation	prep_in	30	SENT_89	[p5l10t1059r326b1120],
35	from	IN	O	from	_	0	SENT_89	[p5l344t1056r477b1105],
36	baseline	NN	O	baseline	prep_from	34	SENT_89	[p5l493t1056r715b1105],
37	to	TO	O	to	_	0	SENT_89	[p5l733t1066r782b1105],
38	4	CD	NUMBER	4	num	41	SENT_89	[p5l800t1061r831b1104],
39	h.	NN	O	h.	nn	41	SENT_89	[p5l845t1056r893b1105],
40	Plasma	NN	O	plasma	nn	41	SENT_89	[p5l917t1056r1111b1105],
41	concentrations	NNS	O	concentration	prep_to	27	SENT_89	[p5l1130t1059r1526b1105],
42	of	IN	O	of	_	0	SENT_89	[p5l10t1134r69b1182],
43	clopidogrel	NN	O	clopidogrel	prep_of	41	SENT_89	[p5l79t1134r378b1198],
44	and	CC	O	and	_	0	SENT_89	[p5l397t1134r496b1182],
45	prasugrel	NN	O	prasugrel	prep_of	41	SENT_89	[p5l513t1134r768b1198],
46	active	JJ	O	active	amod	48	SENT_89	[p5l786t1137r936b1182],
47	drug	NN	O	drug	nn	48	SENT_89	[p5l955t1134r1081b1198],
48	metabolite	NN	O	metabolite	nsubjpass	50	SENT_89	[p5l1098t1134r1383b1182],
49	were	VBD	O	be	auxpass	50	SENT_89	[p5l1400t1151r1528b1182],
50	measured	VBN	O	measure	ccomp	27	SENT_89	[p5l9t1212r276b1261],
51	by	IN	O	by	_	0	SENT_89	[p5l342t1212r404b1276],
52	liquid	JJ	O	liquid	amod	53	SENT_89	[p5l469t1212r627b1276],
53	chromatography	NN	O	chromatography	agent	50	SENT_89	[p5l694t1212r1139b1276],
54	with	IN	O	with	_	0	SENT_89	[p5l1204t1212r1323b1261],
55	mass	NN	O	mass	nn	56	SENT_89	[p5l1390t1230r1526b1261],
56	spectrometry	NN	O	spectrometry	prep_with	50	SENT_89	[p5l11t1300r370b1354],
57	.	.	O	.	_	0	SENT_89	[p5l11t1300r370b1354],

1	18	CD	NUMBER	18	nsubjpass	10	SENT_90	[p5l376t1294r403b1316],
2	The	DT	O	the	det	3	SENT_90	[p5l413t1290r517b1339],
3	area	NN	O	area	dep	1	SENT_90	[p5l530t1308r640b1339],
4	under	IN	O	under	_	0	SENT_90	[p5l651t1290r813b1339],
5	the	DT	O	the	det	8	SENT_90	[p5l823t1290r907b1339],
6	plasma	NN	O	plasma	nn	8	SENT_90	[p5l919t1290r1112b1353],
7	concentrationtime	NN	O	concentrationtime	nn	8	SENT_90	[p5l1125t1293r1530b1339, p5l8t1371r130b1417],
8	curve	NN	O	curve	prep_under	1	SENT_90	[p5l164t1386r307b1417],
9	was	VBD	O	be	auxpass	10	SENT_90	[p5l339t1385r438b1417],
10	analysed	VBN	O	analyse	_	0	SENT_90	[p5l473t1368r704b1432],
11	by	IN	O	by	_	0	SENT_90	[p5l734t1368r797b1432],
12	the	DT	O	the	det	15	SENT_90	[p5l827t1368r910b1417],
13	log-linear	JJ	O	log-linear	amod	15	SENT_90	[p5l942t1368r1199b1432],
14	trapezoidal	NN	O	trapezoidal	nn	15	SENT_90	[p5l1229t1368r1528b1431],
15	method	NN	O	method	agent	10	SENT_90	[p5l9t1447r217b1495],
16	from	IN	O	from	_	0	SENT_90	[p5l261t1447r394b1495],
17	time	NN	O	time	prep_from	10	SENT_90	[p5l437t1450r559b1495],
18	of	IN	O	of	_	0	SENT_90	[p5l606t1447r665b1495],
19	dose	NN	O	dose	prep_of	17	SENT_90	[p5l701t1447r821b1495],
20	to	TO	O	to	_	0	SENT_90	[p5l866t1456r916b1495],
21	the	DT	O	the	det	24	SENT_90	[p5l961t1447r1044b1495],
22	4-h	JJ	O	4-h	amod	24	SENT_90	[p5l1088t1447r1171b1495],
23	measurable	JJ	O	measurable	amod	24	SENT_90	[p5l1215t1447r1528b1495],
24	concentration	NN	O	concentration	prep_to	10	SENT_90	[p5l10t1527r381b1573],
25	(	CD	NUMBER	(	num	27	SENT_90	[p5l404t1527r631b1588],
26	AUC04	NN	O	auc04	nn	27	SENT_90	[p5l404t1527r631b1588],
27	)	NN	O	)	dep	24	SENT_90	[p5l404t1527r631b1588],
28	.	.	O	.	_	0	SENT_90	[p5l404t1527r631b1588],

1	Genotyping	VBG	O	genotype	_	0	SENT_91	[p5l61t1605r375b1666],
2	for	IN	O	for	_	0	SENT_91	[p5l426t1602r502b1651],
3	ABCB1	NN	O	abcb1	prep_for	1	SENT_91	[p5l551t1606r745b1651],
4	was	VBD	O	be	auxpass	5	SENT_91	[p5l793t1619r892b1651],
5	completed	VBN	O	complete	aux	1	SENT_91	[p5l946t1602r1226b1665],
6	with	IN	O	with	_	0	SENT_91	[p5l1275t1602r1394b1651],
7	the	DT	O	the	det	8	SENT_91	[p5l1444t1602r1528b1651],
8	Affymetrix	NNP	O	Affymetrix	prep_with	5	SENT_91	[p5l8t1681r298b1744],
9	Targeted	VBN	O	target	partmod	8	SENT_91	[p5l373t1681r605b1745],
10	Human	JJ	O	human	amod	11	SENT_91	[p5l684t1686r891b1729],
11	DMET	NN	O	dmet	dobj	9	SENT_91	[p5l971t1684r1149b1729],
12	1.0	CD	NUMBER	1.0	num	11	SENT_91	[p5l1227t1685r1297b1729],
13	Assay	NN	O	assay	nn	15	SENT_91	[p5l1374t1684r1530b1745],
14	(	CD	NUMBER	(	num	15	SENT_91	[p5l13t1759r330b1822],
15	Aifymetrix	NNP	O	Aifymetrix	dep	11	SENT_91	[p5l13t1759r330b1822],
16	,	,	O	,	_	0	SENT_91	[p5l13t1759r330b1822],
17	Santa	NNP	LOCATION	Santa	nn	18	SENT_91	[p5l388t1762r533b1807],
18	Clara	NNP	LOCATION	Clara	dep	11	SENT_91	[p5l586t1758r739b1814],
19	,	,	O	,	_	0	SENT_91	[p5l586t1758r739b1814],
20	CA	NNP	LOCATION	CA	dep	11	SENT_91	[p5l795t1762r890b1814],
21	,	,	O	,	_	0	SENT_91	[p5l795t1762r890b1814],
22	USA	NNP	LOCATION	USA	dep	11	SENT_91	[p5l947t1762r1087b1822],
23	)	CD	NUMBER	)	num	22	SENT_91	[p5l947t1762r1087b1822],
24	and	CC	O	and	_	0	SENT_91	[p5l1144t1758r1243b1807],
25	Illumina	NNP	PERSON	Illumina	nn	27	SENT_91	[p5l1296t1758r1529b1807],
26	Inﬁnium	NNP	PERSON	Inﬁnium	nn	27	SENT_91	[p5l12t1836r255b1884],
27	Beadchip	NNP	PERSON	Beadchip	dep	11	SENT_91	[p5l295t1836r541b1899],
28	Assay	NN	PERSON	assay	nn	30	SENT_91	[p5l579t1839r734b1900],
29	(	CD	NUMBER	(	num	30	SENT_91	[p5l775t1836r1040b1900],
30	Illumina	NNP	ORGANIZATION	Illumina	nsubj	1	SENT_91	[p5l775t1836r1040b1900],
31	,	,	O	,	_	0	SENT_91	[p5l775t1836r1040b1900],
32	San	NNP	LOCATION	San	nn	37	SENT_91	[p5l1084t1839r1179b1884],
33	Diego	NNP	LOCATION	Diego	nn	37	SENT_91	[p5l1219t1839r1389b1900],
34	,	,	O	,	_	0	SENT_91	[p5l1219t1839r1389b1900],
35	CA	NNP	LOCATION	CA	appos	37	SENT_91	[p5l1430t1839r1526b1892],
36	,	,	O	,	_	0	SENT_91	[p5l1430t1839r1526b1892],
37	USA	NNP	LOCATION	USA	appos	30	SENT_91	[p5l12t1918r152b1979],
38	)	CD	NUMBER	)	num	37	SENT_91	[p5l12t1918r152b1979],
39	to	TO	O	to	_	0	SENT_91	[p5l198t1924r248b1963],
40	minimise	JJ	O	minimise	amod	42	SENT_91	[p5l291t1918r551b1963],
41	missing	VBG	O	miss	amod	42	SENT_91	[p5l594t1918r810b1979],
42	data	NNS	O	datum	prep_to	37	SENT_91	[p5l853t1915r1008b1963],
43	.	.	O	.	_	0	SENT_91	[p5l853t1915r1008b1963],

1	”	NN	O	”	nsubjpass	28	SENT_92	[p5l853t1915r1008b1963],
2	On	IN	O	on	_	0	SENT_92	[p5l1052t1919r1133b1963],
3	the	DT	O	the	det	4	SENT_92	[p5l1175t1915r1258b1963],
4	basis	NN	O	basis	prep_on	28	SENT_92	[p5l1300t1915r1433b1963],
5	of	IN	O	of	_	0	SENT_92	[p5l1478t1915r1537b1963],
6	previous	JJ	O	previous	amod	7	SENT_92	[p5l9t1994r237b2054],
7	studies	NNS	O	study	prep_of	4	SENT_92	[p5l277t1991r549b2047],
8	,1	CD	NUMBER	,1	nsubjpass	28	SENT_92	[p5l277t1991r549b2047],
9	°	CD	NUMBER	°	number	10	SENT_92	[p5l277t1991r549b2047],
10	’16	CD	NUMBER	’16	num	13	SENT_92	[p5l277t1991r549b2047],
11	the	DT	O	the	det	13	SENT_92	[p5l585t1991r668b2040],
12	main	JJ	O	main	amod	13	SENT_92	[p5l705t1994r845b2040],
13	variant	NN	O	variant	nsubj	20	SENT_92	[p5l879t1994r1067b2040],
14	of	IN	O	of	_	0	SENT_92	[p5l1102t1991r1162b2040],
15	interest	NN	O	interest	prep_of	13	SENT_92	[p5l1189t1994r1394b2040],
16	was	VBD	O	be	cop	20	SENT_92	[p5l1427t2008r1526b2040],
17	3435C	CD	NUMBER	3435c	number	18	SENT_92	[p5l12t2072r279b2118],
18	—	CD	NUMBER	—	num	20	SENT_92	[p5l12t2072r279b2118],
19	>	JJR	O	>	amod	20	SENT_92	[p5l12t2072r279b2118],
20	T	NN	O	t	rcmod	8	SENT_92	[p5l12t2072r279b2118],
21	(	CD	NUMBER	(	num	23	SENT_92	[p5l310t2072r622b2133],
22	rs1045642	NN	O	rs1045642	nn	23	SENT_92	[p5l310t2072r622b2133],
23	)	NN	O	)	dep	20	SENT_92	[p5l310t2072r622b2133],
24	,	,	O	,	_	0	SENT_92	[p5l310t2072r622b2133],
25	and	CC	O	and	_	0	SENT_92	[p5l654t2069r753b2118],
26	participants	NNS	O	participant	conj_and	20	SENT_92	[p5l779t2072r1097b2132],
27	were	VBD	O	be	auxpass	28	SENT_92	[p5l1125t2087r1253b2118],
28	classiﬁed	VBN	O	classiﬁed	_	0	SENT_92	[p5l1282t2069r1529b2118],
29	as	IN	O	as	_	0	SENT_92	[p5l10t2165r61b2196],
30	homozygous	JJ	O	homozygous	amod	52	SENT_92	[p5l81t2148r425b2212],
31	for	IN	O	for	_	0	SENT_92	[p5l445t2148r521b2196],
32	the	DT	O	the	det	37	SENT_92	[p5l538t2148r622b2196],
33	C	NN	O	c	nn	37	SENT_92	[p5l643t2151r680b2196],
34	allele	NN	O	allele	nn	37	SENT_92	[p5l700t2148r838b2196],
35	(	CD	NUMBER	(	num	37	SENT_92	[p5l861t2151r994b2212],
36	CC	NN	O	cc	nn	37	SENT_92	[p5l861t2151r994b2212],
37	)	NN	O	)	prep_for	30	SENT_92	[p5l861t2151r994b2212],
38	,	,	O	,	_	0	SENT_92	[p5l861t2151r994b2212],
39	heterozygous	JJ	O	heterozygous	amod	42	SENT_92	[p5l1014t2148r1372b2212],
40	(	NN	O	(	nn	42	SENT_92	[p5l1397t2151r1526b2212],
41	CT	NN	O	ct	nn	42	SENT_92	[p5l1397t2151r1526b2212],
42	)	NN	O	)	appos	37	SENT_92	[p5l1397t2151r1526b2212],
43	,	,	O	,	_	0	SENT_92	[p5l1397t2151r1526b2212],
44	or	CC	O	or	_	0	SENT_92	[p5l10t2243r65b2274],
45	homozygous	JJ	O	homozygous	amod	52	SENT_92	[p5l81t2225r425b2289],
46	for	IN	O	for	_	0	SENT_92	[p5l446t2225r522b2274],
47	the	DT	O	the	det	51	SENT_92	[p5l539t2225r623b2274],
48	T	NN	O	t	nn	51	SENT_92	[p5l641t2228r679b2273],
49	allele	NN	O	allele	nn	51	SENT_92	[p5l698t2225r835b2274],
50	(	CD	NUMBER	(	num	51	SENT_92	[p5l859t2228r984b2289],
51	TT	NN	O	tt	prep_for	45	SENT_92	[p5l859t2228r984b2289],
52	)	NN	O	)	prep_as	28	SENT_92	[p5l859t2228r984b2289],
53	.	.	O	.	_	0	SENT_92	[p5l859t2228r984b2289],

1	Since	IN	O	since	_	0	SENT_93	[p5l1010t2228r1151b2274],
2	some	DT	O	some	det	3	SENT_93	[p5l1173t2242r1314b2274],
3	in-vitro	FW	O	in-vitro	prep_since	7	SENT_93	[p5l1333t2228r1527b2274],
4	studies	NNS	O	study	nsubj	7	SENT_93	[p5l11t2303r198b2351],
5	have	VBP	O	have	aux	7	SENT_93	[p5l236t2303r358b2351],
6	also	RB	O	also	advmod	7	SENT_93	[p5l396t2303r499b2351],
7	assessed	VBN	O	assess	ccomp	40	SENT_93	[p5l537t2303r767b2351],
8	a	DT	O	a	det	9	SENT_93	[p5l804t2320r830b2351],
9	haplotype	NN	O	haplotype	dobj	7	SENT_93	[p5l865t2303r1127b2366],
10	consisting	VBG	O	consist	xcomp	7	SENT_93	[p5l1165t2306r1441b2367],
11	of	IN	O	of	prep	10	SENT_93	[p5l1478t2303r1537b2351],
12	3435C	NN	O	3435c	dep	28	SENT_93	[p5l12t2384r279b2429],
13	—	CD	NUMBER	—	num	15	SENT_93	[p5l12t2384r279b2429],
14	>	JJR	O	>	amod	15	SENT_93	[p5l12t2384r279b2429],
15	T	NN	O	t	dep	12	SENT_93	[p5l12t2384r279b2429],
16	and	CC	O	and	_	0	SENT_93	[p5l306t2381r405b2429],
17	two	CD	NUMBER	two	num	20	SENT_93	[p5l431t2390r526b2429],
18	other	JJ	O	other	amod	20	SENT_93	[p5l556t2381r697b2429],
19	ABCB1	NN	O	abcb1	nn	20	SENT_93	[p5l722t2384r916b2429],
20	variants	NNS	O	variant	conj_and	12	SENT_93	[p5l941t2384r1168b2436],
21	,	,	O	,	_	0	SENT_93	[p5l941t2384r1168b2436],
22	2677G	NN	O	2677g	appos	20	SENT_93	[p5l1201t2384r1529b2444],
23	—	CD	NUMBER	—	num	22	SENT_93	[p5l1201t2384r1529b2444],
24	>	JJR	O	>	amod	25	SENT_93	[p5l1201t2384r1529b2444],
25	T/A	NN	O	t/a	dep	28	SENT_93	[p5l1201t2384r1529b2444],
26	(	CD	NUMBER	(	num	28	SENT_93	[p5l13t2461r320b2522],
27	rs2032582	NN	O	rs2032582	nn	28	SENT_93	[p5l13t2461r320b2522],
28	)	NN	O	)	dep	33	SENT_93	[p5l13t2461r320b2522],
29	and	CC	O	and	_	0	SENT_93	[p5l394t2458r493b2507],
30	1236C	NN	O	1236c	conj_and	28	SENT_93	[p5l562t2461r827b2507],
31	—	CD	NUMBER	—	num	33	SENT_93	[p5l562t2461r827b2507],
32	>	JJR	O	>	amod	33	SENT_93	[p5l562t2461r827b2507],
33	T	NN	O	t	dep	11	SENT_93	[p5l562t2461r827b2507],
34	(	CD	NUMBER	(	num	36	SENT_93	[p5l899t2461r1212b2522],
35	rs1128503	NN	O	rs1128503	nn	36	SENT_93	[p5l899t2461r1212b2522],
36	)	NN	O	)	dobj	10	SENT_93	[p5l899t2461r1212b2522],
37	,	,	O	,	_	0	SENT_93	[p5l899t2461r1212b2522],
38	we	PRP	O	we	nsubj	40	SENT_93	[p5l1281t2476r1355b2507],
39	also	RB	O	also	advmod	40	SENT_93	[p5l1425t2458r1527b2507],
40	genotyped	VBD	O	genotype	_	0	SENT_93	[p5l10t2536r287b2600],
41	these	DT	O	these	det	42	SENT_93	[p5l321t2536r461b2584],
42	polymorphisms	NNS	O	polymorphism	nsubj	43	SENT_93	[p5l497t2536r921b2599],
43	(	VBP	O	(	ccomp	40	SENT_93	[p5l963t2536r1334b2600],
44	webappendix	NN	O	webappendix	nn	45	SENT_93	[p5l963t2536r1334b2600],
45	p	NN	O	p	nsubj	51	SENT_93	[p5l1368t2553r1400b2599],
46	1	CD	NUMBER	1	num	50	SENT_93	[p5l1438t2539r1529b2600],
47	)	CD	NUMBER	)	num	50	SENT_93	[p5l1438t2539r1529b2600],
48	.2	NN	NUMBER	.2	nn	50	SENT_93	[p5l1438t2539r1529b2600],
49	°	CD	NUMBER	°	num	50	SENT_93	[p5l1438t2539r1529b2600],
50	Genotypes	NNS	O	genotype	dep	45	SENT_93	[p5l11t2618r291b2678],
51	were	VBD	O	be	ccomp	43	SENT_93	[p5l363t2632r490b2663],
52	in	IN	O	in	_	0	SENT_93	[p5l562t2618r616b2662],
53	I-Iardy-Weinberg	NN	O	i-iardy-weinberg	nn	57	SENT_93	[p5l689t2615r1135b2679],
54	equilibrium	NN	O	equilibrium	nn	57	SENT_93	[p5l1207t2615r1528b2678],
55	(	NN	O	(	nn	57	SENT_93	[p5l13t2692r384b2756],
56	webappendix	NN	O	webappendix	nn	57	SENT_93	[p5l13t2692r384b2756],
57	p	NN	O	p	prep_in	51	SENT_93	[p5l402t2710r433b2755],
58	5	CD	NUMBER	5	num	59	SENT_93	[p5l456t2695r516b2756],
59	)	NN	O	)	dep	57	SENT_93	[p5l456t2695r516b2756],
60	.	.	O	.	_	0	SENT_93	[p5l456t2695r516b2756],

1	Because	IN	O	because	mark	8	SENT_94	[p5l62t2775r278b2819],
2	genetic	JJ	O	genetic	amod	3	SENT_94	[p5l329t2773r522b2834],
3	variation	NN	O	variation	nsubjpass	8	SENT_94	[p5l569t2773r807b2819],
4	in	IN	O	in	_	0	SENT_94	[p5l856t2773r909b2818],
5	CYPZCI9	NN	O	cypzci9	prep_in	3	SENT_94	[p5l963t2774r1213b2819],
6	has	VBZ	O	have	aux	8	SENT_94	[p5l1259t2770r1349b2819],
7	been	VBN	O	be	auxpass	8	SENT_94	[p5l1399t2770r1528b2819],
8	associated	VBN	O	associate	advcl	48	SENT_94	[p5l10t2849r283b2897],
9	with	IN	O	with	_	0	SENT_94	[p5l367t2849r486b2897],
10	pharmacological	JJ	O	pharmacological	amod	11	SENT_94	[p5l571t2849r1017b2913],
11	response	NN	O	response	prep_with	8	SENT_94	[p5l1103t2866r1343b2912],
12	and	CC	O	and	_	0	SENT_94	[p5l1430t2849r1529b2897],
13	cardiovascular	JJ	O	cardiovascular	amod	14	SENT_94	[p5l10t2926r396b2975],
14	outcomes	NNS	O	outcome	conj_and	11	SENT_94	[p5l505t2936r763b2975],
15	in	IN	O	in	_	0	SENT_94	[p5l875t2929r928b2974],
16	patients	NNS	O	patient	prep_in	11	SENT_94	[p5l1037t2929r1249b2989],
17	taking	VBG	O	take	partmod	16	SENT_94	[p5l1359t2926r1528b2990],
18	clopidogrel	NN	O	clopidogrel	dobj	17	SENT_94	[p5l10t3004r472b3068],
19	,	,	O	,	_	0	SENT_94	[p5l10t3004r472b3068],
20	*	NN	O	*	appos	16	SENT_94	[p5l10t3004r472b3068],
21	'	''	O	'	_	0	SENT_94	[p5l10t3004r472b3068],
22	1	CD	NUMBER	1	num	23	SENT_94	[p5l10t3004r472b3068],
23	“	NN	O	“	dep	16	SENT_94	[p5l10t3004r472b3068],
24	1	CD	NUMBER	1	number	25	SENT_94	[p5l10t3004r472b3068],
25	'24	CD	NUMBER	'24	num	23	SENT_94	[p5l10t3004r472b3068],
26	we	PRP	O	we	nsubj	27	SENT_94	[p5l503t3022r576b3053],
27	assessed	VBD	O	assess	rcmod	23	SENT_94	[p5l612t3004r842b3053],
28	the	DT	O	the	det	30	SENT_94	[p5l875t3004r959b3053],
29	combined	JJ	O	combined	amod	30	SENT_94	[p5l995t3004r1264b3053],
30	effect	NN	O	effect	nsubj	40	SENT_94	[p5l1298t3004r1444b3053],
31	of	IN	O	of	_	0	SENT_94	[p5l1478t3004r1537b3053],
32	genetic	JJ	O	genetic	amod	33	SENT_94	[p5l10t3086r203b3147],
33	variants	NNS	O	variant	prep_of	30	SENT_94	[p5l222t3086r434b3131],
34	in	IN	O	in	_	0	SENT_94	[p5l458t3086r511b3130],
35	CYPZCI9	NN	O	cypzci9	prep_in	33	SENT_94	[p5l538t3086r788b3131],
36	and	CC	O	and	_	0	SENT_94	[p5l807t3083r906b3131],
37	ABCB1	NN	O	abcb1	prep_in	33	SENT_94	[p5l926t3086r1119b3131],
38	3435C	NN	O	3435c	npadvmod	40	SENT_94	[p5l1143t3086r1414b3131],
39	—	CD	NUMBER	—	num	38	SENT_94	[p5l1143t3086r1414b3131],
40	>	JJR	O	>	xcomp	27	SENT_94	[p5l1143t3086r1414b3131],
41	T.	FW	O	t.	dep	40	SENT_94	[p5l1143t3086r1414b3131],
42	For	IN	O	for	dep	40	SENT_94	[p5l1442t3086r1529b3131],
43	C	NN	O	c	nn	44	SENT_94	[p5l14t3164r52b3209],
44	YP2C19	NN	O	yp2c19	pobj	42	SENT_94	[p5l57t3164r275b3216],
45	,	,	O	,	_	0	SENT_94	[p5l57t3164r275b3216],
46	participants	NNS	O	participant	nsubjpass	50	SENT_94	[p5l298t3163r616b3223],
47	were	VBD	O	be	auxpass	48	SENT_94	[p5l637t3178r765b3209],
48	genotyped	VBN	O	genotype	_	0	SENT_94	[p5l788t3160r1065b3224],
49	and	CC	O	and	_	0	SENT_94	[p5l1086t3160r1186b3209],
50	divided	VBN	O	divide	conj_and	48	SENT_94	[p5l1207t3160r1402b3209],
51	into	IN	O	into	_	0	SENT_94	[p5l1423t3163r1528b3209],
52	two	CD	NUMBER	two	num	53	SENT_94	[p5l8t3248r103b3287],
53	groups	NNS	O	group	prep_into	48	SENT_94	[p5l124t3255r307b3302],
54	on	IN	O	on	_	0	SENT_94	[p5l329t3255r396b3287],
55	the	DT	O	the	det	56	SENT_94	[p5l414t3238r497b3287],
56	basis	NN	O	basis	prep_on	53	SENT_94	[p5l516t3238r649b3287],
57	of	IN	O	of	_	0	SENT_94	[p5l670t3238r730b3287],
58	whether	IN	O	whether	complm	60	SENT_94	[p5l738t3238r960b3287],
59	they	PRP	O	they	nsubj	60	SENT_94	[p5l977t3238r1092b3302],
60	had	VBD	O	have	prepc_of	56	SENT_94	[p5l1108t3238r1208b3287],
61	at	IN	O	at	quantmod	63	SENT_94	[p5l1227t3248r1274b3287],
62	least	JJS	O	least	mwe	61	SENT_94	[p5l1290t3238r1413b3287],
63	one	CD	NUMBER	one	num	66	SENT_94	[p5l1432t3256r1528b3287],
64	reduced-function	JJ	O	reduced-function	amod	66	SENT_94	[p5l9t3317r473b3365],
65	allele	NN	O	allele	nn	66	SENT_94	[p5l495t3317r632b3365],
66	(	NN	O	(	dobj	60	SENT_94	[p5l658t3317r867b3381],
67	termed	VBN	O	term	partmod	66	SENT_94	[p5l658t3317r867b3381],
68	carriers	NNS	O	carrier	nsubj	69	SENT_94	[p5l887t3320r1106b3381],
69	)	VBP	O	)	dep	67	SENT_94	[p5l887t3320r1106b3381],
70	or	CC	O	or	_	0	SENT_94	[p5l1132t3334r1187b3365],
71	no	DT	O	no	det	73	SENT_94	[p5l1207t3334r1274b3365],
72	reducedfunction	NN	O	reducedfunction	nn	73	SENT_94	[p5l1296t3317r1527b3365, p5l9t3394r238b3443],
73	alleles	NNS	O	allele	nsubj	74	SENT_94	[p5l257t3394r421b3443],
74	(	VBP	O	(	dep	67	SENT_94	[p5l446t3394r654b3458],
75	termed	VBN	O	term	dep	74	SENT_94	[p5l446t3394r654b3458],
76	non-carriers	JJ	O	non-carriers	amod	77	SENT_94	[p5l672t3397r1055b3458],
77	)	NN	O	)	dobj	75	SENT_94	[p5l672t3397r1055b3458],
78	?	.	O	?	_	0	SENT_94	[p5l672t3397r1055b3458],

1	Statistical	JJ	O	statistical	amod	3	SENT_95	[p6l10t53r281b102],
2	analysis	NN	O	analysis	nn	3	SENT_95	[p6l299t53r514b117],
3	Analyses	NNS	O	analysis	nsubjpass	5	SENT_95	[p6l8t131r239b195],
4	were	VBD	O	be	auxpass	5	SENT_95	[p6l265t149r390b180],
5	done	VBN	O	do	_	0	SENT_95	[p6l417t131r545b180],
6	with	IN	O	with	_	0	SENT_95	[p6l569t131r686b180],
7	SAS	NNP	O	SAS	nn	9	SENT_95	[p6l715t135r819b180],
8	(	CD	NUMBER	(	num	9	SENT_95	[p6l853t135r1058b195],
9	version	NN	O	version	prep_with	5	SENT_95	[p6l853t135r1058b195],
10	9.1	CD	NUMBER	9.1	num	11	SENT_95	[p6l1085t136r1169b195],
11	)	NN	O	)	dep	9	SENT_95	[p6l1085t136r1169b195],
12	and	CC	O	and	_	0	SENT_95	[p6l1200t131r1297b180],
13	S-PLUS	NN	O	s-plus	nn	15	SENT_95	[p6l1326t135r1525b180],
14	(	CD	NUMBER	(	num	15	SENT_95	[p6l13t212r219b273],
15	version	NN	O	version	prep_with	5	SENT_95	[p6l13t212r219b273],
16	8.0	CD	NUMBER	8.0	num	17	SENT_95	[p6l235t213r342b273],
17	)	NN	O	)	dep	15	SENT_95	[p6l235t213r342b273],
18	.	.	O	.	_	0	SENT_95	[p6l235t213r342b273],

1	On	IN	O	on	_	0	SENT_96	[p6l363t213r443b258],
2	the	DT	O	the	det	3	SENT_96	[p6l458t209r539b258],
3	basis	NN	O	basis	prep_on	11	SENT_96	[p6l555t209r684b258],
4	of	IN	O	of	_	0	SENT_96	[p6l702t209r761b258],
5	previous	JJ	O	previous	amod	6	SENT_96	[p6l767t212r989b272],
6	studies	NNS	O	study	prep_of	3	SENT_96	[p6l1008t209r1204b265],
7	,	,	O	,	_	0	SENT_96	[p6l1008t209r1204b265],
8	the	DT	O	the	det	10	SENT_96	[p6l1222t209r1303b258],
9	primary	JJ	O	primary	amod	10	SENT_96	[p6l1319t212r1530b273],
10	objective	NN	O	objective	nsubj	11	SENT_96	[p6l10t288r237b351],
11	was	VBD	O	be	_	0	SENT_96	[p6l249t305r346b336],
12	to	TO	O	to	aux	13	SENT_96	[p6l360t297r409b336],
13	investigate	VB	O	investigate	xcomp	11	SENT_96	[p6l423t291r701b352],
14	the	DT	O	the	det	15	SENT_96	[p6l714t288r796b336],
15	association	NN	O	association	dep	24	SENT_96	[p6l810t291r1098b336],
16	between	IN	O	between	_	0	SENT_96	[p6l1109t288r1328b336],
17	AB	NNP	O	AB	nn	19	SENT_96	[p6l1340t291r1421b335],
18	C	NNP	O	C	nn	19	SENT_96	[p6l1428t291r1467b336],
19	B1	NN	O	b1	prep_between	15	SENT_96	[p6l1469t292r1529b335],
20	3435C	NN	O	3435c	dep	24	SENT_96	[p6l12t368r273b414],
21	—	CD	NUMBER	—	num	20	SENT_96	[p6l12t368r273b414],
22	>	JJR	O	>	amod	24	SENT_96	[p6l12t368r273b414],
23	T	NN	O	t	nn	24	SENT_96	[p6l12t368r273b414],
24	genotypes	NNS	O	genotype	dep	13	SENT_96	[p6l307t375r567b429],
25	and	CC	O	and	_	0	SENT_96	[p6l603t365r700b414],
26	rates	NNS	O	rate	dep	13	SENT_96	[p6l734t375r856b414],
27	of	IN	O	of	_	0	SENT_96	[p6l893t365r951b414],
28	the	DT	O	the	det	31	SENT_96	[p6l975t365r1057b414],
29	primary	JJ	O	primary	amod	31	SENT_96	[p6l1091t368r1302b429],
30	efficacy	NN	O	efficacy	nn	31	SENT_96	[p6l1336t365r1530b429],
31	endpoint	NN	O	endpoint	prep_of	24	SENT_96	[p6l10t443r245b506],
32	in	IN	O	in	_	0	SENT_96	[p6l283t446r336b491],
33	patients	NNS	O	patient	prep_in	13	SENT_96	[p6l375t446r580b506],
34	in	IN	O	in	_	0	SENT_96	[p6l621t446r674b491],
35	the	DT	O	the	det	36	SENT_96	[p6l712t443r794b492],
36	TRITON	NNP	ORGANIZATION	TRITON	prep_in	33	SENT_96	[p6l833t446r1235b492],
37	.	.	O	.	_	0	SENT_96	[p6l833t446r1235b492],

1	—	NN	O	—	_	0	SENT_97	[p6l833t446r1235b492],
2	.	.	O	.	_	0	SENT_97	[p6l833t446r1235b492],

1	TIMI	NNP	ORGANIZATION	TIMI	_	0	SENT_98	[p6l833t446r1235b492],
2	38	CD	NUMBER	38	num	3	SENT_98	[p6l1281t447r1338b492],
3	study	NN	O	study	dep	1	SENT_98	[p6l1380t443r1525b507],
4	.	.	O	.	_	0	SENT_98	[p6l1380t443r1525b507],

1	For	IN	O	for	_	0	SENT_99	[p6l12t524r97b569],
2	consistency	NN	O	consistency	pobj	1	SENT_99	[p6l151t524r454b584],
3	with	IN	O	with	_	0	SENT_99	[p6l505t521r621b569],
4	the	DT	O	the	det	7	SENT_99	[p6l675t521r756b569],
5	main	JJ	O	main	amod	7	SENT_99	[p6l811t524r948b569],
6	trial	NN	O	trial	nn	7	SENT_99	[p6l1002t521r1105b569],
7	analyses	NNS	O	analysis	prep_with	2	SENT_99	[p6l1160t521r1390b584],
8	,	,	O	,	_	0	SENT_99	[p6l1160t521r1390b584],
9	the	DT	O	the	det	11	SENT_99	[p6l1446t521r1528b569],
10	See	NNP	MISC	See	nn	11	SENT_99	[p6l1591t538r1650b569],
11	Onlineforwebappendix	NNP	MISC	Onlineforwebappendix	appos	7	SENT_99	[p6l1662t535r2088b579],

1	Articles	NNPS	O	Articles	_	0	SENT_100	[p6l101t987r251b1023],

1	Clopidogrel	NNP	O	Clopidogrel	_	0	SENT_101	[p6l378t1274r586b1317],

1	14	CD	NUMBER	14	num	3	SENT_102	[p6l303t1352r346b1385],
2	:	:	O	:	_	0	SENT_102	[p6l410t1366r489b1370],
3	343517	CD	NUMBER	343517	_	0	SENT_102	[p6l505t1352r646b1387],
4	Z	NN	O	z	nn	6	SENT_102	[p6l410t1421r489b1425],
5	3435	CD	NUMBER	3435	num	6	SENT_102	[p6l505t1408r591b1442],
6	CC	NN	O	cc	dep	3	SENT_102	[p6l603t1406r647b1437],
7	—	CD	NUMBER	—	number	8	SENT_102	[p6l410t1476r489b1480],
8	3435	CD	NUMBER	3435	num	9	SENT_102	[p6l505t1463r591b1497],
9	CT	NN	O	ct	dep	6	SENT_102	[p6l603t1461r648b1492],
10	129	CD	NUMBER	129	dep	3	SENT_102	[p6l2032t1436r2106b1470],

1	12	CD	NUMBER	12	num	3	SENT_103	[p6l305t1520r344b1548],
2	3	CD	NUMBER	3	num	3	SENT_103	[p6l242t1633r282b1687],
3	cu	NN	O	cu	_	0	SENT_103	[p6l252t1700r273b1717],
4	10	CD	NUMBER	10	num	5	SENT_103	[p6l304t1688r344b1717],
5	A4	NN	O	a4	dep	3	SENT_103	[p6l240t1719r273b1735],
6	9	CD	NUMBER	9	dep	3	SENT_103	[p6l252t1739r273b1772],

1	5	CD	NUMBER	5	_	0	SENT_104	[p6l252t1815r279b1869],
2	.	.	O	.	_	0	SENT_104	[p6l252t1815r279b1869],

1	8-2	CD	NUMBER	8-2	number	2	SENT_105	[p6l2054t1833r2106b1867],
2	3	CD	NUMBER	3	num	4	SENT_105	[p6l243t1873r273b1913],
3	8	CD	NUMBER	8	number	4	SENT_105	[p6l324t1851r344b1885],
4	7.7	CD	NUMBER	7.7	_	0	SENT_105	[p6l2057t1882r2107b1915],
5	£	NN	MONEY	£	dep	4	SENT_105	[p6l240t1927r279b1973],
6	7	CD	MONEY	7	num	7	SENT_105	[p6l240t1927r279b1973],
7	j	NN	O	j	rcmod	5	SENT_105	[p6l1351t1944r1420b1951],
8	3	CD	NUMBER	3	dep	7	SENT_105	[p6l252t1974r273b2011],
9	-	:	O	-	_	0	SENT_105	[p6l786t1954r1262b2066],
10	.	.	O	.	_	0	SENT_105	[p6l786t1954r1262b2066],

1	—	NN	O	—	_	0	SENT_106	[p6l786t1954r1262b2066],
2	.	.	O	.	_	0	SENT_106	[p6l786t1954r1262b2066],

1	I	PRP	O	I	_	0	SENT_107	[p6l786t1954r1262b2066],
2	-	:	O	-	_	0	SENT_107	[p6l786t1954r1262b2066],
3	''	''	O	''	_	0	SENT_107	[p6l786t1954r1262b2066],
4	'	''	O	'	_	0	SENT_107	[p6l786t1954r1262b2066],
5	_	NN	O	_	dep	1	SENT_107	[p6l786t1954r1262b2066],
6	'	''	O	'	_	0	SENT_107	[p6l240t2014r273b2054],
7	E	NN	O	e	nn	10	SENT_107	[p6l240t2014r273b2054],
8	6	CD	NUMBER	6	num	10	SENT_107	[p6l324t2019r344b2053],
9	L5	NN	O	l5	nn	10	SENT_107	[p6l240t2058r273b2084],
10	g	NN	O	g	dobj	5	SENT_107	[p6l730t2069r782b2081],
11	3	CD	NUMBER	3	num	12	SENT_107	[p6l252t2089r273b2125],
12	Fr	NN	O	fr	dep	10	SENT_107	[p6l517t2085r727b2159],

1	IV	CD	NUMBER	iv	_	0	SENT_108	[p6l326t2360r344b2388],

1	p	NN	O	p	_	0	SENT_109	[p6l1562t2474r1736b2518],
2	=	JJ	O	=	amod	3	SENT_109	[p6l1562t2474r1736b2518],
3	O-0064	NN	O	o-0064	dep	1	SENT_109	[p6l1562t2474r1736b2518],
4	across	IN	O	across	_	0	SENT_109	[p6l1746t2486r1851b2508],
5	genotype	NN	O	genotype	prep_across	3	SENT_109	[p6l1862t2481r2025b2519],

1	o	NN	O	o	nn	2	SENT_110	[p6l324t2528r344b2557],
2	O	NN	O	o	_	0	SENT_110	[p6l366t2574r386b2603],
3	30	CD	NUMBER	30	num	4	SENT_110	[p6l461t2574r504b2607],
4	60 90 120 150	CD	NUMBER	60 90 120 150	dep	2	SENT_110	[p6l879t2574r942b2607],[p6l568t2569r612b2603],
5	180 210 240 270	CD	NUMBER	180 210 240 270	number	6	SENT_110	[p6l1306t2574r1369b2607],[p6l984t2569r1050b2603],
6	300 330 360 390	CD	NUMBER	300 330 360 390	num	8	SENT_110	[p6l1731t2574r1799b2607],[p6l1411t2574r1477b2607],
7	420	CD	NUMBER	420	number	8	SENT_110	[p6l1838t2574r1905b2607],
8	450	CD	NUMBER	450	dep	4	SENT_110	[p6l1945t2574r2012b2607],

1	Number	NN	O	number	_	0	SENT_111	[p6l46t2669r195b2703],
2	at	IN	O	at	dep	1	SENT_111	[p6l204t2675r241b2703],
3	risk	NN	O	risk	nn	4	SENT_111	[p6l253t2669r315b2703],
4	Days	NNS	DURATION	day	pobj	2	SENT_111	[p6l969t2642r1047b2682],
5	from	IN	O	from	dep	1	SENT_111	[p6l1057t2639r1141b2672],
6	randomisation	NN	O	randomisation	pobj	5	SENT_111	[p6l1155t2639r1407b2672],

1	Tl	NN	O	tl	_	0	SENT_112	[p6l269t2727r316b2757],
2	414 377 372 362	CD	NUMBER	414 377 372 362	num	1	SENT_112	[p6l982t2723r1048b2761],[p6l342t2728r410b2761],
3	311 276 200	CD	NUMBER	311 276 200	num	4	SENT_112	[p6l1944t2728r2010b2756],[p6l1311t2728r1372b2761],
4	CC	NN	O	cc	dep	1	SENT_112	[p6l271t2781r314b2812],
5	330 314 310 304	CD	NUMBER	330 314 310 304	number	6	SENT_112	[p6l982t2782r1050b2816],[p6l343t2782r408b2816],
6	275 233 166	CD	NUMBER	275 233 166	num	7	SENT_112	[p6l1943t2778r2010b2811],[p6l1311t2782r1372b2816],
7	CT	NN	O	ct	dep	4	SENT_112	[p6l271t2836r316b2867],
8	727 694 687 672	CD	NUMBER	727 694 687 672	num	9	SENT_112	[p6l985t2832r1047b2870],[p6l344t2837r407b2870],
9	599 524 366	CD	NUMBER	599 524 366	dep	1	SENT_112	[p6l1942t2832r2010b2871],[p6l1308t2837r1375b2871],

1	Figure	NNP	O	Figure	_	0	SENT_113	[p6l9t2949r122b2995],
2	1	CD	NUMBER	1	num	1	SENT_113	[p6l134t2953r166b2983],
3	:	:	O	:	_	0	SENT_113	[p6l134t2953r166b2983],
4	ABCB1	NN	O	abcb1	nn	5	SENT_113	[p6l175t2951r302b2984],
5	3435C	NN	O	3435c	dep	1	SENT_113	[p6l315t2951r513b2989],
6	—	CD	NUMBER	—	num	8	SENT_113	[p6l315t2951r513b2989],
7	>	JJR	O	>	amod	8	SENT_113	[p6l315t2951r513b2989],
8	T	NN	O	t	dep	5	SENT_113	[p6l315t2951r513b2989],
9	and	CC	O	and	_	0	SENT_113	[p6l523t2948r597b2984],
10	cardiovascular	JJ	O	cardiovascular	amod	11	SENT_113	[p6l608t2948r890b2984],
11	outcomes	NNS	O	outcome	conj_and	5	SENT_113	[p6l900t2954r1094b2984],
12	in	IN	O	in	_	0	SENT_113	[p6l1107t2949r1141b2983],
13	patients	NNS	O	patient	prep_in	11	SENT_113	[p6l1153t2949r1317b2994],
14	treated	VBN	O	treat	partmod	13	SENT_113	[p6l1325t2948r1471b2984],
15	with	IN	O	with	_	0	SENT_113	[p6l1480t2948r1571b2984],
16	clopidogrel	NN	O	clopidogrel	nn	18	SENT_113	[p6l1584t2948r1802b2995],
17	Cumulative	JJ	O	cumulative	amod	18	SENT_113	[p6l9t3009r221b3045],
18	risk	NN	O	risk	prep_with	14	SENT_113	[p6l235t3009r296b3045],
19	of	IN	O	of	_	0	SENT_113	[p6l307t3009r347b3045],
20	cardiovascular	JJ	O	cardiovascular	amod	21	SENT_113	[p6l356t3009r620b3045],
21	death	NN	O	death	prep_of	18	SENT_113	[p6l630t3009r745b3051],
22	,	,	O	,	_	0	SENT_113	[p6l630t3009r745b3051],
23	myocardial	JJ	O	myocardial	amod	24	SENT_113	[p6l761t3009r961b3055],
24	infarction	NN	O	infarction	prep_with	14	SENT_113	[p6l977t3009r1154b3045],
25	(	CD	NUMBER	(	num	27	SENT_113	[p6l1169t3011r1254b3054],
26	MI	NNP	O	MI	nn	27	SENT_113	[p6l1169t3011r1254b3054],
27	)	NNP	O	)	dep	24	SENT_113	[p6l1169t3011r1254b3054],
28	,	,	O	,	_	0	SENT_113	[p6l1169t3011r1254b3054],
29	or	CC	O	or	_	0	SENT_113	[p6l1267t3021r1305b3045],
30	stroke	NN	O	stroke	prep_with	14	SENT_113	[p6l1316t3009r1430b3045],
31	for	IN	O	for	_	0	SENT_113	[p6l1441t3009r1495b3045],
32	each	DT	O	each	det	33	SENT_113	[p6l1506t3009r1588b3045],
33	genotype	NN	O	genotype	prep_for	30	SENT_113	[p6l1601t3016r1787b3056],
34	,	,	O	,	_	0	SENT_113	[p6l1601t3016r1787b3056],
35	with	IN	O	with	_	0	SENT_113	[p6l1798t3009r1881b3044],
36	a	DT	O	a	det	38	SENT_113	[p6l1894t3021r1914b3045],
37	p	NN	O	p	nn	38	SENT_113	[p6l1925t3021r1947b3055],
38	value	NN	O	value	prep_with	18	SENT_113	[p6l1958t3009r2056b3045],
39	across	IN	O	across	_	0	SENT_113	[p6l8t3067r121b3091],
40	genotype	NN	O	genotype	prep_across	14	SENT_113	[p6l133t3062r319b3102],
41	.	.	O	.	_	0	SENT_113	[p6l133t3062r319b3102],

1	Gehan-Wilcoxon	JJ	MISC	gehan-wilcoxon	amod	2	SENT_114	[p6l646t3141r1074b3189],
2	test	NN	O	test	nsubjpass	4	SENT_114	[p6l1103t3151r1195b3189],
3	was	VBD	O	be	auxpass	4	SENT_114	[p6l1222t3158r1318b3189],
4	used	VBN	O	use	_	0	SENT_114	[p6l1350t3141r1472b3189],
5	for	IN	O	for	_	0	SENT_114	[p6l1502t3141r1576b3189],
6	the	DT	O	the	det	9	SENT_114	[p6l1604t3141r1685b3189],
7	primary	JJ	O	primary	amod	9	SENT_114	[p6l1715t3144r1923b3204],
8	efﬁcacy	NN	O	efﬁcacy	nn	9	SENT_114	[p6l1953t3141r2144b3204],
9	endpoint	NN	O	endpoint	prep_for	4	SENT_114	[p6l645t3218r877b3280],
10	and	CC	O	and	_	0	SENT_114	[p6l907t3218r1003b3265],
11	log-rank	NN	O	log-rank	prep_for	4	SENT_114	[p6l1032t3218r1247b3281],
12	for	IN	O	for	_	0	SENT_114	[p6l1276t3218r1349b3265],
13	other	JJ	O	other	amod	14	SENT_114	[p6l1379t3218r1514b3265],
14	endpoints	NNS	O	endpoint	prep_for	9	SENT_114	[p6l1544t3218r1814b3280],
15	.	.	O	.	_	0	SENT_114	[p6l1544t3218r1814b3280],

1	Event	NN	O	event	nn	2	SENT_115	[p6l1850t3221r1991b3265],
2	rates	NNS	O	rate	nsubjpass	4	SENT_115	[p6l2021t3227r2141b3265],
3	were	VBD	O	be	auxpass	4	SENT_115	[p6l643t3310r766b3341],
4	expressed	VBN	O	express	_	0	SENT_115	[p6l786t3293r1039b3355],
5	as	IN	O	as	mark	7	SENT_115	[p6l1057t3310r1107b3341],
6	Kaplan-Meier	NNP	O	Kaplan-Meier	nsubj	7	SENT_115	[p6l1131t3293r1479b3355],
7	estimates	VBZ	O	estimate	advcl	4	SENT_115	[p6l1498t3296r1739b3341],
8	at	IN	O	at	_	0	SENT_115	[p6l1761t3303r1806b3341],
9	15	CD	DURATION	15	num	10	SENT_115	[p6l1826t3296r1875b3341],
10	months	NNS	NUMBER	month	prep_at	7	SENT_115	[p6l1897t3293r2142b3341],
11	.	.	O	.	_	0	SENT_115	[p6l1897t3293r2142b3341],

1	”	NN	O	”	nn	3	SENT_116	[p6l1897t3293r2142b3341],
2	Hazard	NN	O	hazard	nn	3	SENT_116	[p6l647t3369r836b3417],
3	ratios	NNS	O	ratio	nsubjpass	9	SENT_116	[p6l852t3372r992b3417],
4	and	CC	O	and	_	0	SENT_116	[p6l1011t3369r1107b3417],
5	95	CD	PERCENT	95	number	6	SENT_116	[p6l1124t3372r1236b3419],
6	%	NN	PERCENT	%	amod	7	SENT_116	[p6l1124t3372r1236b3419],
7	CIs	NNS	O	ci	nsubjpass	9	SENT_116	[p6l1255t3373r1340b3417],
8	were	VBD	O	be	auxpass	9	SENT_116	[p6l1357t3386r1480b3417],
9	calculated	VBN	O	calculate	_	0	SENT_116	[p6l1498t3369r1753b3417],
10	on	IN	O	on	_	0	SENT_116	[p6l1770t3386r1835b3417],
11	the	DT	O	the	det	12	SENT_116	[p6l1851t3369r1931b3417],
12	basis	NN	O	basis	prep_on	9	SENT_116	[p6l1947t3369r2075b3417],
13	of	IN	O	of	_	0	SENT_116	[p6l2094t3369r2152b3417],
14	Cox	NN	ORGANIZATION	cox	nn	16	SENT_116	[p6l646t3450r742b3494],
15	proportional	JJ	O	proportional	amod	16	SENT_116	[p6l762t3447r1083b3509],
16	hazards	NNS	O	hazard	prep_of	12	SENT_116	[p6l1103t3447r1303b3494],
17	regression	NN	O	regression	nn	18	SENT_116	[p6l1326t3450r1596b3510],
18	models	NNS	O	model	dep	16	SENT_116	[p6l1617t3447r1803b3494],
19	with	IN	O	with	_	0	SENT_116	[p6l1825t3447r1939b3494],
20	clinical	JJ	O	clinical	amod	23	SENT_116	[p6l1961t3447r2143b3494],
21	syndrome	NN	O	syndrome	nn	23	SENT_116	[p6l646t3522r902b3585],
22	(	CD	NUMBER	(	num	23	SENT_116	[p6l921t3522r1369b3585],
23	non-ST-elevation	NN	O	non-st-elevation	prep_with	18	SENT_116	[p6l921t3522r1369b3585],
24	vs	CC	O	vs	_	0	SENT_116	[p6l1383t3539r1429b3570],
25	ST-elevation	NN	O	st-elevation	conj_vs	18	SENT_116	[p6l1445t3522r1755b3570],
26	acute	JJ	O	acute	amod	28	SENT_116	[p6l1769t3532r1903b3570],
27	coronary	JJ	O	coronary	amod	28	SENT_116	[p6l1918t3539r2144b3585],
28	syndromes	NNS	O	syndrome	dep	25	SENT_116	[p6l646t3598r944b3661],
29	)	RB	O	)	advmod	9	SENT_116	[p6l646t3598r944b3661],
30	as	IN	O	as	_	0	SENT_116	[p6l975t3615r1025b3646],
31	a	DT	O	a	det	33	SENT_116	[p6l1054t3615r1080b3646],
32	stratiﬁcation	NN	O	stratiﬁcation	nn	33	SENT_116	[p6l1108t3598r1430b3646],
33	factor	NN	O	factor	prep_as	9	SENT_116	[p6l1456t3598r1609b3646],
34	.	.	O	.	_	0	SENT_116	[p6l1456t3598r1609b3646],

1	Two-sided	JJ	O	two-sided	amod	3	SENT_117	[p6l1637t3598r1899b3646],
2	p	NN	O	p	nn	3	SENT_117	[p6l1925t3615r1956b3660],
3	values	NNS	O	value	nsubjpass	5	SENT_117	[p6l1982t3598r2141b3646],
4	were	VBD	O	be	auxpass	5	SENT_117	[p6l643t3692r766b3722],
5	calculated	VBN	O	calculate	_	0	SENT_117	[p6l797t3675r1052b3722],
6	to	TO	O	to	aux	7	SENT_117	[p6l1080t3684r1128b3722],
7	test	VB	O	test	xcomp	5	SENT_117	[p6l1157t3684r1249b3722],
8	for	IN	O	for	_	0	SENT_117	[p6l1277t3675r1351b3722],
9	differences	NNS	O	difference	prep_for	7	SENT_117	[p6l1380t3675r1662b3722],
10	in	IN	O	in	_	0	SENT_117	[p6l1693t3678r1745b3722],
11	cardiovascular	JJ	O	cardiovascular	amod	13	SENT_117	[p6l1775t3675r2144b3722],
12	event	NN	O	event	nn	13	SENT_117	[p7l645t31r782b69],
13	rates	NNS	O	rate	prep_in	9	SENT_117	[p7l809t31r929b69],
14	between	IN	O	between	_	0	SENT_117	[p7l958t21r1173b69],
15	patients	NNS	O	patient	prep_between	13	SENT_117	[p7l1200t24r1403b83],
16	stratiﬁed	VBN	O	stratiﬁed	partmod	15	SENT_117	[p7l1434t21r1660b69],
17	by	IN	O	by	_	0	SENT_117	[p7l1685t21r1746b84],
18	genotype	NN	O	genotype	agent	16	SENT_117	[p7l1773t31r2017b84],
19	.	.	O	.	_	0	SENT_117	[p7l1773t31r2017b84],

1	If	IN	O	if	mark	13	SENT_118	[p7l2051t21r2098b68],
2	a	DT	O	a	det	4	SENT_118	[p7l2117t38r2143b69],
3	signiﬁcant	JJ	O	signiﬁcant	amod	4	SENT_118	[p7l646t97r917b160],
4	association	NN	O	association	nsubjpass	13	SENT_118	[p7l938t100r1222b145],
5	for	IN	O	for	_	0	SENT_118	[p7l1243t97r1316b145],
6	the	DT	O	the	det	11	SENT_118	[p7l1336t97r1417b145],
7	primary	JJ	O	primary	amod	11	SENT_118	[p7l1438t100r1646b160],
8	e1	NN	O	e1	nn	11	SENT_118	[p7l1666t97r1858b159],
9	°	NN	O	°	nn	11	SENT_118	[p7l1666t97r1858b159],
10	ﬁcacy	NN	O	ﬁcacy	nn	11	SENT_118	[p7l1666t97r1858b159],
11	evaluation	NN	O	evaluation	prep_for	4	SENT_118	[p7l1879t97r2143b145],
12	was	VBD	O	be	auxpass	13	SENT_118	[p7l643t190r739b221],
13	identiﬁed	VBN	O	identiﬁed	advcl	25	SENT_118	[p7l793t173r1039b221],
14	in	IN	O	in	_	0	SENT_118	[p7l1090t177r1142b220],
15	patients	NNS	O	patient	prep_in	13	SENT_118	[p7l1193t177r1396b236],
16	treated	VBN	O	treat	partmod	15	SENT_118	[p7l1448t173r1626b221],
17	with	IN	O	with	_	0	SENT_118	[p7l1675t173r1790b221],
18	clopidogrel	NN	O	clopidogrel	prep_with	16	SENT_118	[p7l1842t173r2140b236],
19	,	,	O	,	_	0	SENT_118	[p7l1842t173r2140b236],
20	additional	JJ	O	additional	amod	22	SENT_118	[p7l645t249r901b297],
21	eﬁicacy	NN	O	eﬁicacy	nn	22	SENT_118	[p7l928t249r1120b312],
22	endpoints	NNS	O	endpoint	nsubjpass	25	SENT_118	[p7l1145t249r1401b311],
23	were	VBD	O	be	auxpass	25	SENT_118	[p7l1427t266r1550b297],
24	also	RB	O	also	advmod	25	SENT_118	[p7l1578t249r1677b297],
25	tested	VBN	O	test	_	0	SENT_118	[p7l1703t249r1867b304],
26	,	,	O	,	_	0	SENT_118	[p7l1703t249r1867b304],
27	including	VBG	O	include	_	0	SENT_118	[p7l1896t249r2143b312],
28	the	DT	O	the	det	29	SENT_118	[p7l644t325r724b373],
29	hazards	NNS	O	hazard	prep_including	25	SENT_118	[p7l741t325r942b373],
30	for	IN	O	for	_	0	SENT_118	[p7l961t325r1035b373],
31	the	DT	O	the	det	32	SENT_118	[p7l1051t325r1132b373],
32	components	NNS	O	component	prep_for	29	SENT_118	[p7l1150t334r1469b387],
33	of	IN	O	of	_	0	SENT_118	[p7l1489t325r1547b373],
34	the	DT	O	the	det	37	SENT_118	[p7l1555t325r1635b373],
35	composite	JJ	O	composite	amod	37	SENT_118	[p7l1654t328r1919b387],
36	primary	JJ	O	primary	amod	37	SENT_118	[p7l1937t328r2145b388],
37	endpoint	NN	O	endpoint	prep_of	32	SENT_118	[p7l645t401r889b464],
38	,	,	O	,	_	0	SENT_118	[p7l645t401r889b464],
39	the	DT	O	the	det	41	SENT_118	[p7l926t401r1006b449],
40	primary	JJ	O	primary	amod	41	SENT_118	[p7l1041t404r1249b464],
41	endpoint	NN	O	endpoint	conj_and	37	SENT_118	[p7l1283t401r1515b464],
42	at	IN	O	at	_	0	SENT_118	[p7l1550t411r1595b449],
43	30	CD	DURATION	30	num	44	SENT_118	[p7l1632t406r1689b449],
44	days	NNS	NUMBER	day	prep_at	41	SENT_118	[p7l1725t401r1850b464],
45	,	,	O	,	_	0	SENT_118	[p7l1725t401r1850b464],
46	and	CC	O	and	_	0	SENT_118	[p7l1888t401r1984b449],
47	stent	NN	O	stent	nn	48	SENT_118	[p7l2020t411r2144b449],
48	thrombosis	NN	O	thrombosis	prep_of	32	SENT_118	[p7l644t477r951b525],
49	.	.	O	.	_	0	SENT_118	[p7l644t477r951b525],

1	In	IN	O	in	_	0	SENT_119	[p7l978t482r1032b524],
2	terms	NNS	O	term	prep_in	20	SENT_119	[p7l1053t487r1201b525],
3	of	IN	O	of	_	0	SENT_119	[p7l1225t477r1283b525],
4	safety	NN	O	safety	nn	5	SENT_119	[p7l1297t477r1443b540],
5	endpoints	NNS	O	endpoint	prep_of	2	SENT_119	[p7l1463t477r1733b539],
6	,	,	O	,	_	0	SENT_119	[p7l1463t477r1733b539],
7	TIMI	NNP	O	TIMI	nsubjpass	20	SENT_119	[p7l1756t480r1892b524],
8	major	JJ	O	major	amod	11	SENT_119	[p7l1916t480r2070b540],
9	or	CC	O	or	_	0	SENT_119	[p7l2091t494r2144b525],
10	minor	JJ	O	minor	amod	11	SENT_119	[p7l644t556r807b601],
11	bleeding	NN	O	bleeding	dobj	13	SENT_119	[p7l842t553r1065b616],
12	not	RB	O	not	neg	13	SENT_119	[p7l1103t562r1188b601],
13	related	JJ	O	related	dep	7	SENT_119	[p7l1225t553r1400b601],
14	to	TO	O	to	_	0	SENT_119	[p7l1436t562r1484b600],
15	coronary	JJ	O	coronary	amod	17	SENT_119	[p7l1524t570r1750b616],
16	artery	NN	O	artery	nn	17	SENT_119	[p7l1787t562r1935b616],
17	bypass	NN	O	bypass	prep_to	13	SENT_119	[p7l1970t553r2141b616],
18	grafting	VBG	O	graft	partmod	17	SENT_119	[p7l645t629r847b692],
19	was	VBD	O	be	auxpass	20	SENT_119	[p7l872t646r968b677],
20	assessed	VBN	O	assess	_	0	SENT_119	[p7l997t629r1217b677],
21	until	IN	O	until	_	0	SENT_119	[p7l1241t629r1364b677],
22	15	CD	DURATION	15	num	23	SENT_119	[p7l1392t632r1441b677],
23	months	NNS	NUMBER	month	prep_until	20	SENT_119	[p7l1470t629r1683b677],
24	.	.	O	.	_	0	SENT_119	[p7l1470t629r1683b677],

1	Parallel	JJ	O	parallel	amod	2	SENT_120	[p7l1714t629r1902b677],
2	analyses	NNS	O	analysis	nsubjpass	4	SENT_120	[p7l1929t629r2141b692],
3	were	VBD	O	be	auxpass	4	SENT_120	[p7l643t722r766b753],
4	done	VBN	O	do	_	0	SENT_120	[p7l784t705r910b753],
5	for	IN	O	for	_	0	SENT_120	[p7l927t705r1001b753],
6	patients	NNS	O	patient	prep_for	4	SENT_120	[p7l1016t708r1219b767],
7	allocated	VBN	O	allocate	partmod	6	SENT_120	[p7l1238t705r1463b753],
8	treatment	NN	O	treatment	dobj	7	SENT_120	[p7l1478t715r1732b753],
9	with	IN	O	with	_	0	SENT_120	[p7l1747t705r1861b753],
10	prasugrel	NN	O	prasugrel	prep_with	7	SENT_120	[p7l1877t705r2134b768],
11	.	.	O	.	_	0	SENT_120	[p7l1877t705r2134b768],

1	To	TO	O	to	aux	2	SENT_121	[p7l693t785r755b829],
2	elucidate	VB	O	elucidate	purpcl	16	SENT_121	[p7l806t782r1045b829],
3	further	RB	O	further	advmod	2	SENT_121	[p7l1096t782r1286b829],
4	the	DT	O	the	det	5	SENT_121	[p7l1334t782r1417b829],
5	contribution	NN	O	contribution	dobj	2	SENT_121	[p7l1468t782r1803b829],
6	of	IN	O	of	_	0	SENT_121	[p7l1853t782r1912b829],
7	ABCB1	NN	O	abcb1	nn	8	SENT_121	[p7l1952t785r2144b829],
8	variants	NNS	O	variant	prep_of	5	SENT_121	[p7l643t861r870b913],
9	,	,	O	,	_	0	SENT_121	[p7l643t861r870b913],
10	the	DT	O	the	det	11	SENT_121	[p7l908t857r991b906],
11	associations	NNS	O	association	nsubj	16	SENT_121	[p7l1029t861r1351b906],
12	between	IN	O	between	_	0	SENT_121	[p7l1388t857r1612b906],
13	additional	JJ	O	additional	amod	15	SENT_121	[p7l1649t857r1916b906],
14	ABCB1	NN	O	abcb1	nn	15	SENT_121	[p7l1952t861r2144b906],
15	genotypes	NNS	O	genotype	prep_between	11	SENT_121	[p7l645t944r911b997],
16	(	VBP	O	(	_	0	SENT_121	[p7l947t937r1305b997],
17	2677G	NN	O	2677g	dobj	16	SENT_121	[p7l947t937r1305b997],
18	—	CD	NUMBER	—	num	20	SENT_121	[p7l947t937r1305b997],
19	>	JJR	O	>	amod	20	SENT_121	[p7l947t937r1305b997],
20	T/A	NN	O	t/a	dep	17	SENT_121	[p7l947t937r1305b997],
21	,	,	O	,	_	0	SENT_121	[p7l947t937r1305b997],
22	1236C	NN	O	1236c	dobj	16	SENT_121	[p7l1340t937r1609b989],
23	—	CD	NUMBER	—	num	25	SENT_121	[p7l1340t937r1609b989],
24	>	JJR	O	>	amod	25	SENT_121	[p7l1340t937r1609b989],
25	T	NN	O	t	dep	22	SENT_121	[p7l1340t937r1609b989],
26	,	,	O	,	_	0	SENT_121	[p7l1340t937r1609b989],
27	and	CC	O	and	_	0	SENT_121	[p7l1642t934r1740b982],
28	the	DT	O	the	det	29	SENT_121	[p7l1769t934r1852b982],
29	haplotype	NN	O	haplotype	dobj	16	SENT_121	[p7l1882t934r2142b997],
30	that	WDT	O	that	nsubj	31	SENT_121	[p7l643t1011r748b1058],
31	included	VBD	O	include	rcmod	29	SENT_121	[p7l780t1011r1014b1058],
32	1236C	NN	O	1236c	dobj	31	SENT_121	[p7l1049t1014r1318b1065],
33	—	CD	NUMBER	—	num	35	SENT_121	[p7l1049t1014r1318b1065],
34	>	JJR	O	>	amod	35	SENT_121	[p7l1049t1014r1318b1065],
35	T	NN	O	t	dep	32	SENT_121	[p7l1049t1014r1318b1065],
36	,	,	O	,	_	0	SENT_121	[p7l1049t1014r1318b1065],
37	2677G	NN	O	2677g	conj_and	32	SENT_121	[p7l1356t1014r1696b1073],
38	—	CD	NUMBER	—	num	40	SENT_121	[p7l1356t1014r1696b1073],
39	>	JJR	O	>	amod	40	SENT_121	[p7l1356t1014r1696b1073],
40	T/A	NN	O	t/a	dep	37	SENT_121	[p7l1356t1014r1696b1073],
41	,	,	O	,	_	0	SENT_121	[p7l1356t1014r1696b1073],
42	and	CC	O	and	_	0	SENT_121	[p7l1733t1011r1832b1058],
43	3435C	NN	O	3435c	conj_and	32	SENT_121	[p7l1868t1014r2140b1065],
44	—	CD	NUMBER	—	num	46	SENT_121	[p7l1868t1014r2140b1065],
45	>	JJR	O	>	amod	46	SENT_121	[p7l1868t1014r2140b1065],
46	T	NN	O	t	dep	43	SENT_121	[p7l1868t1014r2140b1065],
47	;	:	O	;	_	0	SENT_121	[p7l1868t1014r2140b1065],
48	webappendix	NN	O	webappendix	nn	49	SENT_121	[p7l643t1086r998b1148],
49	p	NN	O	p	dep	29	SENT_121	[p7l1030t1103r1061b1148],
50	1	CD	NUMBER	1	num	51	SENT_121	[p7l1098t1091r1135b1149],
51	)	NN	O	)	nsubjpass	56	SENT_121	[p7l1098t1091r1135b1149],
52	and	CC	O	and	_	0	SENT_121	[p7l1174t1086r1272b1134],
53	cardiovascular	JJ	O	cardiovascular	amod	54	SENT_121	[p7l1306t1086r1691b1134],
54	outcomes	NNS	O	outcome	conj_and	51	SENT_121	[p7l1724t1096r1981b1134],
55	were	VBD	O	be	auxpass	56	SENT_121	[p7l2015t1103r2142b1134],
56	tested	VBN	O	test	rcmod	49	SENT_121	[p7l644t1162r802b1210],
57	in	IN	O	in	_	0	SENT_121	[p7l819t1165r872b1209],
58	each	DT	O	each	det	60	SENT_121	[p7l890t1162r1010b1210],
59	treatment	NN	O	treatment	nn	60	SENT_121	[p7l1027t1172r1292b1210],
60	group	NN	O	group	prep_in	56	SENT_121	[p7l1309t1179r1480b1225],
61	,	,	O	,	_	0	SENT_121	[p7l1309t1179r1480b1225],
62	with	IN	O	with	_	0	SENT_121	[p7l1499t1162r1617b1210],
63	the	DT	O	the	det	65	SENT_121	[p7l1634t1162r1717b1210],
64	same	JJ	O	same	amod	65	SENT_121	[p7l1738t1179r1875b1210],
65	methods	NNS	O	method	prep_with	29	SENT_121	[p7l1893t1162r2140b1210],
66	.	.	O	.	_	0	SENT_121	[p7l1893t1162r2140b1210],

1	We	PRP	O	we	nsubj	3	SENT_122	[p7l643t1243r727b1287],
2	then	RB	O	then	advmod	3	SENT_122	[p7l743t1239r864b1286],
3	evaluated	VBD	O	evaluate	_	0	SENT_122	[p7l881t1239r1133b1287],
4	3435C	NN	O	3435c	dobj	3	SENT_122	[p7l1152t1242r1417b1286],
5	—	CD	NUMBER	—	num	7	SENT_122	[p7l1152t1242r1417b1286],
6	>	JJR	O	>	amod	7	SENT_122	[p7l1152t1242r1417b1286],
7	T	NN	O	t	dep	3	SENT_122	[p7l1152t1242r1417b1286],
8	in	IN	O	in	_	0	SENT_122	[p7l1432t1242r1485b1286],
9	the	DT	O	the	det	10	SENT_122	[p7l1501t1239r1584b1286],
10	context	NN	O	context	prep_in	3	SENT_122	[p7l1602t1248r1794b1286],
11	of	IN	O	of	_	0	SENT_122	[p7l1810t1239r1869b1286],
12	C	NN	O	c	nn	13	SENT_122	[p7l1881t1242r1919b1286],
13	YPZC	NN	O	ypzc	prep_of	10	SENT_122	[p7l1924t1242r2071b1286],
14	19	CD	NUMBER	19	num	13	SENT_122	[p7l2076t1243r2140b1287],
15	.	.	O	.	_	0	SENT_122	[p7l2076t1243r2140b1287],

1	We	PRP	O	we	nsubj	2	SENT_123	[p7l643t1319r727b1362],
2	created	VBD	O	create	_	0	SENT_123	[p7l746t1314r938b1362],
3	Cox	NN	PERSON	cox	prep	2	SENT_123	[p7l956t1318r1055b1362],
4	proportional	JJ	O	proportional	amod	5	SENT_123	[p7l1071t1314r1406b1376],
5	hazards	NNS	O	hazard	dep	3	SENT_123	[p7l1423t1314r1630b1362],
6	regression	NN	O	regression	nn	7	SENT_123	[p7l1650t1317r1931b1377],
7	models	NNS	O	model	dobj	2	SENT_123	[p7l1948t1314r2141b1362],
8	examining	VBG	O	examine	partmod	7	SENT_123	[p7l645t1393r929b1453],
9	3435C	NN	O	3435c	dobj	8	SENT_123	[p7l960t1393r1225b1438],
10	—	CD	NUMBER	—	num	12	SENT_123	[p7l960t1393r1225b1438],
11	>	JJR	O	>	amod	12	SENT_123	[p7l960t1393r1225b1438],
12	T	NN	O	t	tmod	8	SENT_123	[p7l960t1393r1225b1438],
13	that	WDT	O	that	nsubjpass	15	SENT_123	[p7l1251t1390r1355b1438],
14	were	VBD	O	be	auxpass	15	SENT_123	[p7l1380t1407r1507b1438],
15	adjusted	VBN	O	adjust	rcmod	12	SENT_123	[p7l1537t1390r1763b1453],
16	for	IN	O	for	_	0	SENT_123	[p7l1790t1390r1866b1438],
17	CYP2C19	NN	O	cyp2c19	nn	20	SENT_123	[p7l1897t1393r2146b1438],
18	reduced-function	NN	O	reduced-function	nn	20	SENT_123	[p7l644t1467r1107b1514],
19	allele	NN	O	allele	nn	20	SENT_123	[p7l1140t1467r1277b1514],
20	status	NN	O	status	prep_for	15	SENT_123	[p7l1313t1476r1466b1514],
21	as	RB	O	as	_	0	SENT_123	[p7l1501t1484r1552b1514],
22	well	RB	O	well	_	0	SENT_123	[p7l1585t1467r1694b1514],
23	as	IN	O	as	_	0	SENT_123	[p7l1727t1484r1779b1514],
24	models	NNS	O	model	dobj	2	SENT_123	[p7l1813t1467r2006b1514],
25	that	WDT	O	that	nsubj	26	SENT_123	[p7l2040t1467r2144b1514],
26	stratiﬁed	VBD	O	stratiﬁed	rcmod	24	SENT_123	[p7l646t1542r882b1590],
27	patients	NNS	O	patient	dobj	26	SENT_123	[p7l920t1545r1131b1604],
28	into	IN	O	into	_	0	SENT_123	[p7l1172t1545r1276b1590],
29	four	CD	NUMBER	four	num	30	SENT_123	[p7l1316t1542r1429b1590],
30	groups	NNS	O	group	prep_into	26	SENT_123	[p7l1468t1559r1651b1605],
31	on	IN	O	on	_	0	SENT_123	[p7l1692t1559r1759b1590],
32	the	DT	O	the	det	33	SENT_123	[p7l1797t1542r1880b1590],
33	basis	NN	O	basis	prep_on	26	SENT_123	[p7l1919t1542r2051b1590],
34	of	IN	O	of	_	0	SENT_123	[p7l2093t1542r2152b1590],
35	3435C	NN	O	3435c	npadvmod	37	SENT_123	[p7l647t1621r912b1666],
36	—	CD	NUMBER	—	num	35	SENT_123	[p7l647t1621r912b1666],
37	>	JJR	O	>	amod	39	SENT_123	[p7l647t1621r912b1666],
38	T	NN	O	t	nn	39	SENT_123	[p7l647t1621r912b1666],
39	genotype	NN	O	genotype	prep_of	33	SENT_123	[p7l957t1627r1197b1681],
40	and	CC	O	and	_	0	SENT_123	[p7l1243t1618r1341b1666],
41	CYPZCI9	NN	O	cypzci9	nn	44	SENT_123	[p7l1390t1621r1639b1666],
42	reduced-function	NN	O	reduced-function	nn	44	SENT_123	[p7l1681t1618r2143b1666],
43	allele	NN	O	allele	nn	44	SENT_123	[p7l645t1694r782b1742],
44	status	NN	O	status	conj_and	39	SENT_123	[p7l826t1704r995b1742],
45	.	.	O	.	_	0	SENT_123	[p7l826t1704r995b1742],

1	We	PRP	O	we	nsubj	2	SENT_124	[p7l1039t1699r1122b1742],
2	did	VBD	O	do	_	0	SENT_124	[p7l1165t1694r1249b1742],
3	a	DT	O	a	det	4	SENT_124	[p7l1291t1711r1317b1742],
4	meta-analysis	NN	O	meta-analysis	dobj	2	SENT_124	[p7l1359t1694r1722b1757],
5	that	WDT	O	that	nsubj	6	SENT_124	[p7l1765t1694r1869b1742],
6	included	VBD	O	include	rcmod	4	SENT_124	[p7l1910t1694r2144b1742],
7	results	NNS	O	result	dobj	6	SENT_124	[p7l644t1770r822b1818],
8	from	IN	O	from	_	0	SENT_124	[p7l859t1770r990b1818],
9	FAST-MI	NN	O	fast-mi	prep_from	6	SENT_124	[p7l1028t1773r1301b1818],
10	”	CD	NUMBER	”	num	9	SENT_124	[p7l1028t1773r1301b1818],
11	by	IN	O	by	_	0	SENT_124	[p7l1335t1771r1397b1833],
12	combining	VBG	O	combine	prepc_by	6	SENT_124	[p7l1431t1771r1722b1834],
13	HRS	NNS	DURATION	hr	dobj	12	SENT_124	[p7l1760t1775r1875b1818],
14	for	IN	O	for	_	0	SENT_124	[p7l1912t1770r1988b1818],
15	each	DT	O	each	det	16	SENT_124	[p7l2023t1771r2143b1818],
16	study	NN	O	study	prep_for	13	SENT_124	[p7l11t2176r214b2265],
17	using	VBG	O	use	partmod	16	SENT_124	[p7l243t2180r457b2265],
18	a	DT	O	a	det	20	SENT_124	[p7l489t2200r527b2244],
19	ﬁxed-eﬁcects	JJ	O	ﬁxed-eﬁcects	amod	20	SENT_124	[p7l558t2175r1010b2244],
20	model	NN	O	model	dobj	17	SENT_124	[p7l1044t2176r1282b2244],
21	with	IN	O	with	_	0	SENT_124	[p7l1312t2176r1481b2244],
22	weighting	NN	O	weighting	prep_with	20	SENT_124	[p7l1510t2175r1892b2265],
23	based	VBN	O	base	_	0	SENT_124	[p7l1923t2176r2141b2244],
24	on	IN	O	on	prepc_based_on	17	SENT_124	[p7l9t2285r104b2328],
25	inverse	JJ	O	inverse	amod	26	SENT_124	[p7l131t2265r404b2328],
26	Variance	NN	O	variance	pobj	17	SENT_124	[p7l430t2265r768b2328],
27	.	.	O	.	_	0	SENT_124	[p7l430t2265r768b2328],

1	We	PRP	O	we	nsubj	2	SENT_125	[p7l78t2376r196b2438],
2	tested	VBD	O	test	_	0	SENT_125	[p7l235t2370r458b2438],
3	the	DT	O	the	det	4	SENT_125	[p7l495t2370r612b2437],
4	associations	NNS	O	association	dobj	2	SENT_125	[p7l653t2374r1106b2438],
5	between	IN	O	between	_	0	SENT_125	[p7l1145t2370r1460b2438],
6	genetic	JJ	O	genetic	amod	7	SENT_125	[p7l1500t2374r1770b2460],
7	variation	NN	O	variation	nsubj	13	SENT_125	[p7l1807t2374r2140b2438],
8	and	CC	O	and	_	0	SENT_125	[p7l9t2479r148b2548],
9	pharmacodynamic	JJ	O	pharmacodynamic	amod	12	SENT_125	[p7l168t2479r874b2569],
10	and	CC	O	and	_	0	SENT_125	[p7l897t2479r1035b2548],
11	pharmacokinetic	JJ	O	pharmacokinetic	amod	12	SENT_125	[p7l1055t2479r1692b2568],
12	parameters	NNS	O	parameter	nsubj	13	SENT_125	[p7l1714t2493r2137b2568],
13	using	VBG	O	use	prepc_between	2	SENT_125	[p7l7t2593r219b2678],
14	likelihood	NN	O	likelihood	nn	16	SENT_125	[p7l244t2588r622b2656],
15	ratio	NN	O	ratio	nn	16	SENT_125	[p7l647t2593r816b2656],
16	tests	NNS	O	test	dobj	13	SENT_125	[p7l842t2602r1010b2656],
17	based	VBN	O	base	_	0	SENT_125	[p7l1037t2588r1254b2656],
18	on	IN	O	on	prepc_based_on	13	SENT_125	[p7l1279t2613r1374b2656],
19	linear	JJ	O	linear	amod	20	SENT_125	[p7l1398t2588r1618b2656],
20	regression	NN	O	regression	pobj	13	SENT_125	[p7l1642t2593r2037b2678],
21	or	CC	O	or	_	0	SENT_125	[p7l2064t2613r2141b2656],
22	mixed-eﬁﬁects	JJ	O	mixed-eﬁﬁects	amod	23	SENT_125	[p7l8t2699r508b2767],
23	models	NNS	O	model	conj_or	20	SENT_125	[p7l579t2699r872b2767],
24	.	.	O	.	_	0	SENT_125	[p7l579t2699r872b2767],

1	The	DT	O	the	det	3	SENT_126	[p7l944t2699r1088b2767],
2	primary	JJ	O	primary	amod	3	SENT_126	[p7l1157t2703r1460b2788],
3	outcomes	NNS	O	outcome	nsubj	6	SENT_126	[p7l1528t2712r1890b2767],
4	were	VBD	O	be	cop	6	SENT_126	[p7l1959t2723r2139b2767],
5	platelet	NN	O	platelet	nn	6	SENT_126	[p7l8t2807r284b2896],
6	inhibition	NN	O	inhibition	_	0	SENT_126	[p7l371t2807r747b2876],
7	(	CD	NUMBER	(	num	8	SENT_126	[p7l841t2807r1131b2897],
8	change	NN	O	change	dep	6	SENT_126	[p7l841t2807r1131b2897],
9	in	IN	O	in	_	0	SENT_126	[p7l1220t2812r1295b2874],
10	maximum	NN	O	maximum	nn	11	SENT_126	[p7l1384t2812r1778b2876],
11	platelet	NN	O	platelet	prep_in	8	SENT_126	[p7l1866t2807r2141b2896],
12	aggregation	NN	O	aggregation	nn	13	SENT_126	[p7l9t2921r475b3006],
13	)	NN	O	)	dep	23	SENT_126	[p7l9t2921r475b3006],
14	and	CC	O	and	_	0	SENT_126	[p7l536t2916r675b2984],
15	exposure	NN	O	exposure	dep	23	SENT_126	[p7l729t2940r1065b3005],
16	to	TO	O	to	_	0	SENT_126	[p7l1119t2929r1189b2984],
17	active	JJ	O	active	amod	19	SENT_126	[p7l1245t2921r1455b2984],
18	drug	NN	O	drug	nn	19	SENT_126	[p7l1511t2916r1686b3006],
19	metabolite	NN	O	metabolite	prep_to	13	SENT_126	[p7l1740t2916r2139b2984],
20	[	CD	NUMBER	[	num	21	SENT_126	[p7l13t3026r495b3116],
21	log	NN	O	log	dep	23	SENT_126	[p7l13t3026r495b3116],
22	(	CD	NUMBER	(	num	23	SENT_126	[p7l13t3026r495b3116],
23	AUC04	NN	O	auc04	dep	6	SENT_126	[p7l13t3026r495b3116],
24	)	CD	NUMBER	)	num	25	SENT_126	[p7l13t3026r495b3116],
25	]	NN	O	]	dep	23	SENT_126	[p7l13t3026r495b3116],
26	.	.	O	.	_	0	SENT_126	[p7l13t3026r495b3116],

1	The	DT	O	the	det	2	SENT_127	[p7l523t3026r667b3094],
2	models	NNS	O	model	nsubj	3	SENT_127	[p7l692t3026r964b3094],
3	contained	VBD	O	contain	_	0	SENT_127	[p7l992t3026r1363b3094],
4	subject	JJ	O	subject	acomp	3	SENT_127	[p7l1389t3026r1655b3115],
5	as	IN	O	as	_	0	SENT_127	[p7l1679t3050r1752b3094],
6	a	DT	O	a	det	8	SENT_127	[p7l1780t3050r1817b3093],
7	random	JJ	O	random	amod	8	SENT_127	[p7l1841t3026r2140b3094],
8	effect	NN	O	effect	prep_as	4	SENT_127	[p7l9t3136r213b3204],
9	when	WRB	O	when	advmod	13	SENT_127	[p7l246t3135r454b3204],
10	repeated	VBN	O	repeat	amod	11	SENT_127	[p7l489t3135r812b3224],
11	measures	NNS	O	measure	nsubj	13	SENT_127	[p7l847t3160r1208b3204],
12	were	VBD	O	be	cop	13	SENT_127	[p7l1243t3160r1423b3204],
13	present	JJ	DATE	present	dep	8	SENT_127	[p7l1459t3149r1760b3224],
14	,	,	O	,	_	0	SENT_127	[p7l1459t3149r1760b3224],
15	genotype	NN	O	genotype	prep_as	4	SENT_127	[p7l1801t3149r2139b3225],
16	as	IN	O	as	_	0	SENT_127	[p7l9t3269r82b3314],
17	the	DT	O	the	det	18	SENT_127	[p7l113t3245r230b3314],
18	predictor	NN	O	predictor	prep_as	15	SENT_127	[p7l260t3245r603b3334],
19	of	IN	O	of	_	0	SENT_127	[p7l632t3245r716b3314],
20	main	JJ	O	main	amod	21	SENT_127	[p7l732t3250r929b3314],
21	interest	NN	O	interest	prep_of	18	SENT_127	[p7l957t3250r1263b3324],
22	,	,	O	,	_	0	SENT_127	[p7l957t3250r1263b3324],
23	and	CC	O	and	_	0	SENT_127	[p7l1296t3245r1435b3314],
24	other	JJ	O	other	amod	26	SENT_127	[p7l1464t3245r1662b3314],
25	ﬁxed	JJ	O	ﬁxed	amod	26	SENT_127	[p7l1690t3245r1870b3314],
26	effects	NNS	O	effect	conj_and	8	SENT_127	[p7l1899t3245r2137b3314],
27	including	VBG	O	include	_	0	SENT_127	[p8l8t17r371b107],
28	study	NN	O	study	prep_including	26	SENT_127	[p8l444t17r655b106],
29	,	,	O	,	_	0	SENT_127	[p8l444t17r655b106],
30	dose	NN	O	dose	prep_including	26	SENT_127	[p8l730t17r918b95],
31	,	,	O	,	_	0	SENT_127	[p8l730t17r918b95],
32	and	CC	O	and	_	0	SENT_127	[p8l993t17r1132b84],
33	ethnic	JJ	O	ethnic	amod	34	SENT_127	[p8l1202t17r1436b85],
34	origin	NN	O	origin	conj_and	28	SENT_127	[p8l1507t21r1751b107],
35	,	,	O	,	_	0	SENT_127	[p8l1507t21r1751b107],
36	and	CC	O	and	_	0	SENT_127	[p8l1826t17r1965b84],
37	for	IN	O	for	_	0	SENT_127	[p8l2033t17r2141b84],
38	pharmacodynamics	NNS	O	pharmacodynamic	prep_for	4	SENT_127	[p8l8t126r772b216],
39	,	,	O	,	_	0	SENT_127	[p8l8t126r772b216],
40	maximum	NN	O	maximum	nn	42	SENT_127	[p8l822t131r1216b195],
41	platelet	NN	O	platelet	nn	42	SENT_127	[p8l1262t126r1538b215],
42	aggregation	NN	O	aggregation	appos	38	SENT_127	[p8l1584t131r2028b216],
43	at	IN	O	at	_	0	SENT_127	[p8l2075t140r2141b195],
44	baseline	NN	O	baseline	prep_at	42	SENT_127	[p8l7t235r337b303],
45	.	.	O	.	_	0	SENT_127	[p8l7t235r337b303],

1	Other	JJ	O	other	amod	3	SENT_128	[p8l435t235r652b303],
2	demographic	JJ	O	demographic	amod	3	SENT_128	[p8l743t235r1241b325],
3	variables	NNS	O	variable	nsubjpass	16	SENT_128	[p8l1329t235r1683b313],
4	,	,	O	,	_	0	SENT_128	[p8l1329t235r1683b313],
5	including	VBG	O	include	_	0	SENT_128	[p8l1777t235r2140b325],
6	bodyweight	NN	O	bodyweight	prep_including	3	SENT_128	[p8l7t345r462b435],
7	,	,	O	,	_	0	SENT_128	[p8l7t345r462b435],
8	age	NN	O	age	appos	6	SENT_128	[p8l511t369r655b435],
9	,	,	O	,	_	0	SENT_128	[p8l511t369r655b435],
10	sex	NN	O	sex	appos	6	SENT_128	[p8l706t369r839b423],
11	,	,	O	,	_	0	SENT_128	[p8l706t369r839b423],
12	and	CC	O	and	_	0	SENT_128	[p8l888t345r1027b413],
13	smoking	NN	O	smoking	appos	6	SENT_128	[p8l1073t345r1420b435],
14	,	,	O	,	_	0	SENT_128	[p8l1073t345r1420b435],
15	were	VBD	O	be	auxpass	16	SENT_128	[p8l1466t369r1646b413],
16	included	VBN	O	include	_	0	SENT_128	[p8l1691t345r2020b413],
17	as	IN	O	as	_	0	SENT_128	[p8l2064t369r2137b413],
18	judged	VBN	O	judge	prepc_as	16	SENT_128	[p8l8t453r267b543],
19	to	TO	O	to	aux	21	SENT_128	[p8l288t467r358b522],
20	be	VB	O	be	cop	21	SENT_128	[p8l382t453r468b522],
21	appropriate	JJ	O	appropriate	xcomp	18	SENT_128	[p8l494t458r927b542],
22	for	IN	O	for	_	0	SENT_128	[p8l952t453r1059b522],
23	each	DT	O	each	det	24	SENT_128	[p8l1083t453r1252b522],
24	drug	NN	O	drug	prep_for	21	SENT_128	[p8l1277t453r1471b543],
25	,	,	O	,	_	0	SENT_128	[p8l1277t453r1471b543],
26	as	IN	O	as	mark	29	SENT_128	[p8l1500t478r1573b522],
27	has	VBZ	O	have	aux	29	SENT_128	[p8l1598t453r1724b522],
28	been	VBN	O	be	auxpass	29	SENT_128	[p8l1749t453r1931b522],
29	done	VBN	O	do	dep	18	SENT_128	[p8l1956t453r2139b522],
30	previouslyf	JJ	O	previouslyf	amod	31	SENT_128	[p8l8t562r435b652],
31	‘	NN	O	‘	dobj	29	SENT_128	[p8l8t562r435b652],
32	Additional	JJ	O	additional	amod	33	SENT_128	[p8l479t562r875b630],
33	models	NNS	O	model	nsubjpass	36	SENT_128	[p8l921t562r1193b630],
34	were	VBD	O	be	auxpass	36	SENT_128	[p8l1240t587r1419b630],
35	also	RB	O	also	advmod	36	SENT_128	[p8l1467t562r1611b630],
36	created	VBN	O	create	rcmod	31	SENT_128	[p8l1660t562r1930b630],
37	with	IN	O	with	_	0	SENT_128	[p8l1973t562r2140b630],
38	adjustment	NN	O	adjustment	prep_with	36	SENT_128	[p8l9t673r439b762],
39	for	IN	O	for	_	0	SENT_128	[p8l464t673r572b741],
40	C	NN	O	c	nn	41	SENT_128	[p8l604t678r658b741],
41	YP2C1	NN	O	yp2c1	prep_for	38	SENT_128	[p8l665t678r906b741],
42	9	CD	NUMBER	9	num	41	SENT_128	[p8l918t679r969b741],
43	.	.	O	.	_	0	SENT_128	[p8l918t679r969b741],

1	Role	NN	O	role	_	0	SENT_129	[p8l13t891r170b960],
2	of	IN	O	of	_	0	SENT_129	[p8l193t891r274b960],
3	the	DT	O	the	det	5	SENT_129	[p8l288t891r415b960],
4	funding	NN	O	funding	nn	5	SENT_129	[p8l436t891r741b982],
5	source	NN	O	source	prep_of	1	SENT_129	[p8l767t914r1012b960],
6	The	DT	O	the	det	7	SENT_129	[p8l7t1002r152b1070],
7	TRITON	NNP	ORGANIZATION	TRITON	dep	5	SENT_129	[p8l184t1006r762b1070],
8	.	.	O	.	_	0	SENT_129	[p8l184t1006r762b1070],

1	—	NN	O	—	_	0	SENT_130	[p8l184t1006r762b1070],
2	.	.	O	.	_	0	SENT_130	[p8l184t1006r762b1070],

1	TIMI	NNP	ORGANIZATION	TIMI	nsubjpass	8	SENT_131	[p8l184t1006r762b1070],
2	38	CD	NUMBER	38	num	1	SENT_131	[p8l803t1008r884b1070],
3	genetic	JJ	O	genetic	amod	4	SENT_131	[p8l920t1006r1190b1092],
4	study	NN	O	study	dep	1	SENT_131	[p8l1224t1002r1426b1091],
5	was	VBD	O	be	auxpass	6	SENT_131	[p8l1455t1026r1594b1070],
6	designed	VBN	O	design	_	0	SENT_131	[p8l1631t1002r1970b1092],
7	and	CC	O	and	_	0	SENT_131	[p8l2002t1002r2141b1070],
8	undertaken	VBN	O	undertake	conj_and	6	SENT_131	[p8l7t1110r443b1179],
9	in	IN	O	in	_	0	SENT_131	[p8l490t1115r565b1177],
10	collaboration	NN	O	collaboration	prep_in	6	SENT_131	[p8l614t1110r1105b1179],
11	between	IN	O	between	_	0	SENT_131	[p8l1151t1110r1466b1179],
12	the	DT	O	the	det	15	SENT_131	[p8l1512t1110r1630b1179],
13	TIMI	NNP	ORGANIZATION	TIMI	nn	15	SENT_131	[p8l1677t1115r1873b1177],
14	Study	NNP	ORGANIZATION	Study	nn	15	SENT_131	[p8l1931t1110r2142b1200],
15	Group	NNP	ORGANIZATION	Group	prep_between	10	SENT_131	[p8l11t1225r249b1309],
16	and	CC	O	and	_	0	SENT_131	[p8l278t1220r416b1289],
17	the	DT	O	the	det	18	SENT_131	[p8l441t1220r558b1289],
18	sponsors	NNS	O	sponsor	prep_between	10	SENT_131	[p8l588t1244r943b1309],
19	.	.	O	.	_	0	SENT_131	[p8l588t1244r943b1309],

1	The	DT	O	the	det	3	SENT_132	[p8l972t1220r1117b1289],
2	academic	JJ	O	academic	amod	3	SENT_132	[p8l1145t1220r1497b1289],
3	authors	NNS	O	author	nsubj	18	SENT_132	[p8l1525t1220r1808b1289],
4	directed	VBN	O	direct	dep	3	SENT_132	[p8l1838t1220r2141b1289],
5	and	CC	O	and	_	0	SENT_132	[p8l9t1331r148b1399],
6	had	VBD	O	have	dep	3	SENT_132	[p8l184t1331r324b1399],
7	access	NN	O	access	dobj	6	SENT_132	[p8l362t1355r593b1399],
8	to	TO	O	to	_	0	SENT_132	[p8l633t1344r702b1399],
9	all	PDT	O	all	predet	11	SENT_132	[p8l743t1331r828b1399],
10	the	DT	O	the	det	11	SENT_132	[p8l865t1331r983b1399],
11	analyses	NNS	O	analysis	prep_to	6	SENT_132	[p8l1023t1331r1333b1420],
12	and	CC	O	and	_	0	SENT_132	[p8l1376t1331r1514b1399],
13	the	DT	O	the	det	16	SENT_132	[p8l1551t1331r1667b1399],
14	full	JJ	O	full	amod	16	SENT_132	[p8l1707t1331r1833b1399],
15	clinical	JJ	O	clinical	amod	16	SENT_132	[p8l1872t1331r2140b1399],
16	database	NN	O	database	prep_to	6	SENT_132	[p8l9t1440r352b1519],
17	,	,	O	,	_	0	SENT_132	[p8l9t1440r352b1519],
18	wrote	VBD	O	write	_	0	SENT_132	[p8l375t1454r585b1509],
19	all	DT	O	all	det	20	SENT_132	[p8l609t1440r694b1509],
20	drafts	NNS	O	draft	dobj	18	SENT_132	[p8l717t1440r926b1509],
21	of	IN	O	of	_	0	SENT_132	[p8l951t1440r1035b1509],
22	the	DT	O	the	det	23	SENT_132	[p8l1042t1440r1160b1509],
23	report	NN	O	report	prep_of	20	SENT_132	[p8l1181t1454r1429b1529],
24	,	,	O	,	_	0	SENT_132	[p8l1181t1454r1429b1529],
25	decided	VBD	O	decide	partmod	23	SENT_132	[p8l1455t1440r1745b1509],
26	to	TO	O	to	aux	27	SENT_132	[p8l1764t1454r1834b1509],
27	publish	VB	O	publish	xcomp	25	SENT_132	[p8l1855t1440r2140b1529],
28	the	DT	O	the	det	29	SENT_132	[p8l7t1550r125b1618],
29	results	NNS	O	result	dobj	27	SENT_132	[p8l147t1550r419b1628],
30	,	,	O	,	_	0	SENT_132	[p8l147t1550r419b1628],
31	and	CC	O	and	_	0	SENT_132	[p8l446t1550r584b1618],
32	vouch	NN	O	vouch	conj_and	20	SENT_132	[p8l603t1550r830b1618],
33	for	IN	O	for	_	0	SENT_132	[p8l852t1550r960b1618],
34	the	DT	O	the	det	35	SENT_132	[p8l979t1550r1096b1618],
35	accuracy	NN	O	accuracy	prep_for	32	SENT_132	[p8l1120t1574r1443b1639],
36	and	CC	O	and	_	0	SENT_132	[p8l1465t1550r1603b1618],
37	completeness	NN	O	completeness	prep_for	32	SENT_132	[p8l1625t1550r2138b1639],
38	of	IN	O	of	_	0	SENT_132	[p8l9t1660r93b1727],
39	the	DT	O	the	det	40	SENT_132	[p8l105t1660r223b1727],
40	data	NNS	O	datum	prep_of	35	SENT_132	[p8l251t1660r424b1727],
41	.	.	O	.	_	0	SENT_132	[p8l251t1660r424b1727],

1	Results	NNS	O	result	_	0	SENT_133	[p8l14t1868r321b1947],

1	For	IN	O	for	_	0	SENT_134	[p8l13t1993r134b2056],
2	the	DT	O	the	det	4	SENT_134	[p8l168t1989r285b2056],
3	2932	CD	DATE	2932	num	4	SENT_134	[p8l325t1995r497b2057],
4	patients	NNS	O	patient	pobj	1	SENT_134	[p8l536t1993r830b2078],
5	in	IN	O	in	_	0	SENT_134	[p8l870t1993r944b2055],
6	the	DT	O	the	det	7	SENT_134	[p8l980t1989r1097b2056],
7	TRITON	NNP	ORGANIZATION	TRITON	prep_in	4	SENT_134	[p8l1133t1993r1707b2057],
8	.	.	O	.	_	0	SENT_134	[p8l1133t1993r1707b2057],

1	—	NN	O	—	_	0	SENT_135	[p8l1133t1993r1707b2057],
2	.	.	O	.	_	0	SENT_135	[p8l1133t1993r1707b2057],

1	TIMI	NNP	ORGANIZATION	TIMI	tmod	12	SENT_136	[p8l1133t1993r1707b2057],
2	38	CD	NUMBER	38	num	1	SENT_136	[p8l1752t1995r1834b2056],
3	genetic	JJ	O	genetic	amod	4	SENT_136	[p8l1873t1993r2140b2079],
4	substudy	NN	O	substudy	dep	1	SENT_136	[p8l11t2097r357b2187],
5	,	,	O	,	_	0	SENT_136	[p8l11t2097r357b2187],
6	the	DT	O	the	det	8	SENT_136	[p8l409t2097r525b2166],
7	average	JJ	O	average	amod	8	SENT_136	[p8l577t2122r855b2187],
8	age	NN	O	age	nsubj	12	SENT_136	[p8l907t2122r1030b2187],
9	was	VBD	O	be	cop	12	SENT_136	[p8l1078t2122r1217b2166],
10	60-2	CD	NUMBER	60-2	num	12	SENT_136	[p8l1271t2103r1440b2166],
11	(	CD	NUMBER	(	num	12	SENT_136	[p8l1498t2103r1631b2187],
12	SD	NN	O	sd	_	0	SENT_136	[p8l1498t2103r1631b2187],
13	10-9	CD	NUMBER	10-9	number	14	SENT_136	[p8l1687t2103r1872b2187],
14	)	CD	NUMBER	)	num	15	SENT_136	[p8l1687t2103r1872b2187],
15	years	NNS	NUMBER	year	tmod	12	SENT_136	[p8l1925t2122r2136b2187],
16	,	,	O	,	_	0	SENT_136	[p8l1925t2122r2136b2187],
17	831	CD	PERCENT	831	conj_and	12	SENT_136	[p8l9t2212r132b2274],
18	(	CD	PERCENT	(	num	20	SENT_136	[p8l166t2211r372b2296],
19	28	CD	PERCENT	28	num	20	SENT_136	[p8l166t2211r372b2296],
20	%	NN	PERCENT	%	nsubj	23	SENT_136	[p8l166t2211r372b2296],
21	)	CD	NUMBER	)	dep	20	SENT_136	[p8l166t2211r372b2296],
22	were	VBD	O	be	cop	23	SENT_136	[p8l405t2231r583b2274],
23	women	NNS	O	woman	rcmod	17	SENT_136	[p8l610t2231r909b2284],
24	,	,	O	,	_	0	SENT_136	[p8l610t2231r909b2284],
25	2064	CD	PERCENT	2064	number	26	SENT_136	[p8l944t2212r1117b2274],
26	(	CD	PERCENT	(	appos	23	SENT_136	[p8l1147t2211r1347b2296],
27	70	CD	PERCENT	70	num	28	SENT_136	[p8l1147t2211r1347b2296],
28	%	NN	PERCENT	%	dep	26	SENT_136	[p8l1147t2211r1347b2296],
29	)	CD	NUMBER	)	dep	12	SENT_136	[p8l1147t2211r1347b2296],
30	presented	VBN	O	present	partmod	29	SENT_136	[p8l1381t2206r1750b2295],
31	with	IN	O	with	_	0	SENT_136	[p8l1775t2206r1941b2274],
32	nonST-elevation	JJ	O	nonst-elevation	amod	35	SENT_136	[p8l1969t2231r2138b2274, p8l14t2316r464b2384],
33	acute	JJ	O	acute	amod	35	SENT_136	[p8l504t2329r698b2384],
34	coronary	JJ	O	coronary	amod	35	SENT_136	[p8l738t2340r1065b2405],
35	syndromes	NNS	O	syndrome	prep_with	30	SENT_136	[p8l1105t2316r1533b2405],
36	,	,	O	,	_	0	SENT_136	[p8l1105t2316r1533b2405],
37	and	CC	O	and	_	0	SENT_136	[p8l1576t2316r1714b2384],
38	868	CD	PERCENT	868	number	39	SENT_136	[p8l1752t2322r1882b2383],
39	(	CD	PERCENT	(	conj_and	12	SENT_136	[p8l1928t2320r2134b2406],
40	30	CD	PERCENT	30	num	41	SENT_136	[p8l1928t2320r2134b2406],
41	%	NN	PERCENT	%	dep	39	SENT_136	[p8l1928t2320r2134b2406],
42	)	CD	NUMBER	)	dep	39	SENT_136	[p8l1928t2320r2134b2406],
43	presented	VBN	O	present	partmod	39	SENT_136	[p8l8t2424r377b2513],
44	with	IN	O	with	_	0	SENT_136	[p8l418t2424r584b2493],
45	ST-elevation	NN	MISC	st-elevation	nn	47	SENT_136	[p8l633t2424r1083b2493],
46	myocardial	JJ	O	myocardial	amod	47	SENT_136	[p8l1127t2424r1539b2514],
47	infarction	NN	O	infarction	prep_with	43	SENT_136	[p8l1583t2424r1968b2493],
48	.	.	O	.	_	0	SENT_136	[p8l1583t2424r1968b2493],

1	For	IN	O	for	_	0	SENT_137	[p8l2020t2429r2141b2493],
2	ABCB1	NN	O	abcb1	nn	3	SENT_137	[p8l7t2538r276b2601],
3	3435C	NN	O	3435c	prep_for	21	SENT_137	[p8l314t2537r691b2611],
4	—	CD	NUMBER	—	num	6	SENT_137	[p8l314t2537r691b2611],
5	>	JJR	O	>	amod	6	SENT_137	[p8l314t2537r691b2611],
6	T	NN	O	t	dep	3	SENT_137	[p8l314t2537r691b2611],
7	,	,	O	,	_	0	SENT_137	[p8l314t2537r691b2611],
8	804	CD	PERCENT	804	number	9	SENT_137	[p8l730t2539r860b2601],
9	(	CD	PERCENT	(	amod	13	SENT_137	[p8l896t2537r1095b2623],
10	27	CD	PERCENT	27	num	11	SENT_137	[p8l896t2537r1095b2623],
11	%	NN	PERCENT	%	dep	9	SENT_137	[p8l896t2537r1095b2623],
12	)	NN	O	)	nn	13	SENT_137	[p8l896t2537r1095b2623],
13	participants	NNS	O	participant	nsubj	21	SENT_137	[p8l1135t2538r1575b2622],
14	in	IN	O	in	_	0	SENT_137	[p8l1612t2538r1687b2600],
15	the	DT	O	the	det	18	SENT_137	[p8l1720t2533r1836b2601],
16	genetic	JJ	O	genetic	amod	18	SENT_137	[p8l1873t2538r2140b2623],
17	study	NN	O	study	nn	18	SENT_137	[p8l11t2643r211b2732],
18	population	NN	O	population	prep_in	13	SENT_137	[p8l241t2643r646b2732],
19	were	VBD	O	be	cop	21	SENT_137	[p8l677t2667r856b2711],
20	TT	NN	O	tt	nn	21	SENT_137	[p8l888t2647r997b2709],
21	homozygotes	NNS	O	homozygote	_	0	SENT_137	[p8l1028t2643r1545b2733],
22	,	,	O	,	_	0	SENT_137	[p8l1028t2643r1545b2733],
23	1459	CD	PERCENT	1459	number	24	SENT_137	[p8l1584t2647r1743b2711],
24	(	CD	PERCENT	(	conj_and	21	SENT_137	[p8l1783t2647r1990b2733],
25	50	CD	PERCENT	50	num	26	SENT_137	[p8l1783t2647r1990b2733],
26	%	NN	PERCENT	%	dep	24	SENT_137	[p8l1783t2647r1990b2733],
27	)	CD	NUMBER	)	num	29	SENT_137	[p8l1783t2647r1990b2733],
28	CT	NN	O	ct	nn	29	SENT_137	[p8l2032t2647r2141b2711],
29	heterozygotes	NNS	O	heterozygote	dep	24	SENT_137	[p8l7t2751r543b2841],
30	,	,	O	,	_	0	SENT_137	[p8l7t2751r543b2841],
31	and	CC	O	and	_	0	SENT_137	[p8l573t2751r711b2820],
32	669	CD	PERCENT	669	number	33	SENT_137	[p8l737t2757r865b2820],
33	(	CD	PERCENT	(	conj_and	21	SENT_137	[p8l898t2756r1105b2841],
34	23	CD	PERCENT	23	num	35	SENT_137	[p8l898t2756r1105b2841],
35	%	NN	PERCENT	%	dep	33	SENT_137	[p8l898t2756r1105b2841],
36	)	CD	NUMBER	)	num	38	SENT_137	[p8l898t2756r1105b2841],
37	CC	NN	O	cc	nn	38	SENT_137	[p8l1139t2757r1251b2820],
38	homozygotes	NNS	O	homozygote	dep	33	SENT_137	[p8l1278t2751r1793b2841],
39	.	.	O	.	_	0	SENT_137	[p8l1278t2751r1793b2841],

1	Baseline	NN	O	baseline	nn	2	SENT_138	[p8l1827t2751r2139b2820],
2	characteristics	NNS	O	characteristic	_	0	SENT_138	[p8l9t2860r541b2928],
3	in	IN	O	in	_	0	SENT_138	[p8l563t2865r638b2927],
4	the	DT	O	the	det	5	SENT_138	[p8l656t2860r772b2928],
5	TRITON	NNP	ORGANIZATION	TRITON	prep_in	2	SENT_138	[p8l792t2864r1365b2928],
6	.	.	O	.	_	0	SENT_138	[p8l792t2864r1365b2928],

1	—	NN	O	—	_	0	SENT_139	[p8l792t2864r1365b2928],
2	.	.	O	.	_	0	SENT_139	[p8l792t2864r1365b2928],

1	TIMI	NNP	ORGANIZATION	TIMI	nn	3	SENT_140	[p8l792t2864r1365b2928],
2	38	CD	NUMBER	38	num	3	SENT_140	[p8l1393t2866r1474b2928],
3	trial	NN	O	trial	nsubjpass	11	SENT_140	[p8l1493t2860r1643b2928],
4	by	IN	O	by	_	0	SENT_140	[p8l1661t2860r1748b2950],
5	3435C	NN	O	3435c	npadvmod	7	SENT_140	[p8l1770t2864r2141b2928],
6	—	CD	NUMBER	—	num	5	SENT_140	[p8l1770t2864r2141b2928],
7	>	JJR	O	>	amod	9	SENT_140	[p8l1770t2864r2141b2928],
8	T	NN	O	t	nn	9	SENT_140	[p8l1770t2864r2141b2928],
9	genotype	NN	O	genotype	prep_by	3	SENT_140	[p8l10t2983r345b3059],
10	are	VBP	O	be	auxpass	11	SENT_140	[p8l373t2994r484b3038],
11	shown	VBN	O	show	_	0	SENT_140	[p8l513t2969r757b3038],
12	in	IN	O	in	_	0	SENT_140	[p8l782t2974r857b3036],
13	the	DT	O	the	det	15	SENT_140	[p8l881t2970r997b3038],
14	webappendix	NN	O	webappendix	nn	15	SENT_140	[p8l1022t2969r1519b3058],
15	p	NN	O	p	prep_in	11	SENT_140	[p8l1541t2994r1586b3058],
16	6	CD	NUMBER	6	tmod	11	SENT_140	[p8l1614t2976r1673b3038],
17	.	.	O	.	_	0	SENT_140	[p8l1614t2976r1673b3038],

1	In	IN	O	in	_	0	SENT_141	[p8l83t3085r161b3145],
2	patients	NNS	O	patient	pobj	1	SENT_141	[p8l197t3083r485b3167],
3	in	IN	O	in	_	0	SENT_141	[p8l524t3083r597b3145],
4	the	DT	O	the	det	5	SENT_141	[p8l633t3078r747b3147],
5	TRITON	NNP	ORGANIZATION	TRITON	prep_in	2	SENT_141	[p8l784t3083r1348b3147],
6	.	.	O	.	_	0	SENT_141	[p8l784t3083r1348b3147],

1	—	NN	O	—	_	0	SENT_142	[p8l784t3083r1348b3147],
2	.	.	O	.	_	0	SENT_142	[p8l784t3083r1348b3147],

1	TIMI	NNP	ORGANIZATION	TIMI	nsubjpass	25	SENT_143	[p8l784t3083r1348b3147],
2	38	CD	NUMBER	38	num	1	SENT_143	[p8l1393t3084r1473b3147],
3	genetic	JJ	O	genetic	amod	4	SENT_143	[p8l1512t3083r1774b3168],
4	substudy	NN	O	substudy	nsubj	14	SENT_143	[p8l1813t3078r2142b3168],
5	who	WP	O	who	nsubjpass	7	SENT_143	[p8l7t3187r162b3255],
6	were	VBD	O	be	auxpass	7	SENT_143	[p8l185t3211r360b3255],
7	allocated	VBN	O	allocate	rcmod	4	SENT_143	[p8l386t3187r706b3255],
8	to	TO	O	to	_	0	SENT_143	[p8l727t3200r796b3255],
9	treatment	NN	O	treatment	prep_to	7	SENT_143	[p8l820t3200r1181b3255],
10	with	IN	O	with	_	0	SENT_143	[p8l1202t3187r1365b3255],
11	clopidogrel	NN	O	clopidogrel	nn	13	SENT_143	[p8l1389t3187r1795b3277],
12	(	CD	NUMBER	(	num	13	SENT_143	[p8l1825t3191r2136b3277],
13	n	NN	O	n	prep_with	7	SENT_143	[p8l1825t3191r2136b3277],
14	=	JJ	O	=	rcmod	1	SENT_143	[p8l1825t3191r2136b3277],
15	1471	CD	DATE	1471	num	16	SENT_143	[p8l1825t3191r2136b3277],
16	)	NN	O	)	dobj	14	SENT_143	[p8l1825t3191r2136b3277],
17	,	,	O	,	_	0	SENT_143	[p8l1825t3191r2136b3277],
18	3435C	NN	O	3435c	appos	16	SENT_143	[p8l13t3301r378b3365],
19	—	CD	NUMBER	—	num	18	SENT_143	[p8l13t3301r378b3365],
20	>	JJR	O	>	amod	22	SENT_143	[p8l13t3301r378b3365],
21	T	NN	O	t	nn	22	SENT_143	[p8l13t3301r378b3365],
22	genotype	NN	O	genotype	dep	18	SENT_143	[p8l408t3310r737b3386],
23	was	VBD	O	be	auxpass	25	SENT_143	[p8l766t3321r902b3365],
24	signiﬁcantly	RB	O	signiﬁcantly	advmod	25	SENT_143	[p8l937t3296r1384b3386],
25	associated	VBN	O	associate	_	0	SENT_143	[p8l1413t3296r1785b3365],
26	with	IN	O	with	_	0	SENT_143	[p8l1811t3297r1974b3365],
27	risk	NN	O	risk	prep_with	25	SENT_143	[p8l2003t3296r2142b3365],
28	of	IN	O	of	_	0	SENT_143	[p8l9t3405r92b3473],
29	the	DT	O	the	det	31	SENT_143	[p8l92t3405r207b3473],
30	primary	JJ	O	primary	amod	31	SENT_143	[p8l222t3410r517b3495],
31	endpoint	NN	O	endpoint	prep_of	27	SENT_143	[p8l531t3405r861b3494],
32	of	IN	O	of	_	0	SENT_143	[p8l875t3405r957b3473],
33	cardiovascular	JJ	O	cardiovascular	amod	34	SENT_143	[p8l960t3405r1485b3473],
34	death	NN	O	death	prep_of	31	SENT_143	[p8l1499t3405r1717b3483],
35	,	,	O	,	_	0	SENT_143	[p8l1499t3405r1717b3483],
36	myocardial	JJ	O	myocardial	amod	37	SENT_143	[p8l1735t3405r2140b3495],
37	infarction	NN	O	infarction	prep_of	31	SENT_143	[p8l8t3514r385b3592],
38	,	,	O	,	_	0	SENT_143	[p8l8t3514r385b3592],
39	or	CC	O	or	_	0	SENT_143	[p8l413t3538r488b3582],
40	stroke	NN	O	stroke	nn	42	SENT_143	[p8l512t3514r732b3582],
41	(	NN	O	(	nn	42	SENT_143	[p8l762t3520r920b3604],
42	p	NN	O	p	prep_of	31	SENT_143	[p8l762t3520r920b3604],
43	=	JJ	O	=	amod	44	SENT_143	[p8l762t3520r920b3604],
44	o	NN	O	o	dep	42	SENT_143	[p8l762t3520r920b3604],
45	-	:	O	-	_	0	SENT_143	[p8l937t3553r948b3565],
46	0064	CD	DATE	0064	prep_of	31	SENT_143	[p8l965t3520r1151b3592],
47	;	:	O	;	_	0	SENT_143	[p8l965t3520r1151b3592],
48	ﬁgure	NN	O	ﬁgure	nn	50	SENT_143	[p8l1178t3514r1395b3604],
49	1	CD	NUMBER	1	num	50	SENT_143	[p8l1422t3520r1496b3604],
50	)	NN	O	)	prep_of	31	SENT_143	[p8l1422t3520r1496b3604],
51	.	.	O	.	_	0	SENT_143	[p8l1422t3520r1496b3604],

1	TT	NN	O	tt	nn	2	SENT_144	[p8l1522t3519r1630b3581],
2	homozygotes	NNS	O	homozygote	nsubjpass	6	SENT_144	[p8l1651t3514r2138b3604],
3	were	VBD	O	be	auxpass	6	SENT_144	[p8l7t3648r182b3692],
4	at	IN	O	at	advmod	6	SENT_144	[p8l229t3637r293b3691],
5	signiﬁcantly	RB	O	signiﬁcantly	advmod	6	SENT_144	[p8l340t3624r787b3714],
6	increased	VBN	O	increase	dep	36	SENT_144	[p8l830t3624r1180b3692],
7	risk	NN	O	risk	dobj	6	SENT_144	[p8l1224t3624r1363b3692],
8	compared	VBN	O	compare	_	0	SENT_144	[p8l1407t3624r1774b3713],
9	with	IN	O	with	prepc_compared_with	6	SENT_144	[p8l1816t3624r1979b3692],
10	CC	NN	O	cc	nn	11	SENT_144	[p8l2027t3629r2137b3692],
11	individuals	NNS	O	individual	pobj	6	SENT_144	[p8l8t3732r411b3801],
12	(	VBP	O	(	dep	11	SENT_144	[p8l433t3739r585b3822],
13	HR	NN	DURATION	hr	dobj	12	SENT_144	[p8l433t3739r585b3822],
14	1	CD	NUMBER	1	num	13	SENT_144	[p8l601t3738r659b3799],
15	-	:	O	-	_	0	SENT_144	[p8l601t3738r659b3799],
16	69	CD	DATE	69	nsubj	29	SENT_144	[p8l677t3738r779b3810],
17	,	,	O	,	_	0	SENT_144	[p8l677t3738r779b3810],
18	95	CD	PERCENT	95	num	19	SENT_144	[p8l798t3737r957b3804],
19	%	NN	PERCENT	%	dep	16	SENT_144	[p8l798t3737r957b3804],
20	CI	NN	O	ci	dep	19	SENT_144	[p8l975t3738r1057b3801],
21	1	CD	NUMBER	1	num	20	SENT_144	[p8l1078t3739r1108b3799],
22	-	:	O	-	_	0	SENT_144	[p8l1125t3772r1136b3783],
23	05-2	CD	NUMBER	05-2	num	25	SENT_144	[p8l1153t3737r1324b3801],
24	-72	CD	NUMBER	-72	num	25	SENT_144	[p8l1343t3737r1470b3822],
25	)	NN	O	)	dep	19	SENT_144	[p8l1343t3737r1470b3822],
26	;	:	O	;	_	0	SENT_144	[p8l1481t3757r1494b3811],
27	CT	NN	O	ct	nn	28	SENT_144	[p8l1514t3737r1623b3801],
28	heterozygotes	NNS	O	heterozygote	dep	25	SENT_144	[p8l1634t3732r2137b3822],
29	were	VBD	O	be	parataxis	6	SENT_144	[p9l7t45r182b88],
30	at	IN	O	at	_	0	SENT_144	[p9l222t34r287b88],
31	similar	JJ	O	similar	amod	32	SENT_144	[p9l327t20r584b88],
32	risk	NN	O	risk	prep_at	29	SENT_144	[p9l621t20r760b88],
33	to	TO	O	to	_	0	SENT_144	[p9l795t34r864b88],
34	CC	NN	O	cc	nn	35	SENT_144	[p9l906t25r1016b88],
35	individuals	NNS	O	individual	prep_to	29	SENT_144	[p9l1058t20r1460b89],
36	(	VBP	O	(	_	0	SENT_144	[p9l1508t27r1660b110],
37	HR	NN	DURATION	hr	dobj	36	SENT_144	[p9l1508t27r1660b110],
38	094	CD	NUMBER	094	nsubj	36	SENT_144	[p9l1698t26r1882b98],
39	,	,	O	,	_	0	SENT_144	[p9l1698t26r1882b98],
40	o	NN	O	o	appos	38	SENT_144	[p9l1925t26r1994b88],
41	-	:	O	-	_	0	SENT_144	[p9l1925t26r1994b88],
42	581-51	CD	NUMBER	581-51	num	43	SENT_144	[p9l2014t25r2142b88, p9l12t134r207b220],
43	)	NN	O	)	dep	40	SENT_144	[p9l2014t25r2142b88, p9l12t134r207b220],
44	.	.	O	.	_	0	SENT_144	[p9l2014t25r2142b88, p9l12t134r207b220],

1	Thus	RB	O	thus	advmod	14	SENT_145	[p9l251t130r458b208],
2	,	,	O	,	_	0	SENT_145	[p9l251t130r458b208],
3	TT	NN	O	tt	nn	4	SENT_145	[p9l501t134r609b196],
4	homozygotes	NNS	O	homozygote	nsubj	14	SENT_145	[p9l648t130r1134b220],
5	for	IN	O	for	_	0	SENT_145	[p9l1177t130r1282b197],
6	3435C	NN	O	3435c	prep_for	4	SENT_145	[p9l1326t134r1691b198],
7	—	CD	NUMBER	—	num	6	SENT_145	[p9l1326t134r1691b198],
8	>	JJR	O	>	amod	9	SENT_145	[p9l1326t134r1691b198],
9	T	NN	O	t	nsubj	10	SENT_145	[p9l1326t134r1691b198],
10	had	VBD	O	have	rcmod	6	SENT_145	[p9l1730t130r1867b197],
11	a	DT	O	a	quantmod	12	SENT_145	[p9l1908t154r1945b197],
12	72	CD	PERCENT	72	num	13	SENT_145	[p9l1984t134r2139b201],
13	%	NN	PERCENT	%	dobj	10	SENT_145	[p9l1984t134r2139b201],
14	increased	VBD	O	increase	_	0	SENT_145	[p9l8t238r359b307],
15	risk	NN	O	risk	dobj	14	SENT_145	[p9l379t238r518b307],
16	of	IN	O	of	_	0	SENT_145	[p9l539t238r622b307],
17	the	DT	O	the	det	19	SENT_145	[p9l630t238r744b307],
18	primary	JJ	O	primary	amod	19	SENT_145	[p9l767t243r1062b328],
19	endpoint	NN	O	endpoint	prep_of	15	SENT_145	[p9l1083t238r1414b327],
20	compared	VBN	O	compare	_	0	SENT_145	[p9l1435t238r1801b327],
21	with	IN	O	with	prepc_compared_with	14	SENT_145	[p9l1820t238r1983b307],
22	CT	NN	O	ct	dep	14	SENT_145	[p9l2008t243r2137b327],
23	/	:	O	/	punct	22	SENT_145	[p9l2008t243r2137b327],
24	CC	NN	O	cc	nn	25	SENT_145	[p9l11t352r122b415],
25	individuals	NNS	O	individual	nsubj	26	SENT_145	[p9l145t347r548b415],
26	(	VBP	O	(	dep	22	SENT_145	[p9l577t347r1097b437],
27	Kaplan-Meier	JJ	O	kaplan-meier	amod	29	SENT_145	[p9l577t347r1097b437],
28	event	NN	O	event	nn	29	SENT_145	[p9l1118t360r1313b415],
29	rates	NNS	O	rate	dobj	26	SENT_145	[p9l1332t360r1504b415],
30	12	CD	NUMBER	12	dep	29	SENT_145	[p9l1530t353r1602b414],
31	-	:	O	-	_	0	SENT_145	[p9l1621t386r1632b398],
32	9	CD	PERCENT	9	num	33	SENT_145	[p9l1650t351r1764b418],
33	%	NN	PERCENT	%	dep	29	SENT_145	[p9l1650t351r1764b418],
34	[	CD	NUMBER	[	number	35	SENT_145	[p9l1791t351r1891b436],
35	52	CD	NUMBER	52	num	33	SENT_145	[p9l1791t351r1891b436],
36	of	IN	O	of	_	0	SENT_145	[p9l1916t347r1998b415],
37	414	CD	NUMBER	414	number	38	SENT_145	[p9l2004t353r2135b436],
38	]	CD	NUMBER	]	prep_of	33	SENT_145	[p9l2004t353r2135b436],
39	vs	CC	O	vs	_	0	SENT_145	[p9l8t482r73b525],
40	7-8	CD	PERCENT	7-8	num	41	SENT_145	[p9l100t462r296b529],
41	%	NN	PERCENT	%	dep	29	SENT_145	[p9l100t462r296b529],
42	[	CD	NUMBER	[	number	43	SENT_145	[p9l331t464r433b547],
43	80	CD	NUMBER	80	num	41	SENT_145	[p9l331t464r433b547],
44	of	IN	O	of	_	0	SENT_145	[p9l465t458r547b526],
45	1057	CD	DATE	1057	num	46	SENT_145	[p9l566t462r724b529],
46	participants	NNS	O	participant	prep_of	41	SENT_145	[p9l751t462r1223b547],
47	]	CD	NUMBER	]	dep	41	SENT_145	[p9l751t462r1223b547],
48	;	:	O	;	_	0	SENT_145	[p9l751t462r1223b547],
49	I-IR	NN	O	i-ir	dep	29	SENT_145	[p9l1261t464r1387b525],
50	1-72	CD	NUMBER	1-72	num	49	SENT_145	[p9l1419t462r1591b536],
51	,	,	O	,	_	0	SENT_145	[p9l1419t462r1591b536],
52	95	CD	PERCENT	95	number	53	SENT_145	[p9l1625t462r1783b529],
53	%	NN	PERCENT	%	amod	54	SENT_145	[p9l1625t462r1783b529],
54	CI	NN	O	ci	appos	49	SENT_145	[p9l1817t463r1899b526],
55	1222-44	CD	NUMBER	1222-44	dep	54	SENT_145	[p9l1936t464r2142b525, p9l11t573r189b645],
56	,	,	O	,	_	0	SENT_145	[p9l1936t464r2142b525, p9l11t573r189b645],
57	p	NN	O	p	appos	29	SENT_145	[p9l229t572r561b656],
58	=	JJ	O	=	advmod	26	SENT_145	[p9l229t572r561b656],
59	0-002	CD	NUMBER	0-002	num	60	SENT_145	[p9l229t572r561b656],
60	)	CD	NUMBER	)	dep	58	SENT_145	[p9l229t572r561b656],
61	when	WRB	O	when	advmod	62	SENT_145	[p9l603t566r807b635],
62	assessed	VBN	O	assess	dep	58	SENT_145	[p9l846t566r1159b635],
63	until	IN	O	until	_	0	SENT_145	[p9l1194t566r1368b635],
64	15	CD	DURATION	15	num	65	SENT_145	[p9l1408t571r1479b634],
65	months	NNS	NUMBER	month	prep_until	62	SENT_145	[p9l1520t566r1823b635],
66	.	.	O	.	_	0	SENT_145	[p9l1520t566r1823b635],

1	Among	IN	O	among	_	0	SENT_146	[p9l1863t572r2140b656],
2	3435	CD	NUMBER	3435	num	3	SENT_146	[p9l13t680r174b744],
3	TT	NN	O	tt	prep_among	15	SENT_146	[p9l200t680r308b743],
4	versus	CC	O	versus	prep	3	SENT_146	[p9l328t700r561b744],
5	CT	NN	O	ct	dep	4	SENT_146	[p9l590t680r719b765],
6	/	:	O	/	punct	8	SENT_146	[p9l590t680r719b765],
7	CC	NN	O	cc	nn	8	SENT_146	[p9l726t681r838b744],
8	patients	NNS	O	patient	dep	5	SENT_146	[p9l863t681r1172b765],
9	,	,	O	,	_	0	SENT_146	[p9l863t681r1172b765],
10	the	DT	DATE	the	det	11	SENT_146	[p9l1197t676r1312b744],
11	HR	NN	DATE	hr	nsubj	15	SENT_146	[p9l1340t683r1467b743],
12	for	IN	O	for	_	0	SENT_146	[p9l1489t676r1594b744],
13	cardiovascular	JJ	O	cardiovascular	amod	14	SENT_146	[p9l1617t676r2141b744],
14	death	NN	O	death	prep_for	11	SENT_146	[p9l9t786r210b854],
15	was	VBD	O	be	_	0	SENT_146	[p9l229t810r365b854],
16	1	LS	NUMBER	1	dep	60	SENT_146	[p9l392t792r450b852],
17	-	:	O	-	_	0	SENT_146	[p9l392t792r450b852],
18	63	CD	DATE	63	number	19	SENT_146	[p9l468t792r548b854],
19	(	CD	NUMBER	(	dep	26	SENT_146	[p9l579t786r1099b875],
20	Kaplan-Meier	NNP	O	Kaplan-Meier	prep	19	SENT_146	[p9l579t786r1099b875],
21	event	NN	O	event	dep	20	SENT_146	[p9l1119t799r1314b854],
22	rates	NNS	O	rate	nsubj	26	SENT_146	[p9l1334t799r1506b854],
23	1	LS	NUMBER	1	dep	26	SENT_146	[p9l1532t792r1590b852],
24	-	:	O	-	_	0	SENT_146	[p9l1532t792r1590b852],
25	3	CD	PERCENT	3	num	26	SENT_146	[p9l1610t790r1722b857],
26	%	NN	PERCENT	%	dep	60	SENT_146	[p9l1610t790r1722b857],
27	[	CD	NUMBER	[	num	28	SENT_146	[p9l1748t785r1893b874],
28	ﬁve	NN	O	ﬁve	dep	26	SENT_146	[p9l1748t785r1893b874],
29	of	IN	O	of	_	0	SENT_146	[p9l1916t785r1999b854],
30	414	CD	NUMBER	414	number	31	SENT_146	[p9l2005t792r2135b874],
31	]	CD	NUMBER	]	prep_of	28	SENT_146	[p9l2005t792r2135b874],
32	vs	CC	O	vs	_	0	SENT_146	[p9l8t919r73b962],
33	0-9	CD	PERCENT	0-9	dep	34	SENT_146	[p9l98t899r299b965],
34	%	NN	PERCENT	%	advmod	26	SENT_146	[p9l98t899r299b965],
35	[	CD	NUMBER	[	number	36	SENT_146	[p9l330t894r532b984],
36	eight	CD	NUMBER	eight	conj_vs	26	SENT_146	[p9l330t894r532b984],
37	of	IN	O	of	_	0	SENT_146	[p9l558t894r640b963],
38	1057	CD	DATE	1057	number	39	SENT_146	[p9l656t899r851b983],
39	]	CD	NUMBER	]	prep_of	36	SENT_146	[p9l656t899r851b983],
40	;	:	O	;	_	0	SENT_146	[p9l656t899r851b983],
41	95	CD	PERCENT	95	number	42	SENT_146	[p9l882t899r1041b966],
42	%	NN	PERCENT	%	amod	43	SENT_146	[p9l882t899r1041b966],
43	CI	NN	O	ci	conj_vs	26	SENT_146	[p9l1071t900r1153b963],
44	0-53-4-98	CD	NUMBER	0-53-4-98	dep	43	SENT_146	[p9l1183t899r1585b973],
45	,	,	O	,	_	0	SENT_146	[p9l1183t899r1585b973],
46	p	NN	O	p	nsubj	60	SENT_146	[p9l1614t900r1971b984],
47	=	JJ	O	=	amod	49	SENT_146	[p9l1614t900r1971b984],
48	0-388	CD	NUMBER	0-388	tmod	47	SENT_146	[p9l1614t900r1971b984],
49	)	NN	O	)	rcmod	46	SENT_146	[p9l1614t900r1971b984],
50	,	,	O	,	_	0	SENT_146	[p9l1614t900r1971b984],
51	that	IN	O	that	advmod	49	SENT_146	[p9l1999t894r2141b963],
52	for	IN	O	for	_	0	SENT_146	[p9l8t1003r113b1071],
53	non-fatal	JJ	O	non-fatal	amod	55	SENT_146	[p9l137t1003r463b1071],
54	myocardial	JJ	O	myocardial	amod	55	SENT_146	[p9l488t1003r893b1092],
55	infarction	NN	O	infarction	prep_for	51	SENT_146	[p9l918t1003r1276b1071],
56	was	VBD	O	be	aux	60	SENT_146	[p9l1299t1027r1436b1071],
57	1	LS	NUMBER	1	dep	60	SENT_146	[p9l1466t1009r1524b1070],
58	-	:	O	-	_	0	SENT_146	[p9l1466t1009r1524b1070],
59	82	CD	DATE	82	number	60	SENT_146	[p9l1541t1009r1624b1071],
60	(	CD	NUMBER	(	dep	15	SENT_146	[p9l1657t1009r1753b1093],
61	12	CD	NUMBER	12	dep	60	SENT_146	[p9l1657t1009r1753b1093],
62	-	:	O	-	_	0	SENT_146	[p9l1772t1042r1783b1054],
63	o	NN	PERCENT	o	nn	64	SENT_146	[p9l1800t1007r1916b1074],
64	%	NN	PERCENT	%	dep	60	SENT_146	[p9l1800t1007r1916b1074],
65	[	CD	NUMBER	[	number	66	SENT_146	[p9l1946t1009r2043b1092],
66	48	CD	NUMBER	48	dep	64	SENT_146	[p9l1946t1009r2043b1092],
67	of	IN	O	of	_	0	SENT_146	[p9l2070t1003r2153b1071],
68	414	CD	NUMBER	414	number	69	SENT_146	[p9l7t1119r138b1201],
69	]	CD	NUMBER	]	prep_of	66	SENT_146	[p9l7t1119r138b1201],
70	vs	CC	O	vs	_	0	SENT_146	[p9l173t1137r238b1180],
71	6-8	CD	PERCENT	6-8	num	72	SENT_146	[p9l270t1117r470b1184],
72	%	NN	PERCENT	%	conj_vs	60	SENT_146	[p9l270t1117r470b1184],
73	[	CD	NUMBER	[	number	74	SENT_146	[p9l507t1117r603b1201],
74	70	CD	NUMBER	70	num	76	SENT_146	[p9l507t1117r603b1201],
75	of1057	NN	O	of1057	nn	76	SENT_146	[p9l637t1112r936b1201],
76	]	NN	O	]	dep	72	SENT_146	[p9l637t1112r936b1201],
77	;	:	O	;	_	0	SENT_146	[p9l637t1112r936b1201],
78	1-26-2-62	CD	NUMBER	1-26-2-62	dep	60	SENT_146	[p9l974t1119r1370b1191],
79	,	,	O	,	_	0	SENT_146	[p9l974t1119r1370b1191],
80	p	NN	O	p	nsubj	81	SENT_146	[p9l1405t1119r1797b1202],
81	=	JJ	O	=	dep	60	SENT_146	[p9l1405t1119r1797b1202],
82	0-0013	CD	NUMBER	0-0013	num	83	SENT_146	[p9l1405t1119r1797b1202],
83	)	NN	O	)	dobj	81	SENT_146	[p9l1405t1119r1797b1202],
84	,	,	O	,	_	0	SENT_146	[p9l1405t1119r1797b1202],
85	and	CC	O	and	cc	83	SENT_146	[p9l1833t1113r1969b1181],
86	that	IN	O	that	advmod	83	SENT_146	[p9l1999t1113r2141b1181],

1	Articles	NNPS	O	Articles	_	0	SENT_147	[p9l6t1681r156b1717],
2	I	PRP	O	I	dep	1	SENT_147	[p9l204t1518r252b1716],

1	vwvvv	NN	O	vwvvv	_	0	SENT_148	[p9l794t1383r1327b1434],
2	.	.	O	.	_	0	SENT_148	[p9l794t1383r1327b1434],

1	the	DT	O	the	det	2	SENT_149	[p9l794t1383r1327b1434],
2	|	NN	O	|	_	0	SENT_149	[p9l794t1383r1327b1434],
3	ancet.com	NNP	O	ancet.com	nn	4	SENT_149	[p9l794t1383r1327b1434],
4	Vol	NNP	O	Vol	dep	2	SENT_149	[p9l1370t1383r1457b1434],
5	376	CD	NUMBER	376	num	6	SENT_149	[p9l1477t1382r1580b1441],
6	October	NNP	DATE	October	dep	2	SENT_149	[p9l1626t1383r1850b1434],
7	16,2010	CD	DATE	16,2010	num	6	SENT_149	[p9l1867t1382r2111b1443],

1	Clopidogrel	NNP	O	Clopidogrel	_	0	SENT_150	[p9l713t1913r837b1940],
2	I	PRP	O	I	dep	1	SENT_150	[p9l668t1960r679b1977],
3	-	:	O	-	_	0	SENT_150	[p9l668t1960r679b1977],
4	|	SYM	O	|	dep	6	SENT_150	[p9l668t1960r679b1977],
5	-	:	O	-	_	0	SENT_150	[p9l680t1960r694b1980],
6	is	VBZ	O	be	dep	1	SENT_150	[p9l680t1960r694b1980],

1	I-I	NN	O	i-i	nn	4	SENT_151	[p9l670t2060r680b2077],
2	N	NN	O	n	nn	4	SENT_151	[p9l682t2060r693b2077],
3	H	NN	O	h	nn	4	SENT_151	[p9l669t2160r679b2176],
4	O	NN	O	o	_	0	SENT_151	[p9l681t2160r693b2177],

1	oo	NN	O	oo	nn	3	SENT_152	[p9l681t2257r693b2277],
2	cular	JJ	O	cular	amod	3	SENT_152	[p9l631t2371r651b2419],
3	death	NN	O	death	dep	11	SENT_152	[p9l631t2302r655b2365],
4	,	,	O	,	_	0	SENT_152	[p9l631t2302r655b2365],
5	MI	NNP	O	MI	dep	11	SENT_152	[p9l633t2263r655b2293],
6	,	,	O	,	_	0	SENT_152	[p9l633t2263r655b2293],
7	or	CC	O	or	_	0	SENT_152	[p9l638t2235r651b2256],
8	stroke	NN	O	stroke	conj_or	3	SENT_152	[p9l631t2166r651b2229],
9	(	CD	PERCENT	(	num	10	SENT_152	[p9l632t2127r656b2159],
10	%	NN	PERCENT	%	dep	11	SENT_152	[p9l632t2127r656b2159],
11	)	CD	NUMBER	)	_	0	SENT_152	[p9l632t2127r656b2159],
12	ON	IN	O	on	prep	11	SENT_152	[p9l681t2356r693b2376],

1	Cardiovas	NNP	O	Cardiovas	_	0	SENT_153	[p9l631t2421r651b2520],
2	4	CD	NUMBER	4	number	3	SENT_153	[p9l680t2459r694b2479],
3	>	JJR	O	>	amod	1	SENT_153	[p9l680t2459r694b2479],

1	:	:	O	:	_	0	SENT_154	[p9l1119t2535r1167b2538],
2	CYP	NN	O	cyp	nn	3	SENT_154	[p9l1176t2527r1214b2545],
3	reduced-fu	NN	O	reduced-fu	_	0	SENT_154	[p9l1274t2525r1383b2545],
4	nction	NN	O	nction	nn	5	SENT_154	[p9l1387t2527r1450b2545],
5	carrier	NN	O	carrier	dep	3	SENT_154	[p9l1458t2527r1522b2545],
6	and	CC	O	and	_	0	SENT_154	[p9l1528t2525r1565b2545],
7	ABCB1	NN	O	abcb1	conj_and	3	SENT_154	[p9l1571t2527r1637b2545],
8	3435	CD	NUMBER	3435	number	9	SENT_154	[p9l1643t2528r1695b2548],
9	‘	CD	NUMBER	‘	dep	7	SENT_154	[p9l1700t2527r1728b2545],
10	IT	PRP	O	it	dep	3	SENT_154	[p9l1700t2527r1728b2545],

1	2	CD	NUMBER	2	num	3	SENT_155	[p9l682t2559r693b2576],
2	T	NN	O	t	nn	3	SENT_155	[p9l1119t2568r1167b2570],
3	CYP	NN	O	cyp	nsubj	4	SENT_155	[p9l1176t2559r1214b2578],
4	reduced	VBD	O	reduce	_	0	SENT_155	[p9l1273t2557r1383b2578],
5	—	CD	NUMBER	—	iobj	4	SENT_155	[p9l1273t2557r1383b2578],
6	fu	NN	O	fu	nn	8	SENT_155	[p9l1273t2557r1383b2578],
7	nction	NN	O	nction	nn	8	SENT_155	[p9l1387t2559r1450b2578],
8	non-carrier	NN	O	non-carrier	dobj	4	SENT_155	[p9l1459t2559r1572b2578],
9	and	CC	O	and	_	0	SENT_155	[p9l1578t2558r1616b2578],
10	ABCB1	NN	O	abcb1	nn	11	SENT_155	[p9l1621t2559r1687b2578],
11	3435TT	NN	O	3435tt	dobj	4	SENT_155	[p9l1694t2560r1778b2580],
12	:	:	O	:	_	0	SENT_155	[p9l1120t2601r1167b2603],
13	CYP2C19	NN	O	cyp2c19	nn	16	SENT_155	[p9l1176t2592r1265b2613],
14	reduced-fu	NN	O	reduced-fu	nn	16	SENT_155	[p9l1273t2590r1383b2610],
15	nction	NN	O	nction	nn	16	SENT_155	[p9l1387t2592r1450b2610],
16	carrier	NN	O	carrier	dep	8	SENT_155	[p9l1458t2592r1522b2610],
17	and	CC	O	and	_	0	SENT_155	[p9l1528t2590r1565b2610],
18	ABCB1	NN	O	abcb1	conj_and	16	SENT_155	[p9l1571t2592r1637b2610],
19	3	CD	NUMBER	3	num	22	SENT_155	[p9l1643t2593r1655b2613],
20	CC/CT	NN	O	cc/ct	nn	22	SENT_155	[p9l1702t2591r1764b2613],
21	T	NN	O	t	nn	22	SENT_155	[p9l1119t2631r1167b2633],
22	CYPZCI9	NN	O	cypzci9	nsubj	23	SENT_155	[p9l1176t2624r1265b2645],
23	reduced	VBD	O	reduce	rcmod	16	SENT_155	[p9l1273t2623r1450b2643],
24	—	CD	NUMBER	—	num	25	SENT_155	[p9l1273t2623r1450b2643],
25	function	NN	O	function	iobj	23	SENT_155	[p9l1273t2623r1450b2643],
26	non-carrier	JJ	O	non-carrier	dobj	23	SENT_155	[p9l1459t2624r1572b2643],
27	and	CC	O	and	_	0	SENT_155	[p9l1578t2623r1616b2643],
28	AB	NNP	O	AB	dobj	23	SENT_155	[p9l1621t2624r1649b2642],
29	3435	CD	NUMBER	3435	num	31	SENT_155	[p9l1694t2625r1746b2645],
30	CC/CT	NNP	O	CC/CT	nn	31	SENT_155	[p9l1753t2623r1815b2645],
31	o	NN	O	o	dep	28	SENT_155	[p9l706t2686r718b2703],
32	310	CD	NUMBER	310	number	33	SENT_155	[p9l769t2668r795b2706],
33	6	CD	NUMBER	6	dep	31	SENT_155	[p9l840t2668r866b2703],
34	'	''	O	'	_	0	SENT_155	[p9l840t2668r866b2703],
35	0	CD	NUMBER	0	dobj	23	SENT_155	[p9l840t2668r866b2703],
36	9	CD	NUMBER	9	dep	35	SENT_155	[p9l910t2666r936b2706],
37	'	''	O	'	_	0	SENT_155	[p9l910t2666r936b2706],
38	0	CD	NUMBER	0	num	39	SENT_155	[p9l910t2666r936b2706],
39	120	CD	NUMBER	120	dobj	23	SENT_155	[p9l975t2668r1012b2703],
40	150	CD	NUMBER	150	number	41	SENT_155	[p9l1045t2666r1083b2706],
41	18	CD	NUMBER	18	num	42	SENT_155	[p9l1115t2668r1154b2703],
42	|	NN	O	|	dep	39	SENT_155	[p9l1115t2668r1154b2703],
43	0	CD	NUMBER	0	num	44	SENT_155	[p9l1115t2668r1154b2703],
44	2ClO	NN	O	2clo	dep	39	SENT_155	[p9l1186t2666r1224b2703],
45	240 270 300	CD	NUMBER	240 270 300	number	46	SENT_155	[p9l1396t2666r1436b2706],[p9l1256t2668r1295b2706],
46	33	CD	NUMBER	33	num	47	SENT_155	[p9l1467t2668r1506b2706],
47	|	NN	O	|	dep	44	SENT_155	[p9l1467t2668r1506b2706],
48	’	CD	NUMBER	’	num	49	SENT_155	[p9l1467t2668r1506b2706],
49	O	NN	O	o	dep	44	SENT_155	[p9l1467t2668r1506b2706],
50	300	CD	MONEY	300	number	51	SENT_155	[p9l1537t2666r1577b2706],
51	3	CD	MONEY	3	num	52	SENT_155	[p9l1607t2668r1647b2706],
52	£	NN	MONEY	£	dep	49	SENT_155	[p9l1607t2668r1647b2706],
53	l	NN	O	l	tmod	49	SENT_155	[p9l1607t2668r1647b2706],
54	)	CD	NUMBER	)	num	55	SENT_155	[p9l1607t2668r1647b2706],
55	0	CD	NUMBER	0	dep	49	SENT_155	[p9l1607t2668r1647b2706],
56	420	CD	NUMBER	420	number	57	SENT_155	[p9l1678t2666r1718b2706],
57	450	CD	NUMBER	450	dep	55	SENT_155	[p9l1748t2668r1788b2706],

1	Number	NN	O	number	_	0	SENT_156	[p9l511t2743r600b2763],
2	at	IN	O	at	dep	1	SENT_156	[p9l605t2746r627b2763],
3	risk	NN	O	risk	nn	4	SENT_156	[p9l634t2743r672b2763],
4	Days	NNS	DURATION	day	pobj	2	SENT_156	[p9l1117t2726r1164b2750],
5	from	IN	O	from	dep	1	SENT_156	[p9l1169t2724r1219b2744],
6	randomisation	NN	O	randomisation	pobj	5	SENT_156	[p9l1228t2725r1378b2744],

1	CYP2C19	NN	O	cyp2c19	nn	3	SENT_157	[p9l121t2777r210b2798],
2	reduced-function	NN	O	reduced-function	nn	3	SENT_157	[p9l218t2775r395b2795],
3	carrier	NN	O	carrier	dep	7	SENT_157	[p9l402t2777r466b2795],
4	and	CC	O	and	_	0	SENT_157	[p9l472t2775r510b2795],
5	ABCB1	NN	O	abcb1	conj_and	3	SENT_157	[p9l515t2777r581b2795],
6	3435	CD	NUMBER	3435	dep	7	SENT_157	[p9l588t2778r639b2798],
7	T	NN	O	t	dep	17	SENT_157	[p9l644t2777r672b2795],
8	"	''	O	"	punct	7	SENT_157	[p9l644t2777r672b2795],
9	125 110 108 105	CD	NUMBER	125 110 108 105	num	10	SENT_157	[p9l1115t2777r1152b2797],[p9l694t2777r730b2797],
10	90	CD	NUMBER	90	dep	7	SENT_157	[p9l1338t2777r1364b2797],
11	83	CD	NUMBER	83	number	12	SENT_157	[p9l1548t2774r1573b2797],
12	58	CD	NUMBER	58	num	16	SENT_157	[p9l1759t2774r1784b2797],
13	CYP2C19	NN	O	cyp2c19	nn	16	SENT_157	[p9l70t2809r159b2830],
14	reduced-function	NN	O	reduced-function	nn	16	SENT_157	[p9l167t2807r344b2828],
15	non-carrier	JJ	O	non-carrier	amod	16	SENT_157	[p9l353t2809r466b2828],
16	andABCB1	NN	O	andabcb1	dep	10	SENT_157	[p9l472t2808r581b2828],
17	34351	CD	NUMBER	34351	dep	19	SENT_157	[p9l588t2810r672b2830],
18	"	``	O	"	punct	19	SENT_157	[p9l588t2810r672b2830],
19	288 266 263 256	CD	NUMBER	288 266 263 256	_	0	SENT_157	[p9l1114t2807r1153b2830],[p9l692t2807r732b2827],
20	220 193 142	CD	NUMBER	220 193 142	num	21	SENT_157	[p9l1747t2810r1784b2830],[p9l1326t2810r1364b2827],
21	CYP2C19	NN	O	cyp2c19	nsubj	22	SENT_157	[p9l84t2842r173b2863],
22	reduced	VBD	O	reduce	rcmod	19	SENT_157	[p9l181t2840r358b2860],
23	~	CD	NUMBER	~	num	25	SENT_157	[p9l181t2840r358b2860],
24	function	NN	O	function	nn	25	SENT_157	[p9l181t2840r358b2860],
25	carrier	NN	O	carrier	iobj	22	SENT_157	[p9l365t2842r429b2860],
26	and	CC	O	and	_	0	SENT_157	[p9l435t2840r473b2860],
27	ABCB1	NN	O	abcb1	nn	29	SENT_157	[p9l478t2842r544b2860],
28	3435	CD	NUMBER	3435	num	29	SENT_157	[p9l551t2843r603b2863],
29	CC/C	NNP	O	CC/C	conj_and	25	SENT_157	[p9l609t2841r672b2863],
30	"	``	O	"	punct	33	SENT_157	[p9l609t2841r672b2863],
31	268 252 250 241	CD	NUMBER	268 252 250 241	number	32	SENT_157	[p9l1115t2842r1153b2862],[p9l691t2839r732b2859],
32	214 185 123	CD	NUMBER	214 185 123	num	33	SENT_157	[p9l1748t2842r1784b2862],[p9l1326t2842r1365b2862],
33	CYPZCI9	NN	O	cypzci9	dobj	22	SENT_157	[p9l33t2874r122b2895],
34	reduced	VBD	O	reduce	partmod	33	SENT_157	[p9l130t2872r240b2893],
35	—	CD	NUMBER	—	num	38	SENT_157	[p9l130t2872r240b2893],
36	fu	NN	O	fu	nn	38	SENT_157	[p9l130t2872r240b2893],
37	nction	NN	O	nction	nn	38	SENT_157	[p9l244t2874r307b2893],
38	non-carrier	NN	O	non-carrier	dobj	34	SENT_157	[p9l316t2874r429b2893],
39	and	CC	O	and	_	0	SENT_157	[p9l435t2873r473b2893],
40	ABCB1	NN	O	abcb1	nn	42	SENT_157	[p9l478t2874r544b2893],
41	3435	CD	NUMBER	3435	num	42	SENT_157	[p9l551t2875r603b2895],
42	CC/C	NNP	O	CC/C	dobj	22	SENT_157	[p9l609t2873r672b2895],
43	"	``	O	"	punct	42	SENT_157	[p9l609t2873r672b2895],
44	773 740 733 721	CD	NUMBER	773 740 733 721	num	45	SENT_157	[p9l1115t2875r1152b2894],[p9l693t2875r729b2895],
45	649 562 400	CD	NUMBER	649 562 400	dep	42	SENT_157	[p9l1744t2875r1785b2895],[p9l1323t2872r1364b2895],

1	Figure	NN	O	figure	_	0	SENT_158	[p9l7t2950r75b2977],
2	2	CD	NUMBER	2	num	1	SENT_158	[p9l80t2952r100b2970],
3	:	:	O	:	_	0	SENT_158	[p9l80t2952r100b2970],
4	ABCB1	NN	O	abcb1	nn	5	SENT_158	[p9l106t2951r182b2970],
5	3435C	NN	O	3435c	dep	1	SENT_158	[p9l189t2951r312b2974],
6	—	CD	NUMBER	—	num	8	SENT_158	[p9l189t2951r312b2974],
7	>	JJR	O	>	amod	8	SENT_158	[p9l189t2951r312b2974],
8	T	NN	O	t	dep	5	SENT_158	[p9l189t2951r312b2974],
9	,	,	O	,	_	0	SENT_158	[p9l189t2951r312b2974],
10	CYP2C19	NN	O	cyp2c19	appos	8	SENT_158	[p9l320t2951r428b2974],
11	,	,	O	,	_	0	SENT_158	[p9l320t2951r428b2974],
12	and	CC	O	and	_	0	SENT_158	[p9l436t2949r479b2970],
13	cardiovascular	JJ	O	cardiovascular	amod	14	SENT_158	[p9l486t2949r654b2970],
14	outcomes	NNS	O	outcome	conj_and	5	SENT_158	[p9l660t2953r775b2970],
15	in	IN	O	in	_	0	SENT_158	[p9l783t2950r803b2970],
16	patients	NNS	O	patient	prep_in	14	SENT_158	[p9l810t2950r907b2977],
17	treated	VBN	O	treat	partmod	16	SENT_158	[p9l912t2949r999b2970],
18	with	IN	O	with	_	0	SENT_158	[p9l1005t2949r1058b2970],
19	clopidogrel	NN	O	clopidogrel	nn	21	SENT_158	[p9l1066t2949r1196b2977],
20	Cumulative	JJ	O	cumulative	amod	21	SENT_158	[p9l6t2985r166b3012],
21	risk	NN	O	risk	prep_with	17	SENT_158	[p9l176t2985r223b3012],
22	of	IN	O	of	_	0	SENT_158	[p9l230t2985r261b3012],
23	cardiovascular	JJ	O	cardiovascular	amod	24	SENT_158	[p9l267t2985r467b3012],
24	death	NN	O	death	prep_of	21	SENT_158	[p9l475t2985r562b3017],
25	,	,	O	,	_	0	SENT_158	[p9l475t2985r562b3017],
26	myocardial	JJ	O	myocardial	amod	27	SENT_158	[p9l573t2985r725b3021],
27	infarction	NN	O	infarction	conj_or	21	SENT_158	[p9l736t2985r871b3012],
28	(	CD	NUMBER	(	num	30	SENT_158	[p9l882t2987r946b3020],
29	MI	NNP	O	MI	nn	30	SENT_158	[p9l882t2987r946b3020],
30	)	NNP	O	)	dep	27	SENT_158	[p9l882t2987r946b3020],
31	,	,	O	,	_	0	SENT_158	[p9l882t2987r946b3020],
32	or	CC	O	or	_	0	SENT_158	[p9l956t2994r985b3012],
33	stroke	NN	O	stroke	prep_with	17	SENT_158	[p9l993t2985r1079b3012],
34	for	IN	O	for	_	0	SENT_158	[p9l1087t2985r1128b3012],
35	the	DT	O	the	det	38	SENT_158	[p9l1134t2985r1181b3012],
36	four	CD	NUMBER	four	num	38	SENT_158	[p9l1189t2985r1248b3012],
37	genotype	NN	O	genotype	nn	38	SENT_158	[p9l1256t2990r1389b3021],
38	categories	NNS	O	category	prep_for	33	SENT_158	[p9l1398t2987r1549b3021],
39	,	,	O	,	_	0	SENT_158	[p9l1398t2987r1549b3021],
40	with	IN	O	with	_	0	SENT_158	[p9l1557t2985r1620b3012],
41	the	DT	O	the	det	43	SENT_158	[p9l1628t2985r1674b3012],
42	p	NN	O	p	nn	43	SENT_158	[p9l1683t2994r1700b3021],
43	value	NN	O	value	prep_with	21	SENT_158	[p9l1708t2985r1782b3012],
44	across	IN	O	across	_	0	SENT_158	[p9l1791t2994r1876b3012],
45	genotype	NN	O	genotype	nn	46	SENT_158	[p9l1885t2990r2018b3021],
46	category	NN	O	category	prep_across	17	SENT_158	[p9l2027t2990r2154b3021],
47	.	.	O	.	_	0	SENT_158	[p9l2027t2990r2154b3021],

1	for	IN	O	for	_	0	SENT_159	[p9l7t3141r113b3208],
2	non-fatal	JJ	O	non-fatal	amod	3	SENT_159	[p9l144t3141r472b3208],
3	stroke	NN	O	stroke	prep_for	6	SENT_159	[p9l508t3141r728b3209],
4	was	VBD	O	be	cop	6	SENT_159	[p9l760t3165r898b3209],
5	1-66	CD	PERCENT	1-66	num	6	SENT_159	[p9l936t3147r1095b3209],
6	(	CD	PERCENT	(	_	0	SENT_159	[p9l1136t3145r1360b3231],
7	0-6	CD	PERCENT	0-6	num	8	SENT_159	[p9l1136t3145r1360b3231],
8	%	NN	PERCENT	%	dep	6	SENT_159	[p9l1136t3145r1360b3231],
9	[	CD	NUMBER	[	number	10	SENT_159	[p9l1398t3147r1545b3230],
10	two	CD	NUMBER	two	num	8	SENT_159	[p9l1398t3147r1545b3230],
11	of	IN	O	of	_	0	SENT_159	[p9l1581t3141r1663b3208],
12	414	CD	NUMBER	414	num	13	SENT_159	[p9l1681t3147r1813b3230],
13	]	CD	NUMBER	]	prep_of	8	SENT_159	[p9l1681t3147r1813b3230],
14	vs	CC	O	vs	_	0	SENT_159	[p9l1850t3165r1916b3208],
15	o	NN	O	o	prep_of	8	SENT_159	[p9l1947t3147r2016b3209],
16	-	:	O	-	_	0	SENT_159	[p9l1947t3147r2016b3209],
17	3	CD	PERCENT	3	num	18	SENT_159	[p9l2037t3145r2149b3212],
18	%	NN	PERCENT	%	dep	13	SENT_159	[p9l2037t3145r2149b3212],
19	[	CD	NUMBER	[	number	20	SENT_159	[p9l12t3249r217b3338],
20	three	CD	NUMBER	three	num	18	SENT_159	[p9l12t3249r217b3338],
21	of	IN	O	of	_	0	SENT_159	[p9l234t3249r317b3318],
22	1057	CD	DATE	1057	num	23	SENT_159	[p9l321t3254r480b3320],
23	participants	NNS	O	participant	prep_of	18	SENT_159	[p9l493t3254r967b3338],
24	]	CD	NUMBER	]	dep	18	SENT_159	[p9l493t3254r967b3338],
25	;	:	O	;	_	0	SENT_159	[p9l493t3254r967b3338],
26	o	NN	O	o	dep	13	SENT_159	[p9l987t3255r1056b3318],
27	-	:	O	-	_	0	SENT_159	[p9l987t3255r1056b3318],
28	28-9	CD	NUMBER	28-9	dep	13	SENT_159	[p9l1075t3255r1246b3318],
29	-	:	O	-	_	0	SENT_159	[p9l1263t3289r1275b3300],
30	93	CD	DATE	93	dep	13	SENT_159	[p9l1293t3256r1396b3328],
31	,	,	O	,	_	0	SENT_159	[p9l1293t3256r1396b3328],
32	p	NN	O	p	nn	34	SENT_159	[p9l1414t3255r1551b3338],
33	=	JJ	O	=	amod	34	SENT_159	[p9l1414t3255r1551b3338],
34	o	NN	O	o	appos	13	SENT_159	[p9l1414t3255r1551b3338],
35	-	:	O	-	_	0	SENT_159	[p9l1569t3289r1580b3300],
36	575	CD	NUMBER	575	num	37	SENT_159	[p9l1600t3254r1765b3339],
37	)	NN	O	)	dep	34	SENT_159	[p9l1600t3254r1765b3339],
38	.	.	O	.	_	0	SENT_159	[p9l1600t3254r1765b3339],

1	Moreover	RB	O	moreover	_	0	SENT_160	[p9l1787t3256r2147b3328],
2	,	,	O	,	_	0	SENT_160	[p9l1787t3256r2147b3328],
3	the	DT	O	the	det	5	SENT_160	[p9l6t3358r122b3426],
4	increased	VBN	O	increase	amod	5	SENT_160	[p9l153t3358r505b3426],
5	risk	NN	O	risk	nsubj	7	SENT_160	[p9l534t3358r674b3426],
6	was	VBD	O	be	cop	7	SENT_160	[p9l700t3382r838b3427],
7	evident	JJ	O	evident	dep	1	SENT_160	[p9l872t3358r1140b3426],
8	by	IN	O	by	_	0	SENT_160	[p9l1168t3358r1255b3448],
9	30	CD	DURATION	30	num	10	SENT_160	[p9l1288t3364r1369b3426],
10	days	NNS	NUMBER	day	prep_by	7	SENT_160	[p9l1402t3358r1580b3448],
11	,	,	O	,	_	0	SENT_160	[p9l1402t3358r1580b3448],
12	by	IN	O	by	_	0	SENT_160	[p9l1613t3358r1699b3448],
13	which	WDT	O	which	det	14	SENT_160	[p9l1727t3358r1952b3426],
14	time	NN	O	time	rel	30	SENT_160	[p9l1982t3363r2149b3426],
15	the	DT	O	the	det	16	SENT_160	[p9l6t3469r122b3537],
16	risk	NN	O	risk	nsubj	30	SENT_160	[p9l187t3469r327b3537],
17	of	IN	O	of	_	0	SENT_160	[p9l391t3469r473b3537],
18	the	DT	O	the	det	20	SENT_160	[p9l524t3469r639b3537],
19	primary	JJ	O	primary	amod	20	SENT_160	[p9l705t3473r1001b3558],
20	endpoint	NN	O	endpoint	prep_of	16	SENT_160	[p9l1065t3469r1397b3558],
21	for	IN	O	for	_	0	SENT_160	[p9l1461t3469r1566b3537],
22	the	DT	O	the	det	25	SENT_160	[p9l1628t3469r1744b3537],
23	3435	CD	DATE	3435	num	25	SENT_160	[p9l1813t3473r1976b3537],
24	TT	NN	O	tt	nn	25	SENT_160	[p9l2043t3473r2152b3536],
25	homozygotes	NNS	O	homozygote	prep_for	20	SENT_160	[p9l6t3577r495b3667],
26	was	VBD	O	be	cop	30	SENT_160	[p9l521t3602r658b3646],
27	roughly	RB	O	roughly	quantmod	28	SENT_160	[p9l686t3577r971b3667],
28	twice	RB	O	twice	dep	30	SENT_160	[p9l993t3582r1183b3646],
29	as	RB	O	as	advmod	30	SENT_160	[p9l1210t3602r1282b3646],
30	high	JJ	O	high	rcmod	10	SENT_160	[p9l1308t3577r1477b3667],
31	as	IN	O	as	mark	38	SENT_160	[p9l1503t3602r1574b3646],
32	that	DT	O	that	nsubj	38	SENT_160	[p9l1601t3577r1744b3646],
33	for	IN	O	for	_	0	SENT_160	[p9l1768t3577r1873b3646],
34	CT	NN	O	ct	prep_for	32	SENT_160	[p9l1899t3582r2029b3666],
35	/	:	O	/	punct	37	SENT_160	[p9l1899t3582r2029b3666],
36	CC	NN	O	cc	nn	37	SENT_160	[p9l2037t3583r2148b3646],
37	individuals	NNS	O	individual	dep	34	SENT_160	[p9l7t3686r412b3754],
38	(	VBP	O	(	dep	7	SENT_160	[p9l453t3686r976b3776],
39	Kaplan-Meier	JJ	O	kaplan-meier	amod	41	SENT_160	[p9l453t3686r976b3776],
40	event	NN	O	event	nn	41	SENT_160	[p9l1007t3699r1204b3754],
41	rates	NNS	O	rate	dobj	38	SENT_160	[p9l1234t3699r1407b3754],
42	8	CD	NUMBER	8	tmod	38	SENT_160	[p9l1443t3692r1511b3754],
43	-	:	O	-	_	0	SENT_160	[p9l1443t3692r1511b3754],
44	5	CD	PERCENT	5	num	45	SENT_160	[p9l1532t3690r1644b3757],
45	%	NN	PERCENT	%	dep	1	SENT_160	[p9l1532t3690r1644b3757],
46	[	CD	NUMBER	[	number	47	SENT_160	[p9l1682t3690r1782b3775],
47	35	CD	NUMBER	35	num	45	SENT_160	[p9l1682t3690r1782b3775],
48	of	IN	O	of	_	0	SENT_160	[p9l1819t3686r1901b3754],
49	414	CD	NUMBER	414	prep_of	45	SENT_160	[p9l1919t3692r2051b3775],
50	]	CD	NUMBER	]	dep	45	SENT_160	[p9l1919t3692r2051b3775],
51	vs	CC	O	vs	cc	50	SENT_160	[p9l2087t3710r2152b3753],

1	4-5	CD	PERCENT	4-5	num	2	SENT_161	[p10l6t21r206b88],
2	%	NN	PERCENT	%	_	0	SENT_161	[p10l6t21r206b88],
3	[	CD	NUMBER	[	number	4	SENT_161	[p10l251t21r345b106],
4	47	CD	NUMBER	47	dep	2	SENT_161	[p10l251t21r345b106],
5	of	IN	O	of	_	0	SENT_161	[p10l385t17r468b85],
6	1057	CD	DATE	1057	num	7	SENT_161	[p10l498t21r656b88],
7	participants	NNS	O	participant	prep_of	4	SENT_161	[p10l694t21r1169b106],
8	]	CD	NUMBER	]	dep	2	SENT_161	[p10l694t21r1169b106],
9	;	:	O	;	_	0	SENT_161	[p10l694t21r1169b106],
10	I-IR	NN	O	i-ir	dep	8	SENT_161	[p10l1218t23r1345b84],
11	1-96	CD	NUMBER	1-96	num	10	SENT_161	[p10l1387t23r1566b95],
12	,	,	O	,	_	0	SENT_161	[p10l1387t23r1566b95],
13	95	CD	PERCENT	95	number	14	SENT_161	[p10l1612t21r1771b88],
14	%	NN	PERCENT	%	amod	15	SENT_161	[p10l1612t21r1771b88],
15	CI	NN	O	ci	appos	2	SENT_161	[p10l1815t22r1898b85],
16	1263-03	CD	DATE	1263-03	dep	15	SENT_161	[p10l1946t23r2153b85, p10l12t131r198b203],
17	,	,	O	,	_	0	SENT_161	[p10l1946t23r2153b85, p10l12t131r198b203],
18	p	NN	O	p	nn	20	SENT_161	[p10l225t131r363b214],
19	=	JJ	O	=	amod	20	SENT_161	[p10l225t131r363b214],
20	o	NN	O	o	appos	2	SENT_161	[p10l225t131r363b214],
21	-	:	O	-	_	0	SENT_161	[p10l380t165r391b176],
22	0022	CD	DATE	0022	number	23	SENT_161	[p10l409t131r627b215],
23	)	CD	NUMBER	)	dep	20	SENT_161	[p10l409t131r627b215],
24	.	.	O	.	_	0	SENT_161	[p10l409t131r627b215],

1	Rates	NNS	O	rate	nsubj	5	SENT_162	[p10l83t241r273b302],
2	of	IN	O	of	_	0	SENT_162	[p10l323t234r406b302],
3	stent	JJ	O	stent	amod	4	SENT_162	[p10l441t247r619b302],
4	thrombosis	NN	O	thrombosis	prep_of	1	SENT_162	[p10l663t234r1080b302],
5	did	VBD	O	do	_	0	SENT_162	[p10l1130t234r1246b302],
6	not	RB	O	not	neg	7	SENT_162	[p10l1291t247r1413b302],
7	diﬁer	JJ	O	diﬁer	dobj	5	SENT_162	[p10l1458t234r1657b302],
8	signiﬁcantly	RB	O	signiﬁcantly	advmod	7	SENT_162	[p10l1705t234r2153b324],
9	between	IN	O	between	_	0	SENT_162	[p10l6t344r314b412],
10	3435	CD	NUMBER	3435	num	11	SENT_162	[p10l356t348r517b412],
11	TT	NN	O	tt	prep_between	7	SENT_162	[p10l558t348r667b410],
12	and	CC	O	and	_	0	SENT_162	[p10l705t344r841b412],
13	CT	NN	O	ct	conj_and	11	SENT_162	[p10l881t348r1011b432],
14	/	:	O	/	punct	17	SENT_162	[p10l881t348r1011b432],
15	CC	NN	O	cc	nn	16	SENT_162	[p10l1018t349r1129b412],
16	individuals	NNS	O	individual	nsubj	17	SENT_162	[p10l1170t344r1573b412],
17	(	VBP	O	(	dep	7	SENT_162	[p10l1620t344r2152b433],
18	Kaplan-Meier	JJ	O	kaplan-meier	amod	20	SENT_162	[p10l1620t344r2152b433],
19	event	NN	O	event	nn	20	SENT_162	[p10l8t467r208b522],
20	rates	NNS	O	rate	dobj	17	SENT_162	[p10l269t467r445b522],
21	1-3	CD	PERCENT	1-3	dep	22	SENT_162	[p10l513t458r706b525],
22	%	NN	PERCENT	%	advmod	7	SENT_162	[p10l513t458r706b525],
23	[	CD	NUMBER	[	num	24	SENT_162	[p10l771t453r917b542],
24	ﬁve	NN	O	ﬁve	dep	7	SENT_162	[p10l771t453r917b542],
25	of	IN	O	of	_	0	SENT_162	[p10l978t453r1061b522],
26	396	CD	NUMBER	396	number	27	SENT_162	[p10l1112t459r1255b542],
27	]	CD	NUMBER	]	prep_of	24	SENT_162	[p10l1112t459r1255b542],
28	vs	CC	O	vs	_	0	SENT_162	[p10l1320t478r1385b521],
29	1	LS	NUMBER	1	dep	32	SENT_162	[p10l1446t459r1504b521],
30	-	:	O	-	_	0	SENT_162	[p10l1446t459r1504b521],
31	3	CD	PERCENT	3	num	32	SENT_162	[p10l1526t458r1639b524],
32	%	NN	PERCENT	%	conj_vs	24	SENT_162	[p10l1526t458r1639b524],
33	[	CD	NUMBER	[	number	34	SENT_162	[p10l1704t459r1797b542],
34	12	CD	NUMBER	12	num	32	SENT_162	[p10l1704t459r1797b542],
35	of	IN	O	of	_	0	SENT_162	[p10l1860t453r1943b522],
36	1004	CD	DATE	1004	num	37	SENT_162	[p10l1993t459r2154b522],
37	participants	NNS	O	participant	amod	51	SENT_162	[p10l7t567r479b651],
38	]	CD	NUMBER	]	dep	37	SENT_162	[p10l7t567r479b651],
39	;	:	O	;	_	0	SENT_162	[p10l7t567r479b651],
40	I-IR	NN	O	i-ir	dep	38	SENT_162	[p10l519t569r647b629],
41	1-07	CD	NUMBER	1-07	num	40	SENT_162	[p10l681t567r852b640],
42	,	,	O	,	_	0	SENT_162	[p10l681t567r852b640],
43	95	CD	PERCENT	95	number	44	SENT_162	[p10l890t567r1051b633],
44	%	NN	PERCENT	%	amod	45	SENT_162	[p10l890t567r1051b633],
45	CI	NN	O	ci	appos	40	SENT_162	[p10l1089t567r1172b630],
46	0-38-3-04	CD	NUMBER	0-38-3-04	dep	45	SENT_162	[p10l1212t568r1614b640],
47	,	,	O	,	_	0	SENT_162	[p10l1212t568r1614b640],
48	p	NN	O	p	nn	50	SENT_162	[p10l1649t568r1917b652],
49	=	JJ	O	=	amod	50	SENT_162	[p10l1649t568r1917b652],
50	O-9	NN	O	o-9	appos	40	SENT_162	[p10l1649t568r1917b652],
51	)	NN	O	)	prep_of	32	SENT_162	[p10l1649t568r1917b652],
52	.	.	O	.	_	0	SENT_162	[p10l1649t568r1917b652],

1	Rates	NNS	O	rate	nsubj	17	SENT_163	[p10l1957t569r2148b630],
2	of	IN	O	of	_	0	SENT_163	[p10l8t671r91b740],
3	TIMI	NNP	O	TIMI	nn	14	SENT_163	[p10l108t676r301b739],
4	major	JJ	O	major	amod	14	SENT_163	[p10l337t676r556b761],
5	or	CC	O	or	_	0	SENT_163	[p10l587t696r663b740],
6	minor	JJ	O	minor	amod	7	SENT_163	[p10l692t676r923b740],
7	bleeding	NN	O	bleeding	amod	14	SENT_163	[p10l952t671r1269b761],
8	not	RB	O	not	neg	9	SENT_163	[p10l1300t685r1421b740],
9	related	JJ	O	related	amod	13	SENT_163	[p10l1451t671r1700b740],
10	to	TO	O	to	_	0	SENT_163	[p10l1729t685r1797b740],
11	coronary	JJ	O	coronary	amod	12	SENT_163	[p10l1831t696r2153b761],
12	artery	NN	O	artery	prep_to	9	SENT_163	[p10l8t794r219b870],
13	bypass	NN	O	bypass	dep	4	SENT_163	[p10l278t780r521b870],
14	grafting	NN	O	grafting	prep_of	1	SENT_163	[p10l587t780r875b870],
15	did	VBD	O	do	aux	17	SENT_163	[p10l937t780r1054b848],
16	not	RB	O	not	neg	17	SENT_163	[p10l1114t794r1236b848],
17	differ	VB	O	differ	_	0	SENT_163	[p10l1297t780r1497b848],
18	signiﬁcantly	RB	O	signiﬁcantly	advmod	17	SENT_163	[p10l1559t780r2007b870],
19	by	IN	O	by	_	0	SENT_163	[p10l2066t780r2153b870],
20	genotype	NN	O	genotype	prep_by	18	SENT_163	[p10l9t902r338b979],
21	(	CD	NUMBER	(	num	24	SENT_163	[p10l379t889r912b979],
22	Kaplan-Meier	NNP	O	Kaplan-Meier	nn	24	SENT_163	[p10l379t889r912b979],
23	event	NN	O	event	nn	24	SENT_163	[p10l948t902r1148b957],
24	rates	NNS	O	rate	dobj	17	SENT_163	[p10l1183t902r1359b957],
25	3-6	CD	PERCENT	3-6	num	26	SENT_163	[p10l1403t893r1603b960],
26	%	NN	PERCENT	%	dep	24	SENT_163	[p10l1403t893r1603b960],
27	[	CD	NUMBER	[	number	28	SENT_163	[p10l1642t893r1733b978],
28	15	CD	NUMBER	15	num	26	SENT_163	[p10l1642t893r1733b978],
29	of	IN	O	of	_	0	SENT_163	[p10l1772t889r1855b957],
30	414	CD	NUMBER	414	number	31	SENT_163	[p10l1875t895r2006b978],
31	]	CD	NUMBER	]	num	33	SENT_163	[p10l1875t895r2006b978],
32	TT	NN	O	tt	nn	33	SENT_163	[p10l2043t893r2152b956],
33	homozygotes	NNS	O	homozygote	prep_of	26	SENT_163	[p10l6t999r493b1088],
34	vs	CC	O	vs	_	0	SENT_163	[p10l522t1023r587b1066],
35	2	LS	NUMBER	2	amod	60	SENT_163	[p10l614t1005r681b1065],
36	-	:	O	-	_	0	SENT_163	[p10l614t1005r681b1065],
37	5	CD	PERCENT	5	num	38	SENT_163	[p10l703t1003r816b1070],
38	%	NN	PERCENT	%	dep	35	SENT_163	[p10l703t1003r816b1070],
39	[	CD	NUMBER	[	number	40	SENT_163	[p10l848t1005r950b1087],
40	26	CD	NUMBER	26	num	38	SENT_163	[p10l848t1005r950b1087],
41	of	IN	O	of	_	0	SENT_163	[p10l978t998r1061b1067],
42	1052	CD	DATE	1052	number	43	SENT_163	[p10l1077t1003r1257b1087],
43	]	CD	NUMBER	]	num	44	SENT_163	[p10l1077t1003r1257b1087],
44	CT	NN	O	ct	prep_of	38	SENT_163	[p10l1290t1003r1420b1087],
45	/	:	O	/	punct	47	SENT_163	[p10l1290t1003r1420b1087],
46	CC	NN	O	cc	nn	47	SENT_163	[p10l1427t1004r1538b1067],
47	individuals	NNS	O	individual	dep	44	SENT_163	[p10l1567t998r1990b1077],
48	;	:	O	;	_	0	SENT_163	[p10l1567t998r1990b1077],
49	HR	NN	DURATION	hr	dep	47	SENT_163	[p10l2024t1005r2152b1065],
50	1.49	CD	NUMBER	1.49	num	49	SENT_163	[p10l11t1113r184b1185],
51	,	,	O	,	_	0	SENT_163	[p10l11t1113r184b1185],
52	95	CD	PERCENT	95	number	53	SENT_163	[p10l213t1112r374b1178],
53	%	NN	PERCENT	%	amod	55	SENT_163	[p10l213t1112r374b1178],
54	CI	NN	O	ci	nn	55	SENT_163	[p10l403t1112r487b1175],
55	O-79-2-82	NN	O	o-79-2-82	appos	49	SENT_163	[p10l518t1112r918b1185],
56	,	,	O	,	_	0	SENT_163	[p10l518t1112r918b1185],
57	p	NN	O	p	dep	47	SENT_163	[p10l945t1113r1288b1197],
58	=	JJ	O	=	amod	60	SENT_163	[p10l945t1113r1288b1197],
59	O-214	NN	O	o-214	nn	60	SENT_163	[p10l945t1113r1288b1197],
60	)	NN	O	)	conj_vs	24	SENT_163	[p10l945t1113r1288b1197],
61	.	.	O	.	_	0	SENT_163	[p10l945t1113r1288b1197],

1	To	TO	O	to	aux	2	SENT_164	[p10l77t1221r165b1284],
2	elucidate	VB	O	elucidate	purpcl	23	SENT_164	[p10l190t1217r525b1284],
3	further	RB	O	further	advmod	2	SENT_164	[p10l549t1217r815b1284],
4	the	DT	O	the	det	5	SENT_164	[p10l835t1217r953b1284],
5	contribution	NN	O	contribution	dobj	2	SENT_164	[p10l977t1217r1446b1284],
6	of	IN	O	of	_	0	SENT_164	[p10l1470t1217r1554b1284],
7	AB	NNP	O	AB	nn	9	SENT_164	[p10l1562t1222r1678b1283],
8	CB1	NN	O	cb1	nn	9	SENT_164	[p10l1688t1222r1833b1284],
9	variants	NNS	O	variant	prep_of	5	SENT_164	[p10l1853t1221r2148b1284],
10	in	IN	O	in	_	0	SENT_164	[p10l7t1330r83b1392],
11	the	DT	O	the	det	12	SENT_164	[p10l121t1326r238b1394],
12	setting	NN	O	setting	prep_in	2	SENT_164	[p10l283t1330r534b1415],
13	of	IN	O	of	_	0	SENT_164	[p10l575t1325r659b1394],
14	treatment	NN	O	treatment	prep_of	12	SENT_164	[p10l685t1339r1056b1394],
15	with	IN	O	with	_	0	SENT_164	[p10l1093t1325r1259b1394],
16	clopidogrel	NN	O	clopidogrel	prep_with	2	SENT_164	[p10l1301t1326r1737b1415],
17	,	,	O	,	_	0	SENT_164	[p10l1301t1326r1737b1415],
18	two	CD	NUMBER	two	num	21	SENT_164	[p10l1780t1339r1913b1394],
19	other	JJ	O	other	amod	21	SENT_164	[p10l1955t1326r2152b1394],
20	ABCB1	NN	O	abcb1	nn	21	SENT_164	[p10l6t1439r277b1502],
21	polymorphisms	NNS	O	polymorphism	nsubjpass	23	SENT_164	[p10l307t1434r900b1524],
22	were	VBD	O	be	auxpass	23	SENT_164	[p10l933t1459r1112b1502],
23	explored	VBN	O	explore	_	0	SENT_164	[p10l1145t1434r1483b1523],
24	:	:	O	:	_	0	SENT_164	[p10l1145t1434r1483b1523],
25	2677G	NN	O	2677g	dobj	23	SENT_164	[p10l1521t1439r1981b1523],
26	—	CD	NUMBER	—	num	28	SENT_164	[p10l1521t1439r1981b1523],
27	>	JJR	O	>	amod	28	SENT_164	[p10l1521t1439r1981b1523],
28	T/A	NN	O	t/a	dep	25	SENT_164	[p10l1521t1439r1981b1523],
29	and	CC	O	and	_	0	SENT_164	[p10l2013t1434r2152b1502],
30	1236C	NN	O	1236c	nn	59	SENT_164	[p10l11t1548r389b1612],
31	—	CD	NUMBER	—	num	32	SENT_164	[p10l11t1548r389b1612],
32	>	JJR	O	>	nn	59	SENT_164	[p10l11t1548r389b1612],
33	T.	FW	O	t.	nsubjpass	38	SENT_164	[p10l11t1548r389b1612],
34	Neither	CC	O	neither	dep	33	SENT_164	[p10l442t1544r723b1612],
35	variant	NN	O	variant	conj	33	SENT_164	[p10l767t1548r1029b1612],
36	was	VBD	O	be	auxpass	38	SENT_164	[p10l1072t1568r1212b1612],
37	signiﬁcantly	RB	O	signiﬁcantly	advmod	38	SENT_164	[p10l1264t1544r1723b1634],
38	associated	VBN	O	associate	rcmod	32	SENT_164	[p10l1770t1544r2152b1612],
39	with	IN	O	with	_	0	SENT_164	[p10l6t1652r172b1721],
40	risk	NN	O	risk	prep_with	38	SENT_164	[p10l204t1652r347b1721],
41	of	IN	O	of	_	0	SENT_164	[p10l378t1652r461b1721],
42	cardiovascular	JJ	O	cardiovascular	amod	43	SENT_164	[p10l481t1652r1021b1721],
43	death	NN	O	death	prep_of	40	SENT_164	[p10l1053t1652r1277b1731],
44	,	,	O	,	_	0	SENT_164	[p10l1053t1652r1277b1731],
45	myocardial	JJ	O	myocardial	amod	46	SENT_164	[p10l1312t1652r1727b1742],
46	infarction	NN	O	infarction	appos	43	SENT_164	[p10l1759t1652r2147b1731],
47	,	,	O	,	_	0	SENT_164	[p10l1759t1652r2147b1731],
48	or	CC	O	or	_	0	SENT_164	[p10l8t1786r86b1829],
49	stroke	NN	O	stroke	nn	52	SENT_164	[p10l121t1761r347b1829],
50	(	NN	O	(	nn	52	SENT_164	[p10l387t1761r906b1851],
51	webappendix	NN	O	webappendix	nn	52	SENT_164	[p10l387t1761r906b1851],
52	pp	NN	O	pp	nn	59	SENT_164	[p10l939t1786r1032b1850],
53	2	CD	NUMBER	2	dep	52	SENT_164	[p10l1070t1768r1128b1839],
54	,	,	O	,	_	0	SENT_164	[p10l1070t1768r1128b1839],
55	7	CD	NUMBER	7	num	53	SENT_164	[p10l1166t1766r1221b1839],
56	,	,	O	,	_	0	SENT_164	[p10l1166t1766r1221b1839],
57	and	CC	NUMBER	and	_	0	SENT_164	[p10l1260t1761r1398b1829],
58	8	CD	NUMBER	8	conj_and	53	SENT_164	[p10l1433t1767r1520b1851],
59	)	NN	O	)	conj_and	25	SENT_164	[p10l1433t1767r1520b1851],
60	.	.	O	.	_	0	SENT_164	[p10l1433t1767r1520b1851],

1	We	PRP	O	we	nsubj	2	SENT_165	[p10l1557t1768r1676b1830],
2	constructed	VBD	O	construct	dep	8	SENT_165	[p10l1712t1761r2152b1829],
3	haplotypes	NNS	O	haplotype	dobj	2	SENT_165	[p10l6t1871r408b1960],
4	using	VBG	O	use	xcomp	2	SENT_165	[p10l441t1875r653b1961],
5	the	DT	O	the	det	7	SENT_165	[p10l683t1871r800b1938],
6	three	CD	NUMBER	three	num	7	SENT_165	[p10l833t1871r1025b1939],
7	loci	NNS	O	locus	dobj	4	SENT_165	[p10l1057t1871r1189b1939],
8	(	VBP	O	(	_	0	SENT_165	[p10l1227t1875r1631b1961],
9	1236C	NN	O	1236c	dobj	8	SENT_165	[p10l1227t1875r1631b1961],
10	—	CD	NUMBER	—	num	12	SENT_165	[p10l1227t1875r1631b1961],
11	>	JJR	O	>	amod	12	SENT_165	[p10l1227t1875r1631b1961],
12	T	NN	O	t	dep	9	SENT_165	[p10l1227t1875r1631b1961],
13	,	,	O	,	_	0	SENT_165	[p10l1227t1875r1631b1961],
14	2677G	NN	O	2677g	conj_and	9	SENT_165	[p10l1669t1875r2147b1960],
15	—	CD	NUMBER	—	num	17	SENT_165	[p10l1669t1875r2147b1960],
16	>	JJR	O	>	amod	17	SENT_165	[p10l1669t1875r2147b1960],
17	T/A	NN	O	t/a	dep	14	SENT_165	[p10l1669t1875r2147b1960],
18	,	,	O	,	_	0	SENT_165	[p10l1669t1875r2147b1960],
19	and	CC	O	and	_	0	SENT_165	[p10l8t1979r147b2048],
20	3435C	NN	O	3435c	conj_and	9	SENT_165	[p10l180t1984r574b2069],
21	—	CD	NUMBER	—	num	20	SENT_165	[p10l180t1984r574b2069],
22	>	JJR	O	>	amod	24	SENT_165	[p10l180t1984r574b2069],
23	T	NN	O	t	nn	24	SENT_165	[p10l180t1984r574b2069],
24	)	NN	O	)	dep	20	SENT_165	[p10l180t1984r574b2069],
25	and	CC	O	and	_	0	SENT_165	[p10l611t1979r750b2048],
26	did	VBD	O	do	aux	28	SENT_165	[p10l780t1979r898b2048],
27	not	RB	O	not	neg	28	SENT_165	[p10l927t1993r1051b2048],
28	identify	VB	O	identify	conj_and	8	SENT_165	[p10l1079t1979r1367b2069],
29	associations	NNS	O	association	dobj	28	SENT_165	[p10l1396t1984r1846b2048],
30	beyond	IN	O	beyond	_	0	SENT_165	[p10l1877t1979r2152b2069],
31	what	WP	O	what	nsubjpass	33	SENT_165	[p10l6t2088r189b2156],
32	was	VBD	O	be	auxpass	33	SENT_165	[p10l212t2112r350b2156],
33	seen	VBN	O	see	prepc_beyond	28	SENT_165	[p10l381t2112r549b2156],
34	for	IN	O	for	_	0	SENT_165	[p10l575t2088r682b2156],
35	3435C	NN	O	3435c	prep_for	33	SENT_165	[p10l711t2092r1083b2156],
36	—	CD	NUMBER	—	num	38	SENT_165	[p10l711t2092r1083b2156],
37	>	JJR	O	>	amod	38	SENT_165	[p10l711t2092r1083b2156],
38	T	NN	O	t	tmod	33	SENT_165	[p10l711t2092r1083b2156],
39	alone	RB	O	alone	advmod	38	SENT_165	[p10l1109t2088r1309b2156],
40	(	RB	O	(	advmod	33	SENT_165	[p10l1342t2088r1861b2178],
41	webappendix	JJ	O	webappendix	amod	42	SENT_165	[p10l1342t2088r1861b2178],
42	p	NN	O	p	dobj	8	SENT_165	[p10l1884t2112r1929b2177],
43	2	CD	NUMBER	2	num	44	SENT_165	[p10l1958t2094r2043b2178],
44	)	NN	O	)	nsubj	28	SENT_165	[p10l1958t2094r2043b2178],
45	.	.	O	.	_	0	SENT_165	[p10l1958t2094r2043b2178],

1	In	IN	O	in	_	0	SENT_166	[p10l83t2204r160b2264],
2	a	DT	O	a	det	3	SENT_166	[p10l190t2222r226b2266],
3	model	NN	O	model	pobj	1	SENT_166	[p10l255t2198r486b2266],
4	containing	VBG	O	contain	partmod	3	SENT_166	[p10l515t2202r908b2288],
5	both	CC	O	both	prep	4	SENT_166	[p10l934t2198r1101b2266],
6	ABCB1	NN	O	abcb1	nn	7	SENT_166	[p10l1127t2203r1394b2266],
7	3435C	NN	O	3435c	dep	5	SENT_166	[p10l1424t2202r1792b2266],
8	—	CD	NUMBER	—	num	10	SENT_166	[p10l1424t2202r1792b2266],
9	>	JJR	O	>	amod	10	SENT_166	[p10l1424t2202r1792b2266],
10	T	NN	O	t	dep	19	SENT_166	[p10l1424t2202r1792b2266],
11	genotype	NN	O	genotype	nn	14	SENT_166	[p10l1820t2211r2149b2288],
12	and	CC	O	and	_	0	SENT_166	[p10l8t2306r145b2375],
13	C	NN	O	c	conj_and	11	SENT_166	[p10l203t2312r258b2375],
14	YPZC	NN	O	ypzc	dep	10	SENT_166	[p10l263t2312r468b2375],
15	19	CD	NUMBER	19	num	16	SENT_166	[p10l473t2313r546b2375],
16	reduced-function	NN	O	reduced-function	dep	19	SENT_166	[p10l594t2306r1226b2375],
17	allele	NN	O	allele	nn	19	SENT_166	[p10l1279t2306r1466b2375],
18	carrier	NN	O	carrier	nn	19	SENT_166	[p10l1520t2311r1760b2375],
19	status	NN	O	status	dep	4	SENT_166	[p10l1813t2320r2022b2375],
20	in	IN	O	in	_	0	SENT_166	[p10l2077t2311r2151b2374],
21	patients	NNS	O	patient	prep_in	19	SENT_166	[p10l7t2421r295b2505],
22	in	IN	O	in	_	0	SENT_166	[p10l322t2421r396b2483],
23	the	DT	O	the	det	24	SENT_166	[p10l418t2416r533b2484],
24	TRITON	NNP	ORGANIZATION	TRITON	prep_in	4	SENT_166	[p10l556t2420r1122b2484],
25	.	.	O	.	_	0	SENT_166	[p10l556t2420r1122b2484],

1	—	NN	O	—	_	0	SENT_167	[p10l556t2420r1122b2484],
2	.	.	O	.	_	0	SENT_167	[p10l556t2420r1122b2484],

1	TIMI	NNP	ORGANIZATION	TIMI	nsubj	5	SENT_168	[p10l556t2420r1122b2484],
2	38	CD	NUMBER	38	num	1	SENT_168	[p10l1154t2422r1234b2484],
3	genetic	JJ	O	genetic	amod	4	SENT_168	[p10l1260t2421r1522b2506],
4	substudy	NN	O	substudy	dep	1	SENT_168	[p10l1548t2416r1878b2506],
5	treated	VBN	O	treat	_	0	SENT_168	[p10l1899t2416r2152b2484],
6	with	IN	O	with	_	0	SENT_168	[p10l6t2526r169b2594],
7	clopidogrel	NN	O	clopidogrel	prep_with	5	SENT_168	[p10l273t2525r698b2615],
8	,	,	O	,	_	0	SENT_168	[p10l273t2525r698b2615],
9	both	CC	O	both	dep	5	SENT_168	[p10l803t2525r970b2594],
10	variants	NNS	O	variant	nsubj	15	SENT_168	[p10l1071t2530r1359b2594],
11	were	VBD	O	be	cop	15	SENT_168	[p10l1463t2550r1638b2594],
12	signiﬁcant	JJ	O	signiﬁcant	amod	15	SENT_168	[p10l1746t2525r2147b2615],
13	,	,	O	,	_	0	SENT_168	[p10l1746t2525r2147b2615],
14	independent	JJ	O	independent	amod	15	SENT_168	[p10l7t2634r474b2723],
15	predictors	NNS	O	predictor	conj	5	SENT_168	[p10l490t2634r856b2723],
16	of	IN	O	of	_	0	SENT_168	[p10l877t2634r959b2703],
17	cardiovascular	JJ	O	cardiovascular	amod	18	SENT_168	[p10l964t2634r1490b2703],
18	death	NN	O	death	prep_of	15	SENT_168	[p10l1506t2634r1725b2713],
19	,	,	O	,	_	0	SENT_168	[p10l1506t2634r1725b2713],
20	myocardial	JJ	O	myocardial	amod	21	SENT_168	[p10l1745t2634r2151b2724],
21	www	NN	O	www	appos	18	SENT_168	[p10l6t2906r542b2957],
22	.	.	O	.	_	0	SENT_168	[p10l6t2906r542b2957],

1	the	DT	O	the	det	2	SENT_169	[p10l6t2906r542b2957],
2	|	NN	O	|	_	0	SENT_169	[p10l6t2906r542b2957],
3	ancet.com	NNP	O	ancet.com	nn	4	SENT_169	[p10l6t2906r542b2957],
4	Vol	NNP	O	Vol	dep	2	SENT_169	[p10l585t2906r673b2957],
5	376	CD	NUMBER	376	num	6	SENT_169	[p10l692t2905r797b2964],
6	October	NNP	DATE	October	dep	2	SENT_169	[p10l843t2906r1068b2957],
7	16,2010	CD	DATE	16,2010	num	6	SENT_169	[p10l1085t2905r1330b2966],

1	infarction	NN	O	infarction	_	0	SENT_170	[p10l9t3094r276b3150],
2	,	,	O	,	_	0	SENT_170	[p10l9t3094r276b3150],
3	or	CC	O	or	dep	1	SENT_170	[p10l299t3112r352b3143],
4	stroke	NN	O	stroke	dep	10	SENT_170	[p10l372t3094r528b3143],
5	(	CD	NUMBER	(	num	6	SENT_170	[p10l552t3098r755b3158],
6	ABCB1	NN	O	abcb1	dep	4	SENT_170	[p10l552t3098r755b3158],
7	3435	CD	NUMBER	3435	num	8	SENT_170	[p10l776t3097r891b3143],
8	TT	NN	O	tt	dep	10	SENT_170	[p10l912t3097r989b3142],
9	125	CD	NUMBER	125	num	10	SENT_170	[p10l1007t3112r1054b3143],
10	CT	NN	O	ct	dep	47	SENT_170	[p10l1073t3097r1165b3157],
11	/	:	O	/	punct	12	SENT_170	[p10l1073t3097r1165b3157],
12	CC	NN	O	cc	dep	10	SENT_170	[p10l1171t3098r1264b3150],
13	,	,	O	,	_	0	SENT_170	[p10l1171t3098r1264b3150],
14	HR	NN	DURATION	hr	appos	12	SENT_170	[p10l1288t3099r1379b3142],
15	2-01	CD	NUMBER	2-01	num	14	SENT_170	[p10l1399t3099r1526b3150],
16	,	,	O	,	_	0	SENT_170	[p10l1399t3099r1526b3150],
17	95	CD	PERCENT	95	number	18	SENT_170	[p10l10t3174r123b3221],
18	%	NN	PERCENT	%	dep	12	SENT_170	[p10l10t3174r123b3221],
19	CI	NN	O	ci	dep	10	SENT_170	[p10l149t3174r208b3219],
20	1-30-3-11	CD	NUMBER	1-30-3-11	num	19	SENT_170	[p10l236t3175r505b3226],
21	,	,	O	,	_	0	SENT_170	[p10l236t3175r505b3226],
22	p	NN	O	p	appos	10	SENT_170	[p10l531t3174r785b3234],
23	=	JJ	O	=	amod	22	SENT_170	[p10l531t3174r785b3234],
24	0-0017	CD	NUMBER	0-0017	tmod	23	SENT_170	[p10l531t3174r785b3234],
25	;	:	O	;	_	0	SENT_170	[p10l531t3174r785b3234],
26	CYPZCI9	CD	NUMBER	cypzci9	num	29	SENT_170	[p10l817t3174r1060b3219],
27	reduced-function	JJ	O	reduced-function	amod	29	SENT_170	[p10l1081t3171r1529b3219],
28	allele	NN	O	allele	nn	29	SENT_170	[p10l10t3249r142b3298],
29	carrier	NN	O	carrier	dep	10	SENT_170	[p10l158t3253r328b3298],
30	vs	CC	O	vs	_	0	SENT_170	[p10l341t3267r388b3298],
31	non-carrier	NN	O	non-carrier	conj_vs	29	SENT_170	[p10l401t3253r699b3305],
32	,	,	O	,	_	0	SENT_170	[p10l401t3253r699b3305],
33	HR	NN	DURATION	hr	appos	31	SENT_170	[p10l719t3254r810b3297],
34	1-77	CD	NUMBER	1-77	num	33	SENT_170	[p10l826t3252r943b3305],
35	,	,	O	,	_	0	SENT_170	[p10l826t3252r943b3305],
36	1	LS	NUMBER	1	prep	10	SENT_170	[p10l962t3254r1003b3297],
37	-	:	O	-	_	0	SENT_170	[p10l962t3254r1003b3297],
38	11-2	CD	NUMBER	11-2	num	40	SENT_170	[p10l1016t3254r1124b3297],
39	-	:	O	-	_	0	SENT_170	[p10l1137t3277r1145b3285],
40	80	CD	DATE	80	dep	36	SENT_170	[p10l1158t3254r1231b3305],
41	,	,	O	,	_	0	SENT_170	[p10l1158t3254r1231b3305],
42	p	NN	O	p	nn	44	SENT_170	[p10l1247t3254r1345b3313],
43	=	JJ	O	=	amod	44	SENT_170	[p10l1247t3254r1345b3313],
44	o	NN	O	o	appos	40	SENT_170	[p10l1247t3254r1345b3313],
45	-	:	O	-	_	0	SENT_170	[p10l1357t3277r1365b3285],
46	0155	CD	DATE	0155	num	47	SENT_170	[p10l1377t3252r1525b3313],
47	)	CD	NUMBER	)	dep	1	SENT_170	[p10l1377t3252r1525b3313],
48	.	.	O	.	_	0	SENT_170	[p10l1377t3252r1525b3313],

1	When	WRB	O	when	advmod	5	SENT_171	[p10l8t3327r168b3376],
2	the	DT	O	the	det	3	SENT_171	[p10l192t3327r274b3376],
3	participants	NNS	O	participant	nsubjpass	5	SENT_171	[p10l299t3330r604b3390],
4	were	VBD	O	be	auxpass	5	SENT_171	[p10l630t3345r755b3376],
5	divided	VBN	O	divide	advcl	62	SENT_171	[p10l781t3327r970b3376],
6	into	IN	O	into	_	0	SENT_171	[p10l995t3330r1096b3376],
7	four	CD	NUMBER	four	num	8	SENT_171	[p10l1122t3327r1232b3376],
8	groups	NNS	O	group	prep_into	5	SENT_171	[p10l1257t3344r1435b3391],
9	on	IN	O	on	_	0	SENT_171	[p10l1463t3344r1529b3376],
10	the	DT	O	the	det	11	SENT_171	[p10l8t3405r90b3453],
11	basis	NN	O	basis	prep_on	8	SENT_171	[p10l122t3405r251b3453],
12	of	IN	O	of	_	0	SENT_171	[p10l287t3405r345b3453],
13	ABCB1	NN	O	abcb1	nn	14	SENT_171	[p10l368t3408r557b3453],
14	3435C	NN	O	3435c	prep_of	11	SENT_171	[p10l592t3408r853b3453],
15	—	CD	NUMBER	—	num	14	SENT_171	[p10l592t3408r853b3453],
16	>	JJR	O	>	amod	18	SENT_171	[p10l592t3408r853b3453],
17	T	NN	O	t	nn	18	SENT_171	[p10l592t3408r853b3453],
18	genotype	NN	O	genotype	dep	11	SENT_171	[p10l886t3415r1120b3469],
19	and	CC	O	and	_	0	SENT_171	[p10l1154t3405r1251b3453],
20	CYPZCI9	NN	O	cypzci9	nn	23	SENT_171	[p10l1288t3408r1531b3454],
21	status	NN	O	status	nn	23	SENT_171	[p10l11t3493r159b3532],
22	(	NN	O	(	nn	23	SENT_171	[p10l185t3483r354b3547],
23	ﬁgure	NN	O	ﬁgure	conj_and	11	SENT_171	[p10l185t3483r354b3547],
24	2	CD	NUMBER	2	num	25	SENT_171	[p10l376t3488r436b3547],
25	)	NN	O	)	dep	23	SENT_171	[p10l376t3488r436b3547],
26	,	,	O	,	_	0	SENT_171	[p10l376t3488r436b3547],
27	the	DT	O	the	det	29	SENT_171	[p10l457t3483r538b3532],
28	773	CD	NUMBER	773	num	29	SENT_171	[p10l558t3486r639b3534],
29	patients	NNS	O	patient	nsubj	62	SENT_171	[p10l661t3487r866b3547],
30	(	IN	O	(	_	0	SENT_171	[p10l891t3486r1020b3547],
31	53	CD	PERCENT	53	num	32	SENT_171	[p10l891t3486r1020b3547],
32	%	NN	PERCENT	%	prep_(	29	SENT_171	[p10l891t3486r1020b3547],
33	of	IN	O	of	_	0	SENT_171	[p10l1041t3483r1100b3532],
34	1454	CD	DATE	1454	prep_of	32	SENT_171	[p10l1112t3486r1224b3532],
35	genotyped	VBN	O	genotype	partmod	34	SENT_171	[p10l1242t3483r1524b3547],
36	)	NN	O	)	dobj	35	SENT_171	[p10l1242t3483r1524b3547],
37	who	WP	O	who	nsubj	40	SENT_171	[p10l8t3561r118b3610],
38	did	VBD	O	do	aux	40	SENT_171	[p10l144t3561r227b3610],
39	not	RB	O	not	neg	40	SENT_171	[p10l250t3571r336b3610],
40	carry	VB	O	carry	rcmod	36	SENT_171	[p10l359t3578r488b3625],
41	at-risk	JJ	O	at-risk	amod	42	SENT_171	[p10l512t3561r673b3610],
42	genotypes	NNS	O	genotype	dobj	40	SENT_171	[p10l697t3571r956b3625],
43	in	IN	O	in	prep	29	SENT_171	[p10l982t3564r1034b3609],
44	either	CC	O	either	dep	43	SENT_171	[p10l1059t3561r1210b3610],
45	gene	NN	O	gene	conj	43	SENT_171	[p10l1234t3578r1356b3625],
46	had	VBD	O	have	rcmod	45	SENT_171	[p10l1381t3561r1478b3610],
47	a	DT	O	a	det	49	SENT_171	[p10l1502t3578r1529b3610],
48	low	JJ	O	low	amod	49	SENT_171	[p10l8t3639r101b3687],
49	rate	NN	O	rate	dobj	46	SENT_171	[p10l120t3648r217b3687],
50	of	IN	O	of	_	0	SENT_171	[p10l238t3639r297b3687],
51	cardiovascular	JJ	O	cardiovascular	amod	52	SENT_171	[p10l308t3639r681b3687],
52	death	NN	O	death	prep_of	49	SENT_171	[p10l700t3639r855b3694],
53	,	,	O	,	_	0	SENT_171	[p10l700t3639r855b3694],
54	myocardial	JJ	O	myocardial	amod	55	SENT_171	[p10l878t3639r1165b3702],
55	infarction	NN	O	infarction	prep_of	49	SENT_171	[p10l1185t3639r1452b3694],
56	,	,	O	,	_	0	SENT_171	[p10l1185t3639r1452b3694],
57	or	CC	O	or	_	0	SENT_171	[p10l1476t3656r1530b3687],
58	stroke	NN	O	stroke	prep_of	49	SENT_171	[p10l11t3716r167b3765],
59	at	IN	O	at	_	0	SENT_171	[p10l189t3726r234b3765],
60	15	CD	DURATION	15	num	61	SENT_171	[p10l255t3719r306b3765],
61	months	NNS	NUMBER	month	prep_at	46	SENT_171	[p10l329t3716r529b3765],
62	(	VBP	O	(	_	0	SENT_171	[p10l556t3716r925b3780],
63	Kaplan-Meier	JJ	O	kaplan-meier	amod	65	SENT_171	[p10l556t3716r925b3780],
64	event	NN	O	event	nn	65	SENT_171	[p10l945t3726r1083b3765],
65	rate	NN	O	rate	dobj	62	SENT_171	[p10l1103t3726r1200b3765],
66	6	CD	NUMBER	6	dep	65	SENT_171	[p10l1222t3721r1270b3765],
67	-	:	O	-	_	0	SENT_171	[p10l1222t3721r1270b3765],
68	3	CD	PERCENT	3	num	69	SENT_171	[p10l1284t3719r1378b3772],
69	%	NN	PERCENT	%	dep	65	SENT_171	[p10l1284t3719r1378b3772],
70	,	,	O	,	_	0	SENT_171	[p10l1284t3719r1378b3772],
71	48	CD	NUMBER	48	appos	69	SENT_171	[p10l1399t3721r1457b3765],
72	of	IN	O	of	prep	71	SENT_171	[p10l1479t3716r1538b3765],

1	773	CD	NUMBER	773	num	2	SENT_172	[p11l8t17r89b64],
2	participants	NNS	O	participant	_	0	SENT_172	[p11l107t17r445b78],
3	)	CD	NUMBER	)	dep	2	SENT_172	[p11l107t17r445b78],
4	.	.	O	.	_	0	SENT_172	[p11l107t17r445b78],

1	By	IN	O	by	_	0	SENT_173	[p11l466t19r528b78],
2	contrast	NN	O	contrast	prep_by	8	SENT_173	[p11l542t24r762b70],
3	,	,	O	,	_	0	SENT_173	[p11l542t24r762b70],
4	event	NN	O	event	nn	5	SENT_173	[p11l780t24r919b63],
5	rates	NNS	O	rate	nsubj	8	SENT_173	[p11l933t24r1055b63],
6	were	VBD	O	be	cop	8	SENT_173	[p11l1070t32r1195b63],
7	signiﬁcantly	RB	O	signiﬁcantly	advmod	8	SENT_173	[p11l1213t14r1530b78],
8	higher	JJR	O	higher	dep	81	SENT_173	[p11l8t93r181b157],
9	in	IN	O	in	_	0	SENT_173	[p11l206t96r259b140],
10	the	DT	O	the	det	12	SENT_173	[p11l284t93r366b141],
11	681	CD	NUMBER	681	num	12	SENT_173	[p11l394t97r479b141],
12	patients	NNS	O	patient	prep_in	8	SENT_173	[p11l505t96r710b156],
13	(	IN	O	(	_	0	SENT_173	[p11l742t96r863b157],
14	47	CD	PERCENT	47	num	15	SENT_173	[p11l742t96r863b157],
15	%	NN	PERCENT	%	prep_(	8	SENT_173	[p11l742t96r863b157],
16	of	IN	O	of	_	0	SENT_173	[p11l891t93r950b141],
17	1454	CD	DATE	1454	prep_of	15	SENT_173	[p11l969t96r1081b141],
18	genotyped	VBN	O	genotype	partmod	17	SENT_173	[p11l1105t93r1388b157],
19	)	NN	O	)	dobj	18	SENT_173	[p11l1105t93r1388b157],
20	who	WP	O	who	nsubj	23	SENT_173	[p11l1417t93r1528b141],
21	were	VBD	O	be	cop	23	SENT_173	[p11l8t188r132b219],
22	either	DT	O	either	dep	23	SENT_173	[p11l154t170r305b219],
23	carriers	NNS	O	carrier	rcmod	19	SENT_173	[p11l326t173r519b219],
24	of	IN	O	of	_	0	SENT_173	[p11l543t170r601b219],
25	a	DT	O	a	det	29	SENT_173	[p11l613t188r640b219],
26	C	NN	O	c	nn	29	SENT_173	[p11l665t174r704b219],
27	YP2C19	NN	O	yp2c19	nn	29	SENT_173	[p11l708t174r909b219],
28	reduced-function	NN	O	reduced-function	nn	29	SENT_173	[p11l927t170r1374b219],
29	allele	NN	O	allele	prep_of	23	SENT_173	[p11l1396t170r1528b219],
30	only	RB	O	only	advmod	32	SENT_173	[p11l10t248r121b312],
31	(	RB	O	(	advmod	32	SENT_173	[p11l133t248r502b312],
32	Kaplan-Meier	JJ	O	kaplan-meier	amod	34	SENT_173	[p11l133t248r502b312],
33	event	NN	O	event	nn	34	SENT_173	[p11l512t258r651b297],
34	rate	NN	O	rate	dep	19	SENT_173	[p11l659t258r756b297],
35	11	CD	NUMBER	11	dep	19	SENT_173	[p11l769t253r816b296],
36	-	:	O	-	_	0	SENT_173	[p11l827t276r835b284],
37	5	CD	PERCENT	5	number	38	SENT_173	[p11l849t251r943b304],
38	%	NN	PERCENT	%	amod	35	SENT_173	[p11l849t251r943b304],
39	,	,	O	,	_	0	SENT_173	[p11l849t251r943b304],
40	29	CD	NUMBER	29	number	42	SENT_173	[p11l957t253r1015b297],
41	of	IN	O	of	quantmod	42	SENT_173	[p11l1026t248r1085b297],
42	268	CD	NUMBER	268	num	43	SENT_173	[p11l1087t252r1177b297],
43	participants	NNS	O	participant	appos	35	SENT_173	[p11l1187t251r1526b312],
44	)	RB	O	)	advmod	43	SENT_173	[p11l1187t251r1526b312],
45	,	,	O	,	_	0	SENT_173	[p11l1187t251r1526b312],
46	ABCB1	NN	O	abcb1	appos	35	SENT_173	[p11l8t330r197b375],
47	3435	CD	NUMBER	3435	num	46	SENT_173	[p11l227t330r342b375],
48	TT	NN	O	tt	nn	49	SENT_173	[p11l372t330r449b374],
49	homozygotes	NNS	O	homozygote	nsubj	51	SENT_173	[p11l475t327r821b391],
50	only	RB	O	only	advmod	51	SENT_173	[p11l852t327r963b390],
51	(	VBP	O	(	rcmod	46	SENT_173	[p11l994t327r1363b391],
52	Kaplan-Meier	JJR	O	kaplan-meier	amod	54	SENT_173	[p11l994t327r1363b391],
53	event	NN	O	event	nn	54	SENT_173	[p11l1391t336r1529b375],
54	rate	NN	O	rate	dobj	51	SENT_173	[p11l9t414r106b453],
55	12	CD	NUMBER	12	num	54	SENT_173	[p11l127t409r179b452],
56	-	:	O	-	_	0	SENT_173	[p11l192t432r200b440],
57	6	CD	PERCENT	6	num	58	SENT_173	[p11l213t407r307b460],
58	%	NN	PERCENT	%	dobj	18	SENT_173	[p11l213t407r307b460],
59	,	,	O	,	_	0	SENT_173	[p11l213t407r307b460],
60	35	CD	NUMBER	35	appos	58	SENT_173	[p11l332t407r387b453],
61	of	IN	O	of	_	0	SENT_173	[p11l409t404r468b453],
62	288	CD	NUMBER	288	num	63	SENT_173	[p11l479t409r569b453],
63	participants	NNS	O	participant	prep_of	60	SENT_173	[p11l588t407r927b468],
64	)	RB	O	)	advmod	63	SENT_173	[p11l588t407r927b468],
65	,	,	O	,	_	0	SENT_173	[p11l588t407r927b468],
66	or	CC	O	or	_	0	SENT_173	[p11l949t422r1003b453],
67	both	DT	O	both	dep	68	SENT_173	[p11l1020t404r1138b453],
68	(	FW	O	(	dobj	18	SENT_173	[p11l1160t404r1529b468],
69	Kaplan-Meier	JJR	O	kaplan-meier	amod	71	SENT_173	[p11l1160t404r1529b468],
70	event	NN	O	event	nn	71	SENT_173	[p11l10t492r148b530],
71	rate	NN	O	rate	dep	68	SENT_173	[p11l167t492r264b530],
72	13	CD	NUMBER	13	dep	68	SENT_173	[p11l286t486r336b530],
73	-	:	O	-	_	0	SENT_173	[p11l350t510r358b518],
74	6	CD	PERCENT	6	num	75	SENT_173	[p11l371t485r466b538],
75	%	NN	PERCENT	%	dep	68	SENT_173	[p11l371t485r466b538],
76	,	,	O	,	_	0	SENT_173	[p11l371t485r466b538],
77	17	CD	NUMBER	17	appos	75	SENT_173	[p11l490t485r539b532],
78	of	IN	O	of	_	0	SENT_173	[p11l558t482r617b530],
79	125	CD	NUMBER	125	num	80	SENT_173	[p11l629t485r710b530],
80	participants	NNS	O	participant	prep_of	77	SENT_173	[p11l733t485r1054b546],
81	)	VBP	O	)	_	0	SENT_173	[p11l733t485r1054b546],
82	(	CD	NUMBER	(	num	84	SENT_173	[p11l1082t482r1272b546],
83	pooled	JJ	O	pooled	amod	84	SENT_173	[p11l1082t482r1272b546],
84	HR	NN	DURATION	hr	nsubj	85	SENT_173	[p11l1293t487r1383b530],
85	1-97	CD	NUMBER	1-97	xcomp	81	SENT_173	[p11l1404t485r1526b538],
86	,	,	O	,	_	0	SENT_173	[p11l1404t485r1526b538],
87	95	CD	PERCENT	95	number	88	SENT_173	[p11l10t563r124b611],
88	%	NN	PERCENT	%	amod	89	SENT_173	[p11l10t563r124b611],
89	CI	NN	O	ci	appos	85	SENT_173	[p11l145t564r205b608],
90	1	CD	NUMBER	1	num	92	SENT_173	[p11l228t565r269b607],
91	-	:	O	-	_	0	SENT_173	[p11l228t565r269b607],
92	38-2-82	CD	NUMBER	38-2-82	nsubj	81	SENT_173	[p11l284t564r509b616],
93	,	,	O	,	_	0	SENT_173	[p11l284t564r509b616],
94	p	NN	O	p	appos	92	SENT_173	[p11l528t564r812b624],
95	=	JJ	O	=	amod	97	SENT_173	[p11l528t564r812b624],
96	0-0002	CD	NUMBER	0-0002	tmod	95	SENT_173	[p11l528t564r812b624],
97	)	NN	O	)	dep	94	SENT_173	[p11l528t564r812b624],
98	.	.	O	.	_	0	SENT_173	[p11l528t564r812b624],

1	When	WRB	O	when	dep	121	SENT_174	[p11l58t637r219b686],
2	We	PRP	O	we	dep	121	SENT_174	[p11l252t655r325b686],
3	examined	VBD	O	examine	dep	121	SENT_174	[p11l361t637r616b686],
4	the	DT	O	the	dep	121	SENT_174	[p11l649t637r732b686],
5	early	JJ	O	early	dep	121	SENT_174	[p11l768t637r892b701],
6	timepoint	NN	O	timepoint	dep	121	SENT_174	[p11l925t640r1184b700],
7	of	IN	O	of	dep	121	SENT_174	[p11l1218t637r1277b686],
8	30	CD	DURATION	30	dep	121	SENT_174	[p11l1305t642r1363b686],
9	days	NNS	NUMBER	day	dep	121	SENT_174	[p11l1399t637r1526b701],
10	,	,	O	,	_	0	SENT_174	[p11l1399t637r1526b701],
11	individuals	NNS	O	individual	dep	121	SENT_174	[p11l9t715r296b763],
12	who	WP	O	who	dep	121	SENT_174	[p11l314t715r425b763],
13	did	VBD	O	do	dep	121	SENT_174	[p11l445t715r528b763],
14	not	RB	O	not	dep	121	SENT_174	[p11l545t725r631b763],
15	carry	VB	O	carry	dep	121	SENT_174	[p11l649t732r778b779],
16	either	CC	O	either	dep	121	SENT_174	[p11l795t715r947b763],
17	at-risl	NN	O	at-risl	dep	121	SENT_174	[p11l965t715r1127b763],
18	<	JJR	O	<	dep	121	SENT_174	[p11l965t715r1127b763],
19	variant	NN	O	variant	dep	121	SENT_174	[p11l1142t718r1324b763],
20	were	VBD	O	be	dep	121	SENT_174	[p11l1339t732r1464b763],
21	at	IN	O	at	dep	121	SENT_174	[p11l1484t725r1530b763],
22	low	JJ	O	low	dep	121	SENT_174	[p11l8t793r101b842],
23	risk	NN	O	risk	dep	121	SENT_174	[p11l166t793r264b842],
24	(	CD	NUMBER	(	dep	121	SENT_174	[p11l333t793r703b857],
25	Kaplan-Meier	NNP	O	Kaplan-Meier	dep	121	SENT_174	[p11l333t793r703b857],
26	event	NN	O	event	dep	121	SENT_174	[p11l769t803r908b842],
27	rate	NN	O	rate	dep	121	SENT_174	[p11l972t803r1069b842],
28	4-0	JJ	PERCENT	4-0	dep	121	SENT_174	[p11l1134t796r1290b849],
29	%	NN	PERCENT	%	dep	121	SENT_174	[p11l1134t796r1290b849],
30	,	,	O	,	_	0	SENT_174	[p11l1134t796r1290b849],
31	31	CD	NUMBER	31	dep	121	SENT_174	[p11l1361t798r1413b842],
32	of	IN	O	of	dep	121	SENT_174	[p11l1479t793r1538b842],
33	773	CD	NUMBER	773	dep	121	SENT_174	[p11l8t874r89b922],
34	participants	NNS	O	participant	dep	121	SENT_174	[p11l115t874r455b935],
35	)	RB	O	)	dep	121	SENT_174	[p11l115t874r455b935],
36	,	,	O	,	_	0	SENT_174	[p11l115t874r455b935],
37	those	DT	O	those	dep	121	SENT_174	[p11l480t871r620b920],
38	who	WP	O	who	dep	121	SENT_174	[p11l642t871r753b920],
39	were	VBD	O	be	dep	121	SENT_174	[p11l776t889r901b920],
40	either	DT	O	either	dep	121	SENT_174	[p11l925t871r1077b920],
41	ABCB1	NN	O	abcb1	dep	121	SENT_174	[p11l1098t875r1287b920],
42	3435	CD	NUMBER	3435	dep	121	SENT_174	[p11l1312t874r1427b920],
43	TT	NN	O	tt	dep	121	SENT_174	[p11l1452t874r1529b919],
44	homozygotes	NNS	O	homozygote	dep	121	SENT_174	[p11l8t949r355b1013],
45	or	CC	O	or	dep	121	SENT_174	[p11l382t966r436b997],
46	carriers	NNS	O	carrier	dep	121	SENT_174	[p11l460t952r655b997],
47	of	IN	O	of	dep	121	SENT_174	[p11l682t949r741b997],
48	a	DT	O	a	dep	121	SENT_174	[p11l757t966r783b997],
49	CYP2C19	NN	O	cyp2c19	dep	121	SENT_174	[p11l813t952r1057b998],
50	reduced-function	NN	O	reduced-function	dep	121	SENT_174	[p11l1079t949r1529b997],
51	allele	NN	O	allele	dep	121	SENT_174	[p11l10t1027r142b1076],
52	were	VBD	O	be	dep	121	SENT_174	[p11l166t1045r291b1076],
53	at	IN	O	at	dep	121	SENT_174	[p11l318t1037r363b1076],
54	intermediate	JJ	O	intermediate	dep	121	SENT_174	[p11l387t1027r721b1076],
55	risk	NN	O	risk	dep	121	SENT_174	[p11l746t1027r845b1076],
56	(	CD	NUMBER	(	dep	121	SENT_174	[p11l873t1027r1243b1091],
57	Kaplan-Meier	NNP	O	Kaplan-Meier	dep	121	SENT_174	[p11l873t1027r1243b1091],
58	event	NN	O	event	dep	121	SENT_174	[p11l1268t1037r1407b1076],
59	rate	NN	O	rate	dep	121	SENT_174	[p11l1430t1037r1528b1076],
60	7-0	CD	PERCENT	7-0	dep	121	SENT_174	[p11l8t1108r148b1156],
61	%	NN	PERCENT	%	dep	121	SENT_174	[p11l8t1108r148b1156],
62	[	CD	NUMBER	[	dep	121	SENT_174	[p11l182t1109r255b1168],
63	20	CD	NUMBER	20	dep	121	SENT_174	[p11l182t1109r255b1168],
64	of	IN	O	of	dep	121	SENT_174	[p11l287t1105r345b1154],
65	288	CD	NUMBER	288	dep	121	SENT_174	[p11l369t1109r459b1154],
66	participants	NNS	O	participant	dep	121	SENT_174	[p11l489t1108r810b1168],
67	]	VBP	O	]	dep	121	SENT_174	[p11l489t1108r810b1168],
68	for	IN	O	for	dep	121	SENT_174	[p11l844t1105r918b1154],
69	TT	NN	O	tt	dep	121	SENT_174	[p11l947t1108r1024b1153],
70	homozygotes	NNS	O	homozygote	dep	121	SENT_174	[p11l1053t1105r1399b1169],
71	and	CC	O	and	dep	121	SENT_174	[p11l1432t1105r1529b1154],
72	6-0	CD	PERCENT	6-0	dep	121	SENT_174	[p11l10t1185r153b1232],
73	%	NN	PERCENT	%	dep	121	SENT_174	[p11l10t1185r153b1232],
74	[	CD	NUMBER	[	dep	121	SENT_174	[p11l186t1186r252b1245],
75	16	CD	NUMBER	16	dep	121	SENT_174	[p11l186t1186r252b1245],
76	of	IN	O	of	dep	121	SENT_174	[p11l283t1182r342b1230],
77	268	CD	NUMBER	268	dep	121	SENT_174	[p11l364t1186r454b1230],
78	participants	NNS	O	participant	dep	121	SENT_174	[p11l484t1185r805b1245],
79	]	VBP	O	]	dep	121	SENT_174	[p11l484t1185r805b1245],
80	for	IN	O	for	dep	121	SENT_174	[p11l837t1182r912b1230],
81	carriers	NNS	O	carrier	dep	121	SENT_174	[p11l941t1185r1135b1230],
82	of	IN	O	of	dep	121	SENT_174	[p11l1167t1182r1226b1230],
83	a	DT	O	a	dep	121	SENT_174	[p11l1247t1199r1273b1230],
84	reducedfunction	NN	O	reducedfunction	dep	121	SENT_174	[p11l1302t1182r1527b1230, p11l9t1259r231b1308],
85	allele	NN	O	allele	dep	121	SENT_174	[p11l274t1259r420b1315],
86	;	:	O	;	_	0	SENT_174	[p11l274t1259r420b1315],
87	pooled	VBN	O	pool	dep	121	SENT_174	[p11l464t1259r639b1322],
88	HR	NN	DURATION	hr	dep	121	SENT_174	[p11l683t1264r774b1307],
89	1-64	CD	NUMBER	1-64	dep	121	SENT_174	[p11l817t1264r941b1315],
90	,	,	O	,	_	0	SENT_174	[p11l817t1264r941b1315],
91	95	CD	PERCENT	95	dep	121	SENT_174	[p11l986t1262r1099b1310],
92	%	NN	PERCENT	%	dep	121	SENT_174	[p11l986t1262r1099b1310],
93	CI	NN	O	ci	dep	121	SENT_174	[p11l1144t1263r1203b1308],
94	1-01-2-65	CD	DATE	1-01-2-65	dep	121	SENT_174	[p11l1250t1262r1526b1315],
95	,	,	O	,	_	0	SENT_174	[p11l1250t1262r1526b1315],
96	p	NN	O	p	dep	121	SENT_174	[p11l9t1341r107b1400],
97	=	JJ	O	=	dep	121	SENT_174	[p11l9t1341r107b1400],
98	o	NN	O	o	dep	121	SENT_174	[p11l9t1341r107b1400],
99	-	:	O	-	_	0	SENT_174	[p11l119t1365r127b1373],
100	0441	CD	DATE	0441	dep	121	SENT_174	[p11l139t1341r250b1386],
101	vs	CC	O	vs	dep	121	SENT_174	[p11l268t1355r314b1385],
102	carriers	NNS	O	carrier	dep	121	SENT_174	[p11l331t1340r526b1386],
103	of	IN	O	of	dep	121	SENT_174	[p11l546t1337r605b1386],
104	neither	CC	O	neither	dep	121	SENT_174	[p11l614t1337r833b1401],
105	)	NN	O	)	dep	121	SENT_174	[p11l614t1337r833b1401],
106	,	,	O	,	_	0	SENT_174	[p11l614t1337r833b1401],
107	and	CC	O	and	dep	121	SENT_174	[p11l855t1337r952b1386],
108	individuals	NNS	O	individual	dep	121	SENT_174	[p11l969t1337r1256b1386],
109	who	WP	O	who	dep	121	SENT_174	[p11l1275t1337r1385b1386],
110	were	VBD	O	be	dep	121	SENT_174	[p11l1403t1354r1528b1386],
111	both	DT	O	both	dep	121	SENT_174	[p11l8t1416r127b1464],
112	C	NN	O	c	dep	121	SENT_174	[p11l146t1419r185b1464],
113	YPZC	NN	O	ypzc	dep	121	SENT_174	[p11l189t1419r335b1464],
114	19	CD	NUMBER	19	dep	121	SENT_174	[p11l338t1420r390b1465],
115	reduced-function	NN	O	reduced-function	dep	121	SENT_174	[p11l403t1416r853b1464],
116	allele	NN	O	allele	dep	121	SENT_174	[p11l868t1416r1001b1464],
117	carriers	NNS	O	carrier	dep	121	SENT_174	[p11l1017t1419r1212b1464],
118	and	CC	O	and	dep	121	SENT_174	[p11l1230t1416r1327b1464],
119	AB	NNP	O	AB	dep	121	SENT_174	[p11l1340t1419r1421b1464],
120	C	NNP	O	C	dep	121	SENT_174	[p11l1428t1419r1466b1464],
121	B1	NN	O	b1	_	0	SENT_174	[p11l1469t1420r1529b1464],

1	3435	CD	NUMBER	3435	num	3	SENT_175	[p11l12t1496r127b1542],
2	TT	NN	O	tt	nn	3	SENT_175	[p11l159t1496r237b1541],
3	homozygotes	NNS	O	homozygote	nsubj	4	SENT_175	[p11l266t1493r612b1557],
4	were	VBD	O	be	_	0	SENT_175	[p11l643t1511r768b1542],
5	at	IN	O	at	_	0	SENT_175	[p11l801t1503r847b1542],
6	high	JJ	O	high	amod	7	SENT_175	[p11l875t1493r995b1557],
7	risk	NN	O	risk	prep_at	4	SENT_175	[p11l1026t1493r1125b1542],
8	(	CD	NUMBER	(	num	11	SENT_175	[p11l1159t1493r1529b1557],
9	Kaplan-Meier	NNP	O	Kaplan-Meier	nn	11	SENT_175	[p11l1159t1493r1529b1557],
10	event	NN	O	event	nn	11	SENT_175	[p11l10t1580r149b1618],
11	rate	NN	O	rate	dep	7	SENT_175	[p11l166t1580r263b1619],
12	12	CD	NUMBER	12	dep	11	SENT_175	[p11l283t1574r335b1618],
13	-	:	O	-	_	0	SENT_175	[p11l348t1598r356b1606],
14	o	NN	PERCENT	o	nn	15	SENT_175	[p11l369t1573r464b1626],
15	%	NN	PERCENT	%	dep	11	SENT_175	[p11l369t1573r464b1626],
16	,	,	O	,	_	0	SENT_175	[p11l369t1573r464b1626],
17	15	CD	NUMBER	15	appos	15	SENT_175	[p11l487t1573r537b1618],
18	of	IN	O	of	_	0	SENT_175	[p11l559t1570r617b1618],
19	125	CD	NUMBER	125	num	20	SENT_175	[p11l628t1573r710b1618],
20	participants	NNS	O	participant	prep_of	17	SENT_175	[p11l730t1573r1051b1633],
21	;	:	O	;	_	0	SENT_175	[p11l730t1573r1051b1633],
22	HR	NN	DURATION	hr	dep	11	SENT_175	[p11l1075t1575r1165b1618],
23	3-16	CD	NUMBER	3-16	num	22	SENT_175	[p11l1185t1574r1311b1626],
24	,	,	O	,	_	0	SENT_175	[p11l1185t1574r1311b1626],
25	95	CD	PERCENT	95	number	26	SENT_175	[p11l1333t1573r1446b1620],
26	%	NN	PERCENT	%	amod	27	SENT_175	[p11l1333t1573r1446b1620],
27	CI	NN	O	ci	appos	22	SENT_175	[p11l1467t1574r1525b1619],
28	1	CD	NUMBER	1	dep	27	SENT_175	[p11l11t1653r33b1696],
29	-	:	O	-	_	0	SENT_175	[p11l44t1677r52b1685],
30	71-5	CD	NUMBER	71-5	num	31	SENT_175	[p11l63t1652r174b1699],
31	-85	CD	NUMBER	-85	dep	11	SENT_175	[p11l189t1652r282b1705],
32	,	,	O	,	_	0	SENT_175	[p11l189t1652r282b1705],
33	p	NN	O	p	nn	35	SENT_175	[p11l301t1653r399b1712],
34	=	JJ	O	=	amod	35	SENT_175	[p11l301t1653r399b1712],
35	o	NN	O	o	appos	31	SENT_175	[p11l301t1653r399b1712],
36	-	:	O	-	_	0	SENT_175	[p11l412t1677r420b1685],
37	0003	CD	DATE	0003	dep	11	SENT_175	[p11l432t1653r552b1697],
38	vs	CC	O	vs	_	0	SENT_175	[p11l572t1666r618b1697],
39	carriers	NNS	O	carrier	dep	11	SENT_175	[p11l635t1652r829b1697],
40	of	IN	O	of	prep	11	SENT_175	[p11l848t1649r907b1697],
41	neither	CC	O	neither	dep	11	SENT_175	[p11l915t1649r1134b1713],
42	)	NN	O	)	conj	11	SENT_175	[p11l915t1649r1134b1713],
43	.	.	O	.	_	0	SENT_175	[p11l915t1649r1134b1713],

1	I	PRP	O	I	_	0	SENT_176	[p11l6t1953r54b2152],
2	Articles	NNPS	O	Articles	dep	1	SENT_176	[p11l101t2116r251b2152],

1	Cardiovascular	NNP	O	Cardiovascular	nn	2	SENT_177	[p12l243t884r277b1136],
2	death	NN	O	death	_	0	SENT_177	[p12l243t767r283b875],
3	,	,	O	,	_	0	SENT_177	[p12l243t767r283b875],
4	MI	NNP	O	MI	conj_or	2	SENT_177	[p12l247t703r283b754],
5	,	,	O	,	_	0	SENT_177	[p12l247t703r283b754],
6	or	CC	O	or	_	0	SENT_177	[p12l255t656r277b691],
7	stroke	NN	O	stroke	conj_or	2	SENT_177	[p12l243t539r277b646],
8	(	CD	PERCENT	(	num	9	SENT_177	[p12l245t472r285b527],
9	%	NN	PERCENT	%	dep	2	SENT_177	[p12l245t472r285b527],
10	)	CD	NUMBER	)	dep	9	SENT_177	[p12l245t472r285b527],

1	Number	NN	O	number	_	0	SENT_178	[p12l48t1513r197b1546],
2	at	IN	O	at	_	0	SENT_178	[p12l207t1519r244b1546],
3	risk	NN	O	risk	nn	5	SENT_178	[p12l255t1513r319b1546],
4	TT	NN	O	tt	nn	5	SENT_178	[p12l273t1571r319b1601],
5	CC	NN	O	cc	prep_at	1	SENT_178	[p12l274t1625r318b1656],
6	CT	NN	O	ct	dep	1	SENT_178	[p12l275t1680r319b1711],
7	14	CD	NUMBER	14	num	6	SENT_178	[p12l306t190r349b224],

1	|	NN	O	|	_	0	SENT_179	[p12l307t528r325b556],
2	.	.	O	.	_	0	SENT_179	[p12l307t528r325b556],

1	—	NN	O	—	_	0	SENT_180	[p12l307t528r325b556],
2	.	.	O	.	_	0	SENT_180	[p12l307t528r325b556],

1	‘	NN	O	‘	nn	2	SENT_181	[p12l307t528r325b556],
2	O	NN	O	o	_	0	SENT_181	[p12l328t528r348b557],

1	Prasugrel	NNP	O	Prasugrel	_	0	SENT_182	[p12l383t112r550b156],
2	#	#	MONEY	#	number	4	SENT_182	[p12l413t191r651b226],
3	343517	CD	MONEY	343517	number	4	SENT_182	[p12l413t191r651b226],
4	:3435	CD	MONEY	:3435	num	5	SENT_182	[p12l413t245r651b281],
5	CC	NN	O	cc	dep	1	SENT_182	[p12l413t245r651b281],
6	:3435	CD	NUMBER	:3435	num	7	SENT_182	[p12l414t300r652b335],
7	CT	NN	O	ct	dep	5	SENT_182	[p12l414t300r652b335],

1	p	NN	O	p	_	0	SENT_183	[p12l1573t1322r1743b1361],
2	=	JJ	O	=	amod	3	SENT_183	[p12l1573t1322r1743b1361],
3	0-4003	CD	NUMBER	0-4003	dep	1	SENT_183	[p12l1573t1322r1743b1361],
4	across	IN	O	across	_	0	SENT_183	[p12l1755t1329r1860b1351],
5	genotype	NN	O	genotype	prep_across	3	SENT_183	[p12l1871t1324r2035b1361],

1	o	NN	O	o	nn	2	SENT_184	[p12l328t1371r348b1400],
2	O	NN	O	o	_	0	SENT_184	[p12l369t1417r390b1446],
3	30	CD	NUMBER	30	num	4	SENT_184	[p12l465t1417r508b1451],
4	60 90 120 150	CD	NUMBER	60 90 120 150	dep	2	SENT_184	[p12l884t1417r948b1451],[p12l572t1412r617b1446],
5	180 210 240 270	CD	NUMBER	180 210 240 270	number	6	SENT_184	[p12l1314t1417r1377b1450],[p12l990t1412r1056b1446],
6	300 330 360 390	CD	NUMBER	300 330 360 390	num	8	SENT_184	[p12l1740t1417r1808b1451],[p12l1419t1417r1486b1451],
7	420	CD	NUMBER	420	number	8	SENT_184	[p12l1848t1417r1915b1450],
8	450	CD	NUMBER	450	dep	4	SENT_184	[p12l1955t1417r2022b1451],

1	Days	NNS	DURATION	day	_	0	SENT_185	[p12l975t1486r1054b1526],
2	from	IN	O	from	_	0	SENT_185	[p12l1064t1482r1148b1516],
3	randomisation	NN	O	randomisation	prep_from	1	SENT_185	[p12l1162t1482r1415b1516],

1	Figure	NNP	O	Figure	_	0	SENT_186	[p12l9t1798r123b1844],
2	3	CD	NUMBER	3	num	1	SENT_186	[p12l131t1801r166b1838],
3	:	:	O	:	_	0	SENT_186	[p12l131t1801r166b1838],
4	ABCB1	NN	O	abcb1	nn	5	SENT_186	[p12l176t1799r304b1832],
5	3435C	NN	O	3435c	dep	1	SENT_186	[p12l317t1799r517b1838],
6	—	CD	NUMBER	—	num	8	SENT_186	[p12l317t1799r517b1838],
7	>	JJR	O	>	amod	8	SENT_186	[p12l317t1799r517b1838],
8	T	NN	O	t	nsubj	14	SENT_186	[p12l317t1799r517b1838],
9	and	CC	O	and	_	0	SENT_186	[p12l526t1796r600b1832],
10	cardiovascular	JJ	O	cardiovascular	amod	11	SENT_186	[p12l611t1796r895b1832],
11	outcomes	NNS	O	outcome	nsubj	14	SENT_186	[p12l905t1802r1100b1832],
12	in	IN	O	in	_	0	SENT_186	[p12l1112t1798r1146b1832],
13	patients	NNS	O	patient	prep_in	8	SENT_186	[p12l1159t1798r1323b1843],
14	treated	VBN	O	treat	rcmod	5	SENT_186	[p12l1332t1796r1478b1832],
15	with	IN	O	with	_	0	SENT_186	[p12l1487t1796r1578b1832],
16	prasug	NN	O	prasug	nn	17	SENT_186	[p12l1591t1808r1723b1844],
17	rel	NN	O	rel	prep_with	14	SENT_186	[p12l1729t1796r1773b1832],
18	Cumulative	JJ	O	cumulative	amod	19	SENT_186	[p12l9t1859r222b1894],
19	risk	NN	O	risk	dobj	14	SENT_186	[p12l236t1859r297b1894],
20	of	IN	O	of	_	0	SENT_186	[p12l308t1858r348b1894],
21	cardiovascular	JJ	O	cardiovascular	amod	22	SENT_186	[p12l357t1859r622b1894],
22	death	NN	O	death	prep_of	19	SENT_186	[p12l633t1859r748b1901],
23	,	,	O	,	_	0	SENT_186	[p12l633t1859r748b1901],
24	myocardial	JJ	O	myocardial	amod	25	SENT_186	[p12l764t1859r965b1905],
25	infarction	NN	O	infarction	conj_or	19	SENT_186	[p12l980t1858r1159b1894],
26	(	CD	NUMBER	(	num	28	SENT_186	[p12l1174t1861r1260b1904],
27	MI	NNP	O	MI	nn	28	SENT_186	[p12l1174t1861r1260b1904],
28	)	NNP	O	)	dep	25	SENT_186	[p12l1174t1861r1260b1904],
29	,	,	O	,	_	0	SENT_186	[p12l1174t1861r1260b1904],
30	or	CC	O	or	_	0	SENT_186	[p12l1272t1871r1310b1894],
31	stroke	NN	O	stroke	conj_or	19	SENT_186	[p12l1321t1859r1436b1894],
32	for	IN	O	for	_	0	SENT_186	[p12l1446t1858r1501b1894],
33	each	DT	O	each	det	34	SENT_186	[p12l1512t1859r1594b1894],
34	genotype	NN	O	genotype	prep_for	31	SENT_186	[p12l1608t1865r1794b1906],
35	,	,	O	,	_	0	SENT_186	[p12l1608t1865r1794b1906],
36	with	IN	O	with	_	0	SENT_186	[p12l1806t1859r1889b1894],
37	a	DT	O	a	det	39	SENT_186	[p12l1902t1871r1921b1894],
38	p	NN	O	p	nn	39	SENT_186	[p12l1933t1871r1955b1905],
39	value	NN	O	value	prep_with	1	SENT_186	[p12l1966t1859r2064b1894],
40	across	IN	O	across	_	0	SENT_186	[p12l8t1922r121b1946],
41	genotype	NN	O	genotype	prep_across	39	SENT_186	[p12l134t1917r320b1957],
42	.	.	O	.	_	0	SENT_186	[p12l134t1917r320b1957],

1	There	EX	O	there	expl	2	SENT_187	[p12l696t1999r853b2047],
2	was	VBD	O	be	_	0	SENT_187	[p12l875t2016r974b2047],
3	no	DT	O	no	det	5	SENT_187	[p12l998t2016r1064b2047],
4	signiﬁcant	JJ	O	signiﬁcant	amod	5	SENT_187	[p12l1090t1999r1373b2062],
5	association	NN	O	association	nsubj	2	SENT_187	[p12l1395t2002r1693b2047],
6	between	IN	O	between	_	0	SENT_187	[p12l1714t1999r1938b2047],
7	ABCB1	NN	O	abcb1	nn	8	SENT_187	[p12l1960t2003r2152b2047],
8	3435C	NN	O	3435c	prep_between	5	SENT_187	[p12l650t2079r915b2123],
9	—	CD	NUMBER	—	num	11	SENT_187	[p12l650t2079r915b2123],
10	>	JJR	O	>	amod	11	SENT_187	[p12l650t2079r915b2123],
11	T	NN	O	t	dep	8	SENT_187	[p12l650t2079r915b2123],
12	genotype	NN	O	genotype	dep	8	SENT_187	[p12l948t2085r1189b2139],
13	and	CC	O	and	_	0	SENT_187	[p12l1223t2076r1322b2123],
14	risk	NN	O	risk	dep	8	SENT_187	[p12l1353t2076r1455b2123],
15	of	IN	O	of	_	0	SENT_187	[p12l1486t2076r1546b2123],
16	cardiovascular	JJ	O	cardiovascular	amod	17	SENT_187	[p12l1570t2076r1956b2123],
17	death	NN	O	death	prep_of	12	SENT_187	[p12l1989t2076r2149b2131],
18	,	,	O	,	_	0	SENT_187	[p12l1989t2076r2149b2131],
19	myocardial	JJ	O	myocardial	amod	20	SENT_187	[p12l647t2151r944b2214],
20	infarction	NN	O	infarction	appos	17	SENT_187	[p12l968t2151r1247b2206],
21	,	,	O	,	_	0	SENT_187	[p12l968t2151r1247b2206],
22	or	CC	O	or	_	0	SENT_187	[p12l1275t2168r1329b2199],
23	stroke	NN	O	stroke	conj_or	8	SENT_187	[p12l1355t2151r1516b2199],
24	among	IN	O	among	_	0	SENT_187	[p12l1542t2168r1728b2214],
25	patients	NNS	O	patient	prep_among	23	SENT_187	[p12l1752t2154r1964b2213],
26	in	IN	O	in	_	0	SENT_187	[p12l1991t2154r2044b2198],
27	the	DT	O	the	det	28	SENT_187	[p12l2067t2151r2151b2199],
28	TRITON	NNP	ORGANIZATION	TRITON	prep_in	25	SENT_187	[p12l646t2230r1057b2275],
29	.	.	O	.	_	0	SENT_187	[p12l646t2230r1057b2275],

1	—	NN	O	—	_	0	SENT_188	[p12l646t2230r1057b2275],
2	.	.	O	.	_	0	SENT_188	[p12l646t2230r1057b2275],

1	TIMI	NNP	ORGANIZATION	TIMI	_	0	SENT_189	[p12l646t2230r1057b2275],
2	38	CD	NUMBER	38	num	1	SENT_189	[p12l1105t2231r1164b2275],
3	genetic	JJ	O	genetic	npadvmod	4	SENT_189	[p12l1208t2230r1401b2290],
4	substudy	JJ	O	substudy	amod	1	SENT_189	[p12l1445t2227r1686b2290],
5	Who	WP	O	who	nsubjpass	8	SENT_189	[p12l1726t2227r1839b2275],
6	had	VBD	O	have	aux	8	SENT_189	[p12l1882t2227r1981b2275],
7	been	VBN	O	be	auxpass	8	SENT_189	[p12l2022t2227r2152b2275],
8	allocated	VBN	O	allocate	rcmod	1	SENT_189	[p12l648t2304r883b2351],
9	to	TO	O	to	_	0	SENT_189	[p12l896t2313r946b2351],
10	prasugrel	NN	O	prasugrel	nn	12	SENT_189	[p12l961t2304r1216b2367],
11	(	NN	O	(	nn	12	SENT_189	[p12l1235t2308r1449b2367],
12	n	NN	O	n	prep_to	8	SENT_189	[p12l1235t2308r1449b2367],
13	=	JJ	O	=	amod	12	SENT_189	[p12l1235t2308r1449b2367],
14	1461	CD	DATE	1461	tmod	13	SENT_189	[p12l1235t2308r1449b2367],
15	;	:	O	;	_	0	SENT_189	[p12l1235t2308r1449b2367],
16	ﬁgure	NN	O	ﬁgure	tmod	1	SENT_189	[p12l1467t2304r1625b2367],
17	3	CD	NUMBER	3	num	16	SENT_189	[p12l1643t2308r1667b2351],
18	and	CC	O	and	_	0	SENT_189	[p12l1685t2304r1784b2351],
19	Webappendix	NNP	PERSON	Webappendix	nn	20	SENT_189	[p12l1796t2304r2153b2366],
20	p	NN	O	p	tmod	1	SENT_189	[p12l646t2396r678b2441],
21	2	CD	NUMBER	2	num	22	SENT_189	[p12l723t2384r784b2442],
22	)	NN	O	)	dep	20	SENT_189	[p12l723t2384r784b2442],
23	.	.	O	.	_	0	SENT_189	[p12l723t2384r784b2442],

1	Speciﬁcally	RB	O	speciﬁcally	advmod	7	SENT_190	[p12l834t2379r1142b2442],
2	,	,	O	,	_	0	SENT_190	[p12l834t2379r1142b2442],
3	TT	NN	O	tt	nn	4	SENT_190	[p12l1186t2382r1264b2426],
4	homozygotes	NNS	O	homozygote	nsubj	7	SENT_190	[p12l1304t2379r1660b2442],
5	did	VBD	O	do	aux	7	SENT_190	[p12l1705t2379r1790b2427],
6	not	RB	O	not	neg	7	SENT_190	[p12l1831t2389r1919b2427],
7	have	VB	O	have	_	0	SENT_190	[p12l1959t2379r2082b2427],
8	a	DT	O	a	det	11	SENT_190	[p12l2126t2396r2152b2427],
9	signiﬁcantly	RB	O	signiﬁcantly	advmod	10	SENT_190	[p12l649t2455r978b2518],
10	higher	JJR	O	higher	amod	11	SENT_190	[p12l992t2455r1170b2518],
11	risk	NN	O	risk	dobj	7	SENT_190	[p12l1184t2455r1286b2503],
12	of	IN	O	of	_	0	SENT_190	[p12l1301t2455r1360b2503],
13	the	DT	O	the	det	16	SENT_190	[p12l1366t2455r1450b2503],
14	primary	JJ	O	primary	amod	16	SENT_190	[p12l1466t2458r1682b2518],
15	eﬁﬁcacy	NN	O	eﬁﬁcacy	nn	16	SENT_190	[p12l1697t2455r1896b2518],
16	endpoint	NN	O	endpoint	prep_of	11	SENT_190	[p12l1910t2455r2153b2517],
17	of	IN	O	of	_	0	SENT_190	[p12l647t2532r707b2580],
18	cardiovascular	JJ	O	cardiovascular	amod	19	SENT_190	[p12l717t2532r1103b2580],
19	death	NN	O	death	prep_of	16	SENT_190	[p12l1121t2532r1281b2587],
20	,	,	O	,	_	0	SENT_190	[p12l1121t2532r1281b2587],
21	myocardial	JJ	O	myocardial	amod	22	SENT_190	[p12l1302t2532r1599b2595],
22	infarction	NN	O	infarction	conj_or	19	SENT_190	[p12l1617t2532r1895b2587],
23	,	,	O	,	_	0	SENT_190	[p12l1617t2532r1895b2587],
24	or	CC	O	or	_	0	SENT_190	[p12l1916t2549r1971b2580],
25	stroke	NN	O	stroke	prep_of	16	SENT_190	[p12l1990t2532r2151b2580],
26	than	IN	O	than	mark	27	SENT_190	[p12l646t2608r768b2656],
27	did	VBD	O	do	advcl	7	SENT_190	[p12l811t2608r895b2656],
28	CT/CC	NNP	O	CT/CC	nn	29	SENT_190	[p12l939t2611r1119b2670],
29	carriers	NNS	O	carrier	nsubj	30	SENT_190	[p12l1164t2611r1365b2656],
30	(	VBP	O	(	ccomp	27	SENT_190	[p12l1414t2608r1797b2671],
31	Kaplan-Meier	JJ	O	kaplan-meier	amod	33	SENT_190	[p12l1414t2608r1797b2671],
32	event	NN	O	event	nn	33	SENT_190	[p12l1839t2618r1982b2656],
33	rates	NNS	O	rate	dobj	30	SENT_190	[p12l2024t2618r2150b2656],
34	11-0	CD	PERCENT	11-0	num	35	SENT_190	[p12l649t2687r813b2734],
35	%	NN	PERCENT	%	dep	33	SENT_190	[p12l649t2687r813b2734],
36	[	CD	NUMBER	[	number	37	SENT_190	[p12l854t2688r920b2747],
37	41	CD	NUMBER	41	num	35	SENT_190	[p12l854t2688r920b2747],
38	of	IN	O	of	_	0	SENT_190	[p12l958t2684r1017b2732],
39	390	CD	NUMBER	390	number	40	SENT_190	[p12l1048t2688r1153b2747],
40	]	CD	NUMBER	]	prep_of	35	SENT_190	[p12l1048t2688r1153b2747],
41	vs	CC	O	vs	_	0	SENT_190	[p12l1193t2701r1240b2732],
42	8-7	CD	PERCENT	8-7	num	43	SENT_190	[p12l1277t2687r1417b2734],
43	%	NN	PERCENT	%	dobj	30	SENT_190	[p12l1277t2687r1417b2734],
44	[	CD	NUMBER	[	number	45	SENT_190	[p12l1458t2688r1528b2747],
45	91	CD	NUMBER	91	num	43	SENT_190	[p12l1458t2688r1528b2747],
46	of	IN	O	of	_	0	SENT_190	[p12l1565t2684r1624b2732],
47	1071	CD	NUMBER	1071	num	48	SENT_190	[p12l1654t2687r1763b2734],
48	participants	NNS	O	participant	prep_of	43	SENT_190	[p12l1799t2687r2149b2747],
49	]	CD	NUMBER	]	dep	43	SENT_190	[p12l1799t2687r2149b2747],
50	;	:	O	;	_	0	SENT_190	[p12l1799t2687r2149b2747],
51	HR	NN	DURATION	hr	conj_vs	33	SENT_190	[p12l650t2766r741b2808],
52	1-25	CD	NUMBER	1-25	num	51	SENT_190	[p12l768t2764r899b2816],
53	,	,	O	,	_	0	SENT_190	[p12l768t2764r899b2816],
54	95	CD	PERCENT	95	number	55	SENT_190	[p12l929t2764r1043b2811],
55	%	NN	PERCENT	%	amod	57	SENT_190	[p12l929t2764r1043b2811],
56	CI	NN	O	ci	nn	57	SENT_190	[p12l1071t2765r1131b2809],
57	O-86-1-81	NN	O	o-86-1-81	appos	51	SENT_190	[p12l1160t2766r1447b2817],
58	,	,	O	,	_	0	SENT_190	[p12l1160t2766r1447b2817],
59	p	NN	O	p	appos	57	SENT_190	[p12l1475t2764r1719b2824],
60	=	JJ	O	=	advmod	30	SENT_190	[p12l1475t2764r1719b2824],
61	0-235	CD	NUMBER	0-235	num	62	SENT_190	[p12l1475t2764r1719b2824],
62	)	CD	NUMBER	)	dep	60	SENT_190	[p12l1475t2764r1719b2824],
63	when	WRB	O	when	advmod	64	SENT_190	[p12l1747t2761r1896b2809],
64	assessed	VBN	O	assess	dep	60	SENT_190	[p12l1922t2761r2152b2809],
65	until	IN	O	until	_	0	SENT_190	[p12l646t2837r774b2885],
66	15	CD	DURATION	15	num	67	SENT_190	[p12l792t2840r844b2885],
67	months	NNS	NUMBER	month	prep_until	64	SENT_190	[p12l863t2837r1084b2885],
68	.	.	O	.	_	0	SENT_190	[p12l863t2837r1084b2885],

1	Rates	NNS	O	rate	nsubj	17	SENT_191	[p12l1106t2842r1246b2885],
2	of	IN	O	of	_	0	SENT_191	[p12l1265t2837r1324b2885],
3	TIMI	NNP	O	TIMI	nn	14	SENT_191	[p12l1331t2840r1471b2884],
4	major	JJ	O	major	amod	14	SENT_191	[p12l1490t2840r1650b2900],
5	or	CC	O	or	_	0	SENT_191	[p12l1666t2854r1721b2885],
6	minor	JJ	O	minor	amod	7	SENT_191	[p12l1736t2840r1904b2885],
7	bleeding	NN	O	bleeding	amod	14	SENT_191	[p12l1919t2837r2152b2900],
8	not	RB	O	not	neg	9	SENT_191	[p12l647t2922r735b2961],
9	related	JJ	O	related	amod	13	SENT_191	[p12l763t2913r946b2961],
10	to	TO	O	to	_	0	SENT_191	[p12l974t2922r1023b2961],
11	coronary	JJ	O	coronary	amod	12	SENT_191	[p12l1054t2930r1290b2975],
12	artery	NN	O	artery	prep_to	9	SENT_191	[p12l1319t2922r1473b2976],
13	bypass	NN	O	bypass	dep	4	SENT_191	[p12l1500t2913r1678b2976],
14	grafting	NN	O	grafting	prep_of	1	SENT_191	[p12l1710t2913r1922b2976],
15	did	VBD	O	do	aux	17	SENT_191	[p12l1952t2913r2036b2961],
16	not	RB	O	not	neg	17	SENT_191	[p12l2065t2922r2153b2961],
17	differ	VB	O	differ	_	0	SENT_191	[p12l647t2989r793b3037],
18	signiﬁcantly	RB	O	signiﬁcantly	advmod	17	SENT_191	[p12l847t2989r1177b3052],
19	by	IN	O	by	_	0	SENT_191	[p12l1228t2989r1291b3052],
20	ABCB1	NN	O	abcb1	nn	21	SENT_191	[p12l1342t2993r1535b3037],
21	3435C	NN	O	3435c	nn	25	SENT_191	[p12l1590t2992r1856b3037],
22	—	CD	NUMBER	—	npadvmod	23	SENT_191	[p12l1590t2992r1856b3037],
23	>	JJR	O	>	amod	25	SENT_191	[p12l1590t2992r1856b3037],
24	T	NN	O	t	nn	25	SENT_191	[p12l1590t2992r1856b3037],
25	genotype	NN	O	genotype	prep_by	17	SENT_191	[p12l1910t2999r2151b3052],
26	(	CD	NUMBER	(	num	28	SENT_191	[p12l651t3065r1023b3128],
27	Webappendix	NNP	O	Webappendix	nn	28	SENT_191	[p12l651t3065r1023b3128],
28	p	NN	O	p	tmod	17	SENT_191	[p12l1047t3082r1078b3127],
29	2	CD	NUMBER	2	num	30	SENT_191	[p12l1107t3070r1168b3128],
30	)	NN	O	)	dep	28	SENT_191	[p12l1107t3070r1168b3128],
31	.	.	O	.	_	0	SENT_191	[p12l1107t3070r1168b3128],

1	In	IN	O	in	_	0	SENT_192	[p12l1200t3070r1256b3112],
2	terms	NNS	O	term	prep_in	23	SENT_192	[p12l1281t3075r1435b3113],
3	of	IN	O	of	_	0	SENT_192	[p12l1463t3065r1523b3113],
4	other	JJ	O	other	amod	6	SENT_192	[p12l1540t3065r1681b3113],
5	ABCB1	NN	O	abcb1	nn	6	SENT_192	[p12l1705t3068r1898b3113],
6	variants	NNS	O	variant	prep_of	2	SENT_192	[p12l1921t3068r2149b3120],
7	,	,	O	,	_	0	SENT_192	[p12l1921t3068r2149b3120],
8	the	DT	O	the	det	9	SENT_192	[p12l646t3141r730b3189],
9	2677G	NN	O	2677g	nsubjpass	23	SENT_192	[p12l758t3144r1086b3203],
10	—	CD	NUMBER	—	num	12	SENT_192	[p12l758t3144r1086b3203],
11	>	JJR	O	>	amod	12	SENT_192	[p12l758t3144r1086b3203],
12	T/A	NN	O	t/a	dep	9	SENT_192	[p12l758t3144r1086b3203],
13	and	CC	O	and	_	0	SENT_192	[p12l1111t3141r1210b3189],
14	1236C	NN	O	1236c	nsubjpass	23	SENT_192	[p12l1237t3144r1501b3189],
15	—	CD	NUMBER	—	num	14	SENT_192	[p12l1237t3144r1501b3189],
16	>	JJR	O	>	amod	18	SENT_192	[p12l1237t3144r1501b3189],
17	T	NN	O	t	nn	18	SENT_192	[p12l1237t3144r1501b3189],
18	genotypes	NNS	O	genotype	dep	14	SENT_192	[p12l1527t3150r1794b3204],
19	overall	JJ	O	overall	advmod	23	SENT_192	[p12l1822t3141r1999b3189],
20	were	VBD	O	be	auxpass	23	SENT_192	[p12l2023t3158r2151b3189],
21	not	RB	O	not	neg	23	SENT_192	[p12l647t3227r735b3265],
22	signiﬁcantly	RB	O	signiﬁcantly	advmod	23	SENT_192	[p12l771t3217r1101b3280],
23	associated	VBN	O	associate	_	0	SENT_192	[p12l1135t3217r1409b3265],
24	with	IN	O	with	_	0	SENT_192	[p12l1442t3217r1561b3265],
25	risk	NN	O	risk	prep_with	23	SENT_192	[p12l1597t3217r1698b3265],
26	of	IN	O	of	_	0	SENT_192	[p12l1733t3217r1792b3265],
27	the	DT	O	the	det	30	SENT_192	[p12l1818t3217r1901b3265],
28	primary	JJ	O	primary	amod	30	SENT_192	[p12l1937t3221r2153b3280],
29	eﬂicacy	NN	O	eﬂicacy	nn	30	SENT_192	[p12l648t3293r846b3356],
30	endpoint	NN	O	endpoint	prep_of	25	SENT_192	[p12l883t3293r1125b3355],
31	in	IN	O	in	_	0	SENT_192	[p12l1162t3296r1215b3340],
32	patients	NNS	O	patient	prep_in	30	SENT_192	[p12l1252t3296r1464b3355],
33	treated	VBN	O	treat	partmod	32	SENT_192	[p12l1503t3293r1689b3341],
34	with	IN	O	with	_	0	SENT_192	[p12l1724t3293r1843b3341],
35	prasugrel	NN	O	prasugrel	prep_with	33	SENT_192	[p12l1880t3293r2149b3356],
36	,	,	O	,	_	0	SENT_192	[p12l1880t3293r2149b3356],
37	although	IN	O	although	mark	39	SENT_192	[p12l648t3370r887b3433],
38	there	EX	O	there	expl	39	SENT_192	[p12l948t3370r1086b3417],
39	was	VBD	O	be	advcl	23	SENT_192	[p12l1147t3387r1246b3417],
40	a	DT	O	a	det	42	SENT_192	[p12l1311t3387r1337b3417],
41	non-signiﬁcant	JJ	O	non-signiﬁcant	amod	42	SENT_192	[p12l1399t3370r1810b3433],
42	trend	NN	O	trend	nsubj	39	SENT_192	[p12l1870t3370r2015b3417],
43	for	IN	O	for	_	0	SENT_192	[p12l2076t3370r2153b3417],
44	2677	CD	DATE	2677	num	46	SENT_192	[p12l649t3448r765b3495],
45	TT	NN	O	tt	nn	46	SENT_192	[p12l805t3448r883b3492],
46	homozygotes	NNS	O	homozygote	prep_for	42	SENT_192	[p12l923t3445r1279b3508],
47	versus	CC	O	versus	_	0	SENT_192	[p12l1321t3462r1493b3493],
48	CT/CC	NN	O	ct/cc	nn	49	SENT_192	[p12l1538t3448r1718b3508],
49	individuals	NNS	O	individual	nsubj	39	SENT_192	[p12l1762t3445r2059b3493],
50	to	TO	O	to	aux	53	SENT_192	[p12l2101t3455r2151b3493],
51	be	VB	O	be	auxpass	53	SENT_192	[p12l646t3521r708b3569],
52	at	IN	O	at	advmod	53	SENT_192	[p12l773t3531r819b3569],
53	increased	VBN	O	increase	infmod	49	SENT_192	[p12l883t3521r1140b3569],
54	risk	NN	O	risk	iobj	53	SENT_192	[p12l1203t3521r1305b3569],
55	(	CD	NUMBER	(	num	58	SENT_192	[p12l1372t3521r1754b3584],
56	Kaplan-Meier	NNP	O	Kaplan-Meier	nn	58	SENT_192	[p12l1372t3521r1754b3584],
57	event	NN	O	event	nn	58	SENT_192	[p12l1818t3531r1961b3569],
58	rates	NNS	O	rate	dobj	53	SENT_192	[p12l2024t3531r2150b3569],
59	11-8	CD	PERCENT	11-8	num	60	SENT_192	[p12l649t3601r813b3648],
60	%	NN	PERCENT	%	dep	58	SENT_192	[p12l649t3601r813b3648],
61	[	CD	NUMBER	[	number	62	SENT_192	[p12l852t3602r926b3661],
62	29	CD	NUMBER	29	dep	68	SENT_192	[p12l852t3602r926b3661],
63	of	IN	O	of	_	0	SENT_192	[p12l963t3598r1023b3646],
64	253	CD	NUMBER	253	prep_of	62	SENT_192	[p12l1050t3601r1156b3661],
65	]	NN	O	]	dep	68	SENT_192	[p12l1050t3601r1156b3661],
66	125	CD	PERCENT	125	num	65	SENT_192	[p12l1194t3615r1241b3646],
67	8-8	CD	PERCENT	8-8	num	68	SENT_192	[p12l1276t3601r1421b3648],
68	%	NN	PERCENT	%	dep	74	SENT_192	[p12l1276t3601r1421b3648],
69	[	CD	NUMBER	[	number	70	SENT_192	[p12l1460t3602r1535b3661],
70	94	CD	NUMBER	94	num	68	SENT_192	[p12l1460t3602r1535b3661],
71	of	IN	O	of	_	0	SENT_192	[p12l1568t3598r1627b3646],
72	1104	CD	DATE	1104	num	73	SENT_192	[p12l1655t3602r1767b3646],
73	participants	NNS	O	participant	prep_of	68	SENT_192	[p12l1799t3601r2149b3661],
74	]	CD	NUMBER	]	dep	58	SENT_192	[p12l1799t3601r2149b3661],
75	;	:	O	;	_	0	SENT_192	[p12l1799t3601r2149b3661],
76	HR	NN	DURATION	hr	nsubj	39	SENT_192	[p12l650t3679r741b3722],
77	1-38	CD	NUMBER	1-38	num	76	SENT_192	[p12l771t3679r902b3730],
78	,	,	O	,	_	0	SENT_192	[p12l771t3679r902b3730],
79	95	CD	PERCENT	95	number	80	SENT_192	[p12l935t3677r1050b3725],
80	%	NN	PERCENT	%	amod	81	SENT_192	[p12l935t3677r1050b3725],
81	CI	NN	O	ci	appos	76	SENT_192	[p12l1082t3678r1141b3723],
82	0-91-2-09	CD	NUMBER	0-91-2-09	dep	81	SENT_192	[p12l1174t3679r1466b3730],
83	,	,	O	,	_	0	SENT_192	[p12l1174t3679r1466b3730],
84	p	NN	O	p	nsubj	39	SENT_192	[p12l1498t3679r1765b3737],
85	=	JJ	O	=	amod	84	SENT_192	[p12l1498t3679r1765b3737],
86	0-1290	CD	NUMBER	0-1290	tmod	85	SENT_192	[p12l1498t3679r1765b3737],
87	;	:	O	;	_	0	SENT_192	[p12l1498t3679r1765b3737],
88	Webappendix	NNP	O	Webappendix	nn	89	SENT_192	[p12l1796t3674r2153b3737],
89	pp	NN	O	pp	nsubj	39	SENT_192	[p12l647t3768r713b3813],
90	3	CD	NUMBER	3	num	89	SENT_192	[p12l737t3756r778b3806],
91	,	,	O	,	_	0	SENT_192	[p12l737t3756r778b3806],
92	9	CD	NUMBER	9	appos	89	SENT_192	[p12l802t3756r844b3806],
93	,	,	O	,	_	0	SENT_192	[p12l802t3756r844b3806],
94	and	CC	NUMBER	and	_	0	SENT_192	[p12l868t3751r967b3799],
95	10	CD	NUMBER	10	num	96	SENT_192	[p12l989t3755r1076b3814],
96	)	NN	O	)	nsubj	39	SENT_192	[p12l989t3755r1076b3814],
97	.	.	O	.	_	0	SENT_192	[p12l989t3755r1076b3814],

1	When	WRB	O	when	advmod	3	SENT_193	[p12l1099t3751r1262b3799],
2	we	PRP	O	we	nsubj	3	SENT_193	[p12l1281t3768r1354b3799],
3	divided	VBD	O	divide	advcl	39	SENT_193	[p12l1376t3751r1571b3799],
4	patients	NNS	O	patient	dobj	3	SENT_193	[p12l1591t3754r1803b3813],
5	on	IN	O	on	_	0	SENT_193	[p12l1827t3768r1893b3799],
6	the	DT	O	the	det	7	SENT_193	[p12l1913t3751r1997b3799],
7	basis	NN	O	basis	prep_on	4	SENT_193	[p12l2017t3751r2150b3799],
8	of	IN	O	of	_	0	SENT_193	[p13l648t14r707b61],
9	ABCB1	NN	O	abcb1	nn	10	SENT_193	[p13l731t17r923b61],
10	3435C	NN	O	3435c	prep_of	7	SENT_193	[p13l959t17r1225b61],
11	—	CD	NUMBER	—	num	14	SENT_193	[p13l959t17r1225b61],
12	>	JJR	O	>	amod	14	SENT_193	[p13l959t17r1225b61],
13	T	NN	O	t	nn	14	SENT_193	[p13l959t17r1225b61],
14	genotypes	NNS	O	genotype	tmod	3	SENT_193	[p13l1258t23r1525b77],
15	and	CC	O	and	_	0	SENT_193	[p13l1561t14r1660b61],
16	CYP2C19	NN	O	cyp2c19	nn	17	SENT_193	[p13l1698t17r1947b62],
17	status	NN	O	status	conj_and	14	SENT_193	[p13l1980t23r2149b69],
18	,	,	O	,	_	0	SENT_193	[p13l1980t23r2149b69],
19	rates	NNS	O	rate	nsubj	39	SENT_193	[p13l647t99r773b137],
20	of	IN	O	of	_	0	SENT_193	[p13l800t89r859b137],
21	cardiovascular	JJ	O	cardiovascular	amod	22	SENT_193	[p13l874t89r1261b137],
22	death	NN	O	death	prep_of	19	SENT_193	[p13l1285t89r1445b144],
23	,	,	O	,	_	0	SENT_193	[p13l1285t89r1445b144],
24	myocardial	JJ	O	myocardial	amod	25	SENT_193	[p13l1472t89r1769b152],
25	infarction	NN	O	infarction	prep_of	19	SENT_193	[p13l1793t89r2071b144],
26	,	,	O	,	_	0	SENT_193	[p13l1793t89r2071b144],
27	or	CC	O	or	_	0	SENT_193	[p13l2098t106r2153b137],
28	stroke	NN	O	stroke	conj_or	22	SENT_193	[p13l649t165r810b213],
29	at	IN	O	at	_	0	SENT_193	[p13l843t174r889b213],
30	15	CD	DURATION	15	num	31	SENT_193	[p13l921t168r973b212],
31	months	NNS	NUMBER	month	prep_at	28	SENT_193	[p13l1006t165r1212b213],
32	were	VBD	O	be	cop	39	SENT_193	[p13l1244t182r1371b213],
33	similar	JJ	O	similar	amod	39	SENT_193	[p13l1405t165r1594b213],
34	in	IN	O	in	_	0	SENT_193	[p13l1624t168r1677b212],
35	the	DT	O	the	det	37	SENT_193	[p13l1707t165r1791b213],
36	four	CD	NUMBER	four	num	37	SENT_193	[p13l1822t165r1936b213],
37	groups	NNS	O	group	prep_in	33	SENT_193	[p13l1967t182r2150b228],
38	(	CD	NUMBER	(	tmod	33	SENT_193	[p13l651t246r766b305],
39	p	NN	O	p	_	0	SENT_193	[p13l651t246r766b305],
40	=	JJ	O	=	amod	39	SENT_193	[p13l651t246r766b305],
41	O	NN	O	o	tmod	40	SENT_193	[p13l651t246r766b305],
42	-4851	CD	NUMBER	-4851	num	41	SENT_193	[p13l780t245r932b297],
43	,	,	O	,	_	0	SENT_193	[p13l780t245r932b297],
44	ﬁgure	NN	O	ﬁgure	nn	46	SENT_193	[p13l953t242r1111b305],
45	4	CD	NUMBER	4	num	46	SENT_193	[p13l1130t246r1191b305],
46	)	NN	O	)	appos	41	SENT_193	[p13l1130t246r1191b305],
47	.	.	O	.	_	0	SENT_193	[p13l1130t246r1191b305],

1	In	IN	O	in	_	0	SENT_194	[p13l700t322r755b364],
2	healthy	JJ	O	healthy	amod	3	SENT_194	[p13l771t317r965b380],
3	participants	NNS	O	participant	prep_in	13	SENT_194	[p13l980t320r1290b379],
4	treated	VBN	O	treat	partmod	3	SENT_194	[p13l1308t317r1490b365],
5	with	IN	O	with	_	0	SENT_194	[p13l1504t317r1621b365],
6	clopidogrel	NN	O	clopidogrel	prep_with	4	SENT_194	[p13l1638t317r1945b380],
7	,	,	O	,	_	0	SENT_194	[p13l1638t317r1945b380],
8	AB	NNP	O	AB	nn	12	SENT_194	[p13l1962t321r2043b364],
9	CB1	NNP	O	CB1	nn	12	SENT_194	[p13l2051t321r2152b365],
10	3435	CD	NUMBER	3435	num	12	SENT_194	[p13l650t396r765b441],
11	TT	NN	O	tt	nn	12	SENT_194	[p13l809t396r886b440],
12	homozygotes	NNS	O	homozygote	nsubj	13	SENT_194	[p13l925t393r1275b456],
13	had	VBD	O	have	_	0	SENT_194	[p13l1317t393r1416b441],
14	a	DT	O	a	det	17	SENT_194	[p13l1457t410r1483b440],
15	diminished	VBN	O	diminish	amod	17	SENT_194	[p13l1525t393r1829b441],
16	pharmacodynamic	JJ	O	pharmacodynamic	amod	17	SENT_194	[p13l1869t393r2150b455, p13l647t469r873b532],
17	effect	NN	O	effect	dobj	13	SENT_194	[p13l894t470r1049b525],
18	,	,	O	,	_	0	SENT_194	[p13l894t470r1049b525],
19	with	IN	O	with	_	0	SENT_194	[p13l1070t469r1187b517],
20	an	DT	O	a	det	22	SENT_194	[p13l1207t486r1270b517],
21	absolute	JJ	O	absolute	amod	22	SENT_194	[p13l1290t469r1509b517],
22	reduction	NN	O	reduction	prep_with	17	SENT_194	[p13l1529t469r1783b517],
23	in	IN	O	in	_	0	SENT_194	[p13l1803t472r1856b516],
24	maximum	NN	O	maximum	nn	26	SENT_194	[p13l1875t472r2152b517],
25	platelet	NN	O	platelet	nn	26	SENT_194	[p13l646t545r839b607],
26	aggregation	NN	O	aggregation	prep_in	22	SENT_194	[p13l860t548r1170b608],
27	in	IN	O	in	_	0	SENT_194	[p13l1191t548r1244b592],
28	response	NN	O	response	prep_in	26	SENT_194	[p13l1265t562r1501b607],
29	to	TO	O	to	_	0	SENT_194	[p13l1522t555r1570b593],
30	a	DT	O	a	det	31	SENT_194	[p13l1593t562r1619b593],
31	clopidogrel	NN	O	clopidogrel	prep_to	28	SENT_194	[p13l1641t545r1934b608],
32	loading	VBG	O	load	partmod	31	SENT_194	[p13l1954t545r2152b608],
33	dose	NN	O	dose	dobj	32	SENT_194	[p13l9t955r177b1023],
34	that	WDT	O	that	nsubj	37	SENT_194	[p13l198t955r343b1023],
35	was	VBD	O	be	cop	37	SENT_194	[p13l361t979r499b1023],
36	7	CD	NUMBER	7	num	37	SENT_194	[p13l523t959r587b1026],
37	~	NN	O	~	rcmod	33	SENT_194	[p13l523t959r587b1026],
38	3	CD	NUMBER	3	number	39	SENT_194	[p13l608t961r642b1023],
39	percentage	NN	O	percentage	amod	37	SENT_194	[p13l667t968r1074b1045],
40	points	NNS	O	point	npadvmod	41	SENT_194	[p13l1095t960r1326b1044],
41	lower	JJR	O	lower	advmod	37	SENT_194	[p13l1348t955r1556b1023],
42	(	CD	NUMBER	(	num	43	SENT_194	[p13l1581t960r1685b1045],
43	ie	NN	O	ie	dep	37	SENT_194	[p13l1581t960r1685b1045],
44	,	,	O	,	_	0	SENT_194	[p13l1581t960r1685b1045],
45	less	JJR	O	less	amod	48	SENT_194	[p13l1709t955r1846b1023],
46	platelet	NN	O	platelet	nn	48	SENT_194	[p13l1869t955r2141b1044],
47	inhibition	NN	O	inhibition	nn	48	SENT_194	[p13l8t1064r403b1154],
48	)	NN	O	)	appos	37	SENT_194	[p13l8t1064r403b1154],
49	than	IN	O	than	_	0	SENT_194	[p13l493t1065r662b1133],
50	that	DT	O	that	prep_than	48	SENT_194	[p13l745t1064r890b1133],
51	seen	VBN	O	see	partmod	50	SENT_194	[p13l975t1089r1142b1133],
52	in	IN	O	in	_	0	SENT_194	[p13l1227t1069r1301b1131],
53	CT	NNP	O	CT	prep_in	51	SENT_194	[p13l1388t1069r1519b1153],
54	/	:	O	/	punct	57	SENT_194	[p13l1388t1069r1519b1153],
55	CC	NN	O	cc	nn	56	SENT_194	[p13l1528t1070r1639b1133],
56	individuals	NNS	O	individual	nsubj	57	SENT_194	[p13l1726t1065r2137b1133],
57	(	VBP	O	(	dep	33	SENT_194	[p13l14t1179r175b1263],
58	p	NN	O	p	nn	60	SENT_194	[p13l14t1179r175b1263],
59	=	JJ	O	=	amod	60	SENT_194	[p13l14t1179r175b1263],
60	O	NN	O	o	dobj	57	SENT_194	[p13l14t1179r175b1263],
61	-	:	O	-	_	0	SENT_194	[p13l193t1213r204b1224],
62	0127	CD	DATE	0127	num	63	SENT_194	[p13l222t1178r429b1263],
63	)	CD	NUMBER	)	dep	33	SENT_194	[p13l222t1178r429b1263],
64	.	.	O	.	_	0	SENT_194	[p13l222t1178r429b1263],

1	After	IN	O	after	_	0	SENT_195	[p13l459t1173r649b1242],
2	adjustment	NN	O	adjustment	prep_after	14	SENT_195	[p13l675t1173r1101b1263],
3	for	IN	O	for	_	0	SENT_195	[p13l1127t1173r1234b1242],
4	C	NN	O	c	nn	5	SENT_195	[p13l1266t1179r1320b1242],
5	YPZC	NN	O	ypzc	prep_for	2	SENT_195	[p13l1326t1179r1533b1242],
6	19	CD	NUMBER	19	num	7	SENT_195	[p13l1539t1179r1613b1242],
7	genotype	NN	O	genotype	dep	5	SENT_195	[p13l1638t1187r1993b1263],
8	,	,	O	,	_	0	SENT_195	[p13l1638t1187r1993b1263],
9	the	DT	O	the	det	10	SENT_195	[p13l2022t1173r2139b1242],
10	response	NN	O	response	nsubj	14	SENT_195	[p13l8t1306r342b1371],
11	was	VBD	O	be	cop	14	SENT_195	[p13l390t1306r528b1350],
12	6-6	CD	NUMBER	6-6	num	14	SENT_195	[p13l580t1288r706b1350],
13	percentage	NN	O	percentage	nn	14	SENT_195	[p13l756t1295r1162b1372],
14	points	NNS	O	point	_	0	SENT_195	[p13l1211t1287r1442b1371],
15	lower	JJR	O	lower	amod	17	SENT_195	[p13l1491t1282r1699b1350],
16	(	NN	O	(	nn	17	SENT_195	[p13l1751t1288r2136b1372],
17	p	NN	O	p	dep	14	SENT_195	[p13l1751t1288r2136b1372],
18	=	JJ	O	=	amod	20	SENT_195	[p13l1751t1288r2136b1372],
19	O-022	NN	O	o-022	nn	20	SENT_195	[p13l1751t1288r2136b1372],
20	)	NN	O	)	dep	17	SENT_195	[p13l1751t1288r2136b1372],
21	.	.	O	.	_	0	SENT_195	[p13l1751t1288r2136b1372],

1	The	DT	O	the	det	3	SENT_196	[p13l7t1392r151b1460],
2	pharmacodynamic	JJ	O	pharmacodynamic	amod	3	SENT_196	[p13l211t1391r911b1481],
3	effects	NNS	O	effect	nsubj	10	SENT_196	[p13l973t1392r1208b1460],
4	of	IN	O	of	_	0	SENT_196	[p13l1272t1391r1355b1460],
5	clopidogrel	NN	O	clopidogrel	prep_of	3	SENT_196	[p13l1404t1391r1819b1481],
6	on	IN	O	on	_	0	SENT_196	[p13l1880t1416r1973b1460],
7	TT	NN	O	tt	nn	8	SENT_196	[p13l2032t1396r2141b1458],
8	carriers	NNS	O	carrier	prep_on	5	SENT_196	[p13l9t1505r288b1568],
9	were	VBD	O	be	cop	10	SENT_196	[p13l329t1525r507b1568],
10	discernible	JJ	O	discernible	_	0	SENT_196	[p13l549t1500r959b1568],
11	only	RB	O	only	advmod	10	SENT_196	[p13l1001t1500r1160b1590],
12	after	IN	O	after	_	0	SENT_196	[p13l1200t1500r1368b1568],
13	a	DT	O	a	det	16	SENT_196	[p13l1407t1525r1444b1568],
14	loading	VBG	O	load	amod	16	SENT_196	[p13l1483t1500r1763b1590],
15	dose	NN	O	dose	nn	16	SENT_196	[p13l1803t1500r1971b1568],
16	(	NN	O	(	prep_after	10	SENT_196	[p13l2018t1500r2141b1590],
17	for	IN	O	for	_	0	SENT_196	[p13l2018t1500r2141b1590],
18	both	DT	O	both	det	20	SENT_196	[p13l7t1609r176b1677],
19	300	CD	NUMBER	300	num	20	SENT_196	[p13l206t1615r332b1677],
20	mg	NN	O	mg	prep_for	10	SENT_196	[p13l359t1633r480b1699],
21	and	CC	O	and	_	0	SENT_196	[p13l507t1609r644b1677],
22	600	CD	NUMBER	600	num	24	SENT_196	[p13l670t1615r799b1677],
23	mg	NN	O	mg	nn	24	SENT_196	[p13l826t1616r994b1699],
24	)	NN	O	)	prep_for	10	SENT_196	[p13l826t1616r994b1699],
25	;	:	O	;	_	0	SENT_196	[p13l826t1616r994b1699],
26	no	DT	O	no	det	28	SENT_196	[p13l1023t1633r1116b1677],
27	signiﬁcant	JJ	O	signiﬁcant	amod	28	SENT_196	[p13l1145t1609r1538b1699],
28	association	NN	O	association	nsubjpass	30	SENT_196	[p13l1563t1614r1976b1677],
29	was	VBD	O	be	auxpass	30	SENT_196	[p13l1999t1633r2138b1677],
30	identiﬁed	VBN	O	identiﬁed	parataxis	10	SENT_196	[p13l8t1718r366b1787],
31	during	IN	O	during	_	0	SENT_196	[p13l418t1719r670b1808],
32	maintenance	NN	O	maintenance	nn	33	SENT_196	[p13l721t1723r1209b1787],
33	dosing	NN	O	dosing	prep_during	30	SENT_196	[p13l1262t1718r1530b1808],
34	.	.	O	.	_	0	SENT_196	[p13l1262t1718r1530b1808],

1	There	EX	O	there	expl	2	SENT_197	[p13l1584t1719r1803b1787],
2	was	VBD	O	be	_	0	SENT_197	[p13l1853t1743r1992b1787],
3	no	DT	O	no	det	5	SENT_197	[p13l2045t1743r2139b1787],
4	signiﬁcant	JJ	O	signiﬁcant	amod	5	SENT_197	[p13l11t1827r404b1917],
5	association	NN	O	association	nsubj	2	SENT_197	[p13l436t1832r849b1895],
6	between	IN	O	between	_	0	SENT_197	[p13l880t1827r1192b1895],
7	3435C	CD	NUMBER	3435c	number	8	SENT_197	[p13l1229t1832r1600b1895],
8	—	CD	NUMBER	—	npadvmod	9	SENT_197	[p13l1229t1832r1600b1895],
9	>	JJR	O	>	amod	11	SENT_197	[p13l1229t1832r1600b1895],
10	T	NN	O	t	nn	11	SENT_197	[p13l1229t1832r1600b1895],
11	genotype	NN	O	genotype	prep_between	5	SENT_197	[p13l1633t1841r1969b1917],
12	and	CC	O	and	_	0	SENT_197	[p13l2003t1827r2141b1895],
13	exposure	NN	O	exposure	prep_between	5	SENT_197	[p13l9t1961r343b2026],
14	to	TO	O	to	_	0	SENT_197	[p13l368t1950r438b2004],
15	clopidogrel	NN	O	clopidogrel	nn	18	SENT_197	[p13l465t1937r881b2027],
16	active	JJ	O	active	amod	18	SENT_197	[p13l907t1941r1116b2005],
17	metabolite	NN	O	metabolite	nn	18	SENT_197	[p13l1142t1937r1537b2005],
18	concentrations	NNS	O	concentration	prep_to	2	SENT_197	[p13l1564t1941r2136b2005],
19	.	.	O	.	_	0	SENT_197	[p13l1564t1941r2136b2005],

1	In	IN	O	in	_	0	SENT_198	[p13l13t2052r91b2112],
2	prasugrel-treated	JJ	O	prasugrel-treated	amod	3	SENT_198	[p13l116t2046r754b2135],
3	individuals	NNS	O	individual	prep_in	14	SENT_198	[p13l778t2046r1211b2124],
4	,	,	O	,	_	0	SENT_198	[p13l778t2046r1211b2124],
5	343	CD	NUMBER	343	num	6	SENT_198	[p13l1244t2052r1362b2114],
6	5C	NN	O	5c	nsubjpass	14	SENT_198	[p13l1374t2050r1615b2114],
7	—	CD	NUMBER	—	dep	6	SENT_198	[p13l1374t2050r1615b2114],
8	>	JJR	O	>	amod	10	SENT_198	[p13l1374t2050r1615b2114],
9	T	NN	O	t	nn	10	SENT_198	[p13l1374t2050r1615b2114],
10	genotype	NN	O	genotype	dep	6	SENT_198	[p13l1640t2059r1975b2135],
11	was	VBD	O	be	auxpass	14	SENT_198	[p13l1999t2070r2138b2114],
12	not	RB	O	not	neg	14	SENT_198	[p13l8t2168r131b2222],
13	signiﬁcantly	RB	O	signiﬁcantly	advmod	14	SENT_198	[p13l213t2154r670b2244],
14	associated	VBN	O	associate	_	0	SENT_198	[p13l750t2154r1130b2222],
15	with	IN	O	with	_	0	SENT_198	[p13l1207t2154r1373b2222],
16	platelet	NN	O	platelet	nn	17	SENT_198	[p13l1454t2154r1726b2243],
17	response	NN	O	response	prep_with	14	SENT_198	[p13l1805t2178r2139b2243],
18	(	CD	NUMBER	(	number	19	SENT_198	[p13l14t2270r153b2354],
19	1-3	CD	NUMBER	1-3	num	22	SENT_198	[p13l14t2270r153b2354],
20	percentage	NN	O	percentage	nn	22	SENT_198	[p13l188t2277r595b2354],
21	points	NNS	O	point	dep	22	SENT_198	[p13l626t2268r857b2353],
22	higher	JJR	O	higher	dep	17	SENT_198	[p13l889t2264r1151b2354],
23	;	:	O	;	_	0	SENT_198	[p13l889t2264r1151b2354],
24	p	NN	O	p	dep	17	SENT_198	[p13l1186t2268r1560b2354],
25	=	JJ	O	=	amod	27	SENT_198	[p13l1186t2268r1560b2354],
26	O-4345	NN	O	o-4345	nn	27	SENT_198	[p13l1186t2268r1560b2354],
27	)	NN	O	)	dep	24	SENT_198	[p13l1186t2268r1560b2354],
28	or	CC	O	or	_	0	SENT_198	[p13l1599t2288r1675b2332],
29	exposure	NN	O	exposure	conj_or	17	SENT_198	[p13l1705t2288r2039b2353],
30	to	TO	O	to	_	0	SENT_198	[p13l2070t2277r2139b2331],
31	prasugrel	NN	O	prasugrel	poss	34	SENT_198	[p13l8t2372r415b2462],
32	’s	POS	O	’s	_	0	SENT_198	[p13l8t2372r415b2462],
33	active	JJ	O	active	amod	34	SENT_198	[p13l478t2377r686b2441],
34	metabolite	NN	O	metabolite	prep_to	29	SENT_198	[p13l746t2372r1160b2441],
35	.	.	O	.	_	0	SENT_198	[p13l746t2372r1160b2441],

1	There	EX	O	there	expl	2	SENT_199	[p13l1223t2372r1441b2441],
2	was	VBD	O	be	_	0	SENT_199	[p13l1499t2397r1638b2441],
3	no	DT	O	no	det	4	SENT_199	[p13l1700t2397r1793b2441],
4	relation	NN	O	relation	nsubj	2	SENT_199	[p13l1854t2372r2140b2441],
5	between	IN	O	between	_	0	SENT_199	[p13l7t2481r320b2549],
6	genotype	NN	O	genotype	nn	7	SENT_199	[p13l389t2495r724b2571],
7	status	NN	O	status	prep_between	4	SENT_199	[p13l796t2495r1009b2549],
8	for	IN	O	for	_	0	SENT_199	[p13l1079t2481r1186b2549],
9	either	CC	O	either	preconj	10	SENT_199	[p13l1253t2481r1471b2549],
10	2677G	NN	O	2677g	prep_for	7	SENT_199	[p13l1540t2486r1997b2570],
11	—	CD	NUMBER	—	num	10	SENT_199	[p13l1540t2486r1997b2570],
12	>	JJR	O	>	amod	13	SENT_199	[p13l1540t2486r1997b2570],
13	T/A	NN	O	t/a	num	18	SENT_199	[p13l1540t2486r1997b2570],
14	or	CC	O	or	_	0	SENT_199	[p13l2065t2506r2141b2549],
15	1236C	NN	O	1236c	conj_or	13	SENT_199	[p13l12t2596r380b2660],
16	—	CD	NUMBER	—	num	15	SENT_199	[p13l12t2596r380b2660],
17	>	JJR	O	>	amod	18	SENT_199	[p13l12t2596r380b2660],
18	T	NN	O	t	dep	10	SENT_199	[p13l12t2596r380b2660],
19	and	CC	O	and	_	0	SENT_199	[p13l418t2592r556b2660],
20	pharmacodynamic	JJ	O	pharmacodynamic	amod	21	SENT_199	[p13l592t2592r1293b2681],
21	outcomes	NNS	O	outcome	conj_and	10	SENT_199	[p13l1331t2605r1690b2660],
22	in	IN	O	in	_	0	SENT_199	[p13l1731t2596r1805b2659],
23	patients	NNS	O	patient	prep_in	4	SENT_199	[p13l1843t2596r2138b2681],
24	treated	VBN	O	treat	partmod	23	SENT_199	[p13l7t2700r266b2769],
25	with	IN	O	with	_	0	SENT_199	[p13l288t2700r454b2769],
26	clopidogrel	NN	O	clopidogrel	prep_with	24	SENT_199	[p13l480t2700r895b2790],
27	or	CC	O	or	_	0	SENT_199	[p13l922t2725r998b2769],
28	prasugrel	NN	O	prasugrel	conj_or	26	SENT_199	[p13l1022t2700r1394b2790],
29	.	.	O	.	_	0	SENT_199	[p13l1022t2700r1394b2790],

1	Discussion	NN	O	discussion	_	0	SENT_200	[p13l14t2912r467b2989],

1	The	DT	O	the	det	5	SENT_201	[p13l7t3030r152b3098],
2	pharmacological	JJ	O	pharmacological	amod	5	SENT_201	[p13l171t3030r803b3120],
3	and	CC	O	and	_	0	SENT_201	[p13l822t3030r961b3098],
4	clinical	JJ	O	clinical	conj_and	2	SENT_201	[p13l979t3030r1250b3098],
5	response	NN	O	response	nsubj	8	SENT_201	[p13l1268t3054r1608b3119],
6	to	TO	O	to	_	0	SENT_201	[p13l1626t3044r1696b3098],
7	clopidogrel	NN	O	clopidogrel	prep_to	5	SENT_201	[p13l1716t3030r2140b3120],
8	varies	VBZ	O	vary	_	0	SENT_201	[p13l7t3144r226b3208],
9	widely	RB	O	widely	advmod	8	SENT_201	[p13l261t3140r508b3229],
10	between	IN	O	between	_	0	SENT_201	[p13l538t3140r856b3208],
11	patients	NNS	O	patient	prep_between	8	SENT_201	[p13l889t3144r1212b3229],
12	,	,	O	,	_	0	SENT_201	[p13l889t3144r1212b3229],
13	and	CC	O	and	_	0	SENT_201	[p13l1250t3140r1390b3208],
14	genetic	JJ	O	genetic	amod	15	SENT_201	[p13l1424t3144r1697b3230],
15	variants	NNS	O	variant	nsubjpass	20	SENT_201	[p13l1728t3144r2029b3208],
16	in	IN	O	in	_	0	SENT_201	[p13l2065t3144r2140b3206],
17	CYPZCI9	NN	O	cypzci9	prep_in	15	SENT_201	[p13l15t3255r369b3318],
18	have	VBP	O	have	aux	20	SENT_201	[p13l422t3249r596b3318],
19	been	VBN	O	be	auxpass	20	SENT_201	[p13l654t3249r838b3318],
20	shown	VBN	O	show	conj_and	8	SENT_201	[p13l899t3249r1147b3318],
21	to	TO	O	to	aux	22	SENT_201	[p13l1204t3263r1274b3318],
22	affect	VB	O	affect	xcomp	20	SENT_201	[p13l1335t3250r1541b3318],
23	the	DT	O	the	det	24	SENT_201	[p13l1597t3249r1715b3318],
24	response	NN	O	response	dobj	22	SENT_201	[p13l1776t3274r2136b3338],
25	.	.	O	.	_	0	SENT_201	[p13l1776t3274r2136b3338],

1	P-glycoprotein	NN	O	p-glycoprotein	nsubj	3	SENT_202	[p13l13t3358r562b3448],
2	is	VBZ	O	be	cop	3	SENT_202	[p13l623t3363r682b3426],
3	important	JJ	O	important	_	0	SENT_202	[p13l745t3363r1130b3447],
4	in	IN	O	in	_	0	SENT_202	[p13l1190t3363r1265b3425],
5	drug	NN	O	drug	nn	6	SENT_202	[p13l1328t3358r1504b3448],
6	transport	NN	O	transport	prep_in	3	SENT_202	[p13l1564t3372r1935b3447],
7	,	,	O	,	_	0	SENT_202	[p13l1564t3372r1935b3447],
8	and	CC	O	and	_	0	SENT_202	[p13l2002t3358r2141b3426],
9	pharmacogenetic	JJ	O	pharmacogenetic	amod	10	SENT_202	[p13l8t3468r668b3558],
10	interactions	NNS	O	interaction	nsubjpass	18	SENT_202	[p13l717t3472r1167b3536],
11	with	IN	O	with	_	0	SENT_202	[p13l1217t3468r1385b3536],
12	various	JJ	O	various	amod	13	SENT_202	[p13l1431t3472r1707b3536],
13	classes	NNS	O	class	prep_with	10	SENT_202	[p13l1759t3468r2017b3536],
14	of	IN	O	of	_	0	SENT_202	[p13l2069t3468r2153b3535],
15	drugs	NNS	O	drug	prep_of	13	SENT_202	[p13l9t3576r223b3666],
16	have	VBP	O	have	aux	18	SENT_202	[p13l249t3576r421b3645],
17	been	VBN	O	be	auxpass	18	SENT_202	[p13l445t3576r628b3645],
18	suggested	VBN	O	suggest	conj_and	3	SENT_202	[p13l656t3576r1102b3666],
19	.	.	O	.	_	0	SENT_202	[p13l656t3576r1102b3666],

1	“	NN	O	“	_	0	SENT_203	[p13l656t3576r1102b3666],
2	Our	PRP$	O	we	poss	3	SENT_203	[p13l1129t3582r1278b3645],
3	ﬁndings	NNS	O	ﬁndings	nsubj	4	SENT_203	[p13l1301t3576r1614b3666],
4	show	VBP	O	show	rcmod	1	SENT_203	[p13l1643t3576r1840b3645],
5	that	IN	O	that	_	0	SENT_203	[p13l1861t3576r2009b3645],
6	TT	NN	O	tt	nn	7	SENT_203	[p13l2031t3581r2141b3643],
7	homozygotes	NNS	O	homozygote	prep_that	4	SENT_203	[p13l7t3685r511b3775],
8	for	IN	O	for	_	0	SENT_203	[p13l583t3685r692b3753],
9	the	DT	O	the	det	14	SENT_203	[p13l758t3685r876b3753],
10	3435C	NN	O	3435c	npadvmod	12	SENT_203	[p13l950t3690r1326b3753],
11	—	CD	NUMBER	—	num	10	SENT_203	[p13l950t3690r1326b3753],
12	>	JJR	O	>	amod	14	SENT_203	[p13l950t3690r1326b3753],
13	T	NN	O	t	nn	14	SENT_203	[p13l950t3690r1326b3753],
14	variant	NN	O	variant	prep_for	7	SENT_203	[p13l1393t3690r1658b3753],
15	in	IN	O	in	_	0	SENT_203	[p13l1726t3690r1801b3752],
16	ABCB1	NN	O	abcb1	prep_in	14	SENT_203	[p13l1869t3690r2141b3753],

1	(	NN	O	(	nsubj	35	SENT_204	[p14l14t21r194b107],
2	27	CD	PERCENT	27	number	3	SENT_204	[p14l14t21r194b107],
3	%	NN	PERCENT	%	amod	1	SENT_204	[p14l14t21r194b107],
4	of	IN	O	of	_	0	SENT_204	[p14l222t17r306b84],
5	the	DT	O	the	det	7	SENT_204	[p14l318t17r436b85],
6	study	NN	O	study	nn	7	SENT_204	[p14l465t17r668b106],
7	population	NN	O	population	prep_of	1	SENT_204	[p14l691t17r1153b107],
8	)	CD	NUMBER	)	tmod	7	SENT_204	[p14l691t17r1153b107],
9	,	,	O	,	_	0	SENT_204	[p14l691t17r1153b107],
10	as	IN	O	as	mark	19	SENT_204	[p14l1183t41r1256b85],
11	compared	VBN	O	compare	_	0	SENT_204	[p14l1285t17r1664b106],
12	with	IN	O	with	prepc_compared_with	19	SENT_204	[p14l1686t17r1855b85],
13	CT	NN	O	ct	pobj	19	SENT_204	[p14l1883t21r2016b106],
14	/	:	O	/	punct	16	SENT_204	[p14l1883t21r2016b106],
15	CC	NN	O	cc	nn	16	SENT_204	[p14l2025t22r2138b85],
16	individuals	NNS	O	individual	dep	13	SENT_204	[p14l8t126r451b205],
17	,	,	O	,	_	0	SENT_204	[p14l8t126r451b205],
18	had	VBD	O	have	aux	19	SENT_204	[p14l517t126r658b195],
19	reduced	VBN	O	reduce	dep	8	SENT_204	[p14l720t126r1026b195],
20	platelet	NN	O	platelet	nn	21	SENT_204	[p14l1088t126r1366b215],
21	inhibition	NN	O	inhibition	dobj	19	SENT_204	[p14l1429t126r1810b195],
22	with	IN	O	with	_	0	SENT_204	[p14l1870t126r2039b195],
23	a	DT	O	a	det	24	SENT_204	[p14l2103t151r2140b195],
24	clopidogrel	NN	O	clopidogrel	prep_with	19	SENT_204	[p14l9t235r434b325],
25	loading	VBG	O	load	partmod	24	SENT_204	[p14l468t235r752b325],
26	dose	NN	O	dose	dobj	25	SENT_204	[p14l788t235r958b303],
27	in	IN	O	in	_	0	SENT_204	[p14l993t240r1069b302],
28	a	DT	O	a	det	30	SENT_204	[p14l1105t259r1142b303],
29	healthy	JJ	O	healthy	amod	30	SENT_204	[p14l1175t235r1455b324],
30	study	NN	O	study	prep_in	25	SENT_204	[p14l1491t235r1694b324],
31	population	NN	O	population	dep	30	SENT_204	[p14l1727t235r2140b324],
32	and	CC	O	and	_	0	SENT_204	[p14l9t345r149b413],
33	a	DT	O	a	dep	30	SENT_204	[p14l253t369r290b413],
34	signiﬁcantly	RB	O	signiﬁcantly	advmod	35	SENT_204	[p14l397t345r863b435],
35	increased	VBN	O	increase	_	0	SENT_204	[p14l965t345r1330b413],
36	risk	NN	O	risk	dobj	35	SENT_204	[p14l1432t345r1577b413],
37	of	IN	O	of	_	0	SENT_204	[p14l1680t345r1764b412],
38	adverse	JJ	O	adverse	amod	40	SENT_204	[p14l1856t345r2139b413],
39	cardiovascular	JJ	O	cardiovascular	amod	40	SENT_204	[p14l9t453r558b522],
40	events	NNS	O	event	prep_of	36	SENT_204	[p14l581t467r819b522],
41	during	IN	O	during	_	0	SENT_204	[p14l846t453r1102b543],
42	treatment	NN	O	treatment	nsubj	51	SENT_204	[p14l1126t467r1502b522],
43	with	IN	O	with	_	0	SENT_204	[p14l1522t453r1691b522],
44	clopidogrel	NN	O	clopidogrel	prep_with	42	SENT_204	[p14l1716t453r2140b543],
45	in	IN	O	in	_	0	SENT_204	[p14l8t568r84b630],
46	patients	NNS	O	patient	prep_in	44	SENT_204	[p14l115t568r415b652],
47	with	IN	O	with	_	0	SENT_204	[p14l448t563r616b631],
48	acute	JJ	O	acute	amod	50	SENT_204	[p14l649t576r846b631],
49	coronary	JJ	O	coronary	amod	50	SENT_204	[p14l880t587r1214b652],
50	syndromes	NNS	O	syndrome	prep_with	46	SENT_204	[p14l1247t563r1660b652],
51	undergoing	VBG	O	undergo	prepc_during	35	SENT_204	[p14l1694t563r2140b653],
52	percutaneous	JJ	O	percutaneous	amod	54	SENT_204	[p14l8t686r522b761],
53	coronary	JJ	O	coronary	amod	54	SENT_204	[p14l640t697r974b762],
54	intervention	NN	O	intervention	dobj	51	SENT_204	[p14l1087t677r1575b741],
55	.	.	O	.	_	0	SENT_204	[p14l1087t677r1575b741],

1	When	WRB	O	when	advmod	3	SENT_205	[p14l1693t673r1923b741],
2	we	PRP	O	we	nsubj	3	SENT_205	[p14l2036t697r2139b741],
3	considered	VBD	O	consider	advcl	27	SENT_205	[p14l9t781r426b850],
4	AB	NNP	O	AB	nn	6	SENT_205	[p14l450t787r566b848],
5	CB1	NN	O	cb1	nn	6	SENT_205	[p14l577t787r723b850],
6	3435C	NN	O	3435c	dep	3	SENT_205	[p14l751t786r1128b850],
7	—	CD	NUMBER	—	num	10	SENT_205	[p14l751t786r1128b850],
8	>	JJR	O	>	amod	10	SENT_205	[p14l751t786r1128b850],
9	T	NN	O	t	nn	10	SENT_205	[p14l751t786r1128b850],
10	genotype	NN	O	genotype	dobj	3	SENT_205	[p14l1155t795r1496b871],
11	in	IN	O	in	_	0	SENT_205	[p14l1523t786r1599b848],
12	the	DT	O	the	det	13	SENT_205	[p14l1624t781r1742b850],
13	context	NN	O	context	prep_in	3	SENT_205	[p14l1770t795r2043b850],
14	of	IN	O	of	_	0	SENT_205	[p14l2069t781r2153b850],
15	C	NN	O	c	nn	19	SENT_205	[p14l15t896r69b959],
16	YPZCI9	NN	O	ypzci9	nn	19	SENT_205	[p14l77t896r369b960],
17	reduced-function	NN	O	reduced-function	nn	19	SENT_205	[p14l429t891r1087b959],
18	allele	NN	O	allele	nn	19	SENT_205	[p14l1151t891r1346b959],
19	status	NN	O	status	prep_of	13	SENT_205	[p14l1413t904r1631b959],
20	in	IN	O	in	_	0	SENT_205	[p14l1698t896r1774b958],
21	patients	NNS	O	patient	prep_in	19	SENT_205	[p14l1837t896r2137b980],
22	treated	VBN	O	treat	partmod	21	SENT_205	[p14l7t1000r271b1069],
23	with	IN	O	with	_	0	SENT_205	[p14l296t1001r464b1069],
24	clopidogrel	NN	O	clopidogrel	prep_with	22	SENT_205	[p14l493t1001r937b1090],
25	,	,	O	,	_	0	SENT_205	[p14l493t1001r937b1090],
26	we	PRP	O	we	nsubj	27	SENT_205	[p14l967t1025r1071b1069],
27	showed	VBD	O	show	_	0	SENT_205	[p14l1102t1000r1389b1069],
28	that	IN	O	that	complm	34	SENT_205	[p14l1415t1001r1563b1069],
29	variants	NNS	O	variant	nsubj	34	SENT_205	[p14l1588t1005r1888b1069],
30	in	IN	O	in	_	0	SENT_205	[p14l1918t1005r1994b1067],
31	the	DT	O	the	det	33	SENT_205	[p14l2021t1000r2139b1069],
32	two	CD	NUMBER	two	num	33	SENT_205	[p14l7t1123r141b1177],
33	genes	NNS	O	gene	prep_in	29	SENT_205	[p14l172t1133r387b1199],
34	offered	VBD	O	offer	ccomp	27	SENT_205	[p14l419t1109r687b1177],
35	signiﬁcant	JJ	O	signiﬁcant	amod	38	SENT_205	[p14l717t1109r1136b1199],
36	,	,	O	,	_	0	SENT_205	[p14l717t1109r1136b1199],
37	independent	JJ	O	independent	amod	38	SENT_205	[p14l1168t1109r1652b1198],
38	information	NN	O	information	dobj	34	SENT_205	[p14l1679t1109r2140b1177],
39	about	IN	O	about	_	0	SENT_205	[p14l9t1218r222b1286],
40	the	DT	O	the	det	41	SENT_205	[p14l284t1218r402b1286],
41	risk	NN	O	risk	prep_about	38	SENT_205	[p14l468t1218r612b1286],
42	of	IN	O	of	_	0	SENT_205	[p14l675t1218r759b1286],
43	cardiovascular	JJ	O	cardiovascular	amod	44	SENT_205	[p14l812t1218r1360b1286],
44	death	NN	O	death	prep_of	41	SENT_205	[p14l1424t1218r1651b1296],
45	,	,	O	,	_	0	SENT_205	[p14l1424t1218r1651b1296],
46	myocardial	JJ	O	myocardial	amod	47	SENT_205	[p14l1719t1218r2140b1308],
47	infarction	NN	O	infarction	prep_of	41	SENT_205	[p14l8t1327r403b1406],
48	,	,	O	,	_	0	SENT_205	[p14l8t1327r403b1406],
49	or	CC	O	or	_	0	SENT_205	[p14l490t1352r567b1396],
50	stroke	NN	O	stroke	conj_or	44	SENT_205	[p14l652t1327r900b1396],
51	.	.	O	.	_	0	SENT_205	[p14l652t1327r900b1396],

1	Conversely	RB	O	conversely	advmod	4	SENT_206	[p14l990t1327r1418b1417],
2	,	,	O	,	_	0	SENT_206	[p14l990t1327r1418b1417],
3	there	EX	O	there	expl	4	SENT_206	[p14l1503t1328r1698b1396],
4	were	VBD	O	be	_	0	SENT_206	[p14l1781t1352r1961b1396],
5	no	DT	O	no	det	7	SENT_206	[p14l2045t1352r2139b1396],
6	signiﬁcant	JJ	O	signiﬁcant	amod	7	SENT_206	[p14l11t1436r412b1526],
7	associations	NNS	O	association	nsubj	4	SENT_206	[p14l464t1441r922b1504],
8	between	IN	O	between	_	0	SENT_206	[p14l975t1436r1293b1505],
9	the	DT	O	the	det	11	SENT_206	[p14l1345t1436r1463b1504],
10	ABCB1	NN	O	abcb1	nn	11	SENT_206	[p14l1515t1441r1788b1504],
11	variants	NNS	O	variant	prep_between	7	SENT_206	[p14l1837t1441r2138b1504],
12	tested	VBN	O	test	partmod	11	SENT_206	[p14l7t1546r233b1614],
13	and	CC	O	and	_	0	SENT_206	[p14l261t1546r400b1614],
14	the	DT	O	the	det	15	SENT_206	[p14l425t1546r543b1613],
15	response	NN	O	response	conj_and	11	SENT_206	[p14l572t1570r912b1635],
16	to	TO	O	to	_	0	SENT_206	[p14l939t1559r1009b1613],
17	prasugrel	NN	O	prasugrel	prep_to	15	SENT_206	[p14l1037t1546r1417b1636],
18	.	.	O	.	_	0	SENT_206	[p14l1037t1546r1417b1636],

1	ABCB1	NN	O	abcb1	nsubj	2	SENT_207	[p14l78t1660r347b1723],
2	encodes	VBZ	O	encode	_	0	SENT_207	[p14l386t1655r683b1723],
3	the	DT	O	the	det	6	SENT_207	[p14l724t1655r840b1723],
4	P-glycoprotein	NN	MISC	p-glycoprotein	nn	6	SENT_207	[p14l883t1654r1422b1744],
5	efﬂux	NN	O	efﬂux	nn	6	SENT_207	[p14l1461t1654r1670b1723],
6	transporter	NN	O	transporter	dobj	2	SENT_207	[p14l1705t1668r2136b1743],
7	.	.	O	.	_	0	SENT_207	[p14l1705t1668r2136b1743],

1	Clopidogrel	NNP	O	Clopidogrel	nsubj	5	SENT_208	[p14l11t1763r446b1853],
2	is	VBZ	O	be	cop	5	SENT_208	[p14l476t1768r534b1831],
3	a	DT	O	a	det	5	SENT_208	[p14l567t1788r604b1831],
4	P-glycoprotein	NN	MISC	p-glycoprotein	nn	5	SENT_208	[p14l638t1763r1176b1853],
5	substrate	NN	O	substrate	_	0	SENT_208	[p14l1208t1763r1566b1841],
6	,	,	O	,	_	0	SENT_208	[p14l1208t1763r1566b1841],
7	and	CC	O	and	_	0	SENT_208	[p14l1600t1763r1738b1831],
8	inhibition	NN	O	inhibition	nsubj	11	SENT_208	[p14l1767t1763r2140b1831],
9	of	IN	O	of	_	0	SENT_208	[p14l9t1873r92b1940],
10	P-glycoprotein	NN	MISC	p-glycoprotein	prep_of	8	SENT_208	[p14l100t1873r638b1963],
11	affects	VBZ	O	affect	conj_and	5	SENT_208	[p14l655t1873r890b1941],
12	the	DT	O	the	det	13	SENT_208	[p14l908t1873r1025b1940],
13	bioavailability	NN	O	bioavailability	dobj	11	SENT_208	[p14l1040t1873r1559b1962],
14	of	IN	O	of	_	0	SENT_208	[p14l1574t1873r1657b1940],
15	clopidogrel	NN	O	clopidogrel	prep_of	13	SENT_208	[p14l1662t1873r2140b1963],
16	.	.	O	.	_	0	SENT_208	[p14l1662t1873r2140b1963],

1	“	NN	O	“	attr	10	SENT_209	[p14l1662t1873r2140b1963],
2	The	DT	O	the	det	7	SENT_209	[p14l7t1982r151b2049],
3	3435C	NN	O	3435c	npadvmod	5	SENT_209	[p14l205t1986r577b2049],
4	—	CD	NUMBER	—	num	3	SENT_209	[p14l205t1986r577b2049],
5	>	JJR	O	>	amod	7	SENT_209	[p14l205t1986r577b2049],
6	T	NN	O	t	nn	7	SENT_209	[p14l205t1986r577b2049],
7	variant	NN	O	variant	npadvmod	1	SENT_209	[p14l623t1986r883b2049],
8	in	IN	O	in	_	0	SENT_209	[p14l932t1986r1006b2048],
9	ABCB1	NN	O	abcb1	prep_in	1	SENT_209	[p14l1054t1987r1324b2049],
10	is	VBZ	O	be	_	0	SENT_209	[p14l1372t1986r1429b2049],
11	one	CD	NUMBER	one	nsubj	10	SENT_209	[p14l1483t2006r1617b2049],
12	of	IN	O	of	_	0	SENT_209	[p14l1668t1982r1751b2049],
13	the	DT	O	the	prep_of	11	SENT_209	[p14l1787t1982r1903b2049],
14	most	RBS	O	most	advmod	13	SENT_209	[p14l1954t1995r2141b2049],
15	studied	VBN	O	study	dep	13	SENT_209	[p14l11t2090r285b2159],
16	polymorphisms	NNS	O	polymorphism	dobj	15	SENT_209	[p14l335t2090r924b2180],
17	in	IN	O	in	_	0	SENT_209	[p14l978t2095r1053b2157],
18	pharmacogenetic	JJ	O	pharmacogenetic	amod	19	SENT_209	[p14l1103t2090r1751b2180],
19	research	NN	O	research	prep_in	16	SENT_209	[p14l1802t2090r2136b2168],
20	,	,	O	,	_	0	SENT_209	[p14l1802t2090r2136b2168],
21	and	CC	O	and	_	0	SENT_209	[p14l9t2200r147b2269],
22	has	VBZ	O	have	aux	24	SENT_209	[p14l203t2200r328b2269],
23	been	VBN	O	be	auxpass	24	SENT_209	[p14l388t2200r568b2269],
24	associated	VBN	O	associate	dep	13	SENT_209	[p14l627t2200r1007b2269],
25	with	IN	O	with	_	0	SENT_209	[p14l1062t2200r1228b2269],
26	altered	JJ	O	altered	amod	27	SENT_209	[p14l1286t2200r1539b2269],
27	disposition	NN	O	disposition	prep_with	24	SENT_209	[p14l1598t2200r2011b2289],
28	of	IN	O	of	_	0	SENT_209	[p14l2070t2200r2153b2269],
29	several	JJ	O	several	amod	30	SENT_209	[p14l11t2310r265b2378],
30	drugs	NNS	O	drug	prep_of	27	SENT_209	[p14l323t2310r602b2400],
31	?	.	O	?	_	0	SENT_209	[p14l323t2310r602b2400],

1	“	NN	O	“	dep	7	SENT_210	[p14l323t2310r602b2400],
2	Although	IN	O	although	dep	7	SENT_210	[p14l658t2310r1012b2400],
3	a	DT	O	a	det	6	SENT_210	[p14l1071t2334r1107b2377],
4	genome-wide	JJ	O	genome-wide	amod	6	SENT_210	[p14l1166t2310r1668b2400],
5	association	NN	O	association	nn	6	SENT_210	[p14l1728t2314r2140b2378],
6	study	NN	O	study	nsubj	7	SENT_210	[p14l11t2418r211b2508],
7	identiﬁed	VBD	O	identiﬁed	dep	23	SENT_210	[p14l243t2418r601b2487],
8	only	RB	O	only	advmod	10	SENT_210	[p14l635t2418r794b2508],
9	C	NN	O	c	nn	10	SENT_210	[p14l833t2424r887b2487],
10	YP2C19	NN	O	yp2c19	dobj	7	SENT_210	[p14l894t2424r1181b2487],
11	as	IN	O	as	_	0	SENT_210	[p14l1212t2443r1284b2487],
12	being	VBG	O	be	auxpass	13	SENT_210	[p14l1319t2418r1529b2508],
13	associated	VBN	O	associate	prepc_as	7	SENT_210	[p14l1564t2418r1944b2487],
14	with	IN	O	with	_	0	SENT_210	[p14l1975t2418r2140b2487],
15	the	DT	O	the	det	17	SENT_210	[p14l7t2527r124b2595],
16	pharmacodynamic	JJ	O	pharmacodynamic	amod	17	SENT_210	[p14l146t2527r846b2617],
17	response	NN	O	response	prep_with	13	SENT_210	[p14l867t2551r1202b2616],
18	to	TO	O	to	_	0	SENT_210	[p14l1223t2541r1292b2595],
19	clopidogrel	NN	O	clopidogrel	prep_to	13	SENT_210	[p14l1316t2527r1750b2617],
20	,	,	O	,	_	0	SENT_210	[p14l1316t2527r1750b2617],
21	that	WDT	O	that	det	22	SENT_210	[p14l1775t2527r1920b2595],
22	study	NN	O	study	nsubj	23	SENT_210	[p14l1942t2527r2142b2617],
23	showed	VBD	O	show	_	0	SENT_210	[p14l11t2637r293b2705],
24	that	IN	O	that	complm	31	SENT_210	[p14l325t2637r471b2704],
25	platelet	NN	O	platelet	nn	26	SENT_210	[p14l503t2637r776b2726],
26	response	NN	O	response	nsubj	33	SENT_210	[p14l809t2661r1143b2726],
27	to	TO	O	to	_	0	SENT_210	[p14l1177t2650r1246b2704],
28	clopidogrel	NN	O	clopidogrel	prep_to	26	SENT_210	[p14l1283t2637r1698b2727],
29	was	VBD	O	be	cop	31	SENT_210	[p14l1731t2661r1869b2705],
30	highly	RB	O	highly	advmod	31	SENT_210	[p14l1905t2637r2142b2727],
31	heritable	JJ	O	heritable	ccomp	23	SENT_210	[p14l7t2745r336b2814],
32	and	CC	O	and	_	0	SENT_210	[p14l364t2745r502b2814],
33	was	VBD	O	be	ccomp	23	SENT_210	[p14l524t2770r663b2814],
34	not	RB	O	not	dep	36	SENT_210	[p14l691t2759r814b2814],
35	entirely	RB	O	entirely	advmod	36	SENT_210	[p14l839t2745r1120b2835],
36	accounted	VBD	O	account	dep	33	SENT_210	[p14l1145t2745r1525b2814],
37	for	IN	O	for	prep	36	SENT_210	[p14l1550t2745r1656b2814],
38	by	IN	O	by	pcomp	37	SENT_210	[p14l1679t2745r1766b2835],
39	C	NN	O	c	nn	40	SENT_210	[p14l1796t2751r1850b2814],
40	YPZC	NN	O	ypzc	pobj	38	SENT_210	[p14l1857t2751r2064b2814],
41	19	CD	NUMBER	19	num	42	SENT_210	[p14l2069t2752r2144b2814],
42	status	NN	O	status	nsubj	36	SENT_210	[p14l11t2867r246b2932],
43	,	,	O	,	_	0	SENT_210	[p14l11t2867r246b2932],
44	suggesting	VBG	O	suggest	partmod	36	SENT_210	[p14l282t2859r686b2944],
45	that	IN	O	that	complm	51	SENT_210	[p14l714t2854r860b2922],
46	additional	JJ	O	additional	amod	48	SENT_210	[p14l890t2854r1262b2922],
47	genetic	JJ	O	genetic	amod	48	SENT_210	[p14l1294t2859r1561b2944],
48	variants	NNS	O	variant	nsubj	51	SENT_210	[p14l1589t2859r1883b2922],
49	might	MD	O	might	aux	51	SENT_210	[p14l1916t2854r2141b2944],
50	be	VB	O	be	cop	51	SENT_210	[p14l7t2964r93b3031],
51	relevant	JJ	O	relevant	ccomp	44	SENT_210	[p14l117t2964r432b3032],
52	.	.	O	.	_	0	SENT_210	[p14l117t2964r432b3032],

1	In	IN	O	in	_	0	SENT_211	[p14l463t2970r541b3030],
2	a	DT	O	a	det	3	SENT_211	[p14l565t2988r602b3031],
3	study	NN	O	study	prep_in	18	SENT_211	[p14l627t2964r826b3053],
4	of	IN	O	of	_	0	SENT_211	[p14l848t2964r931b3031],
5	patients	NNS	O	patient	prep_of	3	SENT_211	[p14l940t2968r1234b3053],
6	treated	VBN	O	treat	partmod	5	SENT_211	[p14l1259t2964r1516b3031],
7	with	IN	O	with	_	0	SENT_211	[p14l1536t2964r1702b3032],
8	clopidogrel	NN	O	clopidogrel	prep_with	6	SENT_211	[p14l1725t2964r2140b3054],
9	after	IN	O	after	_	0	SENT_211	[p14l9t3072r178b3141],
10	elective	JJ	O	elective	amod	13	SENT_211	[p14l271t3072r544b3141],
11	percutaneous	JJ	O	percutaneous	amod	13	SENT_211	[p14l638t3086r1142b3161],
12	coronary	JJ	O	coronary	amod	13	SENT_211	[p14l1239t3097r1567b3162],
13	intervention	NN	O	intervention	prep_after	6	SENT_211	[p14l1658t3077r2136b3150],
14	,	,	O	,	_	0	SENT_211	[p14l1658t3077r2136b3150],
15	3435	CD	NUMBER	3435	num	17	SENT_211	[p14l13t3185r177b3249],
16	TT	NN	O	tt	nn	17	SENT_211	[p14l237t3185r346b3248],
17	homozygotes	NNS	O	homozygote	nsubj	18	SENT_211	[p14l402t3181r897b3271],
18	had	VBD	O	have	_	0	SENT_211	[p14l956t3181r1095b3249],
19	signiﬁcantly	RB	O	signiﬁcantly	advmod	20	SENT_211	[p14l1155t3181r1611b3271],
20	lower	JJR	O	lower	amod	24	SENT_211	[p14l1667t3181r1874b3249],
21	active	JJ	O	active	amod	24	SENT_211	[p14l1931t3186r2139b3249],
22	clopidogrel	NN	O	clopidogrel	nn	24	SENT_211	[p14l9t3290r425b3380],
23	metabolite	NN	O	metabolite	nn	24	SENT_211	[p14l470t3290r864b3359],
24	concentrations	NNS	O	concentration	dobj	18	SENT_211	[p14l911t3295r1461b3359],
25	than	IN	O	than	dep	26	SENT_211	[p14l1508t3291r1677b3359],
26	did	VBD	O	do	dep	24	SENT_211	[p14l1722t3290r1840b3359],
27	CT	NNP	O	CT	nsubj	26	SENT_211	[p14l1887t3295r2018b3379],
28	/	:	O	/	punct	29	SENT_211	[p14l1887t3295r2018b3379],
29	CC	NN	O	cc	dep	27	SENT_211	[p14l2026t3296r2138b3359],

1	vwvw	NN	O	vwvw	_	0	SENT_212	[p14l794t3561r1327b3612],
2	.	.	O	.	_	0	SENT_212	[p14l794t3561r1327b3612],

1	the	DT	O	the	det	2	SENT_213	[p14l794t3561r1327b3612],
2	|	NN	O	|	_	0	SENT_213	[p14l794t3561r1327b3612],
3	ancet.com	NNP	O	ancet.com	nn	4	SENT_213	[p14l794t3561r1327b3612],
4	Vol	NNP	O	Vol	dep	2	SENT_213	[p14l1370t3561r1457b3612],
5	376	CD	NUMBER	376	num	6	SENT_213	[p14l1477t3560r1580b3619],
6	October	NNP	DATE	October	dep	2	SENT_213	[p14l1626t3561r1850b3612],
7	16,2010	CD	DATE	16,2010	num	6	SENT_213	[p14l1867t3560r2111b3621],

1	Articles	NNPS	O	Articles	_	0	SENT_214	[p15l6t207r156b243],
2	I	PRP	O	I	dep	1	SENT_214	[p15l204t44r252b242],

1	14	CD	NUMBER	14	num	2	SENT_215	[p15l661t466r686b486],
2	p	NN	O	p	_	0	SENT_215	[p15l1076t458r1176b484],
3	=	JJ	O	=	amod	4	SENT_215	[p15l1076t458r1176b484],
4	O-4851	NN	O	o-4851	dep	2	SENT_215	[p15l1076t458r1176b484],
5	across	IN	O	across	_	0	SENT_215	[p15l1183t465r1245b478],
6	genotype	NN	O	genotype	prep_across	4	SENT_215	[p15l1252t462r1349b484],

1	12	CD	NUMBER	12	num	2	SENT_216	[p15l662t566r685b583],
2	IFTIZ-2	NN	O	iftiz-2	_	0	SENT_216	[p15l1588t562r1811b645],
3	10	CD	NUMBER	10	number	4	SENT_216	[p15l661t666r685b683],
4	9	CD	NUMBER	9	num	5	SENT_216	[p15l1778t712r1797b782],
5	°	NN	O	°	dep	2	SENT_216	[p15l1778t712r1797b782],
6	90	CD	NUMBER	90	num	7	SENT_216	[p15l1778t712r1797b782],
7	“	NN	O	“	dep	5	SENT_216	[p15l1778t712r1797b782],
8	?	.	O	?	_	0	SENT_216	[p15l1778t712r1797b782],

1	N4	NN	O	n4	_	0	SENT_217	[p15l1798t742r1812b782],
2	:	:	O	:	_	0	SENT_217	[p15l1798t742r1812b782],
3	o	NN	O	o	nn	5	SENT_217	[p15l1799t712r1811b730],
4	ular	JJ	O	ular	amod	5	SENT_217	[p15l623t877r643b915],
5	death	NN	O	death	dep	1	SENT_217	[p15l623t808r647b872],
6	,	,	O	,	_	0	SENT_217	[p15l623t808r647b872],
7	MI	NNP	O	MI	dep	1	SENT_217	[p15l625t770r647b800],
8	,	,	O	,	_	0	SENT_217	[p15l625t770r647b800],
9	or	CC	O	or	_	0	SENT_217	[p15l630t742r643b763],
10	stroke	NN	O	stroke	conj_or	5	SENT_217	[p15l623t673r643b736],
11	(	CD	PERCENT	(	num	12	SENT_217	[p15l625t633r648b666],
12	%	NN	PERCENT	%	dep	5	SENT_217	[p15l625t633r648b666],
13	)	CD	NUMBER	)	dep	12	SENT_217	[p15l625t633r648b666],

1	Cardi	NNP	PERSON	Cardi	_	0	SENT_218	[p15l623t976r643b1026],
2	ovasc	NN	O	ovasc	dep	1	SENT_218	[p15l630t917r643b973],

1	T	NN	O	t	nn	2	SENT_219	[p15l1121t1042r1169b1044],
2	CYPZCI9	NN	O	cypzci9	_	0	SENT_219	[p15l1178t1033r1267b1054],
3	reduced	VBD	O	reduce	partmod	2	SENT_219	[p15l1275t1031r1452b1052],
4	—	CD	NUMBER	—	num	5	SENT_219	[p15l1275t1031r1452b1052],
5	function	NN	O	function	iobj	3	SENT_219	[p15l1275t1031r1452b1052],
6	non	JJ	O	non	amod	10	SENT_219	[p15l1461t1033r1574b1052],
7	—	NN	O	—	nn	10	SENT_219	[p15l1461t1033r1574b1052],
8	carrier	NN	O	carrier	nn	10	SENT_219	[p15l1461t1033r1574b1052],
9	andABCB1	NN	O	andabcb1	nn	10	SENT_219	[p15l1580t1032r1689b1052],
10	3435TT	NN	O	3435tt	dobj	3	SENT_219	[p15l1696t1034r1780b1054],
11	2	CD	NUMBER	2	dep	10	SENT_219	[p15l674t1065r685b1082],
12	:	:	O	:	_	0	SENT_219	[p15l1121t1075r1169b1077],
13	CYP	NN	O	cyp	nn	14	SENT_219	[p15l1178t1066r1216b1084],
14	reduced-function	NN	O	reduced-function	dep	2	SENT_219	[p15l1275t1064r1452b1084],
15	non	JJ	O	non	amod	17	SENT_219	[p15l1461t1066r1574b1084],
16	—	NN	O	—	nn	17	SENT_219	[p15l1461t1066r1574b1084],
17	carrier	NN	O	carrier	dep	14	SENT_219	[p15l1461t1066r1574b1084],
18	andABCB1	NN	O	andabcb1	nn	20	SENT_219	[p15l1580t1064r1689b1084],
19	3435	CD	NUMBER	3435	num	20	SENT_219	[p15l1696t1067r1747b1087],
20	CC/CT	NNP	O	CC/CT	dep	14	SENT_219	[p15l1754t1065r1817b1087],

1	—	NN	O	—	nn	2	SENT_220	[p15l1121t1107r1168b1109],
2	CYP	NN	O	cyp	dep	3	SENT_220	[p15l1178t1098r1216b1117],
3	reduced	VBD	O	reduce	_	0	SENT_220	[p15l1275t1097r1452b1117],
4	—	CD	NUMBER	—	num	6	SENT_220	[p15l1275t1097r1452b1117],
5	function	NN	O	function	nn	6	SENT_220	[p15l1275t1097r1452b1117],
6	carrier	NN	O	carrier	iobj	3	SENT_220	[p15l1460t1098r1524b1117],
7	and	CC	O	and	_	0	SENT_220	[p15l1529t1097r1567b1117],
8	ABCB1	NN	O	abcb1	nn	10	SENT_220	[p15l1573t1098r1639b1117],
9	3435	CD	NUMBER	3435	num	10	SENT_220	[p15l1645t1099r1697b1119],
10	CC/CT	NNP	O	CC/CT	iobj	3	SENT_220	[p15l1704t1097r1766b1119],
11	T	NN	O	t	nn	14	SENT_220	[p15l1121t1138r1169b1140],
12	CYP2C19	NN	O	cyp2c19	nn	14	SENT_220	[p15l1178t1131r1267b1152],
13	reduced-function	NN	O	reduced-function	nn	14	SENT_220	[p15l1275t1129r1452b1149],
14	carrier	NN	O	carrier	dobj	3	SENT_220	[p15l1460t1131r1524b1149],
15	and	CC	O	and	_	0	SENT_220	[p15l1529t1129r1567b1149],
16	ABCB1	NN	O	abcb1	nn	18	SENT_220	[p15l1573t1131r1639b1149],
17	3435	CD	NUMBER	3435	num	18	SENT_220	[p15l1645t1132r1697b1152],
18	TI	NNP	O	TI	dobj	3	SENT_220	[p15l1702t1131r1729b1149],
19	’	CD	NUMBER	’	nsubj	3	SENT_220	[p15l1702t1131r1729b1149],

1	Days	NNS	DURATION	day	_	0	SENT_221	[p15l1097t1233r1144b1257],
2	from	IN	O	from	_	0	SENT_221	[p15l1150t1231r1200b1251],
3	randomisation	NN	O	randomisation	prep_from	1	SENT_221	[p15l1208t1231r1358b1251],

1	Number	NN	O	number	_	0	SENT_222	[p15l510t1249r598b1269],
2	at	IN	O	at	_	0	SENT_222	[p15l604t1253r626b1269],
3	risk	NN	O	risk	prep_at	1	SENT_222	[p15l633t1249r670b1269],

1	C	NN	O	c	nsubj	34	SENT_223	[p15l119t1283r208b1305],
2	‘	CD	NUMBER	‘	num	1	SENT_223	[p15l119t1283r208b1305],
3	/	:	O	/	punct	33	SENT_223	[p15l119t1283r208b1305],
4	PZC19	NN	O	pzc19	nn	6	SENT_223	[p15l119t1283r208b1305],
5	reduced-function	NN	O	reduced-function	nn	6	SENT_223	[p15l216t1282r393b1302],
6	carrier	NN	O	carrier	dep	11	SENT_223	[p15l401t1283r464b1302],
7	and	CC	O	and	_	0	SENT_223	[p15l470t1282r508b1302],
8	ABCB1	NN	O	abcb1	dep	11	SENT_223	[p15l514t1283r579b1302],
9	3435	CD	NUMBER	3435	dep	11	SENT_223	[p15l586t1284r670b1305],
10	"	``	O	"	punct	11	SENT_223	[p15l586t1284r670b1305],
11	|	NN	O	|	dep	22	SENT_223	[p15l586t1284r670b1305],
12	'	''	O	'	_	0	SENT_223	[p15l586t1284r670b1305],
13	110 101 100	CD	NUMBER	110 101 100	number	14	SENT_223	[p15l893t1284r932b1301],[p15l686t1284r722b1301],
14	98	CD	NUMBER	98	dep	11	SENT_223	[p15l1104t1281r1131b1304],
15	90	CD	NUMBER	90	dep	14	SENT_223	[p15l1315t1284r1342b1304],
16	79	CD	NUMBER	79	number	17	SENT_223	[p15l1520t1284r1545b1304],
17	54	CD	NUMBER	54	num	22	SENT_223	[p15l1727t1284r1754b1304],
18	CYP2C1	NN	O	cyp2c1	nn	22	SENT_223	[p15l68t1316r143b1334],
19	reduced-function	NN	O	reduced-function	nn	22	SENT_223	[p15l166t1314r343b1334],
20	non	JJ	O	non	amod	22	SENT_223	[p15l351t1316r464b1334],
21	~	NN	O	~	nn	22	SENT_223	[p15l351t1316r464b1334],
22	carrier	NN	O	carrier	dep	29	SENT_223	[p15l351t1316r464b1334],
23	and	CC	O	and	prep	22	SENT_223	[p15l470t1314r508b1334],
24	ABCB1	NN	O	abcb1	nn	27	SENT_223	[p15l514t1316r579b1334],
25	3435	CD	NUMBER	3435	num	27	SENT_223	[p15l586t1316r670b1337],
26	'	''	O	'	_	0	SENT_223	[p15l586t1316r670b1337],
27	T	NN	O	t	dep	23	SENT_223	[p15l586t1316r670b1337],
28	278 259 256 249	CD	NUMBER	278 259 256 249	number	29	SENT_223	[p15l1091t1316r1131b1336],[p15l685t1313r723b1336],
29	219 193 131	CD	NUMBER	219 193 131	dep	33	SENT_223	[p15l1717t1316r1753b1336],[p15l1304t1316r1341b1336],
30	C	NN	O	c	prep	29	SENT_223	[p15l82t1348r120b1367],
31	‘	CD	NUMBER	‘	dep	30	SENT_223	[p15l82t1348r120b1367],
32	/	:	O	/	punct	33	SENT_223	[p15l82t1348r120b1367],
33	P	NN	O	p	dep	1	SENT_223	[p15l82t1348r120b1367],
34	reduced	VBD	O	reduce	_	0	SENT_223	[p15l179t1347r356b1367],
35	—	CD	NUMBER	—	num	37	SENT_223	[p15l179t1347r356b1367],
36	function	NN	O	function	nn	37	SENT_223	[p15l179t1347r356b1367],
37	carrier	NN	O	carrier	nsubj	45	SENT_223	[p15l364t1348r428b1367],
38	and	CC	O	and	_	0	SENT_223	[p15l433t1347r471b1367],
39	ABCB1	NN	O	abcb1	nn	41	SENT_223	[p15l477t1348r543b1367],
40	3435	CD	NUMBER	3435	num	41	SENT_223	[p15l549t1349r601b1370],
41	CC/CT	NNP	O	CC/CT	nsubj	45	SENT_223	[p15l608t1348r670b1369],
42	296 281 276 266	CD	NUMBER	296 281 276 266	number	43	SENT_223	[p15l1091t1346r1131b1366],[p15l684t1346r724b1369],
43	230 197 134	CD	NUMBER	230 197 134	num	44	SENT_223	[p15l1715t1349r1754b1369],[p15l1304t1349r1342b1369],
44	CYP2C19	NN	O	cyp2c19	dep	41	SENT_223	[p15l32t1381r121b1402],
45	reduced	VBD	O	reduce	ccomp	34	SENT_223	[p15l129t1379r306b1399],
46	~	CD	NUMBER	~	num	47	SENT_223	[p15l129t1379r306b1399],
47	function	NN	O	function	iobj	45	SENT_223	[p15l129t1379r306b1399],
48	non	JJ	O	non	amod	50	SENT_223	[p15l314t1381r428b1399],
49	~	NN	O	~	nn	50	SENT_223	[p15l314t1381r428b1399],
50	carrier	NN	O	carrier	dobj	45	SENT_223	[p15l314t1381r428b1399],
51	and	CC	O	and	_	0	SENT_223	[p15l433t1379r471b1399],
52	ABCB1	NN	O	abcb1	nn	54	SENT_223	[p15l477t1381r543b1399],
53	3435	CD	NUMBER	3435	num	54	SENT_223	[p15l549t1382r601b1402],
54	CC/CT	NNP	O	CC/CT	conj_and	50	SENT_223	[p15l608t1380r670b1402],
55	767 729 723 699	CD	NUMBER	767 729 723 699	number	56	SENT_223	[p15l1090t1378r1131b1401],[p15l684t1378r723b1401],
56	627 554 410	CD	NUMBER	627 554 410	dep	54	SENT_223	[p15l1714t1381r1753b1401],[p15l1304t1378r1342b1401],

1	Figure	NNP	O	Figure	_	0	SENT_224	[p15l7t1447r75b1474],
2	4	CD	NUMBER	4	num	1	SENT_224	[p15l79t1449r100b1471],
3	:	:	O	:	_	0	SENT_224	[p15l79t1449r100b1471],
4	ABCB1	NN	O	abcb1	nn	5	SENT_224	[p15l106t1448r182b1467],
5	3435C	NN	O	3435c	dep	1	SENT_224	[p15l189t1448r312b1471],
6	—	CD	NUMBER	—	num	8	SENT_224	[p15l189t1448r312b1471],
7	>	JJR	O	>	amod	8	SENT_224	[p15l189t1448r312b1471],
8	T	NN	O	t	dep	5	SENT_224	[p15l189t1448r312b1471],
9	,	,	O	,	_	0	SENT_224	[p15l189t1448r312b1471],
10	CYP2C19	NN	O	cyp2c19	appos	8	SENT_224	[p15l320t1448r428b1471],
11	,	,	O	,	_	0	SENT_224	[p15l320t1448r428b1471],
12	and	CC	O	and	_	0	SENT_224	[p15l436t1446r479b1467],
13	cardiovascular	JJ	O	cardiovascular	amod	14	SENT_224	[p15l486t1446r654b1467],
14	outcomes	NNS	O	outcome	conj_and	5	SENT_224	[p15l660t1450r775b1467],
15	in	IN	O	in	_	0	SENT_224	[p15l783t1447r803b1467],
16	patients	NNS	O	patient	prep_in	14	SENT_224	[p15l810t1447r907b1474],
17	treated	VBN	O	treat	partmod	16	SENT_224	[p15l912t1446r999b1467],
18	with	IN	O	with	_	0	SENT_224	[p15l1005t1446r1058b1467],
19	prasugrel	NN	O	prasugrel	nn	21	SENT_224	[p15l1066t1446r1174b1474],
20	Cumulative	JJ	O	cumulative	amod	21	SENT_224	[p15l6t1482r166b1509],
21	risk	NN	O	risk	prep_with	17	SENT_224	[p15l176t1482r223b1509],
22	of	IN	O	of	_	0	SENT_224	[p15l230t1482r261b1509],
23	cardiovascular	JJ	O	cardiovascular	amod	24	SENT_224	[p15l267t1482r467b1509],
24	death	NN	O	death	prep_of	21	SENT_224	[p15l475t1482r562b1514],
25	,	,	O	,	_	0	SENT_224	[p15l475t1482r562b1514],
26	myocardial	JJ	O	myocardial	amod	27	SENT_224	[p15l573t1482r725b1518],
27	infarction	NN	O	infarction	conj_or	21	SENT_224	[p15l736t1482r871b1509],
28	(	CD	NUMBER	(	num	30	SENT_224	[p15l882t1484r946b1516],
29	MI	NNP	O	MI	nn	30	SENT_224	[p15l882t1484r946b1516],
30	)	NNP	O	)	dep	27	SENT_224	[p15l882t1484r946b1516],
31	,	,	O	,	_	0	SENT_224	[p15l882t1484r946b1516],
32	or	CC	O	or	_	0	SENT_224	[p15l956t1491r985b1509],
33	stroke	NN	O	stroke	prep_with	17	SENT_224	[p15l993t1482r1079b1509],
34	for	IN	O	for	_	0	SENT_224	[p15l1087t1482r1128b1509],
35	the	DT	O	the	det	38	SENT_224	[p15l1134t1482r1181b1509],
36	four	CD	NUMBER	four	num	38	SENT_224	[p15l1189t1482r1248b1509],
37	genotype	NN	O	genotype	nn	38	SENT_224	[p15l1256t1487r1389b1518],
38	categories	NNS	O	category	prep_for	33	SENT_224	[p15l1398t1484r1549b1518],
39	,	,	O	,	_	0	SENT_224	[p15l1398t1484r1549b1518],
40	with	IN	O	with	_	0	SENT_224	[p15l1557t1482r1620b1509],
41	the	DT	O	the	det	43	SENT_224	[p15l1628t1482r1674b1509],
42	p	NN	O	p	nn	43	SENT_224	[p15l1683t1491r1700b1518],
43	value	NN	O	value	prep_with	21	SENT_224	[p15l1708t1482r1782b1509],
44	across	IN	O	across	_	0	SENT_224	[p15l1791t1491r1876b1509],
45	genotype	NN	O	genotype	nn	46	SENT_224	[p15l1885t1487r2018b1518],
46	category	NN	O	category	prep_across	17	SENT_224	[p15l2027t1487r2154b1518],
47	.	.	O	.	_	0	SENT_224	[p15l2027t1487r2154b1518],

1	individuals	NNS	O	individual	nsubj	13	SENT_225	[p15l7t1598r443b1676],
2	,	,	O	,	_	0	SENT_225	[p15l7t1598r443b1676],
3	suggesting	VBG	O	suggest	partmod	1	SENT_225	[p15l544t1603r949b1688],
4	increased	VBN	O	increase	amod	6	SENT_225	[p15l1043t1598r1402b1666],
5	intestinal	JJ	O	intestinal	amod	6	SENT_225	[p15l1496t1598r1848b1666],
6	eiﬁux	NN	O	eiﬁux	dobj	3	SENT_225	[p15l1943t1598r2153b1666],
7	possibly	RB	O	possibly	advmod	8	SENT_225	[p15l7t1708r313b1797],
8	mediated	VBN	O	mediate	partmod	6	SENT_225	[p15l354t1708r704b1776],
9	by	IN	O	by	_	0	SENT_225	[p15l745t1708r833b1797],
10	higher	JJR	O	higher	amod	12	SENT_225	[p15l872t1708r1121b1798],
11	P-glycoprotein	NN	MISC	p-glycoprotein	nn	12	SENT_225	[p15l1166t1708r1707b1798],
12	expression	NN	O	expression	agent	8	SENT_225	[p15l1751t1712r2151b1797],
13	associated	VBN	O	associate	_	0	SENT_225	[p15l8t1816r390b1885],
14	with	IN	O	with	_	0	SENT_225	[p15l461t1816r628b1884],
15	the	DT	O	the	det	18	SENT_225	[p15l700t1816r817b1885],
16	3435	CD	DATE	3435	num	18	SENT_225	[p15l896t1821r1061b1885],
17	TT	NN	O	tt	nn	18	SENT_225	[p15l1137t1821r1247b1883],
18	genotype	NN	O	genotype	prep_with	13	SENT_225	[p15l1321t1821r1723b1906],
19	.	.	O	.	_	0	SENT_225	[p15l1321t1821r1723b1906],

1	“	NN	O	“	dep	10	SENT_226	[p15l1321t1821r1723b1906],
2	Although	IN	O	although	dep	10	SENT_226	[p15l1795t1816r2151b1906],
3	evidence	NN	O	evidence	nsubj	10	SENT_226	[p15l8t1926r333b1994],
4	on	IN	O	on	_	0	SENT_226	[p15l387t1951r482b1994],
5	P-glycoprotein	NN	O	p-glycoprotein	nn	6	SENT_226	[p15l538t1926r1079b2016],
6	expression	NN	O	expression	prep_on	3	SENT_226	[p15l1132t1931r1532b2015],
7	and	CC	O	and	_	0	SENT_226	[p15l1586t1926r1725b1994],
8	activity	NN	O	activity	conj_and	6	SENT_226	[p15l1777t1931r2040b2016],
9	is	VBZ	O	be	cop	10	SENT_226	[p15l2090t1931r2148b1994],
10	inconsistent	JJ	O	inconsistent	advcl	19	SENT_226	[p15l7t2040r488b2114],
11	,	,	O	,	_	0	SENT_226	[p15l7t2040r488b2114],
12	mRNA	NN	O	mrna	nn	13	SENT_226	[p15l521t2041r785b2104],
13	expression	NN	O	expression	nsubjpass	19	SENT_226	[p15l814t2040r1214b2125],
14	in	IN	O	in	_	0	SENT_226	[p15l1243t2040r1319b2103],
15	duodenal	JJ	O	duodenal	amod	16	SENT_226	[p15l1349t2036r1697b2104],
16	enterocytes	NNS	O	enterocyte	prep_in	13	SENT_226	[p15l1727t2049r2148b2125],
17	has	VBZ	O	have	aux	19	SENT_226	[p15l6t2144r132b2213],
18	been	VBN	O	be	auxpass	19	SENT_226	[p15l160t2144r341b2213],
19	reported	VBN	O	report	_	0	SENT_226	[p15l367t2144r685b2233],
20	to	TO	O	to	aux	23	SENT_226	[p15l709t2158r778b2213],
21	be	VB	O	be	cop	23	SENT_226	[p15l804t2144r890b2213],
22	two-to-three-times	NNS	O	two-to-three-time	npadvmod	23	SENT_226	[p15l916t2144r1602b2213],
23	higher	JJR	O	higher	xcomp	19	SENT_226	[p15l1629t2144r1878b2234],
24	for	IN	O	for	_	0	SENT_226	[p15l1903t2144r2010b2213],
25	the	DT	O	the	det	29	SENT_226	[p15l2033t2144r2150b2213],
26	ABCB1	NN	O	abcb1	nn	29	SENT_226	[p15l6t2258r277b2321],
27	3435	CD	NUMBER	3435	num	29	SENT_226	[p15l314t2257r479b2321],
28	TT	NN	O	tt	nn	29	SENT_226	[p15l515t2257r625b2320],
29	genotype	NN	O	genotype	prep_for	23	SENT_226	[p15l659t2266r997b2343],
30	than	IN	O	than	prep	29	SENT_226	[p15l1030t2253r1200b2321],
31	for	IN	O	for	pcomp	30	SENT_226	[p15l1235t2253r1342b2321],
32	either	CC	O	either	dep	31	SENT_226	[p15l1375t2253r1594b2321],
33	the	DT	O	the	det	37	SENT_226	[p15l1626t2253r1743b2321],
34	CC	NN	O	cc	nn	37	SENT_226	[p15l1780t2258r1892b2321],
35	or	CC	O	or	_	0	SENT_226	[p15l1930t2277r2007b2321],
36	CT	NN	O	ct	conj_or	34	SENT_226	[p15l2042t2257r2152b2321],
37	genotype	NN	O	genotype	conj	31	SENT_226	[p15l9t2366r479b2453],
38	.27	CD	NUMBER	.27	nsubj	74	SENT_226	[p15l9t2366r479b2453],
39	‘	CD	NUMBER	‘	number	40	SENT_226	[p15l9t2366r479b2453],
40	29	CD	NUMBER	29	num	38	SENT_226	[p15l9t2366r479b2453],
41	In	IN	O	in	_	0	SENT_226	[p15l516t2369r595b2429],
42	the	DT	O	the	det	44	SENT_226	[p15l627t2363r744b2431],
43	healthy	JJ	O	healthy	amod	44	SENT_226	[p15l776t2363r1053b2452],
44	participants	NNS	O	participant	prep_in	38	SENT_226	[p15l1084t2367r1526b2452],
45	in	IN	O	in	_	0	SENT_226	[p15l1562t2367r1637b2429],
46	our	PRP$	O	we	poss	47	SENT_226	[p15l1671t2387r1799b2431],
47	analysis	NN	O	analysis	prep_in	44	SENT_226	[p15l1832t2363r2147b2452],
48	,	,	O	,	_	0	SENT_226	[p15l1832t2363r2147b2452],
49	TT	NN	ORGANIZATION	tt	nn	50	SENT_226	[p15l6t2476r116b2538],
50	homozygotes	NNS	O	homozygote	nsubj	51	SENT_226	[p15l137t2471r635b2561],
51	had	VBD	O	have	parataxis	74	SENT_226	[p15l660t2471r800b2540],
52	an	DT	O	a	det	54	SENT_226	[p15l824t2496r913b2540],
53	absolute	JJ	O	absolute	amod	54	SENT_226	[p15l938t2471r1249b2540],
54	reduction	NN	O	reduction	dobj	51	SENT_226	[p15l1274t2471r1635b2540],
55	in	IN	O	in	_	0	SENT_226	[p15l1659t2476r1733b2538],
56	maximum	NN	O	maximum	nn	58	SENT_226	[p15l1757t2476r2151b2540],
57	platelet	NN	O	platelet	nn	58	SENT_226	[p15l7t2580r281b2669],
58	aggregation	NN	O	aggregation	prep_in	54	SENT_226	[p15l321t2585r763b2670],
59	after	IN	O	after	_	0	SENT_226	[p15l804t2580r973b2648],
60	a	DT	O	a	det	62	SENT_226	[p15l1013t2605r1050b2648],
61	loading	VBG	O	load	amod	62	SENT_226	[p15l1089t2580r1370b2670],
62	dose	NN	O	dose	prep_after	51	SENT_226	[p15l1411t2580r1579b2648],
63	of	IN	O	of	_	0	SENT_226	[p15l1621t2580r1705b2648],
64	clopidogrel	NN	O	clopidogrel	prep_of	62	SENT_226	[p15l1733t2580r2151b2670],
65	that	WDT	O	that	nsubj	66	SENT_226	[p15l6t2690r153b2757],
66	was	VBD	O	be	rcmod	62	SENT_226	[p15l207t2714r346b2758],
67	7-3	CD	NUMBER	7-3	num	68	SENT_226	[p15l405t2694r525b2760],
68	percentage	NN	O	percentage	npadvmod	70	SENT_226	[p15l587t2703r995b2780],
69	points	NNS	O	point	dep	68	SENT_226	[p15l1054t2694r1285b2779],
70	lower	JJR	O	lower	advmod	66	SENT_226	[p15l1344t2690r1553b2758],
71	(	CD	NUMBER	(	num	72	SENT_226	[p15l1615t2694r1720b2780],
72	ie	NN	O	ie	dep	70	SENT_226	[p15l1615t2694r1720b2780],
73	,	,	O	,	_	0	SENT_226	[p15l1615t2694r1720b2780],
74	decreased	VBD	O	decrease	rcmod	37	SENT_226	[p15l1782t2690r2152b2758],
75	platelet	NN	O	platelet	nn	77	SENT_226	[p15l7t2798r281b2887],
76	inhibition	NN	O	inhibition	nn	77	SENT_226	[p15l349t2798r745b2888],
77	)	NN	O	)	dobj	74	SENT_226	[p15l349t2798r745b2888],
78	than	IN	O	than	prep	74	SENT_226	[p15l819t2798r988b2867],
79	in	IN	O	in	pcomp	78	SENT_226	[p15l1057t2803r1132b2865],
80	CC	NN	O	cc	nn	83	SENT_226	[p15l1203t2804r1316b2867],
81	or	CC	O	or	_	0	SENT_226	[p15l1388t2823r1465b2867],
82	CT	NN	O	ct	nn	83	SENT_226	[p15l1534t2803r1644b2867],
83	individuals	NNS	O	individual	pobj	79	SENT_226	[p15l1712t2798r2147b2867],
84	.	.	O	.	_	0	SENT_226	[p15l1712t2798r2147b2867],

1	Although	IN	O	although	mark	5	SENT_227	[p15l6t2907r362b2997],
2	we	PRP	O	we	nsubj	5	SENT_227	[p15l411t2931r514b2975],
3	did	VBD	O	do	aux	5	SENT_227	[p15l567t2907r685b2975],
4	not	RB	O	not	neg	5	SENT_227	[p15l735t2920r859b2975],
5	record	VB	O	record	advcl	22	SENT_227	[p15l908t2907r1148b2975],
6	a	DT	O	a	det	8	SENT_227	[p15l1200t2931r1237b2975],
7	signiﬁcant	JJ	O	signiﬁcant	amod	8	SENT_227	[p15l1290t2907r1685b2997],
8	association	NN	O	association	dobj	5	SENT_227	[p15l1736t2912r2151b2975],
9	between	IN	O	between	_	0	SENT_227	[p15l6t3017r320b3085],
10	3435C	CD	NUMBER	3435c	number	11	SENT_227	[p15l357t3021r731b3085],
11	—	CD	NUMBER	—	prep_between	8	SENT_227	[p15l357t3021r731b3085],
12	>	JJR	O	>	amod	14	SENT_227	[p15l357t3021r731b3085],
13	T	NN	O	t	nn	14	SENT_227	[p15l357t3021r731b3085],
14	genotype	NN	O	genotype	dep	11	SENT_227	[p15l764t3030r1101b3107],
15	and	CC	O	and	_	0	SENT_227	[p15l1136t3017r1275b3085],
16	pharmacokinetic	JJ	O	pharmacokinetic	amod	17	SENT_227	[p15l1307t3017r1941b3106],
17	data	NNS	O	datum	prep_between	8	SENT_227	[p15l1975t3017r2147b3095],
18	,	,	O	,	_	0	SENT_227	[p15l1975t3017r2147b3095],
19	other	JJ	O	other	amod	20	SENT_227	[p15l8t3125r205b3193],
20	researchers	NNS	O	researcher	nsubj	22	SENT_227	[p15l260t3125r689b3193],
21	have	VBP	O	have	aux	22	SENT_227	[p15l746t3125r917b3193],
22	shown	VBN	O	show	_	0	SENT_227	[p15l977t3125r1222b3193],
23	this	DT	O	this	det	24	SENT_227	[p15l1277t3125r1414b3193],
24	relation	NN	O	relation	dobj	22	SENT_227	[p15l1473t3125r1780b3204],
25	,	,	O	,	_	0	SENT_227	[p15l1473t3125r1780b3204],
26	and	CC	O	and	_	0	SENT_227	[p15l1841t3125r1979b3193],
27	the	DT	O	the	det	28	SENT_227	[p15l2033t3125r2150b3193],
28	differences	NNS	O	difference	nsubjpass	33	SENT_227	[p15l8t3235r420b3303],
29	in	IN	O	in	_	0	SENT_227	[p15l490t3240r565b3302],
30	results	NNS	O	result	prep_in	28	SENT_227	[p15l631t3235r880b3303],
31	could	MD	O	could	aux	33	SENT_227	[p15l949t3235r1154b3303],
32	be	VB	O	be	auxpass	33	SENT_227	[p15l1219t3235r1305b3303],
33	related	VBN	O	relate	conj_and	22	SENT_227	[p15l1373t3235r1628b3303],
34	to	TO	O	to	_	0	SENT_227	[p15l1693t3248r1762b3303],
35	patients	NNS	O	patient	prep_to	33	SENT_227	[p15l1830t3240r2147b3324],
36	,	,	O	,	_	0	SENT_227	[p15l1830t3240r2147b3324],
37	methods	NNS	O	method	conj_and	35	SENT_227	[p15l7t3344r355b3423],
38	,	,	O	,	_	0	SENT_227	[p15l7t3344r355b3423],
39	and	CC	O	and	_	0	SENT_227	[p15l481t3345r620b3413],
40	single-centre	JJ	O	single-centre	prep_to	33	SENT_227	[p15l745t3344r1225b3434],
41	versus	CC	O	versus	prep	40	SENT_227	[p15l1347t3369r1586b3413],
42	multicentre	JJ	O	multicentre	amod	44	SENT_227	[p15l1711t3345r2150b3413],
43	study	NN	O	study	nn	44	SENT_227	[p15l10t3453r211b3543],
44	design	NN	O	design	dep	41	SENT_227	[p15l236t3453r501b3543],
45	.	.	O	.	_	0	SENT_227	[p15l236t3453r501b3543],

1	In	IN	O	in	_	0	SENT_228	[p15l83t3569r160b3629],
2	terms	NNS	O	term	prep_in	8	SENT_228	[p15l195t3575r406b3630],
3	of	IN	O	of	_	0	SENT_228	[p15l445t3562r527b3630],
4	clinical	JJ	O	clinical	amod	5	SENT_228	[p15l551t3562r810b3630],
5	outcomes	NNS	O	outcome	prep_of	2	SENT_228	[p15l847t3575r1221b3640],
6	,	,	O	,	_	0	SENT_228	[p15l847t3575r1221b3640],
7	we	PRP	O	we	nsubj	8	SENT_228	[p15l1258t3586r1360b3630],
8	showed	VBD	O	show	_	0	SENT_228	[p15l1399t3562r1677b3630],
9	that	IN	O	that	_	0	SENT_228	[p15l1710t3562r1853b3630],
10	ABCB1	NN	O	abcb1	prep_that	8	SENT_228	[p15l1886t3567r2152b3630],

1	3435	CD	NUMBER	3435	num	3	SENT_229	[p16l12t27r173b91],
2	TT	NN	O	tt	nn	3	SENT_229	[p16l200t27r308b89],
3	homozygotes	NNS	O	homozygote	nsubj	4	SENT_229	[p16l331t23r817b112],
4	had	VBD	O	have	_	0	SENT_229	[p16l843t22r981b91],
5	a	DT	O	a	det	7	SENT_229	[p16l1005t47r1042b91],
6	72	CD	PERCENT	72	num	7	SENT_229	[p16l1066t27r1221b94],
7	%	NN	PERCENT	%	dobj	4	SENT_229	[p16l1066t27r1221b94],
8	increased	VBD	O	increase	rcmod	7	SENT_229	[p16l1246t23r1597b91],
9	risk	NN	O	risk	dobj	8	SENT_229	[p16l1620t23r1759b91],
10	of	IN	O	of	_	0	SENT_229	[p16l1782t22r1864b91],
11	adverse	JJ	O	adverse	amod	13	SENT_229	[p16l1877t22r2150b91],
12	cardiovascular	JJ	O	cardiovascular	amod	13	SENT_229	[p16l8t132r534b201],
13	events	NNS	O	event	prep_of	9	SENT_229	[p16l555t146r782b201],
14	compared	VBN	O	compare	_	0	SENT_229	[p16l807t132r1174b221],
15	with	IN	O	with	prepc_compared_with	8	SENT_229	[p16l1192t132r1355b201],
16	CT/CC	NN	O	ct/cc	nn	17	SENT_229	[p16l1379t137r1627b221],
17	individuals	NNS	O	individual	pobj	8	SENT_229	[p16l1651t132r2053b201],
18	in	IN	O	in	_	0	SENT_229	[p16l2077t137r2151b199],
19	the	DT	O	the	det	20	SENT_229	[p16l6t241r121b309],
20	setting	NN	O	setting	prep_in	17	SENT_229	[p16l173t246r418b331],
21	of	IN	O	of	_	0	SENT_229	[p16l467t241r550b309],
22	treatment	NN	O	treatment	prep_of	20	SENT_229	[p16l584t254r946b309],
23	with	IN	O	with	_	0	SENT_229	[p16l991t241r1154b309],
24	clopidogrel	NN	O	clopidogrel	prep_with	22	SENT_229	[p16l1203t241r1610b331],
25	in	IN	O	in	_	0	SENT_229	[p16l1659t246r1732b308],
26	TRITONTIMI	NNP	O	TRITONTIMI	prep_in	24	SENT_229	[p16l1780t245r2153b309, p16l6t355r200b417],
27	38	CD	NUMBER	38	num	26	SENT_229	[p16l228t357r327b419],
28	.	.	O	.	_	0	SENT_229	[p16l228t357r327b419],

1	Likewise	RB	O	likewise	advmod	47	SENT_230	[p16l355t351r688b429],
2	,	,	O	,	_	0	SENT_230	[p16l355t351r688b429],
3	in	IN	O	in	_	0	SENT_230	[p16l711t355r785b417],
4	a	DT	O	a	det	6	SENT_230	[p16l806t375r843b419],
5	previous	JJ	O	previous	amod	6	SENT_230	[p16l863t355r1174b439],
6	study	NN	O	study	nsubj	9	SENT_230	[p16l1199t351r1395b440],
7	in	IN	O	in	_	0	SENT_230	[p16l1414t355r1488b417],
8	patients	NNS	O	patient	prep_in	6	SENT_230	[p16l1507t355r1795b439],
9	receiving	VBG	O	receive	prepc_in	47	SENT_230	[p16l1817t355r2151b440],
10	clopidogrel	NN	O	clopidogrel	dobj	9	SENT_230	[p16l8t459r415b549],
11	after	IN	O	after	_	0	SENT_230	[p16l438t459r603b527],
12	an	DT	O	a	det	15	SENT_230	[p16l624t484r713b527],
13	acute	JJ	O	acute	amod	14	SENT_230	[p16l735t473r926b527],
14	myocardial	JJ	O	myocardial	amod	15	SENT_230	[p16l948t459r1354b549],
15	infarction	NN	O	infarction	prep_after	9	SENT_230	[p16l1375t459r1752b537],
16	,	,	O	,	_	0	SENT_230	[p16l1375t459r1752b537],
17	those	DT	O	those	appos	15	SENT_230	[p16l1776t459r1973b527],
18	who	WP	O	who	nsubj	22	SENT_230	[p16l1994t459r2150b527],
19	were	VBD	O	be	cop	22	SENT_230	[p16l6t593r181b637],
20	3435	CD	NUMBER	3435	num	22	SENT_230	[p16l214t573r375b637],
21	TT	NN	O	tt	nn	22	SENT_230	[p16l405t573r514b635],
22	homozygotes	NNS	O	homozygote	rcmod	17	SENT_230	[p16l539t569r1026b659],
23	had	VBD	O	have	rcmod	22	SENT_230	[p16l1054t569r1192b636],
24	an	DT	O	a	det	25	SENT_230	[p16l1219t593r1308b637],
25	increase	NN	O	increase	dobj	23	SENT_230	[p16l1335t573r1637b637],
26	of	IN	O	of	_	0	SENT_230	[p16l1666t569r1749b636],
27	about	RB	O	about	quantmod	28	SENT_230	[p16l1764t569r1970b637],
28	70	CD	PERCENT	70	num	29	SENT_230	[p16l1995t573r2150b640],
29	%	NN	PERCENT	%	prep_of	25	SENT_230	[p16l1995t573r2150b640],
30	in	IN	O	in	_	0	SENT_230	[p16l7t682r81b744],
31	cardiovascular	JJ	O	cardiovascular	amod	32	SENT_230	[p16l100t678r625b746],
32	events	NNS	O	event	prep_in	29	SENT_230	[p16l642t691r870b746],
33	during	IN	O	during	_	0	SENT_230	[p16l891t677r1139b767],
34	follow-up	NN	O	follow-up	prep_during	23	SENT_230	[p16l1156t677r1562b766],
35	.1	CD	NUMBER	.1	number	36	SENT_230	[p16l1156t677r1562b766],
36	°	CD	NUMBER	°	num	34	SENT_230	[p16l1156t677r1562b766],
37	In	IN	O	in	_	0	SENT_230	[p16l1585t684r1662b745],
38	that	DT	O	that	det	40	SENT_230	[p16l1678t678r1821b746],
39	previous	JJ	O	previous	amod	40	SENT_230	[p16l1836t683r2148b767],
40	study	NN	O	study	prep_in	23	SENT_230	[p16l10t786r215b876],
41	,	,	O	,	_	0	SENT_230	[p16l10t786r215b876],
42	however	RB	O	however	advmod	23	SENT_230	[p16l281t786r601b865],
43	,	,	O	,	_	0	SENT_230	[p16l281t786r601b865],
44	3435	CD	NUMBER	3435	num	46	SENT_230	[p16l672t791r834b855],
45	CT	NN	O	ct	nn	46	SENT_230	[p16l904t791r1012b855],
46	heterozygotes	NNS	O	heterozygote	nsubj	47	SENT_230	[p16l1073t786r1577b876],
47	were	VBD	O	be	_	0	SENT_230	[p16l1641t811r1816b855],
48	also	RB	O	also	advmod	47	SENT_230	[p16l1882t786r2022b855],
49	at	IN	O	at	_	0	SENT_230	[p16l2088t800r2152b855],
50	increased	VBN	O	increase	amod	51	SENT_230	[p16l7t895r358b963],
51	risk	NN	O	risk	prep_at	47	SENT_230	[p16l385t895r525b963],
52	of	IN	O	of	_	0	SENT_230	[p16l552t895r634b963],
53	adverse	JJ	O	adverse	amod	55	SENT_230	[p16l651t895r924b964],
54	cardiovascular	JJ	O	cardiovascular	amod	55	SENT_230	[p16l954t895r1479b963],
55	events	NNS	O	event	prep_of	51	SENT_230	[p16l1508t909r1756b973],
56	,	,	O	,	_	0	SENT_230	[p16l1508t909r1756b973],
57	albeit	IN	O	albeit	mark	63	SENT_230	[p16l1789t895r1988b963],
58	less	RBR	O	less	advmod	59	SENT_230	[p16l2014t895r2148b963],
59	so	RB	O	so	advmod	63	SENT_230	[p16l10t1029r86b1073],
60	than	IN	O	than	dep	59	SENT_230	[p16l136t1005r302b1072],
61	were	VBD	O	be	cop	63	SENT_230	[p16l350t1029r526b1073],
62	TT	NN	O	tt	nn	63	SENT_230	[p16l575t1009r684b1071],
63	homozygotes	NNS	O	homozygote	advcl	47	SENT_230	[p16l732t1005r1239b1095],
64	;	:	O	;	_	0	SENT_230	[p16l732t1005r1239b1095],
65	the	DT	O	the	det	66	SENT_230	[p16l1291t1005r1406b1073],
66	differences	NNS	O	difference	nsubj	72	SENT_230	[p16l1458t1005r1860b1073],
67	in	IN	O	in	_	0	SENT_230	[p16l1912t1009r1986b1071],
68	the	DT	O	the	det	69	SENT_230	[p16l2035t1005r2150b1073],
69	ﬁndings	NNS	O	ﬁndings	prep_in	66	SENT_230	[p16l7t1113r310b1203],
70	could	MD	O	could	aux	72	SENT_230	[p16l348t1113r549b1182],
71	be	VB	O	be	cop	72	SENT_230	[p16l580t1113r666b1182],
72	attributable	JJ	O	attributable	parataxis	47	SENT_230	[p16l702t1113r1120b1182],
73	to	TO	O	to	_	0	SENT_230	[p16l1154t1127r1223b1182],
74	the	DT	O	the	det	76	SENT_230	[p16l1257t1113r1372b1182],
75	patient	NN	O	patient	nn	76	SENT_230	[p16l1407t1118r1662b1202],
76	populations	NNS	O	population	prep_to	72	SENT_230	[p16l1695t1113r2147b1202],
77	.	.	O	.	_	0	SENT_230	[p16l1695t1113r2147b1202],

1	Combination	NN	O	combination	nsubj	12	SENT_231	[p16l10t1223r494b1291],
2	of	IN	O	of	_	0	SENT_231	[p16l525t1223r607b1291],
3	the	DT	O	the	det	4	SENT_231	[p16l623t1223r738b1291],
4	results	NNS	O	result	prep_of	1	SENT_231	[p16l769t1223r1011b1291],
5	of	IN	O	of	_	0	SENT_231	[p16l1044t1223r1127b1291],
6	the	DT	O	the	det	8	SENT_231	[p16l1142t1223r1258b1291],
7	previous	JJ	O	previous	amod	8	SENT_231	[p16l1288t1228r1599b1312],
8	study	NN	O	study	prep_of	4	SENT_231	[p16l1634t1223r1831b1312],
9	and	CC	O	and	_	0	SENT_231	[p16l1860t1223r1996b1291],
10	our	PRP$	O	we	poss	11	SENT_231	[p16l2026t1247r2152b1291],
11	ﬁndings	NNS	O	ﬁndings	prep_of	4	SENT_231	[p16l7t1333r310b1423],
12	yielded	VBD	O	yield	_	0	SENT_231	[p16l345t1333r607b1422],
13	an	DT	O	a	det	14	SENT_231	[p16l641t1357r730b1400],
14	apparent	JJ	O	apparent	dobj	12	SENT_231	[p16l765t1346r1089b1422],
15	graded	VBN	O	grade	partmod	14	SENT_231	[p16l1124t1333r1373b1423],
16	allele-dose	NN	O	allele-dose	nn	18	SENT_231	[p16l1408t1333r1786b1401],
17	response	NN	O	response	nn	18	SENT_231	[p16l1822t1357r2150b1422],
18	www	NN	O	www	dobj	15	SENT_231	[p16l6t1605r542b1656],
19	.	.	O	.	_	0	SENT_231	[p16l6t1605r542b1656],

1	the	DT	O	the	det	2	SENT_232	[p16l6t1605r542b1656],
2	|	NN	O	|	_	0	SENT_232	[p16l6t1605r542b1656],
3	ancet.com	NNP	O	ancet.com	nn	4	SENT_232	[p16l6t1605r542b1656],
4	Vol	NNP	O	Vol	dep	2	SENT_232	[p16l585t1605r673b1656],
5	376	CD	NUMBER	376	num	6	SENT_232	[p16l692t1604r797b1663],
6	October	NNP	DATE	October	dep	2	SENT_232	[p16l843t1605r1068b1656],
7	16,2010	CD	DATE	16,2010	num	6	SENT_232	[p16l1085t1604r1330b1665],

1	with	IN	O	with	dep	14	SENT_233	[p16l7t1793r122b1842],
2	an	DT	DURATION	a	det	3	SENT_233	[p16l158t1810r221b1842],
3	HR	NN	DURATION	hr	pobj	1	SENT_233	[p16l258t1798r349b1841],
4	for	IN	O	for	_	0	SENT_233	[p16l383t1793r457b1842],
5	adverse	JJ	O	adverse	amod	7	SENT_233	[p16l492t1793r685b1842],
6	cardiovascular	JJ	O	cardiovascular	amod	7	SENT_233	[p16l721t1793r1094b1842],
7	events	NNS	O	event	prep_for	3	SENT_233	[p16l1128t1803r1290b1842],
8	of	IN	O	of	_	0	SENT_233	[p16l1328t1793r1386b1842],
9	1-29	CD	PERCENT	1-29	num	10	SENT_233	[p16l1414t1797r1526b1842],
10	(	CD	PERCENT	(	prep_of	7	SENT_233	[p16l12t1875r141b1936],
11	95	CD	PERCENT	95	num	14	SENT_233	[p16l12t1875r141b1936],
12	%	NN	PERCENT	%	nn	14	SENT_233	[p16l12t1875r141b1936],
13	CI	NN	O	ci	nn	14	SENT_233	[p16l158t1875r217b1920],
14	o	NN	O	o	_	0	SENT_233	[p16l234t1876r263b1920],
15	-	:	O	-	_	0	SENT_233	[p16l275t1900r283b1908],
16	99-1	CD	NUMBER	99-1	dep	14	SENT_233	[p16l296t1876r412b1920],
17	-	:	O	-	_	0	SENT_233	[p16l423t1900r431b1908],
18	69	CD	DATE	69	num	19	SENT_233	[p16l444t1876r519b1936],
19	)	NN	O	)	dep	25	SENT_233	[p16l444t1876r519b1936],
20	for	IN	O	for	_	0	SENT_233	[p16l537t1872r612b1920],
21	3435	CD	DATE	3435	prep_for	19	SENT_233	[p16l628t1875r742b1920],
22	CT	NNP	O	CT	dep	25	SENT_233	[p16l761t1875r838b1920],
23	versus	CC	O	versus	_	0	SENT_233	[p16l850t1889r1016b1920],
24	CC	NN	O	cc	nn	25	SENT_233	[p16l1034t1875r1113b1920],
25	individuals	NNS	O	individual	dep	33	SENT_233	[p16l1129t1872r1415b1920],
26	and	CC	O	and	_	0	SENT_233	[p16l1432t1872r1528b1920],
27	a	DT	DURATION	a	det	28	SENT_233	[p16l9t1967r35b1998],
28	HR	NN	DURATION	hr	conj_and	25	SENT_233	[p16l49t1954r139b1997],
29	of	IN	O	of	_	0	SENT_233	[p16l150t1949r209b1998],
30	1	CD	NUMBER	1	prep_of	25	SENT_233	[p16l213t1954r235b1997],
31	-	:	O	-	_	0	SENT_233	[p16l246t1977r254b1985],
32	70	CD	NUMBER	70	num	33	SENT_233	[p16l265t1952r321b2000],
33	(	CD	NUMBER	(	dep	14	SENT_233	[p16l337t1954r376b2013],
34	1	LS	NUMBER	1	dep	14	SENT_233	[p16l337t1954r376b2013],
35	-	:	O	-	_	0	SENT_233	[p16l387t1977r395b1985],
36	28-2	CD	NUMBER	28-2	dep	14	SENT_233	[p16l408t1954r528b1998],
37	-	:	O	-	_	0	SENT_233	[p16l542t1977r550b1985],
38	26	CD	DATE	26	num	39	SENT_233	[p16l563t1953r637b2013],
39	)	NN	O	)	dep	36	SENT_233	[p16l563t1953r637b2013],
40	for	IN	O	for	dep	36	SENT_233	[p16l652t1949r727b1998],
41	3435	CD	DATE	3435	num	42	SENT_233	[p16l740t1952r854b1998],
42	TT	NN	O	tt	pobj	40	SENT_233	[p16l867t1952r944b1997],
43	versus	CC	O	versus	dep	36	SENT_233	[p16l953t1966r1119b1998],
44	CC	NN	O	cc	nn	45	SENT_233	[p16l1133t1953r1212b1998],
45	individuals	NNS	O	individual	dep	43	SENT_233	[p16l1225t1949r1525b1998],
46	.	.	O	.	_	0	SENT_233	[p16l1225t1949r1525b1998],

1	Incorporation	NN	O	incorporation	nsubj	10	SENT_234	[p16l11t2029r368b2089],
2	of	IN	O	of	_	0	SENT_234	[p16l396t2026r454b2074],
3	clinical	JJ	O	clinical	amod	4	SENT_234	[p16l473t2026r656b2074],
4	data	NNS	O	datum	prep_of	1	SENT_234	[p16l684t2026r791b2074],
5	from	IN	O	from	_	0	SENT_234	[p16l817t2026r947b2074],
6	other	JJ	O	other	amod	7	SENT_234	[p16l974t2026r1110b2074],
7	studies	NNS	O	study	prep_from	4	SENT_234	[p16l1138t2026r1319b2074],
8	will	MD	O	will	aux	10	SENT_234	[p16l1346t2026r1441b2074],
9	be	VB	O	be	cop	10	SENT_234	[p16l1466t2026r1527b2074],
10	helpful	JJ	O	helpful	_	0	SENT_234	[p16l7t2104r193b2168],
11	to	TO	O	to	_	0	SENT_234	[p16l208t2114r256b2153],
12	further	JJ	O	further	amod	13	SENT_234	[p16l273t2104r458b2153],
13	reﬁne	NN	O	reﬁne	prep_to	10	SENT_234	[p16l472t2104r624b2153],
14	the	DT	O	the	det	16	SENT_234	[p16l640t2104r721b2153],
15	risk	NN	O	risk	nn	16	SENT_234	[p16l737t2104r836b2153],
16	estimates	NNS	O	estimate	dep	13	SENT_234	[p16l851t2108r1109b2153],
17	.	.	O	.	_	0	SENT_234	[p16l851t2108r1109b2153],

1	In	IN	O	in	_	0	SENT_235	[p16l1131t2109r1186b2152],
2	our	PRP$	O	we	poss	3	SENT_235	[p16l1203t2122r1292b2153],
3	analysis	NN	O	analysis	prep_in	17	SENT_235	[p16l1307t2104r1525b2168],
4	,	,	O	,	_	0	SENT_235	[p16l1307t2104r1525b2168],
5	2677G	NN	O	2677g	nsubj	17	SENT_235	[p16l10t2185r331b2245],
6	—	CD	NUMBER	—	num	8	SENT_235	[p16l10t2185r331b2245],
7	>	JJR	O	>	amod	8	SENT_235	[p16l10t2185r331b2245],
8	T/A	NN	O	t/a	dep	5	SENT_235	[p16l10t2185r331b2245],
9	and	CC	O	and	_	0	SENT_235	[p16l384t2182r480b2231],
10	1236C	NN	O	1236c	nsubj	17	SENT_235	[p16l535t2185r794b2231],
11	—	CD	NUMBER	—	num	10	SENT_235	[p16l535t2185r794b2231],
12	>	JJR	O	>	amod	14	SENT_235	[p16l535t2185r794b2231],
13	T	NN	O	t	nn	14	SENT_235	[p16l535t2185r794b2231],
14	genotypes	NNS	O	genotype	dep	10	SENT_235	[p16l847t2192r1105b2246],
15	did	VBD	O	do	aux	17	SENT_235	[p16l1161t2182r1244b2231],
16	not	RB	O	not	neg	17	SENT_235	[p16l1296t2192r1382b2231],
17	add	VB	O	add	_	0	SENT_235	[p16l1435t2182r1528b2231],
18	additional	JJ	O	additional	amod	20	SENT_235	[p16l9t2260r267b2308],
19	signiﬁcant	JJ	O	signiﬁcant	amod	20	SENT_235	[p16l304t2260r577b2324],
20	information	NN	O	information	dobj	17	SENT_235	[p16l610t2260r937b2308],
21	.	.	O	.	_	0	SENT_235	[p16l610t2260r937b2308],

1	Nonetheless	RB	O	nonetheless	advmod	10	SENT_236	[p16l976t2260r1307b2316],
2	,	,	O	,	_	0	SENT_236	[p16l976t2260r1307b2316],
3	further	JJ	O	further	amod	7	SENT_236	[p16l1344t2260r1529b2308],
4	basic	JJ	O	basic	amod	7	SENT_236	[p16l7t2338r139b2387],
5	genetic	JJ	O	genetic	amod	7	SENT_236	[p16l170t2342r356b2402],
6	pharmacology	NN	O	pharmacology	nn	7	SENT_236	[p16l386t2338r756b2402],
7	studies	NNS	O	study	nsubj	10	SENT_236	[p16l788t2338r968b2387],
8	could	MD	O	could	aux	10	SENT_236	[p16l1001t2338r1143b2387],
9	be	VB	O	be	cop	10	SENT_236	[p16l1172t2338r1233b2387],
10	helpful	JJ	O	helpful	_	0	SENT_236	[p16l1263t2338r1449b2402],
11	to	TO	O	to	_	0	SENT_236	[p16l1478t2348r1527b2387],
12	further	JJ	O	further	amod	13	SENT_236	[p16l8t2416r193b2465],
13	deﬁne	NN	O	deﬁne	prep_to	10	SENT_236	[p16l219t2416r380b2465],
14	the	DT	O	the	det	18	SENT_236	[p16l406t2416r488b2465],
15	actual	JJ	O	actual	amod	16	SENT_236	[p16l515t2416r668b2465],
16	functional	JJ	O	functional	amod	18	SENT_236	[p16l694t2416r960b2465],
17	ABCB1	NN	O	abcb1	nn	18	SENT_236	[p16l985t2419r1174b2465],
18	variants	NNS	O	variant	dep	13	SENT_236	[p16l1198t2419r1402b2465],
19	and	CC	O	and	_	0	SENT_236	[p16l1432t2416r1528b2465],
20	the	DT	O	the	det	24	SENT_236	[p16l7t2494r89b2542],
21	most	RBS	O	most	advmod	22	SENT_236	[p16l134t2504r265b2542],
22	appropriate	JJ	O	appropriate	amod	24	SENT_236	[p16l309t2497r607b2557],
23	genetic	JJ	O	genetic	amod	24	SENT_236	[p16l653t2497r839b2558],
24	model	NN	O	model	conj_and	13	SENT_236	[p16l883t2494r1047b2542],
25	with	IN	O	with	_	0	SENT_236	[p16l1090t2494r1206b2542],
26	respect	NN	O	respect	prep_with	24	SENT_236	[p16l1250t2504r1436b2557],
27	to	TO	O	to	_	0	SENT_236	[p16l1478t2504r1527b2542],
28	response	NN	O	response	prep_to	10	SENT_236	[p16l8t2590r241b2636],
29	to	TO	O	to	_	0	SENT_236	[p16l257t2582r306b2621],
30	clopidogrel	NN	O	clopidogrel	prep_to	10	SENT_236	[p16l324t2572r624b2636],
31	.	.	O	.	_	0	SENT_236	[p16l324t2572r624b2636],

1	In	IN	O	in	_	0	SENT_237	[p16l61t2655r117b2698],
2	our	PRP$	O	we	poss	3	SENT_237	[p16l137t2668r228b2699],
3	study	NN	O	study	prep_in	19	SENT_237	[p16l248t2650r397b2714],
4	,	,	O	,	_	0	SENT_237	[p16l248t2650r397b2714],
5	assessment	NN	O	assessment	nsubj	19	SENT_237	[p16l419t2660r726b2699],
6	of	IN	O	of	_	0	SENT_237	[p16l745t2650r804b2699],
7	the	DT	O	the	det	8	SENT_237	[p16l813t2650r896b2699],
8	contribution	NN	O	contribution	prep_of	5	SENT_237	[p16l916t2650r1249b2699],
9	of	IN	O	of	_	0	SENT_237	[p16l1269t2650r1328b2699],
10	AB	NNP	O	AB	nn	12	SENT_237	[p16l1337t2654r1419b2698],
11	CB1	NN	O	cb1	nn	12	SENT_237	[p16l1426t2654r1529b2699],
12	variants	NNS	O	variant	prep_of	8	SENT_237	[p16l7t2732r216b2777],
13	in	IN	O	in	_	0	SENT_237	[p16l239t2732r292b2777],
14	the	DT	O	the	det	15	SENT_237	[p16l312t2729r395b2777],
15	context	NN	O	context	prep_in	12	SENT_237	[p16l418t2738r609b2777],
16	of	IN	O	of	_	0	SENT_237	[p16l629t2729r689b2777],
17	C	NN	O	c	nn	18	SENT_237	[p16l705t2732r744b2777],
18	YP2C19	NN	O	yp2c19	prep_of	15	SENT_237	[p16l748t2732r953b2778],
19	showed	VBD	O	show	_	0	SENT_237	[p16l974t2729r1175b2777],
20	that	IN	O	that	complm	26	SENT_237	[p16l1194t2729r1297b2777],
21	variants	NNS	O	variant	nsubj	26	SENT_237	[p16l1316t2732r1526b2777],
22	in	IN	O	in	_	0	SENT_237	[p16l8t2810r61b2854],
23	the	DT	O	the	det	25	SENT_237	[p16l95t2806r178b2855],
24	two	CD	NUMBER	two	num	25	SENT_237	[p16l212t2816r306b2855],
25	genes	NNS	O	gene	prep_in	21	SENT_237	[p16l342t2824r493b2870],
26	offered	VBD	O	offer	ccomp	19	SENT_237	[p16l530t2806r718b2855],
27	complementary	JJ	O	complementary	amod	28	SENT_237	[p16l752t2806r1172b2870],
28	information	NN	O	information	dobj	26	SENT_237	[p16l1205t2806r1528b2855],
29	about	IN	O	about	_	0	SENT_237	[p16l9t2883r158b2931],
30	cardiovascular	JJ	O	cardiovascular	amod	31	SENT_237	[p16l176t2883r558b2931],
31	risk	NN	O	risk	prep_about	26	SENT_237	[p16l576t2883r688b2931],
32	.	.	O	.	_	0	SENT_237	[p16l576t2883r688b2931],

1	When	WRB	O	when	advmod	3	SENT_238	[p16l709t2883r871b2932],
2	we	PRP	O	we	nsubj	3	SENT_238	[p16l888t2900r961b2932],
3	divided	VBD	O	divide	advcl	40	SENT_238	[p16l981t2883r1175b2932],
4	patients	NNS	O	patient	dobj	3	SENT_238	[p16l1193t2886r1402b2946],
5	into	IN	O	into	_	0	SENT_238	[p16l1423t2886r1527b2931],
6	four	CD	NUMBER	four	num	7	SENT_238	[p16l8t2962r120b3010],
7	groups	NNS	O	group	prep_into	3	SENT_238	[p16l162t2979r344b3026],
8	on	IN	O	on	_	0	SENT_238	[p16l388t2979r455b3010],
9	the	DT	O	the	det	10	SENT_238	[p16l496t2962r579b3010],
10	basis	NN	O	basis	prep_on	3	SENT_238	[p16l620t2962r752b3010],
11	of	IN	O	of	_	0	SENT_238	[p16l797t2962r856b3010],
12	ABCB1	NN	O	abcb1	nn	13	SENT_238	[p16l888t2965r1080b3010],
13	3435C	NN	O	3435c	prep_of	10	SENT_238	[p16l1124t2965r1388b3010],
14	—	CD	NUMBER	—	num	16	SENT_238	[p16l1124t2965r1388b3010],
15	>	JJR	O	>	amod	16	SENT_238	[p16l1124t2965r1388b3010],
16	T	NN	O	t	dep	13	SENT_238	[p16l1124t2965r1388b3010],
17	and	CC	O	and	_	0	SENT_238	[p16l1430t2962r1528b3010],
18	CYPZCI9	NN	O	cypzci9	nn	21	SENT_238	[p16l13t3042r261b3087],
19	reduced-function	NN	O	reduced-function	nn	21	SENT_238	[p16l323t3038r782b3086],
20	allele	NN	O	allele	nn	21	SENT_238	[p16l847t3038r983b3086],
21	status	NN	O	status	prep_of	10	SENT_238	[p16l1051t3048r1218b3094],
22	,	,	O	,	_	0	SENT_238	[p16l1051t3048r1218b3094],
23	rates	NNS	O	rate	nsubj	40	SENT_238	[p16l1285t3048r1410b3086],
24	of	IN	O	of	_	0	SENT_238	[p16l1478t3038r1537b3086],
25	cardiovascular	JJ	O	cardiovascular	amod	26	SENT_238	[p16l9t3116r391b3165],
26	death	NN	O	death	prep_of	23	SENT_238	[p16l428t3116r587b3172],
27	,	,	O	,	_	0	SENT_238	[p16l428t3116r587b3172],
28	myocardial	JJ	O	myocardial	amod	29	SENT_238	[p16l627t3116r921b3180],
29	infarction	NN	O	infarction	conj_or	26	SENT_238	[p16l959t3116r1234b3172],
30	,	,	O	,	_	0	SENT_238	[p16l959t3116r1234b3172],
31	or	CC	O	or	_	0	SENT_238	[p16l1274t3134r1329b3165],
32	stroke	NN	O	stroke	prep_of	23	SENT_238	[p16l1367t3116r1527b3165],
33	until	IN	O	until	_	0	SENT_238	[p16l7t3195r134b3243],
34	15	CD	DURATION	15	num	35	SENT_238	[p16l161t3198r212b3243],
35	months	NNS	NUMBER	month	prep_until	32	SENT_238	[p16l240t3195r444b3243],
36	were	VBD	O	be	cop	40	SENT_238	[p16l470t3212r597b3243],
37	nearly	RB	O	nearly	advmod	38	SENT_238	[p16l623t3195r787b3258],
38	twice	RB	O	twice	advmod	40	SENT_238	[p16l810t3198r947b3243],
39	as	RB	O	as	advmod	40	SENT_238	[p16l974t3212r1025b3243],
40	high	JJ	O	high	_	0	SENT_238	[p16l1052t3195r1174b3259],
41	in	IN	O	in	_	0	SENT_238	[p16l1199t3198r1252b3242],
42	the	DT	O	the	det	44	SENT_238	[p16l1276t3195r1359b3243],
43	study	NN	O	study	nn	44	SENT_238	[p16l1387t3195r1529b3258],
44	population	NN	O	population	prep_in	40	SENT_238	[p16l8t3271r296b3334],
45	who	WP	O	who	nsubj	48	SENT_238	[p16l339t3271r451b3320],
46	were	VBD	O	be	cop	48	SENT_238	[p16l495t3289r622b3320],
47	either	DT	O	either	dep	48	SENT_238	[p16l667t3271r822b3320],
48	carriers	NNS	O	carrier	rcmod	44	SENT_238	[p16l866t3274r1065b3320],
49	of	IN	O	of	_	0	SENT_238	[p16l1112t3271r1171b3320],
50	a	DT	O	a	det	53	SENT_238	[p16l1207t3289r1233b3320],
51	CYPZCI9	NN	O	cypzci9	nn	53	SENT_238	[p16l1282t3275r1530b3320],
52	reduced-function	NN	O	reduced-function	nn	53	SENT_238	[p16l8t3349r467b3397],
53	allele	NN	O	allele	prep_of	48	SENT_238	[p16l493t3349r643b3405],
54	,	,	O	,	_	0	SENT_238	[p16l493t3349r643b3405],
55	3435	CD	NUMBER	3435	num	57	SENT_238	[p16l673t3352r790b3397],
56	TT	NN	O	tt	nn	57	SENT_238	[p16l817t3352r894b3397],
57	homozygotes	NNS	O	homozygote	conj_or	53	SENT_238	[p16l917t3349r1286b3413],
58	,	,	O	,	_	0	SENT_238	[p16l917t3349r1286b3413],
59	or	CC	O	or	_	0	SENT_238	[p16l1314t3366r1368b3397],
60	both	DT	O	both	conj_or	53	SENT_238	[p16l1391t3349r1525b3405],
61	,	,	O	,	_	0	SENT_238	[p16l1391t3349r1525b3405],
62	compared	VBN	O	compare	_	0	SENT_238	[p16l9t3427r274b3490],
63	with	IN	O	with	prepc_compared_with	40	SENT_238	[p16l310t3427r428b3475],
64	individuals	NNS	O	individual	pobj	40	SENT_238	[p16l465t3427r759b3475],
65	who	WP	O	who	nsubj	68	SENT_238	[p16l797t3427r909b3475],
66	did	VBD	O	do	aux	68	SENT_238	[p16l948t3427r1032b3475],
67	not	RB	O	not	neg	68	SENT_238	[p16l1069t3436r1157b3475],
68	carry	VB	O	carry	rcmod	64	SENT_238	[p16l1194t3444r1326b3490],
69	either	CC	O	either	advmod	68	SENT_238	[p16l1363t3427r1525b3475],
70	.	.	O	.	_	0	SENT_238	[p16l1363t3427r1525b3475],

1	Moreover	RB	O	moreover	advmod	33	SENT_239	[p16l10t3508r270b3559],
2	,	,	O	,	_	0	SENT_239	[p16l10t3508r270b3559],
3	when	WRB	O	when	advmod	9	SENT_239	[p16l297t3503r445b3551],
4	both	CC	O	both	preconj	5	SENT_239	[p16l469t3503r590b3551],
5	ABCB1	NN	O	abcb1	nsubjpass	9	SENT_239	[p16l614t3507r806b3551],
6	and	CC	O	and	_	0	SENT_239	[p16l832t3503r930b3551],
7	CYPZCI9	NN	O	cypzci9	conj_and	5	SENT_239	[p16l960t3507r1208b3552],
8	were	VBD	O	be	auxpass	9	SENT_239	[p16l1229t3521r1356b3551],
9	taken	VBN	O	take	advcl	33	SENT_239	[p16l1381t3503r1528b3551],
10	into	IN	O	into	_	0	SENT_239	[p17l8t20r112b65],
11	account	NN	O	account	prep_into	9	SENT_239	[p17l132t26r352b73],
12	,	,	O	,	_	0	SENT_239	[p17l132t26r352b73],
13	in	IN	O	in	_	0	SENT_239	[p17l373t20r426b65],
14	this	DT	O	this	det	15	SENT_239	[p17l444t17r542b65],
15	population	NN	O	population	prep_in	9	SENT_239	[p17l562t17r851b80],
16	of	IN	O	of	_	0	SENT_239	[p17l870t17r930b65],
17	patients	NNS	O	patient	prep_of	15	SENT_239	[p17l939t20r1149b80],
18	with	IN	O	with	_	0	SENT_239	[p17l1168t17r1286b65],
19	an	DT	O	a	det	22	SENT_239	[p17l1306t34r1369b65],
20	acute	JJ	O	acute	amod	22	SENT_239	[p17l1389t27r1527b65],
21	coronary	JJ	O	coronary	amod	22	SENT_239	[p17l9t113r242b159],
22	syndrome	NN	O	syndrome	prep_with	17	SENT_239	[p17l271t95r536b159],
23	undergoing	VBG	O	undergo	partmod	22	SENT_239	[p17l564t95r877b159],
24	percutaneous	JJ	O	percutaneous	amod	26	SENT_239	[p17l905t105r1264b159],
25	coronary	JJ	O	coronary	amod	26	SENT_239	[p17l1295t113r1529b159],
26	intervention	NN	O	intervention	dobj	23	SENT_239	[p17l8t176r349b229],
27	,	,	O	,	_	0	SENT_239	[p17l8t176r349b229],
28	nearly	RB	O	nearly	quantmod	29	SENT_239	[p17l391t173r556b237],
29	half	NN	O	half	nsubj	33	SENT_239	[p17l593t173r704b222],
30	of	IN	O	of	_	0	SENT_239	[p17l736t173r795b222],
31	the	DT	O	the	det	32	SENT_239	[p17l825t173r908b222],
32	population	NN	O	population	prep_of	29	SENT_239	[p17l948t173r1237b236],
33	carried	VBD	O	carry	_	0	SENT_239	[p17l1277t173r1462b222],
34	a	DT	O	a	det	35	SENT_239	[p17l1501t191r1528b222],
35	genotype	NN	O	genotype	dobj	33	SENT_239	[p17l9t261r248b315],
36	associated	VBN	O	associate	partmod	35	SENT_239	[p17l268t251r539b299],
37	with	IN	O	with	_	0	SENT_239	[p17l555t251r673b299],
38	increased	VBN	O	increase	amod	39	SENT_239	[p17l692t251r947b299],
39	risk	NN	O	risk	prep_with	36	SENT_239	[p17l964t251r1065b299],
40	of	IN	O	of	_	0	SENT_239	[p17l1083t251r1142b299],
41	major	JJ	O	major	amod	44	SENT_239	[p17l1152t254r1310b315],
42	adverse	JJ	O	adverse	amod	44	SENT_239	[p17l1329t251r1527b299],
43	cardiovascular	JJ	O	cardiovascular	amod	44	SENT_239	[p17l9t329r391b378],
44	events	NNS	O	event	prep_of	39	SENT_239	[p17l427t339r592b378],
45	during	IN	O	during	_	0	SENT_239	[p17l631t329r810b393],
46	treatment	NN	O	treatment	prep_during	33	SENT_239	[p17l845t339r1109b378],
47	with	IN	O	with	_	0	SENT_239	[p17l1142t329r1260b378],
48	standard	JJ	O	standard	amod	49	SENT_239	[p17l1298t329r1528b378],
49	doses	NNS	O	dose	prep_with	33	SENT_239	[p17l9t407r154b456],
50	of	IN	O	of	_	0	SENT_239	[p17l174t407r234b456],
51	clopidogrel	NN	O	clopidogrel	prep_of	49	SENT_239	[p17l243t407r552b471],
52	.	.	O	.	_	0	SENT_239	[p17l243t407r552b471],

1	In	IN	O	in	_	0	SENT_240	[p17l61t490r117b533],
2	patients	NNS	O	patient	pobj	1	SENT_240	[p17l157t488r366b548],
3	taking	VBG	O	take	partmod	2	SENT_240	[p17l407t485r575b549],
4	prasugrel	NN	O	prasugrel	dobj	3	SENT_240	[p17l614t485r867b549],
5	in	IN	O	in	_	0	SENT_240	[p17l906t488r960b533],
6	TRITON	NNP	ORGANIZATION	TRITON	prep_in	4	SENT_240	[p17l998t488r1407b533],
7	.	.	O	.	_	0	SENT_240	[p17l998t488r1407b533],

1	—	NN	O	—	_	0	SENT_241	[p17l998t488r1407b533],
2	.	.	O	.	_	0	SENT_241	[p17l998t488r1407b533],

1	TIMI	NNP	ORGANIZATION	TIMI	_	0	SENT_242	[p17l998t488r1407b533],
2	38	CD	NUMBER	38	num	1	SENT_242	[p17l1453t489r1525b541],
3	,	,	O	,	_	0	SENT_242	[p17l1453t489r1525b541],
4	ABCB1	NN	O	abcb1	nn	5	SENT_242	[p17l7t567r199b612],
5	3435C	NN	O	3435c	appos	1	SENT_242	[p17l221t566r486b612],
6	—	CD	NUMBER	—	num	9	SENT_242	[p17l221t566r486b612],
7	>	JJR	O	>	amod	9	SENT_242	[p17l221t566r486b612],
8	T	NN	O	t	nn	9	SENT_242	[p17l221t566r486b612],
9	polymorphisms	NNS	O	polymorphism	nsubjpass	13	SENT_242	[p17l505t563r926b627],
10	were	VBD	O	be	auxpass	13	SENT_242	[p17l946t581r1073b612],
11	not	RB	O	not	neg	13	SENT_242	[p17l1095t573r1182b612],
12	signiﬁcantly	RB	O	signiﬁcantly	advmod	13	SENT_242	[p17l1203t563r1529b627],
13	associated	VBN	O	associate	rcmod	5	SENT_242	[p17l9t640r279b688],
14	with	IN	O	with	_	0	SENT_242	[p17l312t640r430b688],
15	cardiovascular	JJ	O	cardiovascular	amod	16	SENT_242	[p17l466t640r848b688],
16	outcomes	NNS	O	outcome	prep_with	13	SENT_242	[p17l883t650r1154b688],
17	.	.	O	.	_	0	SENT_242	[p17l883t650r1154b688],

1	Likewise	RB	O	likewise	_	0	SENT_243	[p17l1195t640r1437b695],
2	,	,	O	,	_	0	SENT_243	[p17l1195t640r1437b695],
3	in	IN	O	in	dep	1	SENT_243	[p17l1474t643r1528b687],

1	Articles	NNPS	O	Articles	tmod	20	SENT_244	[p17l101t1098r251b1134],
2	healthy	JJ	O	healthy	amod	3	SENT_244	[p17l643t1340r838b1403],
3	participants	NNS	O	participant	dep	1	SENT_244	[p17l896t1343r1221b1403],
4	,	,	O	,	_	0	SENT_244	[p17l896t1343r1221b1403],
5	no	DT	O	no	det	6	SENT_244	[p17l1283t1357r1349b1388],
6	associations	NNS	O	association	nsubjpass	20	SENT_244	[p17l1411t1344r1726b1388],
7	between	IN	O	between	_	0	SENT_244	[p17l1787t1340r2008b1388],
8	the	DT	O	the	det	13	SENT_244	[p17l2066t1340r2148b1388],
9	3435C	NN	O	3435c	npadvmod	11	SENT_244	[p17l647t1419r909b1465],
10	—	CD	NUMBER	—	num	9	SENT_244	[p17l647t1419r909b1465],
11	>	JJR	O	>	amod	13	SENT_244	[p17l647t1419r909b1465],
12	T	NN	O	t	nn	13	SENT_244	[p17l647t1419r909b1465],
13	variant	NN	O	variant	prep_between	6	SENT_244	[p17l946t1419r1130b1464],
14	and	CC	O	and	_	0	SENT_244	[p17l1169t1416r1266b1464],
15	pharmacokinetic	JJ	O	pharmacokinetic	amod	18	SENT_244	[p17l1305t1416r1750b1479],
16	and	CC	O	and	_	0	SENT_244	[p17l1790t1416r1887b1465],
17	pharmacodynamic	JJ	O	pharmacodynamic	conj_and	15	SENT_244	[p17l1926t1416r2148b1479, p17l645t1494r930b1556],
18	outcomes	NNS	O	outcome	conj_and	13	SENT_244	[p17l970t1503r1224b1541],
19	were	VBD	O	be	auxpass	20	SENT_244	[p17l1263t1511r1389b1541],
20	seen	VBN	O	see	_	0	SENT_244	[p17l1431t1511r1549b1541],
21	with	IN	O	with	_	0	SENT_244	[p17l1587t1494r1704b1541],
22	prasugrel	NN	O	prasugrel	prep_with	20	SENT_244	[p17l1743t1494r2005b1557],
23	.	.	O	.	_	0	SENT_244	[p17l1743t1494r2005b1557],

1	The	DT	O	the	det	3	SENT_245	[p17l2047t1494r2148b1541],
2	rapid	JJ	O	rapid	amod	3	SENT_245	[p17l644t1569r781b1631],
3	metabolism	NN	O	metabolism	nsubj	7	SENT_245	[p17l796t1569r1110b1617],
4	of	IN	O	of	_	0	SENT_245	[p17l1125t1569r1184b1617],
5	prasugrel	NN	O	prasugrel	prep_of	3	SENT_245	[p17l1190t1569r1440b1632],
6	might	MD	O	might	aux	7	SENT_245	[p17l1456t1569r1615b1632],
7	mitigate	VB	O	mitigate	_	0	SENT_245	[p17l1629t1572r1846b1632],
8	the	DT	O	the	det	10	SENT_245	[p17l1861t1569r1944b1617],
9	genetic	JJ	O	genetic	amod	10	SENT_245	[p17l1961t1572r2149b1632],
10	effect	NN	O	effect	dobj	7	SENT_245	[p17l645t1645r788b1693],
11	of	IN	O	of	_	0	SENT_245	[p17l807t1645r865b1692],
12	AB	NNP	O	AB	nn	13	SENT_245	[p17l875t1648r956b1692],
13	CB1	NN	O	cb1	prep_of	10	SENT_245	[p17l963t1648r1065b1693],
14	343	CD	NUMBER	343	num	15	SENT_245	[p17l1086t1649r1170b1693],
15	5C	NN	O	5c	dep	13	SENT_245	[p17l1178t1648r1348b1693],
16	—	CD	NUMBER	—	num	19	SENT_245	[p17l1178t1648r1348b1693],
17	>	JJR	O	>	amod	19	SENT_245	[p17l1178t1648r1348b1693],
18	T	NN	O	t	nn	19	SENT_245	[p17l1178t1648r1348b1693],
19	polymorphisms	NNS	O	polymorphism	dep	15	SENT_245	[p17l1366t1645r1798b1708],
20	,	,	O	,	_	0	SENT_245	[p17l1366t1645r1798b1708],
21	even	RB	O	even	advmod	26	SENT_245	[p17l1820t1662r1941b1693],
22	though	IN	O	though	dep	26	SENT_245	[p17l1959t1645r2149b1708],
23	the	DT	O	the	det	24	SENT_245	[p17l643t1722r726b1769],
24	drug	NN	O	drug	nsubj	26	SENT_245	[p17l747t1722r870b1785],
25	is	VBZ	O	be	cop	26	SENT_245	[p17l890t1725r931b1769],
26	subject	JJ	O	subject	dep	7	SENT_245	[p17l954t1722r1140b1785],
27	to	TO	O	to	_	0	SENT_245	[p17l1158t1731r1207b1769],
28	the	DT	O	the	det	30	SENT_245	[p17l1227t1722r1309b1769],
29	P-glycoprotein	NN	MISC	p-glycoprotein	nn	30	SENT_245	[p17l1333t1722r1712b1785],
30	system	NN	O	system	prep_to	26	SENT_245	[p17l1734t1731r1929b1784],
31	.	.	O	.	_	0	SENT_245	[p17l1734t1731r1929b1784],

1	Among	IN	O	among	_	0	SENT_246	[p17l1951t1725r2149b1785],
2	participants	NNS	O	participant	prep_among	8	SENT_246	[p17l644t1800r955b1859],
3	treated	VBN	O	treat	partmod	2	SENT_246	[p17l991t1797r1174b1845],
4	with	IN	O	with	_	0	SENT_246	[p17l1207t1797r1324b1845],
5	prasugrel	NN	O	prasugrel	prep_with	3	SENT_246	[p17l1359t1797r1623b1860],
6	,	,	O	,	_	0	SENT_246	[p17l1359t1797r1623b1860],
7	there	EX	O	there	expl	8	SENT_246	[p17l1660t1797r1795b1845],
8	was	VBD	O	be	_	0	SENT_246	[p17l1830t1814r1928b1845],
9	a	DT	O	a	det	11	SENT_246	[p17l1966t1814r1992b1845],
10	nonsigniﬁcant	JJ	O	nonsigniﬁcant	amod	11	SENT_246	[p17l2028t1814r2147b1845, p17l646t1873r923b1936],
11	trend	NN	O	trend	nsubj	8	SENT_246	[p17l948t1873r1090b1921],
12	towards	IN	O	towards	_	0	SENT_246	[p17l1115t1873r1321b1921],
13	2677	CD	DATE	2677	num	15	SENT_246	[p17l1352t1876r1466b1922],
14	TT	NN	O	tt	nn	15	SENT_246	[p17l1491t1876r1568b1920],
15	homozygotes	NNS	O	homozygote	prep_towards	11	SENT_246	[p17l1593t1873r1943b1936],
16	having	VBG	O	have	partmod	15	SENT_246	[p17l1970t1873r2149b1936],
17	higher	JJR	O	higher	amod	18	SENT_246	[p17l643t1949r818b2012],
18	rates	NNS	O	rate	dobj	16	SENT_246	[p17l842t1959r966b1997],
19	of	IN	O	of	_	0	SENT_246	[p17l994t1949r1052b1997],
20	adverse	JJ	O	adverse	amod	22	SENT_246	[p17l1069t1949r1265b1997],
21	cardiovascular	JJ	O	cardiovascular	amod	22	SENT_246	[p17l1292t1949r1670b1997],
22	events	NNS	O	event	prep_of	18	SENT_246	[p17l1695t1959r1859b1997],
23	compared	VBN	O	compare	_	0	SENT_246	[p17l1887t1949r2150b2012],
24	with	IN	O	with	prepc_compared_with	22	SENT_246	[p17l643t2025r760b2074],
25	the	DT	O	the	det	26	SENT_246	[p17l780t2025r862b2074],
26	rest	NN	O	rest	pobj	22	SENT_246	[p17l884t2035r982b2074],
27	of	IN	O	of	_	0	SENT_246	[p17l1003t2025r1062b2074],
28	the	DT	O	the	det	29	SENT_246	[p17l1073t2025r1155b2074],
29	population	NN	O	population	prep_of	26	SENT_246	[p17l1177t2025r1476b2088],
30	.	.	O	.	_	0	SENT_246	[p17l1177t2025r1476b2088],

1	No	DT	O	no	det	2	SENT_247	[p17l1502t2030r1574b2074],
2	association	NN	O	association	nsubjpass	4	SENT_247	[p17l1597t2028r1888b2074],
3	was	VBD	O	be	auxpass	4	SENT_247	[p17l1908t2042r2006b2074],
4	seen	VBN	O	see	_	0	SENT_247	[p17l2031t2042r2149b2074],
5	with	IN	O	with	_	0	SENT_247	[p17l643t2102r760b2150],
6	2677G	NN	O	2677g	prep_with	4	SENT_247	[p17l786t2105r1109b2164],
7	—	CD	NUMBER	—	num	9	SENT_247	[p17l786t2105r1109b2164],
8	>	JJR	O	>	amod	9	SENT_247	[p17l786t2105r1109b2164],
9	T/A	NN	O	t/a	tmod	4	SENT_247	[p17l786t2105r1109b2164],
10	and	CC	O	and	_	0	SENT_247	[p17l1134t2102r1231b2150],
11	the	DT	O	the	det	13	SENT_247	[p17l1255t2102r1337b2150],
12	pharmacological	JJ	O	pharmacological	amod	13	SENT_247	[p17l1362t2102r1800b2165],
13	data	NNS	O	datum	conj_and	9	SENT_247	[p17l1825t2102r1946b2150],
14	.	.	O	.	_	0	SENT_247	[p17l1825t2102r1946b2150],

1	Future	JJ	DATE	future	amod	2	SENT_248	[p17l1976t2105r2148b2150],
2	studies	NNS	O	study	nsubj	4	SENT_248	[p17l646t2178r829b2226],
3	will	MD	O	will	aux	4	SENT_248	[p17l876t2178r972b2226],
4	assist	VB	O	assist	_	0	SENT_248	[p17l1019t2181r1163b2226],
5	in	IN	O	in	_	0	SENT_248	[p17l1208t2181r1261b2225],
6	further	JJ	O	further	amod	7	SENT_248	[p17l1307t2178r1494b2226],
7	examination	NN	O	examination	prep_in	4	SENT_248	[p17l1540t2181r1868b2226],
8	of	IN	O	of	_	0	SENT_248	[p17l1915t2178r1974b2226],
9	these	DT	O	these	det	11	SENT_248	[p17l2010t2178r2148b2226],
10	exploratory	JJ	O	exploratory	amod	11	SENT_248	[p17l645t2254r939b2317],
11	ﬁndings	NNS	O	ﬁndings	prep_of	7	SENT_248	[p17l956t2254r1187b2317],
12	.	.	O	.	_	0	SENT_248	[p17l956t2254r1187b2317],

1	There	EX	O	there	expl	2	SENT_249	[p17l693t2330r844b2378],
2	are	VBP	O	be	_	0	SENT_249	[p17l869t2347r946b2378],
3	several	JJ	O	several	amod	4	SENT_249	[p17l972t2330r1146b2378],
4	limitations	NNS	O	limitation	nsubj	2	SENT_249	[p17l1169t2330r1447b2378],
5	to	TO	O	to	_	0	SENT_249	[p17l1471t2339r1519b2378],
6	this	DT	O	this	det	7	SENT_249	[p17l1542t2330r1636b2378],
7	analysis	NN	O	analysis	prep_to	4	SENT_249	[p17l1662t2330r1877b2393],
8	.	.	O	.	_	0	SENT_249	[p17l1662t2330r1877b2393],

1	First	RB	ORDINAL	first	advmod	7	SENT_250	[p17l1906t2333r2032b2385],
2	,	,	O	,	_	0	SENT_250	[p17l1906t2333r2032b2385],
3	few	JJ	O	few	amod	5	SENT_250	[p17l2058t2330r2150b2378],
4	non-Caucasian	JJ	MISC	non-caucasian	amod	5	SENT_250	[p17l644t2411r1028b2456],
5	individuals	NNS	O	individual	nsubjpass	7	SENT_250	[p17l1045t2407r1328b2456],
6	were	VBD	O	be	auxpass	7	SENT_250	[p17l1346t2425r1470b2456],
7	included	VBN	O	include	_	0	SENT_250	[p17l1488t2407r1713b2456],
8	in	IN	O	in	_	0	SENT_250	[p17l1730t2410r1781b2455],
9	these	DT	O	these	det	10	SENT_250	[p17l1798t2407r1933b2456],
10	studies	NNS	O	study	prep_in	7	SENT_250	[p17l1953t2407r2146b2463],
11	,	,	O	,	_	0	SENT_250	[p17l1953t2407r2146b2463],
12	and	CC	O	and	_	0	SENT_250	[p17l645t2484r741b2532],
13	future	JJ	DATE	future	amod	14	SENT_250	[p17l766t2484r925b2532],
14	investigations	NNS	O	investigation	nsubj	20	SENT_250	[p17l951t2487r1306b2547],
15	in	IN	O	in	_	0	SENT_250	[p17l1335t2487r1386b2531],
16	other	JJ	O	other	amod	17	SENT_250	[p17l1413t2484r1548b2532],
17	populations	NNS	O	population	prep_in	14	SENT_250	[p17l1573t2484r1877b2546],
18	would	MD	O	would	aux	20	SENT_250	[p17l1903t2484r2064b2532],
19	be	VB	O	be	cop	20	SENT_250	[p17l2088t2484r2148b2532],
20	useful	JJ	O	useful	conj_and	7	SENT_250	[p17l643t2561r816b2608],
21	.	.	O	.	_	0	SENT_250	[p17l643t2561r816b2608],

1	Second	RB	ORDINAL	second	advmod	24	SENT_251	[p17l848t2561r1044b2616],
2	,	,	O	,	_	0	SENT_251	[p17l848t2561r1044b2616],
3	because	IN	O	because	_	0	SENT_251	[p17l1070t2561r1274b2608],
4	of	IN	O	of	prepc_because_of	24	SENT_251	[p17l1301t2561r1359b2608],
5	the	DT	O	the	det	7	SENT_251	[p17l1374t2561r1454b2608],
6	sample	NN	O	sample	nn	7	SENT_251	[p17l1482t2561r1665b2623],
7	handling	NN	O	handling	pobj	24	SENT_251	[p17l1690t2561r1923b2624],
8	and	CC	O	and	_	0	SENT_251	[p17l1948t2561r2044b2608],
9	the	DT	O	the	det	10	SENT_251	[p17l2067t2561r2148b2608],
10	need	NN	O	need	pobj	24	SENT_251	[p17l644t2636r769b2685],
11	for	IN	O	for	_	0	SENT_251	[p17l798t2636r872b2685],
12	repeat	NN	O	repeat	nn	13	SENT_251	[p17l900t2646r1059b2699],
13	measurements	NNS	O	measurement	prep_for	10	SENT_251	[p17l1087t2646r1472b2685],
14	for	IN	O	for	_	0	SENT_251	[p17l1503t2636r1577b2685],
15	the	DT	O	the	det	19	SENT_251	[p17l1604t2636r1685b2685],
16	pharrnacokinetic	JJ	O	pharrnacokinetic	amod	19	SENT_251	[p17l1714t2636r2149b2699],
17	and	CC	O	and	_	0	SENT_251	[p17l645t2713r741b2761],
18	pharmacodynamic	JJ	O	pharmacodynamic	conj_and	16	SENT_251	[p17l764t2713r1247b2776],
19	assessments	NNS	O	assessment	prep_for	13	SENT_251	[p17l1272t2723r1606b2768],
20	,	,	O	,	_	0	SENT_251	[p17l1272t2723r1606b2768],
21	these	DT	O	these	det	22	SENT_251	[p17l1632t2713r1768b2761],
22	investigations	NNS	O	investigation	nsubjpass	24	SENT_251	[p17l1792t2716r2147b2776],
23	were	VBD	O	be	auxpass	24	SENT_251	[p17l643t2807r766b2838],
24	done	VBN	O	do	_	0	SENT_251	[p17l788t2790r914b2838],
25	in	IN	O	in	_	0	SENT_251	[p17l935t2793r986b2837],
26	healthy	JJ	O	healthy	amod	27	SENT_251	[p17l1006t2790r1195b2853],
27	individuals	NNS	O	individual	prep_in	24	SENT_251	[p17l1214t2790r1511b2845],
28	,	,	O	,	_	0	SENT_251	[p17l1214t2790r1511b2845],
29	not	RB	O	not	neg	24	SENT_251	[p17l1534t2799r1619b2838],
30	in	IN	O	in	_	0	SENT_251	[p17l1638t2793r1690b2837],
31	the	DT	O	the	det	36	SENT_251	[p17l1710t2790r1790b2838],
32	acute	JJ	O	acute	amod	36	SENT_251	[p17l1812t2799r1946b2838],
33	clinical	JJ	O	clinical	amod	36	SENT_251	[p17l1967t2790r2149b2838],
34	trial	NN	O	trial	nn	36	SENT_251	[p17l643t2866r746b2914],
35	study	NN	O	study	nn	36	SENT_251	[p17l782t2866r919b2929],
36	population	NN	O	population	prep_in	24	SENT_251	[p17l952t2866r1243b2928],
37	.	.	O	.	_	0	SENT_251	[p17l952t2866r1243b2928],

1	Third	NNP	ORDINAL	Third	nsubj	13	SENT_252	[p17l1279t2866r1437b2921],
2	,	,	O	,	_	0	SENT_252	[p17l1279t2866r1437b2921],
3	in	IN	O	in	_	0	SENT_252	[p17l1473t2869r1525b2913],
4	our	PRP$	O	we	poss	7	SENT_252	[p17l1560t2883r1649b2914],
5	clinical	JJ	O	clinical	amod	7	SENT_252	[p17l1682t2866r1864b2914],
6	outcomes	NNS	O	outcome	nn	7	SENT_252	[p17l1899t2876r2147b2914],
7	study	NN	O	study	prep_in	13	SENT_252	[p17l646t2942r790b3005],
8	,	,	O	,	_	0	SENT_252	[p17l646t2942r790b3005],
9	patients	NNS	O	patient	nsubj	13	SENT_252	[p17l813t2945r1015b3004],
10	treated	VBN	O	treat	partmod	9	SENT_252	[p17l1037t2942r1214b2990],
11	with	IN	O	with	_	0	SENT_252	[p17l1232t2942r1347b2990],
12	clopidogrel	NN	O	clopidogrel	prep_with	10	SENT_252	[p17l1368t2942r1653b3005],
13	received	VBD	O	receive	_	0	SENT_252	[p17l1674t2942r1885b2990],
14	a	DT	O	a	det	18	SENT_252	[p17l1906t2959r1932b2990],
15	300	CD	NUMBER	300	num	18	SENT_252	[p17l1955t2946r2043b2990],
16	mg	NN	O	mg	nn	18	SENT_252	[p17l2064t2959r2149b3005],
17	loading	NN	O	loading	nn	18	SENT_252	[p17l643t3019r836b3082],
18	dose	NN	O	dose	dobj	13	SENT_252	[p17l871t3019r987b3066],
19	and	CC	O	and	_	0	SENT_252	[p17l1022t3019r1118b3066],
20	75	CD	NUMBER	75	num	21	SENT_252	[p17l1151t3022r1205b3068],
21	mg	NN	O	mg	conj_and	18	SENT_252	[p17l1242t3036r1327b3082],
22	daily	JJ	SET	daily	amod	24	SENT_252	[p17l1362t3019r1482b3081],
23	maintenance	NN	O	maintenance	nn	24	SENT_252	[p17l1515t3022r1852b3066],
24	dose	NN	O	dose	dep	21	SENT_252	[p17l1887t3019r2016b3074],
25	,	,	O	,	_	0	SENT_252	[p17l1887t3019r2016b3074],
26	and	CC	O	and	_	0	SENT_252	[p17l2054t3019r2150b3066],
27	patients	NNS	O	patient	nsubj	31	SENT_252	[p17l644t3097r846b3156],
28	treated	VBN	O	treat	partmod	27	SENT_252	[p17l872t3094r1049b3142],
29	with	IN	O	with	_	0	SENT_252	[p17l1071t3094r1186b3142],
30	prasugrel	NN	O	prasugrel	prep_with	28	SENT_252	[p17l1210t3094r1454b3157],
31	received	VBD	O	receive	conj_and	13	SENT_252	[p17l1478t3094r1689b3142],
32	a	DT	O	a	det	36	SENT_252	[p17l1713t3111r1739b3142],
33	60	CD	NUMBER	60	num	36	SENT_252	[p17l1764t3098r1823b3142],
34	mg	NN	O	mg	nn	36	SENT_252	[p17l1848t3111r1933b3157],
35	loading	NN	O	loading	nn	36	SENT_252	[p17l1956t3094r2149b3157],
36	dose	NN	O	dose	dobj	31	SENT_252	[p17l645t3170r761b3218],
37	and	CC	O	and	_	0	SENT_252	[p17l802t3170r898b3218],
38	10	CD	NUMBER	10	num	39	SENT_252	[p17l938t3174r990b3218],
39	mg	NN	O	mg	dobj	31	SENT_252	[p17l1031t3187r1116b3233],
40	daily	JJ	SET	daily	amod	42	SENT_252	[p17l1156t3170r1277b3233],
41	maintenance	NN	O	maintenance	nn	42	SENT_252	[p17l1315t3173r1651b3218],
42	dose	NN	O	dose	dep	39	SENT_252	[p17l1692t3170r1821b3225],
43	;	:	O	;	_	0	SENT_252	[p17l1692t3170r1821b3225],
44	we	PRP	O	we	nsubj	47	SENT_252	[p17l1862t3187r1934b3218],
45	can	MD	O	can	aux	47	SENT_252	[p17l1975t3179r2150b3218],
46	not	RB	O	not	neg	47	SENT_252	[p17l1975t3179r2150b3218],
47	comment	VB	O	comment	parataxis	13	SENT_252	[p17l645t3256r895b3294],
48	on	IN	O	on	_	0	SENT_252	[p17l931t3264r997b3294],
49	the	DT	O	the	det	50	SENT_252	[p17l1033t3247r1113b3294],
50	effect	NN	O	effect	prep_on	47	SENT_252	[p17l1152t3247r1291b3294],
51	of	IN	O	of	_	0	SENT_252	[p17l1328t3247r1386b3294],
52	ABCB1	NN	O	abcb1	prep_of	50	SENT_252	[p17l1413t3250r1600b3294],
53	genetic	JJ	O	genetic	amod	54	SENT_252	[p17l1637t3250r1821b3310],
54	variants	NNS	O	variant	dobj	47	SENT_252	[p17l1856t3250r2058b3294],
55	in	IN	O	in	_	0	SENT_252	[p17l2097t3250r2149b3294],
56	patients	NNS	O	patient	prep_in	54	SENT_252	[p17l644t3325r846b3384],
57	receiving	VBG	O	receive	partmod	56	SENT_252	[p17l870t3325r1104b3385],
58	other	JJ	O	other	amod	59	SENT_252	[p17l1126t3322r1261b3370],
59	doses	NNS	O	dose	dobj	57	SENT_252	[p17l1282t3322r1423b3370],
60	of	IN	O	of	_	0	SENT_252	[p17l1447t3322r1505b3370],
61	these	DT	O	these	det	62	SENT_252	[p17l1516t3322r1651b3370],
62	drugs	NNS	O	drug	prep_of	59	SENT_252	[p17l1674t3322r1833b3385],
63	.	.	O	.	_	0	SENT_252	[p17l1674t3322r1833b3385],

1	Fourth	JJ	ORDINAL	fourth	advmod	12	SENT_253	[p17l1860t3322r2044b3377],
2	,	,	O	,	_	0	SENT_253	[p17l1860t3322r2044b3377],
3	the	DT	O	the	det	4	SENT_253	[p17l2067t3322r2148b3370],
4	number	NN	O	number	nsubj	12	SENT_253	[p17l644t3398r855b3446],
5	of	IN	O	of	_	0	SENT_253	[p17l890t3398r948b3446],
6	bleeding	NN	O	bleeding	nn	10	SENT_253	[p17l973t3398r1196b3461],
7	and	CC	O	and	_	0	SENT_253	[p17l1232t3398r1328b3446],
8	stent	NN	O	stent	nn	10	SENT_253	[p17l1365t3407r1489b3446],
9	thrombosis	NN	O	thrombosis	nn	10	SENT_253	[p17l1523t3398r1816b3446],
10	events	NNS	O	event	prep_of	4	SENT_253	[p17l1854t3407r2015b3446],
11	was	VBD	O	be	cop	12	SENT_253	[p17l2051t3415r2147b3446],
12	small	JJ	O	small	_	0	SENT_253	[p17l646t3474r797b3529],
13	,	,	O	,	_	0	SENT_253	[p17l646t3474r797b3529],
14	and	CC	O	and	_	0	SENT_253	[p17l823t3474r919b3522],
15	our	PRP$	O	we	poss	16	SENT_253	[p17l942t3491r1030b3522],
16	analysis	NN	O	analysis	nsubj	17	SENT_253	[p17l1053t3474r1254b3537],
17	had	VBD	O	have	conj_and	12	SENT_253	[p17l1277t3474r1374b3522],
18	restricted	JJ	O	restricted	amod	19	SENT_253	[p17l1396t3474r1638b3522],
19	power	NN	O	power	nsubj	21	SENT_253	[p17l1659t3491r1819b3537],
20	to	TO	O	to	aux	21	SENT_253	[p17l1840t3484r1888b3522],
21	detect	VB	O	detect	ccomp	17	SENT_253	[p17l1913t3474r2064b3522],
22	an	DT	O	a	det	23	SENT_253	[p17l2087t3491r2149b3522],
23	association	NN	O	association	dobj	21	SENT_253	[p17l645t3553r929b3598],
24	between	IN	O	between	_	0	SENT_253	[p17l950t3550r1166b3598],
25	the	DT	O	the	det	27	SENT_253	[p17l1187t3550r1268b3598],
26	tested	VBN	O	test	amod	27	SENT_253	[p17l1290t3550r1442b3598],
27	ABCB1	NN	O	abcb1	prep_between	23	SENT_253	[p17l1463t3554r1650b3598],
28	variants	NNS	O	variant	tmod	17	SENT_253	[p17l1670t3553r1872b3598],
29	and	CC	O	and	_	0	SENT_253	[p17l1897t3550r1992b3598],
30	these	DT	O	these	det	31	SENT_253	[p17l2013t3550r2148b3598],
31	outcomes	NNS	O	outcome	conj_and	28	SENT_253	[p17l645t3635r907b3674],
32	.	.	O	.	_	0	SENT_253	[p17l645t3635r907b3674],

1	Additional	JJ	O	additional	amod	2	SENT_254	[p17l949t3626r1219b3674],
2	studies	NNS	O	study	nsubj	11	SENT_254	[p17l1261t3626r1440b3674],
3	that	WDT	O	that	nsubj	4	SENT_254	[p17l1480t3626r1581b3674],
4	include	VBP	O	include	rcmod	2	SENT_254	[p17l1620t3626r1810b3674],
5	more	JJR	O	more	amod	7	SENT_254	[p17l1851t3643r1987b3674],
6	such	JJ	O	such	amod	7	SENT_254	[p17l2029t3626r2149b3674],
7	events	NNS	O	event	dobj	4	SENT_254	[p18l645t31r805b69],
8	will	MD	O	will	aux	11	SENT_254	[p18l831t21r925b69],
9	be	VB	O	be	cop	11	SENT_254	[p18l950t21r1009b69],
10	particularly	RB	O	particularly	advmod	11	SENT_254	[p18l1036t21r1328b84],
11	important	JJ	O	important	_	0	SENT_254	[p18l1353t25r1613b84],
12	to	TO	O	to	aux	14	SENT_254	[p18l1637t31r1685b69],
13	further	RB	O	further	advmod	14	SENT_254	[p18l1711t21r1894b69],
14	elucidate	VB	O	elucidate	xcomp	11	SENT_254	[p18l1920t21r2148b69],
15	the	DT	O	the	det	16	SENT_254	[p18l644t97r724b145],
16	relations	NNS	O	relation	dobj	14	SENT_254	[p18l778t97r999b145],
17	between	IN	O	between	_	0	SENT_254	[p18l1053t97r1269b145],
18	ABCB1	NN	O	abcb1	nn	20	SENT_254	[p18l1321t101r1508b145],
19	genetic	JJ	O	genetic	amod	20	SENT_254	[p18l1561t100r1745b160],
20	variants	NNS	O	variant	prep_between	16	SENT_254	[p18l1796t100r1998b145],
21	and	CC	O	and	_	0	SENT_254	[p18l2054t97r2150b145],
22	outcomes	NNS	O	outcome	prep_between	16	SENT_254	[p18l645t182r907b221],
23	.	.	O	.	_	0	SENT_254	[p18l645t182r907b221],

1	Finally	RB	O	finally	advmod	8	SENT_255	[p18l939t173r1117b236],
2	,	,	O	,	_	0	SENT_255	[p18l939t173r1117b236],
3	there	EX	O	there	expl	8	SENT_255	[p18l1145t173r1278b221],
4	might	MD	O	might	aux	8	SENT_255	[p18l1305t173r1462b236],
5	be	VB	O	be	cop	8	SENT_255	[p18l1486t173r1546b221],
6	other	JJ	O	other	amod	8	SENT_255	[p18l1574t173r1709b221],
7	genetic	JJ	O	genetic	amod	8	SENT_255	[p18l1736t176r1920b236],
8	variants	NNS	O	variant	_	0	SENT_255	[p18l1945t176r2147b221],
9	affecting	VBG	O	affect	partmod	8	SENT_255	[p18l645t250r868b312],
10	the	DT	O	the	det	11	SENT_255	[p18l934t249r1015b297],
11	association	NN	O	association	dobj	9	SENT_255	[p18l1083t252r1367b297],
12	between	IN	O	between	_	0	SENT_255	[p18l1433t249r1649b297],
13	treatment	NN	O	treatment	prep_between	11	SENT_255	[p18l1715t259r1970b297],
14	with	IN	O	with	_	0	SENT_255	[p18l2034t249r2149b297],
15	clopidogrel	NN	O	clopidogrel	nn	18	SENT_255	[p18l645t325r931b388],
16	and	CC	O	and	_	0	SENT_255	[p18l948t325r1044b373],
17	cardiovascular	JJ	O	cardiovascular	nn	18	SENT_255	[p18l1060t325r1429b373],
18	outcomes	NNS	O	outcome	prep_with	9	SENT_255	[p18l1445t335r1707b373],
19	.	.	O	.	_	0	SENT_255	[p18l1445t335r1707b373],

1	In	IN	O	in	_	0	SENT_256	[p18l697t407r752b449],
2	conclusion	NN	O	conclusion	prep_in	5	SENT_256	[p18l807t402r1107b457],
3	,	,	O	,	_	0	SENT_256	[p18l807t402r1107b457],
4	we	PRP	O	we	nsubj	5	SENT_256	[p18l1163t419r1235b450],
5	found	VBD	O	find	_	0	SENT_256	[p18l1290t402r1448b450],
6	that	IN	O	that	complm	11	SENT_256	[p18l1500t402r1603b450],
7	ABCB1	NN	O	abcb1	nsubj	11	SENT_256	[p18l1655t405r1845b450],
8	3435	CD	NUMBER	3435	num	10	SENT_256	[p18l1901t405r2017b450],
9	TT	NN	O	tt	nn	10	SENT_256	[p18l2073t405r2150b449],
10	homozygotes	NNS	O	homozygote	dep	7	SENT_256	[p18l643t478r993b541],
11	had	VBD	O	have	ccomp	5	SENT_256	[p18l1060t478r1158b526],
12	an	DT	O	a	det	14	SENT_256	[p18l1224t495r1287b526],
13	increased	VBN	O	increase	amod	14	SENT_256	[p18l1353t478r1605b526],
14	risk	NN	O	risk	dobj	11	SENT_256	[p18l1670t478r1770b526],
15	of	IN	O	of	_	0	SENT_256	[p18l1836t478r1894b526],
16	adverse	JJ	O	adverse	amod	18	SENT_256	[p18l1952t478r2148b526],
17	cardiovascular	JJ	O	cardiovascular	amod	18	SENT_256	[p18l645t554r1024b602],
18	outcomes	NNS	O	outcome	prep_of	14	SENT_256	[p18l1103t564r1356b602],
19	during	IN	O	during	_	0	SENT_256	[p18l1438t554r1616b617],
20	treatment	NN	O	treatment	prep_during	18	SENT_256	[p18l1695t564r1955b602],
21	with	IN	O	with	_	0	SENT_256	[p18l2032t554r2149b602],
22	clopidogrel	NN	O	clopidogrel	prep_with	20	SENT_256	[p18l645t631r938b694],
23	after	IN	O	after	_	0	SENT_256	[p18l958t631r1076b678],
24	an	DT	O	a	det	27	SENT_256	[p18l1095t648r1158b678],
25	acute	JJ	O	acute	amod	27	SENT_256	[p18l1178t640r1314b678],
26	coronary	JJ	O	coronary	amod	27	SENT_256	[p18l1335t648r1566b693],
27	syndrome	NN	O	syndrome	prep_after	11	SENT_256	[p18l1586t631r1847b693],
28	and	CC	O	and	_	0	SENT_256	[p18l1867t631r1965b678],
29	percutaneous	JJ	O	percutaneous	amod	31	SENT_256	[p18l1983t648r2147b693, p18l643t716r849b754],
30	coronary	JJ	O	coronary	amod	31	SENT_256	[p18l892t723r1123b769],
31	intervention	NN	O	intervention	conj_and	27	SENT_256	[p18l1163t709r1500b754],
32	.	.	O	.	_	0	SENT_256	[p18l1163t709r1500b754],

1	Thus	RB	O	thus	advmod	18	SENT_257	[p18l1542t706r1691b761],
2	,	,	O	,	_	0	SENT_257	[p18l1542t706r1691b761],
3	the	DT	O	the	det	4	SENT_257	[p18l1734t706r1816b754],
4	association	NN	O	association	nsubjpass	18	SENT_257	[p18l1858t709r2149b754],
5	between	IN	O	between	_	0	SENT_257	[p18l643t782r864b830],
6	ABCB1	NN	O	abcb1	nn	7	SENT_257	[p18l890t785r1080b830],
7	polymorphisms	NNS	O	polymorphism	prep_between	4	SENT_257	[p18l1107t782r1523b845],
8	and	CC	O	and	_	0	SENT_257	[p18l1553t782r1651b830],
9	ischaemic	JJ	O	ischaemic	amod	10	SENT_257	[p18l1678t782r1943b830],
10	risk	NN	O	risk	prep_between	4	SENT_257	[p18l1970t782r2070b830],
11	in	IN	O	in	_	0	SENT_257	[p18l2096t785r2149b829],
12	patients	NNS	O	patient	prep_in	10	SENT_257	[p18l644t862r852b921],
13	treated	VBN	O	treat	partmod	12	SENT_257	[p18l875t859r1057b906],
14	with	IN	O	with	_	0	SENT_257	[p18l1077t859r1194b906],
15	clopidogrel	NN	O	clopidogrel	prep_with	13	SENT_257	[p18l1217t859r1510b922],
16	has	VBZ	O	have	aux	18	SENT_257	[p18l1531t859r1620b906],
17	been	VBN	O	be	auxpass	18	SENT_257	[p18l1643t859r1770b906],
18	noted	VBN	O	note	_	0	SENT_257	[p18l1792t859r1942b906],
19	now	RB	DATE	now	advmod	18	SENT_257	[p18l1963t876r2076b906],
20	in	IN	O	in	_	0	SENT_257	[p18l2096t862r2149b906],
21	several	JJ	O	several	amod	26	SENT_257	[p18l646t934r825b982],
22	pharmacological	JJ	O	pharmacological	amod	26	SENT_257	[p18l853t934r1291b997],
23	and	CC	O	and	_	0	SENT_257	[p18l1320t934r1417b982],
24	clinical	JJ	O	clinical	amod	25	SENT_257	[p18l1446t934r1633b982],
25	outcomes	NNS	O	outcome	conj_and	22	SENT_257	[p18l1662t944r1916b982],
26	studies	NNS	O	study	prep_in	18	SENT_257	[p18l1948t934r2146b982],
27	.	.	O	.	_	0	SENT_257	[p18l1948t934r2146b982],

1	Our	PRP$	O	we	poss	2	SENT_258	[p18l646t1014r750b1058],
2	analysis	NN	O	analysis	nsubj	4	SENT_258	[p18l767t1010r973b1073],
3	also	RB	O	also	advmod	4	SENT_258	[p18l992t1010r1093b1058],
4	shows	VBZ	O	show	_	0	SENT_258	[p18l1112t1010r1272b1058],
5	that	IN	O	that	complm	16	SENT_258	[p18l1290t1010r1393b1058],
6	the	DT	O	the	det	8	SENT_258	[p18l1407t1010r1490b1058],
7	pharmacogenetic	JJ	O	pharmacogenetic	amod	8	SENT_258	[p18l1506t1010r1963b1073],
8	effects	NNS	O	effect	nsubj	16	SENT_258	[p18l1980t1010r2147b1058],
9	of	IN	O	of	_	0	SENT_258	[p18l645t1087r704b1135],
10	ABCB1	NN	O	abcb1	nn	11	SENT_258	[p18l738t1090r928b1135],
11	3435C	NN	O	3435c	prep_of	8	SENT_258	[p18l974t1090r1236b1135],
12	—	CD	NUMBER	—	num	14	SENT_258	[p18l974t1090r1236b1135],
13	>	JJR	O	>	amod	14	SENT_258	[p18l974t1090r1236b1135],
14	T	NN	O	t	dep	11	SENT_258	[p18l974t1090r1236b1135],
15	are	VBP	O	be	cop	16	SENT_258	[p18l1280t1104r1359b1135],
16	independent	JJ	O	independent	ccomp	4	SENT_258	[p18l1404t1087r1739b1150],
17	of	IN	O	of	dep	16	SENT_258	[p18l1783t1087r1841b1135],
18	and	CC	O	and	_	0	SENT_258	[p18l1878t1087r1975b1135],
19	complementary	JJ	O	complementary	conj_and	16	SENT_258	[p18l2019t1104r2147b1135, p18l644t1163r946b1226],
20	to	TO	O	to	_	0	SENT_258	[p18l1004t1173r1053b1211],
21	those	DT	O	those	prep_to	19	SENT_258	[p18l1114t1163r1255b1211],
22	of	IN	O	of	_	0	SENT_258	[p18l1318t1163r1376b1211],
23	CYPZCI9	NN	O	cypzci9	prep_of	21	SENT_258	[p18l1433t1167r1689b1211],
24	.	.	O	.	_	0	SENT_258	[p18l1433t1167r1689b1211],

1	As	IN	O	as	mark	9	SENT_259	[p18l1752t1167r1818b1211],
2	clinicians	NNS	O	clinician	nsubj	9	SENT_259	[p18l1882t1163r2146b1218],
3	,	,	O	,	_	0	SENT_259	[p18l1882t1163r2146b1218],
4	professional	JJ	O	professional	amod	5	SENT_259	[p18l644t1239r968b1301],
5	societies	NNS	O	society	nsubj	9	SENT_259	[p18l986t1242r1221b1294],
6	,	,	O	,	_	0	SENT_259	[p18l986t1242r1221b1294],
7	and	CC	O	and	_	0	SENT_259	[p18l1241t1239r1338b1287],
8	patients	NNS	O	patient	conj_and	2	SENT_259	[p18l1353t1242r1561b1301],
9	integrate	VBP	O	integrate	advcl	29	SENT_259	[p18l1579t1242r1813b1302],
10	information	NN	O	information	dobj	9	SENT_259	[p18l1830t1239r2149b1287],
11	about	IN	O	about	_	0	SENT_259	[p18l645t1315r793b1363],
12	genetic	JJ	O	genetic	amod	13	SENT_259	[p18l858t1318r1047b1378],
13	factors	NNS	O	factor	prep_about	9	SENT_259	[p18l1113t1315r1287b1363],
14	affecting	VBG	O	affect	partmod	13	SENT_259	[p18l1355t1316r1584b1378],
15	the	DT	O	the	det	16	SENT_259	[p18l1649t1315r1731b1363],
16	response	NN	O	response	dobj	14	SENT_259	[p18l1798t1332r2033b1378],
17	to	TO	O	to	_	0	SENT_259	[p18l2099t1325r2148b1363],
18	thienopyridines	NNS	O	thienopyridine	prep_to	14	SENT_259	[p18l643t1391r1074b1454],
19	,	,	O	,	_	0	SENT_259	[p18l643t1391r1074b1454],
20	the	DT	O	the	det	21	SENT_259	[p18l1099t1391r1181b1439],
21	roles	NNS	O	role	nsubjpass	29	SENT_259	[p18l1205t1391r1330b1439],
22	of	IN	O	of	_	0	SENT_259	[p18l1356t1391r1414b1439],
23	both	DT	O	both	preconj	24	SENT_259	[p18l1427t1391r1546b1439],
24	ABCB1	NN	O	abcb1	prep_of	21	SENT_259	[p18l1569t1395r1759b1439],
25	and	CC	O	and	_	0	SENT_259	[p18l1782t1391r1879b1439],
26	CYP2C19	NN	O	cyp2c19	prep_of	21	SENT_259	[p18l1906t1395r2152b1439],
27	should	MD	O	should	aux	29	SENT_259	[p18l646t1467r824b1515],
28	be	VB	O	be	auxpass	29	SENT_259	[p18l840t1467r901b1515],
29	considered	VBN	O	consider	_	0	SENT_259	[p18l921t1467r1221b1515],
30	.	.	O	.	_	0	SENT_259	[p18l921t1467r1221b1515],

1	Contributors	NNS	O	contributor	nsubj	2	SENT_260	[p18l645t1570r898b1605],
2	]	VBP	O	]	_	0	SENT_260	[p18l645t1633r729b1677],
3	LM	NN	O	lm	nsubj	9	SENT_260	[p18l645t1633r729b1677],
4	and	CC	O	and	_	0	SENT_260	[p18l745t1629r821b1667],
5	MSS	NN	ORGANIZATION	mss	conj_and	3	SENT_260	[p18l836t1632r930b1667],
6	conceived	VBD	O	conceive	ccomp	2	SENT_260	[p18l947t1629r1149b1667],
7	of	IN	O	of	prep	6	SENT_260	[p18l1163t1629r1208b1667],
8	and	CC	O	and	_	0	SENT_260	[p18l1216t1629r1292b1667],
9	designed	VBN	O	design	conj_and	6	SENT_260	[p18l1305t1629r1490b1679],
10	the	DT	O	the	det	11	SENT_260	[p18l1503t1629r1567b1667],
11	research	NN	O	research	dobj	9	SENT_260	[p18l1581t1629r1765b1667],
12	.	.	O	.	_	0	SENT_260	[p18l1581t1629r1765b1667],

1	SDW	NN	O	sdw	nsubj	4	SENT_261	[p18l1784t1632r1891b1667],
2	and	CC	O	and	_	0	SENT_261	[p18l1904t1629r1980b1667],
3	EMA	NN	O	ema	conj_and	1	SENT_261	[p18l1996t1631r2099b1666],
4	acquired	VBD	O	acquire	_	0	SENT_261	[p18l645t1690r822b1739],
5	the	DT	O	the	det	6	SENT_261	[p18l835t1690r899b1727],
6	data	NNS	O	datum	dobj	4	SENT_261	[p18l913t1690r1007b1727],
7	.	.	O	.	_	0	SENT_261	[p18l913t1690r1007b1727],

1	ILM	NNP	ORGANIZATION	ILM	nn	3	SENT_262	[p18l1025t1694r1121b1738],
2	,	,	O	,	_	0	SENT_262	[p18l1025t1694r1121b1738],
3	SLC	NNP	O	SLC	nsubj	9	SENT_262	[p18l1140t1693r1232b1733],
4	,	,	O	,	_	0	SENT_262	[p18l1140t1693r1232b1733],
5	and	CC	O	and	_	0	SENT_262	[p18l1249t1690r1324b1727],
6	MSS	NN	O	mss	conj_and	3	SENT_262	[p18l1339t1693r1433b1727],
7	analysed	VBD	O	analyse	_	0	SENT_262	[p18l1451t1690r1627b1739],
8	and	CC	O	and	_	0	SENT_262	[p18l1641t1690r1717b1727],
9	interpreted	VBD	O	interpret	conj_and	7	SENT_262	[p18l1730t1690r1960b1739],
10	the	DT	O	the	det	11	SENT_262	[p18l1972t1690r2036b1727],
11	data	NNS	O	datum	dobj	9	SENT_262	[p18l2051t1690r2145b1727],
12	.	.	O	.	_	0	SENT_262	[p18l2051t1690r2145b1727],

1	LS	NN	O	l	nsubj	2	SENT_263	[p18l646t1754r694b1788],
2	did	VBD	O	do	_	0	SENT_263	[p18l711t1751r775b1788],
3	statistical	JJ	O	statistical	amod	4	SENT_263	[p18l790t1751r980b1788],
4	analyses	NNS	O	analysis	dobj	2	SENT_263	[p18l995t1751r1175b1800],
5	.	.	O	.	_	0	SENT_263	[p18l995t1751r1175b1800],
6	]	SYM	O	]	dep	2	SENT_263	[p18l1193t1755r1276b1799],

1	LM	NNP	O	LM	nsubj	4	SENT_264	[p18l1193t1755r1276b1799],
2	and	CC	O	and	_	0	SENT_264	[p18l1293t1751r1369b1788],
3	MSS	NNP	ORGANIZATION	MSS	conj_and	1	SENT_264	[p18l1384t1754r1478b1789],
4	drafted	VBD	O	draft	_	0	SENT_264	[p18l1495t1751r1639b1788],
5	the	DT	O	the	det	7	SENT_264	[p18l1652t1751r1716b1788],
6	initial	JJ	O	initial	amod	7	SENT_264	[p18l1730t1751r1850b1788],
7	report	NN	O	report	dobj	4	SENT_264	[p18l1863t1758r1998b1800],
8	.	.	O	.	_	0	SENT_264	[p18l1863t1758r1998b1800],
9	]	SYM	O	]	dep	4	SENT_264	[p18l645t1817r740b1861],

1	RW	NN	O	rw	nsubj	4	SENT_265	[p18l645t1817r740b1861],
2	and	CC	O	and	_	0	SENT_265	[p18l754t1813r829b1850],
3	EB	NNP	O	EB	conj_and	1	SENT_265	[p18l845t1815r899b1850],
4	participated	VBD	O	participate	_	0	SENT_265	[p18l915t1813r1158b1862],
5	in	IN	O	in	_	0	SENT_265	[p18l1171t1815r1212b1850],
6	funding	NN	O	funding	prep_in	4	SENT_265	[p18l1226t1813r1391b1862],
7	and	CC	O	and	_	0	SENT_265	[p18l1405t1813r1481b1850],
8	supervision	NN	O	supervision	prep_in	4	SENT_265	[p18l1496t1815r1743b1862],
9	.	.	O	.	_	0	SENT_265	[p18l1496t1815r1743b1862],

1	ILM	NNP	ORGANIZATION	ILM	nn	7	SENT_266	[p18l1761t1817r1857b1861],
2	,	,	O	,	_	0	SENT_266	[p18l1761t1817r1857b1861],
3	SLC	NNP	ORGANIZATION	SLC	appos	7	SENT_266	[p18l1876t1816r1968b1856],
4	,	,	O	,	_	0	SENT_266	[p18l1876t1816r1968b1856],
5	SDW	NNP	O	SDW	appos	7	SENT_266	[p18l1987t1816r2098b1856],
6	,	,	O	,	_	0	SENT_266	[p18l1987t1816r2098b1856],
7	IRW	NNP	O	IRW	nsubj	17	SENT_266	[p18l645t1878r744b1922],
8	,	,	O	,	_	0	SENT_266	[p18l645t1878r744b1922],
9	TS	NN	O	t	nsubj	17	SENT_266	[p18l759t1876r826b1917],
10	,	,	O	,	_	0	SENT_266	[p18l759t1876r826b1917],
11	EMA	NN	O	ema	nsubj	17	SENT_266	[p18l844t1876r957b1917],
12	,	,	O	,	_	0	SENT_266	[p18l844t1876r957b1917],
13	EB	NNP	O	EB	nsubj	17	SENT_266	[p18l975t1876r1041b1917],
14	,	,	O	,	_	0	SENT_266	[p18l975t1876r1041b1917],
15	and	CC	O	and	_	0	SENT_266	[p18l1058t1874r1133b1911],
16	MSS	NNP	ORGANIZATION	MSS	conj_and	7	SENT_266	[p18l1148t1877r1242b1911],
17	made	VBD	O	make	_	0	SENT_266	[p18l1259t1874r1372b1911],
18	critical	JJ	O	critical	amod	19	SENT_266	[p18l1387t1874r1524b1911],
19	revisions	NNS	O	revision	dobj	17	SENT_266	[p18l1538t1876r1720b1911],
20	to	TO	O	to	_	0	SENT_266	[p18l1735t1881r1773b1911],
21	the	DT	O	the	det	22	SENT_266	[p18l1787t1874r1851b1911],
22	report	NN	O	report	prep_to	17	SENT_266	[p18l1865t1881r1991b1923],
23	for	IN	O	for	_	0	SENT_266	[p18l2004t1874r2063b1911],
24	important	JJ	O	important	amod	26	SENT_266	[p18l644t1936r851b1982],
25	intellectual	JJ	O	intellectual	amod	26	SENT_266	[p18l864t1934r1092b1971],
26	content	NN	O	content	prep_for	17	SENT_266	[p18l1106t1941r1269b1971],
27	.	.	O	.	_	0	SENT_266	[p18l1106t1941r1269b1971],

1	Conﬂicts	NNS	O	conﬂicts	_	0	SENT_267	[p18l9t2330r254b2382],
2	of	IN	O	of	_	0	SENT_267	[p18l270t2330r330b2382],
3	interest	NN	O	interest	prep_of	1	SENT_267	[p18l345t2333r562b2382],

1	The	DT	O	the	det	4	SENT_268	[p18l7t2416r119b2469],
2	TIMI	NNP	ORGANIZATION	TIMI	nn	4	SENT_268	[p18l139t2419r293b2468],
3	Study	NNP	ORGANIZATION	Study	nn	4	SENT_268	[p18l320t2416r484b2486],
4	Group	NNP	ORGANIZATION	Group	nsubj	5	SENT_268	[p18l504t2420r689b2486],
5	receives	VBZ	O	receive	_	0	SENT_268	[p18l710t2419r940b2469],
6	research	NN	O	research	nn	8	SENT_268	[p18l961t2416r1210b2469],
7	grant	NN	O	grant	nn	8	SENT_268	[p18l1230t2427r1384b2486],
8	support	NN	O	support	dobj	5	SENT_268	[p18l1405t2427r1630b2486],
9	from	IN	O	from	_	0	SENT_268	[p18l1648t2416r1793b2469],
10	Daiichi	NNP	ORGANIZATION	Daiichi	nn	11	SENT_268	[p18l1816t2416r2024b2469],
11	Sankyo	NNP	ORGANIZATION	Sankyo	prep_from	8	SENT_268	[p18l13t2503r234b2573],
12	,	,	O	,	_	0	SENT_268	[p18l13t2503r234b2573],
13	Eli	NNP	PERSON	Eli	nn	19	SENT_268	[p18l260t2503r334b2555],
14	Lilly	NNP	PERSON	Lilly	nn	19	SENT_268	[p18l356t2503r486b2573],
15	,	,	O	,	_	0	SENT_268	[p18l356t2503r486b2573],
16	Sanoﬁ-Aventis	NNP	PERSON	Sanoﬁ-Aventis	appos	19	SENT_268	[p18l513t2503r944b2564],
17	,	,	O	,	_	0	SENT_268	[p18l513t2503r944b2564],
18	Bristol-Myers	NNP	O	Bristol-Myers	appos	19	SENT_268	[p18l970t2503r1360b2573],
19	Squibb	NNP	O	Squibb	dep	5	SENT_268	[p18l1387t2503r1605b2572],
20	,	,	O	,	_	0	SENT_268	[p18l1387t2503r1605b2572],
21	AstraZeneca	NNP	ORGANIZATION	AstraZeneca	nn	23	SENT_268	[p18l1626t2506r2010b2564],
22	,	,	O	,	_	0	SENT_268	[p18l1626t2506r2010b2564],
23	Schering-Plough	NNP	ORGANIZATION	Schering-Plough	appos	19	SENT_268	[p18l13t2590r502b2660],
24	/	:	ORGANIZATION	/	punct	19	SENT_268	[p18l507t2595r529b2659],
25	Merck	NNP	ORGANIZATION	Merck	dep	19	SENT_268	[p18l535t2590r732b2651],
26	,	,	ORGANIZATION	,	_	0	SENT_268	[p18l535t2590r732b2651],
27	Iohnson	NNP	ORGANIZATION	Iohnson	conj_and	25	SENT_268	[p18l756t2590r998b2658],
28	&	CC	ORGANIZATION	&	_	0	SENT_268	[p18l1019t2590r1066b2643],
29	Johnson	NNP	ORGANIZATION	Johnson	conj_and	25	SENT_268	[p18l1086t2590r1343b2658],
30	,	,	O	,	_	0	SENT_268	[p18l1086t2590r1343b2658],
31	and	CC	O	and	_	0	SENT_268	[p18l1366t2590r1475b2643],
32	Bayer	NNP	O	Bayer	nn	33	SENT_268	[p18l1497t2595r1659b2660],
33	I-Iealthcare	NNP	O	I-Iealthcare	conj_and	25	SENT_268	[p18l1681t2590r2012b2643],
34	.	.	O	.	_	0	SENT_268	[p18l1681t2590r2012b2643],

1	Additionally	RB	O	additionally	advmod	5	SENT_269	[p18l7t2677r373b2747],
2	,	,	O	,	_	0	SENT_269	[p18l7t2677r373b2747],
3	ILM	NNP	ORGANIZATION	ILM	nsubjpass	5	SENT_269	[p18l397t2682r517b2745],
4	is	VBZ	O	be	auxpass	5	SENT_269	[p18l540t2680r584b2730],
5	supported	VBN	O	support	_	0	SENT_269	[p18l609t2677r904b2746],
6	in	IN	O	in	_	0	SENT_269	[p18l923t2680r981b2729],
7	part	NN	O	part	prep_in	5	SENT_269	[p18l1001t2688r1117b2746],
8	by	IN	O	by	_	0	SENT_269	[p18l1135t2677r1203b2747],
9	grant	NN	O	grant	nn	10	SENT_269	[p18l1223t2688r1376b2747],
10	K99	NN	O	k99	agent	5	SENT_269	[p18l1398t2682r1507b2730],
11	/	:	O	/	punct	13	SENT_269	[p18l1513t2682r1535b2746],
12	Roo	NNP	PERSON	Roo	nn	13	SENT_269	[p18l1543t2682r1653b2730],
13	I-IL098461-01	NNP	O	I-IL098461-01	dep	5	SENT_269	[p18l1677t2682r2052b2730],
14	from	IN	O	from	_	0	SENT_269	[p18l8t2764r153b2817],
15	the	DT	O	the	det	17	SENT_269	[p18l172t2764r263b2817],
16	National	NNP	ORGANIZATION	National	nn	17	SENT_269	[p18l285t2764r531b2817],
17	Institutes	NNPS	ORGANIZATION	Institutes	prep_from	13	SENT_269	[p18l555t2767r829b2817],
18	of	IN	ORGANIZATION	of	_	0	SENT_269	[p18l851t2763r916b2817],
19	Health	NNP	ORGANIZATION	Health	prep_of	13	SENT_269	[p18l929t2764r1125b2817],
20	and	CC	O	and	_	0	SENT_269	[p18l1146t2764r1254b2817],
21	reports	NNS	O	report	nn	23	SENT_269	[p18l1273t2774r1478b2833],
22	consulting	VBG	O	consult	amod	23	SENT_269	[p18l1501t2764r1810b2834],
23	fees	NNS	O	fee	prep_of	13	SENT_269	[p18l1830t2764r1942b2817],
24	from	IN	O	from	_	0	SENT_269	[p18l1965t2764r2109b2817],
25	Sanoﬁ-Aventis	NNP	O	Sanoﬁ-Aventis	prep_from	5	SENT_269	[p18l13t2851r443b2912],
26	,	,	O	,	_	0	SENT_269	[p18l13t2851r443b2912],
27	Bristol-Myers	NNP	O	Bristol-Myers	nn	28	SENT_269	[p18l470t2851r860b2920],
28	Squibb	NNP	O	Squibb	conj_and	25	SENT_269	[p18l886t2851r1104b2920],
29	,	,	O	,	_	0	SENT_269	[p18l886t2851r1104b2920],
30	and	CC	O	and	_	0	SENT_269	[p18l1128t2851r1236b2904],
31	AstraZeneca	NNP	ORGANIZATION	AstraZeneca	prep_from	5	SENT_269	[p18l1254t2854r1636b2904],
32	.	.	O	.	_	0	SENT_269	[p18l1254t2854r1636b2904],

1	SDW	NN	O	sdw	nn	2	SENT_270	[p18l1665t2855r1816b2904],
2	reports	NNS	O	report	_	0	SENT_270	[p18l1835t2862r2040b2920],
3	consulting	VBG	O	consult	partmod	2	SENT_270	[p18l9t2937r318b3008],
4	fees	NNS	O	fee	dobj	3	SENT_270	[p18l338t2937r451b2991],
5	from	IN	O	from	_	0	SENT_270	[p18l472t2937r617b2990],
6	Sanoﬁ-Aventis	NNP	O	Sanoﬁ-Aventis	prep_from	4	SENT_270	[p18l642t2937r1072b2999],
7	,	,	O	,	_	0	SENT_270	[p18l642t2937r1072b2999],
8	Bristol-Myers	NNP	O	Bristol-Myers	nn	15	SENT_270	[p18l1098t2937r1489b3007],
9	Squibb	NNP	O	Squibb	nn	15	SENT_270	[p18l1515t2937r1733b3007],
10	,	,	O	,	_	0	SENT_270	[p18l1515t2937r1733b3007],
11	AstraZeneca	NNP	ORGANIZATION	AstraZeneca	appos	15	SENT_270	[p18l1755t2941r2138b2999],
12	,	,	O	,	_	0	SENT_270	[p18l1755t2941r2138b2999],
13	ARENA	NNP	O	ARENA	appos	15	SENT_270	[p18l7t3028r254b3086],
14	,	,	O	,	_	0	SENT_270	[p18l7t3028r254b3086],
15	Medco	NNP	ORGANIZATION	Medco	conj_and	4	SENT_270	[p18l279t3024r486b3086],
16	,	,	O	,	_	0	SENT_270	[p18l279t3024r486b3086],
17	and	CC	O	and	_	0	SENT_270	[p18l509t3024r618b3078],
18	Portola	NNP	LOCATION	Portola	conj_and	4	SENT_270	[p18l640t3024r859b3086],
19	,	,	O	,	_	0	SENT_270	[p18l640t3024r859b3086],
20	and	CC	O	and	_	0	SENT_270	[p18l882t3024r990b3078],
21	lecture	NN	O	lecture	nn	22	SENT_270	[p18l1008t3024r1207b3078],
22	fees	NNS	O	fee	dobj	3	SENT_270	[p18l1228t3024r1341b3078],
23	for	IN	O	for	_	0	SENT_270	[p18l1362t3024r1446b3078],
24	CME	NNP	O	CME	prep_for	22	SENT_270	[p18l1467t3028r1611b3078],
25	from	IN	O	from	_	0	SENT_270	[p18l1633t3024r1778b3078],
26	ScheringPlough	NNP	O	ScheringPlough	prep_from	3	SENT_270	[p18l1802t3024r2078b3095, p18l12t3111r233b3182],
27	,	,	O	,	_	0	SENT_270	[p18l1802t3024r2078b3095, p18l12t3111r233b3182],
28	Daiichi	NNP	ORGANIZATION	Daiichi	nn	29	SENT_270	[p18l259t3111r466b3165],
29	Sankyo	NNP	ORGANIZATION	Sankyo	prep_from	3	SENT_270	[p18l491t3111r712b3181],
30	,	,	O	,	_	0	SENT_270	[p18l491t3111r712b3181],
31	Eli	NNP	PERSON	Eli	nn	32	SENT_270	[p18l738t3111r812b3164],
32	Lilly	NNP	PERSON	Lilly	prep_from	3	SENT_270	[p18l835t3111r965b3181],
33	,	,	O	,	_	0	SENT_270	[p18l835t3111r965b3181],
34	Novartis	NNP	ORGANIZATION	Novartis	prep_from	3	SENT_270	[p18l989t3115r1246b3173],
35	,	,	O	,	_	0	SENT_270	[p18l989t3115r1246b3173],
36	and	CC	O	and	_	0	SENT_270	[p18l1269t3111r1377b3165],
37	AstraZeneca	NNP	ORGANIZATION	AstraZeneca	prep_from	3	SENT_270	[p18l1395t3115r1778b3165],
38	.	.	O	.	_	0	SENT_270	[p18l1395t3115r1778b3165],

1	TS	NN	O	t	nn	2	SENT_271	[p18l1800t3115r1877b3165],
2	reports	NNS	O	report	nsubj	3	SENT_271	[p18l1900t3122r2105b3181],
3	research	NN	O	research	_	0	SENT_271	[p18l8t3198r255b3251],
4	grant	NN	O	grant	nn	5	SENT_271	[p18l277t3209r430b3268],
5	support	NN	O	support	dobj	3	SENT_271	[p18l451t3209r676b3268],
6	from	IN	O	from	_	0	SENT_271	[p18l695t3198r840b3251],
7	Servier	NNP	ORGANIZATION	Servier	nn	12	SENT_271	[p18l864t3202r1072b3260],
8	,	,	O	,	_	0	SENT_271	[p18l864t3202r1072b3260],
9	Pﬁzer	NNP	PERSON	Pﬁzer	appos	12	SENT_271	[p18l1098t3198r1277b3260],
10	,	,	O	,	_	0	SENT_271	[p18l1098t3198r1277b3260],
11	Daiichi	NNP	PERSON	Daiichi	appos	12	SENT_271	[p18l1303t3198r1511b3251],
12	Sanl	NNP	PERSON	Sanl	prep_from	5	SENT_271	[p18l1536t3198r1757b3268],
13	<	JJR	O	<	amod	14	SENT_271	[p18l1536t3198r1757b3268],
14	yo	NN	O	yo	dep	3	SENT_271	[p18l1536t3198r1757b3268],
15	,	,	O	,	_	0	SENT_271	[p18l1536t3198r1757b3268],
16	Eli	NNP	PERSON	Eli	nn	17	SENT_271	[p18l1783t3198r1857b3251],
17	Lilly	NNP	PERSON	Lilly	conj_and	14	SENT_271	[p18l1879t3198r2009b3268],
18	,	,	O	,	_	0	SENT_271	[p18l1879t3198r2009b3268],
19	Sanoﬁ-Aventis	NNP	PERSON	Sanoﬁ-Aventis	conj_and	14	SENT_271	[p18l13t3285r443b3346],
20	,	,	O	,	_	0	SENT_271	[p18l13t3285r443b3346],
21	AstraZeneca	NNP	ORGANIZATION	AstraZeneca	conj_and	14	SENT_271	[p18l465t3288r848b3346],
22	,	,	O	,	_	0	SENT_271	[p18l465t3288r848b3346],
23	and	CC	O	and	_	0	SENT_271	[p18l872t3285r980b3338],
24	Caisse	NNP	ORGANIZATION	Caisse	nn	26	SENT_271	[p18l1001t3289r1184b3338],
25	d’Assurance	NNP	ORGANIZATION	d’Assurance	nn	26	SENT_271	[p18l1206t3285r1556b3338],
26	Maladie	NNP	ORGANIZATION	Maladie	conj_and	14	SENT_271	[p18l1579t3285r1808b3338],
27	and	CC	O	and	_	0	SENT_271	[p18l1830t3285r1938b3338],
28	consulting	VBG	O	consult	amod	29	SENT_271	[p19l9t20r318b90],
29	fees	NNS	O	fee	conj_and	14	SENT_271	[p19l338t20r451b73],
30	from	IN	O	from	_	0	SENT_271	[p19l472t20r617b73],
31	Eli	NNP	ORGANIZATION	Eli	nn	32	SENT_271	[p19l640t20r714b72],
32	Lilly	NNP	ORGANIZATION	Lilly	prep_from	29	SENT_271	[p19l737t20r866b90],
33	,	,	O	,	_	0	SENT_271	[p19l737t20r866b90],
34	Daiichi	NNP	ORGANIZATION	Daiichi	nn	35	SENT_271	[p19l892t20r1101b73],
35	Sankyo	NNP	ORGANIZATION	Sankyo	conj_and	32	SENT_271	[p19l1125t20r1346b90],
36	,	,	O	,	_	0	SENT_271	[p19l1125t20r1346b90],
37	Sanoﬁ-Aventis	NNP	PERSON	Sanoﬁ-Aventis	conj_and	32	SENT_271	[p19l1373t20r1805b81],
38	,	,	O	,	_	0	SENT_271	[p19l1373t20r1805b81],
39	Bristol-Myers	NNP	O	Bristol-Myers	nn	40	SENT_271	[p19l12t107r402b177],
40	Squibb	NNP	O	Squibb	conj_and	32	SENT_271	[p19l428t107r646b177],
41	,	,	O	,	_	0	SENT_271	[p19l428t107r646b177],
42	and	CC	O	and	_	0	SENT_271	[p19l670t107r777b160],
43	AstraZeneca	NNP	ORGANIZATION	AstraZeneca	conj_and	32	SENT_271	[p19l796t110r1178b160],
44	.	.	O	.	_	0	SENT_271	[p19l796t110r1178b160],

1	EMA	NN	O	ema	nsubj	2	SENT_272	[p19l1205t110r1352b160],
2	has	VBZ	O	have	_	0	SENT_272	[p19l1370t107r1468b160],
3	no	DT	O	no	det	5	SENT_272	[p19l1490t126r1563b160],
4	additional	JJ	O	additional	amod	5	SENT_272	[p19l1584t107r1876b160],
5	relationships	NNS	O	relationship	dobj	2	SENT_272	[p19l8t194r388b263],
6	to	TO	O	to	aux	7	SENT_272	[p19l408t205r463b247],
7	disclose	VB	O	disclose	infmod	5	SENT_272	[p19l484t194r729b247],
8	.	.	O	.	_	0	SENT_272	[p19l484t194r729b247],

1	EB	NNP	O	EB	nsubj	2	SENT_273	[p19l755t197r832b246],
2	reports	VBZ	O	report	_	0	SENT_273	[p19l855t205r1060b263],
3	consulting	NN	O	consulting	nn	4	SENT_273	[p19l1083t194r1392b264],
4	fees	NNS	O	fee	dobj	2	SENT_273	[p19l1412t194r1524b247],
5	from	IN	O	from	_	0	SENT_273	[p19l1547t194r1691b247],
6	Daiichi	NNP	ORGANIZATION	Daiichi	nn	7	SENT_273	[p19l1714t194r1922b247],
7	Sankyo	NNP	ORGANIZATION	Sankyo	prep_from	2	SENT_273	[p19l1947t194r2152b264],
8	and	CC	O	and	_	0	SENT_273	[p19l9t281r117b334],
9	lecture	NN	O	lecture	nn	10	SENT_273	[p19l135t281r335b334],
10	fees	NNS	O	fee	prep_from	2	SENT_273	[p19l355t281r467b334],
11	from	IN	O	from	_	0	SENT_273	[p19l490t281r634b334],
12	Schering-Plough	NNP	ORGANIZATION	Schering-Plough	prep_from	2	SENT_273	[p19l659t281r1148b351],
13	and	CC	O	and	_	0	SENT_273	[p19l1169t281r1277b334],
14	Merck	NNP	PERSON	Merck	conj_and	12	SENT_273	[p19l1298t281r1494b334],
15	.	.	O	.	_	0	SENT_273	[p19l1298t281r1494b334],

1	MSS	NN	ORGANIZATION	mss	nn	2	SENT_274	[p19l1519t284r1653b334],
2	reports	NNS	O	report	_	0	SENT_274	[p19l1677t292r1882b350],
3	consulting	VBG	O	consult	partmod	2	SENT_274	[p19l9t368r318b438],
4	fees	NNS	O	fee	dobj	3	SENT_274	[p19l338t368r451b421],
5	from	IN	O	from	_	0	SENT_274	[p19l472t368r617b421],
6	AstraZeneca	NNP	ORGANIZATION	AstraZeneca	prep_from	3	SENT_274	[p19l636t371r1019b430],
7	,	,	O	,	_	0	SENT_274	[p19l636t371r1019b430],
8	Bristol-Myers	NNP	O	Bristol-Myers	nn	9	SENT_274	[p19l1045t368r1436b438],
9	Squibb	NNP	O	Squibb	prep_from	3	SENT_274	[p19l1462t368r1680b437],
10	,	,	O	,	_	0	SENT_274	[p19l1462t368r1680b437],
11	Sanoﬁ-Aventis	NNP	PERSON	Sanoﬁ-Aventis	prep_from	3	SENT_274	[p19l1707t368r2138b429],
12	,	,	O	,	_	0	SENT_274	[p19l1707t368r2138b429],
13	Daiichi	NNP	ORGANIZATION	Daiichi	nn	14	SENT_274	[p19l12t455r219b508],
14	Sankyo	NNP	ORGANIZATION	Sankyo	conj_and	6	SENT_274	[p19l244t455r465b525],
15	,	,	O	,	_	0	SENT_274	[p19l244t455r465b525],
16	and	CC	O	and	_	0	SENT_274	[p19l489t455r596b508],
17	Eli	NNP	PERSON	Eli	nn	18	SENT_274	[p19l619t455r693b507],
18	Lilly	NNP	PERSON	Lilly	conj_and	6	SENT_274	[p19l716t455r837b525],
19	and	CC	O	and	_	0	SENT_274	[p19l857t455r965b508],
20	lecture	NN	O	lecture	nn	21	SENT_274	[p19l983t455r1182b508],
21	fees	NNS	O	fee	conj_and	6	SENT_274	[p19l1203t454r1316b508],
22	from	IN	O	from	_	0	SENT_274	[p19l1337t455r1482b508],
23	Bristol-Myers	NNP	MISC	Bristol-Myers	nn	24	SENT_274	[p19l1505t455r1896b525],
24	Squibb	NNP	MISC	Squibb	prep_from	3	SENT_274	[p19l1922t455r2140b524],
25	,	,	O	,	_	0	SENT_274	[p19l1922t455r2140b524],
26	Sanoﬁ-Aventis	NNP	PERSON	Sanoﬁ-Aventis	prep_from	3	SENT_274	[p19l13t541r443b603],
27	,	,	O	,	_	0	SENT_274	[p19l13t541r443b603],
28	and	CC	O	and	_	0	SENT_274	[p19l467t542r575b595],
29	Eli	NNP	PERSON	Eli	nn	30	SENT_274	[p19l597t542r671b594],
30	Lilly	NNP	PERSON	Lilly	prep_from	3	SENT_274	[p19l695t542r823b611],
31	.	.	O	.	_	0	SENT_274	[p19l695t542r823b611],

1	IRW	NNP	O	IRW	nsubj	9	SENT_275	[p19l848t547r983b610],
2	is	VBZ	O	be	cop	4	SENT_275	[p19l1002t545r1047b595],
3	an	DT	O	a	det	4	SENT_275	[p19l1070t561r1140b595],
4	employee	NN	O	employee	_	0	SENT_275	[p19l1160t542r1439b611],
5	of	IN	O	of	_	0	SENT_275	[p19l1460t542r1525b595],
6	Daiichi	NNP	ORGANIZATION	Daiichi	nn	7	SENT_275	[p19l1538t542r1747b595],
7	Sankyo	NNP	ORGANIZATION	Sankyo	prep_of	4	SENT_275	[p19l1771t542r1976b612],
8	and	CC	O	and	_	0	SENT_275	[p19l1998t542r2106b595],
9	holds	VBZ	O	hold	conj_and	4	SENT_275	[p19l7t628r165b682],
10	equity	NN	O	equity	nn	11	SENT_275	[p19l188t632r367b698],
11	ownership	NN	O	ownership	dobj	9	SENT_275	[p19l386t628r694b698],
12	or	CC	O	or	_	0	SENT_275	[p19l716t647r776b682],
13	stock	NN	O	stock	nn	14	SENT_275	[p19l796t628r946b682],
14	options	NNS	O	option	dobj	9	SENT_275	[p19l965t632r1180b698],
15	therein	RB	O	therein	advmod	9	SENT_275	[p19l1201t628r1427b682],
16	.	.	O	.	_	0	SENT_275	[p19l1201t628r1427b682],

1	SLC	NNP	O	SLC	nsubj	10	SENT_276	[p19l1454t633r1569b682],
2	is	VBZ	O	be	cop	5	SENT_276	[p19l1591t632r1636b682],
3	a	DT	O	a	det	5	SENT_276	[p19l1659t647r1688b682],
4	former	JJ	O	former	amod	5	SENT_276	[p19l1708t628r1912b682],
5	employee	NN	O	employee	_	0	SENT_276	[p19l9t715r288b785],
6	of	IN	O	of	_	0	SENT_276	[p19l309t715r374b769],
7	Eli	NNP	ORGANIZATION	Eli	nn	8	SENT_276	[p19l387t715r461b768],
8	Lilly	NNP	ORGANIZATION	Lilly	prep_of	5	SENT_276	[p19l484t715r606b785],
9	and	CC	O	and	_	0	SENT_276	[p19l625t715r734b769],
10	holds	VBZ	O	hold	conj_and	5	SENT_276	[p19l751t715r909b769],
11	equity	NN	O	equity	nn	12	SENT_276	[p19l932t719r1111b785],
12	ownership	NN	O	ownership	dobj	10	SENT_276	[p19l1131t715r1439b785],
13	or	CC	O	or	_	0	SENT_276	[p19l1460t734r1520b769],
14	stock	NN	O	stock	nn	15	SENT_276	[p19l1541t715r1690b769],
15	options	NNS	O	option	conj_or	12	SENT_276	[p19l1709t719r1924b785],
16	therein	RB	O	therein	advmod	10	SENT_276	[p19l7t802r233b855],
17	.	.	O	.	_	0	SENT_276	[p19l7t802r233b855],

1	LS	NN	O	l	nsubj	9	SENT_277	[p19l259t806r327b855],
2	is	VBZ	O	be	cop	4	SENT_277	[p19l350t806r395b855],
3	an	DT	O	a	det	4	SENT_277	[p19l419t821r488b855],
4	employee	NN	O	employee	_	0	SENT_277	[p19l509t802r788b872],
5	of	IN	O	of	_	0	SENT_277	[p19l809t802r874b855],
6	Eli	NNP	PERSON	Eli	nn	7	SENT_277	[p19l887t802r961b855],
7	Lilly	NNP	PERSON	Lilly	prep_of	4	SENT_277	[p19l984t802r1106b872],
8	and	CC	O	and	_	0	SENT_277	[p19l1125t802r1233b855],
9	holds	VBZ	O	hold	conj_and	4	SENT_277	[p19l1251t802r1409b855],
10	equity	NN	O	equity	nn	11	SENT_277	[p19l1432t806r1611b872],
11	ownership	NN	O	ownership	dobj	9	SENT_277	[p19l1630t802r1939b872],
12	or	CC	O	or	_	0	SENT_277	[p19l1960t821r2020b855],
13	stock	NN	O	stock	nn	14	SENT_277	[p19l10t889r159b942],
14	options	NNS	O	option	dobj	9	SENT_277	[p19l179t893r394b959],
15	therein	RB	O	therein	advmod	9	SENT_277	[p19l414t889r640b942],
16	.	.	O	.	_	0	SENT_277	[p19l414t889r640b942],

1	References	NNS	O	reference	_	0	SENT_278	[p19l12t1021r310b1073],

1	1	CD	NUMBER	1	num	2	SENT_279	[p19l10t1104r35b1152],
2	Anderson	NNP	PERSON	Anderson	_	0	SENT_279	[p19l149t1099r438b1152],
3	]	CD	NUMBER	]	num	2	SENT_279	[p19l460t1105r534b1168],
4	L	NN	O	l	dep	2	SENT_279	[p19l460t1105r534b1168],
5	,	,	O	,	_	0	SENT_279	[p19l460t1105r534b1168],
6	Adams	NNP	PERSON	Adams	nn	7	SENT_279	[p19l555t1099r759b1152],
7	CD	NNP	O	CD	appos	4	SENT_279	[p19l783t1103r892b1161],
8	,	,	O	,	_	0	SENT_279	[p19l783t1103r892b1161],
9	Antman	NNP	PERSON	Antman	nn	10	SENT_279	[p19l914t1103r1157b1152],
10	EM	NNP	O	EM	appos	4	SENT_279	[p19l1180t1102r1293b1161],
11	,	,	O	,	_	0	SENT_279	[p19l1180t1102r1293b1161],
12	et	FW	O	et	nn	13	SENT_279	[p19l1317t1110r1368b1152],
13	al.	FW	O	al.	appos	4	SENT_279	[p19l1388t1099r1450b1152],
14	.	.	O	.	_	0	SENT_279	[p19l1388t1099r1450b1152],

1	ACC/AHA	NNP	O	ACC/AHA	_	0	SENT_280	[p19l1472t1103r1790b1169],
2	2007	CD	DATE	2007	dep	1	SENT_280	[p19l1812t1102r1944b1155],

1	guidelines	NNS	O	guideline	nsubj	51	SENT_281	[p19l151t1180r453b1250],
2	for	IN	O	for	_	0	SENT_281	[p19l475t1180r558b1233],
3	the	DT	O	the	det	4	SENT_281	[p19l576t1180r667b1233],
4	management	NN	O	management	prep_for	1	SENT_281	[p19l688t1191r1078b1250],
5	of	IN	O	of	_	0	SENT_281	[p19l1098t1180r1163b1233],
6	patients	NNS	O	patient	prep_of	4	SENT_281	[p19l1172t1183r1403b1249],
7	with	IN	O	with	_	0	SENT_281	[p19l1424t1180r1553b1233],
8	unstable	JJ	O	unstable	amod	9	SENT_281	[p19l1572t1180r1822b1233],
9	angina	NN	O	angina	prep_with	6	SENT_281	[p19l1843t1183r2041b1250],
10	/	:	O	/	punct	16	SENT_281	[p19l2046t1185r2068b1249],
11	non-ST-Elevation	JJ	O	non-st-elevation	amod	16	SENT_281	[p19l150t1260r652b1313],
12	myocardial	JJ	O	myocardial	amod	13	SENT_281	[p19l672t1260r995b1330],
13	infarction	NN	O	infarction	dep	16	SENT_281	[p19l1015t1260r1317b1313],
14	:	:	O	:	_	0	SENT_281	[p19l1015t1260r1317b1313],
15	a	DT	O	a	det	16	SENT_281	[p19l1341t1279r1370b1313],
16	report	NN	O	report	dep	1	SENT_281	[p19l1389t1270r1568b1329],
17	of	IN	O	of	_	0	SENT_281	[p19l1588t1260r1653b1313],
18	the	DT	O	the	det	20	SENT_281	[p19l1662t1260r1753b1313],
19	American	NNP	ORGANIZATION	American	nn	20	SENT_281	[p19l1773t1263r2063b1313],
20	College	NNP	ORGANIZATION	College	prep_of	16	SENT_281	[p19l153t1339r366b1409],
21	of	IN	ORGANIZATION	of	_	0	SENT_281	[p19l388t1339r453b1392],
22	Cardiology/American	NNP	ORGANIZATION	Cardiology/American	nn	26	SENT_281	[p19l465t1339r1097b1409],
23	Heart	NNP	ORGANIZATION	Heart	nn	26	SENT_281	[p19l1120t1345r1285b1392],
24	Association	NNP	ORGANIZATION	Association	nn	26	SENT_281	[p19l1303t1343r1643b1392],
25	Task	NNP	ORGANIZATION	Task	nn	26	SENT_281	[p19l1662t1339r1794b1392],
26	Force	NNP	ORGANIZATION	Force	prep_of	20	SENT_281	[p19l1816t1342r1971b1392],
27	on	IN	O	on	_	0	SENT_281	[p19l1994t1358r2066b1392],
28	Practice	NNP	O	Practice	prep_on	26	SENT_281	[p19l154t1423r382b1473],
29	Guidelines	NNS	O	guideline	nsubj	30	SENT_281	[p19l404t1420r719b1473],
30	(	VBP	O	(	rcmod	16	SENT_281	[p19l746t1423r989b1490],
31	Writing	VBG	O	write	xcomp	30	SENT_281	[p19l746t1423r989b1490],
32	Committee	NNP	O	Committee	nsubj	34	SENT_281	[p19l1011t1423r1337b1473],
33	to	TO	O	to	aux	34	SENT_281	[p19l1356t1431r1411b1473],
34	Revise	VB	O	revise	xcomp	31	SENT_281	[p19l1435t1423r1618b1473],
35	the	DT	O	the	det	37	SENT_281	[p19l1638t1420r1729b1473],
36	2002	CD	DATE	2002	num	37	SENT_281	[p19l1752t1425r1886b1473],
37	Guidelines	NNS	O	guideline	dobj	34	SENT_281	[p19l153t1500r467b1553],
38	for	IN	O	for	_	0	SENT_281	[p19l489t1500r573b1553],
39	the	DT	O	the	det	40	SENT_281	[p19l591t1500r682b1553],
40	Management	NN	O	management	prep_for	37	SENT_281	[p19l705t1505r1093b1570],
41	of	IN	O	of	_	0	SENT_281	[p19l1112t1500r1177b1553],
42	Patients	NNS	O	patient	prep_of	16	SENT_281	[p19l1190t1503r1419b1553],
43	With	IN	O	with	_	0	SENT_281	[p19l1441t1500r1583b1553],
44	Unstable	JJ	O	unstable	amod	45	SENT_281	[p19l1606t1500r1866b1553],
45	Angina	NNP	O	Angina	prep_with	42	SENT_281	[p19l1886t1503r2101b1570],
46	/	:	O	/	punct	16	SENT_281	[p19l2106t1505r2128b1569],
47	Non-ST-Elevation	NNP	O	Non-ST-Elevation	nn	50	SENT_281	[p19l152t1579r662b1632],
48	Myocardial	JJ	O	myocardial	amod	50	SENT_281	[p19l684t1579r1006b1649],
49	Infarction	NN	O	infarction	nn	50	SENT_281	[p19l1029t1579r1336b1650],
50	)	NN	O	)	dep	1	SENT_281	[p19l1029t1579r1336b1650],
51	developed	VBD	O	develop	_	0	SENT_281	[p19l1362t1579r1654b1649],
52	in	IN	O	in	_	0	SENT_281	[p19l1673t1583r1732b1632],
53	collaboration	NN	O	collaboration	prep_in	51	SENT_281	[p19l1753t1579r2133b1632],
54	with	IN	O	with	_	0	SENT_281	[p19l149t1660r278b1713],
55	the	DT	O	the	det	57	SENT_281	[p19l297t1660r389b1713],
56	American	NNP	ORGANIZATION	American	nn	57	SENT_281	[p19l408t1663r698b1713],
57	College	NNP	ORGANIZATION	College	prep_with	51	SENT_281	[p19l720t1660r934b1730],
58	of	IN	ORGANIZATION	of	_	0	SENT_281	[p19l955t1660r1020b1713],
59	Emergency	NNP	ORGANIZATION	Emergency	nn	60	SENT_281	[p19l1033t1663r1361b1730],
60	Physicians	NNP	ORGANIZATION	Physicians	prep_of	57	SENT_281	[p19l1383t1660r1707b1730],
61	,	,	O	,	_	0	SENT_281	[p19l1383t1660r1707b1730],
62	the	DT	O	the	det	63	SENT_281	[p19l1729t1660r1821b1713],
63	Society	NNP	ORGANIZATION	Society	prep_with	51	SENT_281	[p19l1845t1663r2048b1730],
64	for	IN	ORGANIZATION	for	_	0	SENT_281	[p19l2066t1660r2150b1713],
65	Cardiovascular	NNP	ORGANIZATION	Cardiovascular	nn	66	SENT_281	[p19l153t1740r586b1793],
66	Angiography	NNP	ORGANIZATION	Angiography	prep_for	63	SENT_281	[p19l603t1740r986b1810],
67	and	CC	O	and	_	0	SENT_281	[p19l1005t1740r1113b1793],
68	Interventions	NNS	O	intervention	conj_and	66	SENT_281	[p19l1135t1743r1542b1801],
69	,	,	O	,	_	0	SENT_281	[p19l1135t1743r1542b1801],
70	and	CC	O	and	_	0	SENT_281	[p19l1566t1740r1674b1793],
71	the	DT	O	the	det	72	SENT_281	[p19l1692t1740r1783b1793],
72	Society	NNP	ORGANIZATION	Society	prep_with	51	SENT_281	[p19l1808t1743r2011b1810],
73	of	IN	ORGANIZATION	of	_	0	SENT_281	[p19l2031t1739r2095b1793],
74	Thoracic	NNP	ORGANIZATION	Thoracic	nn	75	SENT_281	[p19l149t1819r405b1872],
75	Surgeons	NNPS	ORGANIZATION	Surgeons	prep_of	72	SENT_281	[p19l429t1823r698b1890],
76	endorsed	VBN	O	endorse	partmod	75	SENT_281	[p19l720t1819r990b1872],
77	by	IN	O	by	_	0	SENT_281	[p19l1008t1819r1077b1889],
78	the	DT	O	the	det	80	SENT_281	[p19l1094t1819r1186b1872],
79	American	NNP	ORGANIZATION	American	nn	80	SENT_281	[p19l1205t1823r1495b1872],
80	Association	NNP	ORGANIZATION	Association	agent	76	SENT_281	[p19l1514t1823r1854b1872],
81	of	IN	ORGANIZATION	of	_	0	SENT_281	[p19l1874t1819r1940b1872],
82	Cardiovascular	NNP	ORGANIZATION	Cardiovascular	nn	85	SENT_281	[p19l153t1900r586b1953],
83	and	CC	ORGANIZATION	and	_	0	SENT_281	[p19l606t1900r713b1953],
84	Pulmonary	NNP	ORGANIZATION	Pulmonary	conj_and	82	SENT_281	[p19l736t1900r1059b1970],
85	Rehabilitation	NNP	ORGANIZATION	Rehabilitation	prep_of	80	SENT_281	[p19l1081t1900r1490b1953],
86	and	CC	O	and	_	0	SENT_281	[p19l1511t1900r1618b1953],
87	the	DT	O	the	det	88	SENT_281	[p19l1636t1900r1728b1953],
88	Society	NNP	ORGANIZATION	Society	conj_and	80	SENT_281	[p19l1753t1903r1956b1970],
89	for	IN	ORGANIZATION	for	_	0	SENT_281	[p19l1974t1900r2058b1953],
90	Academic	NNP	ORGANIZATION	Academic	nn	94	SENT_281	[p19l149t1980r438b2033],
91	Emergency	NNP	ORGANIZATION	Emergency	nn	94	SENT_281	[p19l461t1983r789b2050],
92	Medicine	NNP	ORGANIZATION	Medicine	nn	94	SENT_281	[p19l810t1980r1094b2033],
93	.	.	O	.	_	0	SENT_281	[p19l810t1980r1094b2033],
94	]	NN	O	]	prep_for	88	SENT_281	[p19l1109t1985r1145b2050],

1	Am	VBP	O	be	dep	3	SENT_282	[p19l1161t1983r1264b2032],
2	Coll	NNP	O	Coll	nn	3	SENT_282	[p19l1288t1980r1394b2033],
3	Cardiol	NNP	O	Cardiol	_	0	SENT_282	[p19l1418t1980r1619b2033],
4	2007	CD	DATE	2007	num	6	SENT_282	[p19l1639t1983r1784b2041],
5	;	:	O	;	_	0	SENT_282	[p19l1639t1983r1784b2041],
6	50	CD	NUMBER	50	dep	3	SENT_282	[p19l1811t1982r1891b2033],
7	:	:	O	:	_	0	SENT_282	[p19l1811t1982r1891b2033],
8	e1	NN	O	e1	nn	9	SENT_282	[p19l1914t1983r2103b2035],
9	—	NN	O	—	dep	3	SENT_282	[p19l1914t1983r2103b2035],
10	157	CD	NUMBER	157	rcmod	9	SENT_282	[p19l1914t1983r2103b2035],
11	.	.	O	.	_	0	SENT_282	[p19l1914t1983r2103b2035],

1	2	CD	NUMBER	2	num	3	SENT_283	[p19l10t2075r39b2123],
2	Kushner	NNP	ORGANIZATION	Kushner	nn	3	SENT_283	[p19l154t2070r403b2123],
3	FG	NNP	ORGANIZATION	FG	_	0	SENT_283	[p19l425t2073r526b2132],
4	,	,	O	,	_	0	SENT_283	[p19l425t2073r526b2132],
5	Hand	NNP	ORGANIZATION	Hand	nn	6	SENT_283	[p19l553t2070r716b2123],
6	M	NNP	ORGANIZATION	M	appos	3	SENT_283	[p19l737t2076r810b2132],
7	,	,	O	,	_	0	SENT_283	[p19l737t2076r810b2132],
8	Smith	NNP	ORGANIZATION	Smith	nn	11	SENT_283	[p19l837t2070r1013b2123],
9	SC	NNP	ORGANIZATION	SC	nn	11	SENT_283	[p19l1037t2074r1115b2123],
10	]	NN	O	]	nn	11	SENT_283	[p19l1138t2076r1195b2139],
11	r	NN	O	r	appos	3	SENT_283	[p19l1138t2076r1195b2139],
12	,	,	O	,	_	0	SENT_283	[p19l1138t2076r1195b2139],
13	et	FW	O	et	nn	14	SENT_283	[p19l1219t2081r1270b2123],
14	al.	FW	O	al.	appos	3	SENT_283	[p19l1290t2070r1352b2123],
15	2009	CD	DATE	2009	dep	14	SENT_283	[p19l1378t2075r1512b2124],
16	Focused	VBN	O	focus	partmod	3	SENT_283	[p19l1537t2070r1775b2123],
17	updates	NNS	O	update	dobj	16	SENT_283	[p19l1793t2070r2036b2140],
18	:	:	O	:	_	0	SENT_283	[p19l1793t2070r2036b2140],

1	ACC/AHA	NNP	O	ACC/AHA	nn	2	SENT_284	[p19l149t2154r468b2220],
2	Guidelines	NNS	O	guideline	_	0	SENT_284	[p19l489t2151r804b2204],
3	for	IN	O	for	_	0	SENT_284	[p19l825t2151r909b2204],
4	the	DT	O	the	det	5	SENT_284	[p19l927t2151r1018b2204],
5	Management	NN	O	management	prep_for	2	SENT_284	[p19l1041t2156r1429b2221],
6	of	IN	O	of	_	0	SENT_284	[p19l1448t2151r1513b2204],
7	Patients	NNS	O	patient	nsubj	13	SENT_284	[p19l1526t2154r1756b2204],
8	With	IN	O	with	_	0	SENT_284	[p19l1777t2151r1919b2204],
9	ST-Elevation	NN	O	st-elevation	nn	12	SENT_284	[p19l155t2230r516b2284],
10	Myocardial	JJ	O	myocardial	amod	12	SENT_284	[p19l538t2230r860b2300],
11	Infarction	NN	O	infarction	nn	12	SENT_284	[p19l883t2230r1174b2284],
12	(	NN	O	(	prep_with	13	SENT_284	[p19l1198t2230r1477b2301],
13	updating	VBG	O	update	prepc_of	5	SENT_284	[p19l1198t2230r1477b2301],
14	the	DT	O	the	det	16	SENT_284	[p19l1496t2230r1588b2284],
15	2004	CD	DATE	2004	num	16	SENT_284	[p19l1611t2235r1746b2284],
16	Guideline	NNP	O	Guideline	dobj	13	SENT_284	[p19l1765t2230r2052b2284],
17	and	CC	O	and	_	0	SENT_284	[p19l151t2310r259b2363],
18	2007	CD	DATE	2007	num	21	SENT_284	[p19l280t2313r413b2366],
19	Focused	NNP	O	Focused	nn	21	SENT_284	[p19l435t2310r672b2363],
20	Update	NNP	O	Update	nn	21	SENT_284	[p19l695t2310r922b2381],
21	)	NN	O	)	conj_and	16	SENT_284	[p19l695t2310r922b2381],
22	and	CC	O	and	_	0	SENT_284	[p19l947t2310r1055b2363],
23	ACC/AHA/SCAI	NNP	O	ACC/AHA/SCAI	nn	24	SENT_284	[p19l1073t2314r1572b2380],
24	Guidelines	NNS	O	guideline	prep_for	2	SENT_284	[p19l1597t2310r1912b2363],
25	on	IN	O	on	_	0	SENT_284	[p19l1935t2329r2009b2363],
26	Percutaneous	JJ	MISC	percutaneous	amod	29	SENT_284	[p19l154t2396r547b2444],
27	Coronary	JJ	MISC	coronary	amod	29	SENT_284	[p19l571t2395r841b2461],
28	Intervention	NN	MISC	intervention	nn	29	SENT_284	[p19l862t2394r1226b2444],
29	(	NN	O	(	prep_on	24	SENT_284	[p19l1250t2391r1530b2461],
30	updating	VBG	O	update	partmod	29	SENT_284	[p19l1250t2391r1530b2461],
31	the	DT	O	the	det	33	SENT_284	[p19l1549t2391r1640b2444],
32	2005	CD	DATE	2005	num	33	SENT_284	[p19l1662t2394r1795b2444],
33	Guideline	NNP	O	Guideline	dobj	30	SENT_284	[p19l1820t2391r2107b2444],
34	and	CC	O	and	_	0	SENT_284	[p19l151t2470r259b2524],
35	2007	CD	DATE	2007	num	38	SENT_284	[p19l280t2474r413b2526],
36	Focused	NNP	O	Focused	nn	38	SENT_284	[p19l435t2470r672b2524],
37	Update	NNP	O	Update	nn	38	SENT_284	[p19l695t2470r941b2541],
38	)	NNP	O	)	dobj	30	SENT_284	[p19l695t2470r941b2541],
39	:	:	O	:	_	0	SENT_284	[p19l695t2470r941b2541],
40	a	DT	O	a	det	41	SENT_284	[p19l965t2489r994b2524],
41	report	NN	O	report	dep	2	SENT_284	[p19l1013t2481r1192b2540],
42	of	IN	O	of	_	0	SENT_284	[p19l1212t2470r1277b2524],
43	the	DT	O	the	det	45	SENT_284	[p19l1285t2470r1377b2524],
44	American	NNP	ORGANIZATION	American	nn	45	SENT_284	[p19l1396t2474r1687b2524],
45	College	NNP	ORGANIZATION	College	prep_of	41	SENT_284	[p19l1708t2470r1922b2541],
46	of	IN	ORGANIZATION	of	_	0	SENT_284	[p19l1943t2470r2008b2524],
47	Cardiology	NNP	ORGANIZATION	Cardiology	nn	54	SENT_284	[p19l153t2550r467b2621],
48	Foundation	NNP	ORGANIZATION	Foundation	nn	54	SENT_284	[p19l488t2550r823b2603],
49	/	:	ORGANIZATION	/	punct	53	SENT_284	[p19l828t2554r1143b2620],
50	American	JJ	ORGANIZATION	american	amod	53	SENT_284	[p19l828t2554r1143b2620],
51	Heart	NNP	ORGANIZATION	Heart	nn	53	SENT_284	[p19l1166t2556r1331b2603],
52	Association	NNP	ORGANIZATION	Association	nn	53	SENT_284	[p19l1349t2554r1689b2603],
53	Task	NNP	ORGANIZATION	Task	dep	54	SENT_284	[p19l1708t2550r1841b2603],
54	Force	NNP	ORGANIZATION	Force	prep_of	45	SENT_284	[p19l1862t2553r2018b2603],
55	on	IN	O	on	_	0	SENT_284	[p19l2039t2569r2112b2603],
56	Practice	NNP	O	Practice	nn	57	SENT_284	[p19l154t2634r382b2684],
57	Guidelines	NNS	O	guideline	prep_on	54	SENT_284	[p19l404t2631r736b2684],
58	.	.	O	.	_	0	SENT_284	[p19l404t2631r736b2684],

1	Circulation	NN	O	circulation	_	0	SENT_285	[p19l765t2631r1076b2684],
2	2009	CD	DATE	2009	num	1	SENT_285	[p19l1096t2636r1247b2691],
3	;	:	O	;	_	0	SENT_285	[p19l1096t2636r1247b2691],
4	120	CD	NUMBER	120	num	6	SENT_285	[p19l1272t2636r1383b2684],
5	:	:	O	:	_	0	SENT_285	[p19l1272t2636r1383b2684],
6	2271-306	CD	NUMBER	2271-306	dep	1	SENT_285	[p19l1408t2634r1687b2686],
7	.	.	O	.	_	0	SENT_285	[p19l1408t2634r1687b2686],

1	3	CD	NUMBER	3	num	3	SENT_286	[p19l12t2724r38b2772],
2	Gurbel	NNP	ORGANIZATION	Gurbel	nn	3	SENT_286	[p19l153t2719r349b2772],
3	PA	NN	ORGANIZATION	pa	_	0	SENT_286	[p19l371t2723r469b2781],
4	,	,	O	,	_	0	SENT_286	[p19l371t2723r469b2781],
5	Bliden	NNP	PERSON	Bliden	nn	6	SENT_286	[p19l493t2719r676b2772],
6	KP	NNP	O	KP	appos	3	SENT_286	[p19l698t2725r794b2780],
7	,	,	O	,	_	0	SENT_286	[p19l698t2725r794b2780],
8	Hiatt	NNP	PERSON	Hiatt	nn	9	SENT_286	[p19l818t2723r963b2772],
9	BL	NN	O	bl	appos	3	SENT_286	[p19l983t2725r1073b2780],
10	,	,	O	,	_	0	SENT_286	[p19l983t2725r1073b2780],
11	O’Connor	NN	O	o’connor	nn	12	SENT_286	[p19l1096t2723r1382b2772],
12	CM	NN	O	cm	appos	3	SENT_286	[p19l1401t2723r1520b2772],
13	.	.	O	.	_	0	SENT_286	[p19l1401t2723r1520b2772],

1	Clopidogrel	NNP	O	Clopidogrel	_	0	SENT_287	[p19l1544t2719r1877b2790],
2	for	IN	O	for	_	0	SENT_287	[p19l1896t2719r1978b2772],
3	coronary	JJ	O	coronary	amod	4	SENT_287	[p19l151t2819r403b2870],
4	stenting	NN	O	stenting	prep_for	1	SENT_287	[p19l422t2803r667b2870],
5	:	:	O	:	_	0	SENT_287	[p19l422t2803r667b2870],
6	response	NN	O	response	nn	7	SENT_287	[p19l689t2819r946b2870],
7	variability	NN	O	variability	conj_and	1	SENT_287	[p19l964t2800r1253b2870],
8	,	,	O	,	_	0	SENT_287	[p19l964t2800r1253b2870],
9	drug	NN	O	drug	nn	10	SENT_287	[p19l1276t2800r1410b2870],
10	resistance	NN	O	resistance	appos	7	SENT_287	[p19l1428t2803r1728b2861],
11	,	,	O	,	_	0	SENT_287	[p19l1428t2803r1728b2861],
12	and	CC	O	and	_	0	SENT_287	[p19l1750t2800r1857b2853],
13	the	DT	O	the	det	14	SENT_287	[p19l1873t2800r1964b2853],
14	effect	NN	O	effect	conj_and	1	SENT_287	[p19l1984t2800r2139b2853],
15	of	IN	O	of	_	0	SENT_287	[p19l151t2879r216b2933],
16	pretreatment	NN	O	pretreatment	nn	18	SENT_287	[p19l224t2891r601b2949],
17	platelet	NN	O	platelet	nn	18	SENT_287	[p19l618t2880r827b2949],
18	reactivity	NN	O	reactivity	prep_of	14	SENT_287	[p19l844t2883r1109b2950],
19	.	.	O	.	_	0	SENT_287	[p19l844t2883r1109b2950],

1	Circulation	NN	O	circulation	_	0	SENT_288	[p19l1136t2880r1440b2933],
2	2003	CD	DATE	2003	num	1	SENT_288	[p19l1460t2885r1607b2941],
3	;	:	O	;	_	0	SENT_288	[p19l1460t2885r1607b2941],
4	107	CD	NUMBER	107	num	6	SENT_288	[p19l1631t2883r1740b2934],
5	:	:	O	:	_	0	SENT_288	[p19l1631t2883r1740b2934],
6	2908-13	CD	NUMBER	2908-13	dep	1	SENT_288	[p19l1763t2885r2007b2933],
7	.	.	O	.	_	0	SENT_288	[p19l1763t2885r2007b2933],

1	4	CD	NUMBER	4	num	3	SENT_289	[p19l7t2976r41b3023],
2	Hochholzer	NNP	O	Hochholzer	nn	3	SENT_289	[p19l154t2971r499b3024],
3	W	NNP	O	W	_	0	SENT_289	[p19l516t2976r588b3033],
4	,	,	O	,	_	0	SENT_289	[p19l516t2976r588b3033],
5	Trenk	NNP	ORGANIZATION	Trenk	nn	6	SENT_289	[p19l609t2971r781b3024],
6	D	NNP	ORGANIZATION	D	appos	3	SENT_289	[p19l802t2976r863b3032],
7	,	,	O	,	_	0	SENT_289	[p19l802t2976r863b3032],
8	Bestehorn	NNP	O	Bestehorn	nn	9	SENT_289	[p19l889t2971r1187b3024],
9	HP	NNP	O	HP	appos	3	SENT_289	[p19l1209t2976r1320b3033],
10	,	,	O	,	_	0	SENT_289	[p19l1209t2976r1320b3033],
11	et	FW	O	et	nn	12	SENT_289	[p19l1343t2982r1395b3024],
12	al.	FW	O	al.	appos	3	SENT_289	[p19l1414t2971r1476b3024],
13	.	.	O	.	_	0	SENT_289	[p19l1414t2971r1476b3024],

1	Impact	NN	O	impact	_	0	SENT_290	[p19l1503t2976r1708b3041],
2	of	IN	O	of	_	0	SENT_290	[p19l1727t2971r1793b3024],
3	the	DT	O	the	det	4	SENT_290	[p19l1801t2971r1893b3024],
4	degree	NN	O	degree	prep_of	1	SENT_290	[p19l1914t2971r2107b3041],
5	of	IN	O	of	_	0	SENT_290	[p19l151t3051r217b3104],
6	peri-interventional	JJ	O	peri-interventional	amod	8	SENT_290	[p19l226t3051r772b3120],
7	platelet	NN	O	platelet	nn	8	SENT_290	[p19l792t3051r1006b3120],
8	inhibition	NN	O	inhibition	prep_of	4	SENT_290	[p19l1024t3051r1317b3104],
9	after	IN	O	after	dep	1	SENT_290	[p19l1337t3051r1469b3104],
10	loading	VBG	O	load	pcomp	9	SENT_290	[p19l1487t3051r1705b3121],
11	with	IN	O	with	prt	10	SENT_290	[p19l1724t3051r1853b3104],
12	Clopidogrel	NN	O	clopidogrel	dobj	10	SENT_290	[p19l151t3130r477b3201],
13	on	IN	O	on	_	0	SENT_290	[p19l497t3149r570b3184],
14	early	JJ	O	early	amod	16	SENT_290	[p19l591t3130r730b3200],
15	clinical	JJ	O	clinical	amod	16	SENT_290	[p19l749t3130r957b3184],
16	outcome	NN	O	outcome	prep_on	12	SENT_290	[p19l978t3141r1230b3184],
17	of	IN	O	of	prep	16	SENT_290	[p19l1252t3130r1317b3184],
18	elective	JJ	O	elective	amod	20	SENT_290	[p19l1328t3130r1542b3184],
19	coronary	JJ	O	coronary	amod	20	SENT_290	[p19l1564t3149r1820b3200],
20	stent	NN	O	stent	dep	17	SENT_290	[p19l1841t3141r1982b3184],
21	placement	NN	O	placement	dep	20	SENT_290	[p19l150t3210r470b3280],
22	.	.	O	.	_	0	SENT_290	[p19l150t3210r470b3280],
23	]	SYM	O	]	dep	12	SENT_290	[p19l485t3216r521b3280],

1	Am	VBP	O	be	dep	3	SENT_291	[p19l537t3214r640b3263],
2	Coll	NNP	O	Coll	nn	3	SENT_291	[p19l664t3210r770b3263],
3	Cardiol	NNP	O	Cardiol	_	0	SENT_291	[p19l794t3210r995b3263],
4	2006	CD	DATE	2006	num	3	SENT_291	[p19l1015t3215r1166b3272],
5	;	:	O	;	_	0	SENT_291	[p19l1015t3215r1166b3272],
6	48	CD	NUMBER	48	dep	3	SENT_291	[p19l1189t3215r1272b3263],
7	:	:	O	:	_	0	SENT_291	[p19l1189t3215r1272b3263],
8	1742-50	CD	NUMBER	1742-50	dep	6	SENT_291	[p19l1296t3213r1537b3266],
9	.	.	O	.	_	0	SENT_291	[p19l1296t3213r1537b3266],

1	5	CD	NUMBER	5	num	3	SENT_292	[p19l12t3305r38b3355],
2	Wiviott	NNP	O	Wiviott	nn	3	SENT_292	[p19l149t3305r360b3355],
3	SD	NN	O	sd	_	0	SENT_292	[p19l384t3305r483b3363],
4	,	,	O	,	_	0	SENT_292	[p19l384t3305r483b3363],
5	Trenk	NN	ORGANIZATION	trenk	nn	6	SENT_292	[p19l505t3302r676b3355],
6	D	NN	ORGANIZATION	d	appos	3	SENT_292	[p19l697t3307r759b3363],
7	,	,	O	,	_	0	SENT_292	[p19l697t3307r759b3363],
8	Frelinger	NNP	ORGANIZATION	Frelinger	nn	9	SENT_292	[p19l785t3302r1049b3372],
9	AL	NNP	ORGANIZATION	AL	appos	3	SENT_292	[p19l1067t3305r1165b3363],
10	,	,	O	,	_	0	SENT_292	[p19l1067t3305r1165b3363],
11	et	FW	O	et	nn	12	SENT_292	[p19l1189t3312r1240b3355],
12	al.	FW	O	al.	appos	3	SENT_292	[p19l1260t3302r1322b3355],
13	.	.	O	.	_	0	SENT_292	[p19l1260t3302r1322b3355],

1	Prasugrel	NNP	O	Prasugrel	_	0	SENT_293	[p19l1348t3302r1626b3372],
2	compared	VBN	O	compare	_	0	SENT_293	[p19l1647t3302r1939b3371],
3	with	IN	O	with	prepc_compared_with	1	SENT_293	[p19l1956t3302r2086b3355],
4	high	JJ	O	high	amod	5	SENT_293	[p19l149t3381r283b3452],
5	loading	NN	O	loading	pobj	1	SENT_293	[p19l302t3381r539b3452],
6	-	:	O	-	_	0	SENT_293	[p19l302t3381r539b3452],
7	and	CC	O	and	_	0	SENT_293	[p19l561t3381r669b3434],
8	maintenance-dose	JJ	O	maintenance-dose	amod	9	SENT_293	[p19l688t3381r1224b3434],
9	Clopidogrel	NNP	O	Clopidogrel	conj_and	1	SENT_293	[p19l1245t3381r1571b3452],
10	in	IN	O	in	_	0	SENT_293	[p19l1590t3385r1649b3434],
11	patients	NNS	O	patient	prep_in	9	SENT_293	[p19l1668t3385r1899b3451],
12	with	IN	O	with	_	0	SENT_293	[p19l1919t3381r2049b3434],
13	planned	VBN	O	plan	amod	16	SENT_293	[p19l150t3462r389b3532],
14	percutaneous	JJ	O	percutaneous	amod	16	SENT_293	[p19l408t3473r802b3532],
15	coronary	JJ	O	coronary	amod	16	SENT_293	[p19l825t3481r1082b3532],
16	intervention	NN	O	intervention	prep_with	11	SENT_293	[p19l1100t3465r1474b3515],
17	:	:	O	:	_	0	SENT_293	[p19l1100t3465r1474b3515],
18	the	DT	O	the	det	19	SENT_293	[p19l1496t3462r1588b3515],
19	Prasugrel	NNP	O	Prasugrel	dep	1	SENT_293	[p19l1612t3462r1889b3532],
20	in	IN	O	in	_	0	SENT_293	[p19l1909t3465r1968b3514],
21	Comparison	NN	O	comparison	prep_in	19	SENT_293	[p19l153t3545r513b3611],
22	to	TO	O	to	_	0	SENT_293	[p19l532t3553r586b3595],
23	Clopidogrel	NNP	O	Clopidogrel	prep_to	21	SENT_293	[p19l609t3542r949b3612],
24	for	IN	O	for	_	0	SENT_293	[p19l970t3542r1053b3595],
25	Inhibition	NN	O	inhibition	prep_for	23	SENT_293	[p19l1075t3542r1370b3595],
26	of	IN	O	of	_	0	SENT_293	[p19l1391t3541r1456b3595],
27	Platelet	NN	O	platelet	nn	28	SENT_293	[p19l1469t3542r1683b3595],
28	Activation	NN	O	activation	prep_of	25	SENT_293	[p19l1701t3545r1997b3595],
29	and	CC	O	and	_	0	SENT_293	[p19l2018t3542r2125b3595],
30	Aggregation-Thrombolysis	NNP	O	Aggregation-Thrombolysis	conj_and	25	SENT_293	[p19l149t3621r935b3692],
31	in	IN	O	in	_	0	SENT_293	[p19l957t3625r1016b3674],
32	Myocardial	JJ	O	myocardial	amod	35	SENT_293	[p19l1038t3621r1360b3691],
33	Infarction	NN	O	infarction	nn	35	SENT_293	[p19l1383t3621r1674b3674],
34	44	CD	NUMBER	44	num	35	SENT_293	[p19l1692t3626r1757b3674],
35	trial	NN	O	trial	prep_in	30	SENT_293	[p19l1773t3621r1904b3674],
36	.	.	O	.	_	0	SENT_293	[p19l1773t3621r1904b3674],

1	Circulation	NN	O	circulation	_	0	SENT_294	[p19l156t3702r467b3755],
2	2007	CD	DATE	2007	num	1	SENT_294	[p19l488t3705r634b3763],
3	;	:	O	;	_	0	SENT_294	[p19l488t3705r634b3763],
4	116	CD	NUMBER	116	num	6	SENT_294	[p19l658t3707r764b3755],
5	:	:	O	:	_	0	SENT_294	[p19l658t3707r764b3755],
6	2923-32	CD	NUMBER	2923-32	dep	1	SENT_294	[p19l789t3707r1045b3755],
7	.	.	O	.	_	0	SENT_294	[p19l789t3707r1045b3755],

1	Wiviott	NNP	PERSON	Wiviott	nn	2	SENT_295	[p20l149t24r360b74],
2	SD	NN	O	sd	_	0	SENT_295	[p20l384t25r483b82],
3	,	,	O	,	_	0	SENT_295	[p20l384t25r483b82],
4	Braunwald	NNP	PERSON	Braunwald	nn	5	SENT_295	[p20l509t20r827b74],
5	E	NNP	O	E	appos	2	SENT_295	[p20l849t24r899b82],
6	,	,	O	,	_	0	SENT_295	[p20l849t24r899b82],
7	McCabe	NNP	PERSON	McCabe	nn	8	SENT_295	[p20l924t20r1159b74],
8	CH	NN	O	ch	appos	2	SENT_295	[p20l1181t25r1298b82],
9	,	,	O	,	_	0	SENT_295	[p20l1181t25r1298b82],
10	et	FW	O	et	nn	11	SENT_295	[p20l1321t31r1372b74],
11	al.	FW	O	al.	appos	2	SENT_295	[p20l1392t20r1454b74],
12	.	.	O	.	_	0	SENT_295	[p20l1392t20r1454b74],

1	Prasugrel	NNP	O	Prasugrel	_	0	SENT_296	[p20l1480t20r1759b91],
2	versus	CC	O	versus	prep	1	SENT_296	[p20l1777t39r1963b74],
3	clopidogrel	NN	O	clopidogrel	dep	2	SENT_296	[p20l151t121r477b191],
4	in	IN	O	in	_	0	SENT_296	[p20l496t124r555b173],
5	patients	NNS	O	patient	prep_in	1	SENT_296	[p20l574t124r805b191],
6	with	IN	O	with	_	0	SENT_296	[p20l825t121r955b174],
7	acute	JJ	O	acute	amod	9	SENT_296	[p20l976t132r1128b174],
8	coronary	JJ	O	coronary	amod	9	SENT_296	[p20l1149t140r1406b191],
9	syndromes	NNS	O	syndrome	prep_with	5	SENT_296	[p20l1426t121r1761b191],
10	.	.	O	.	_	0	SENT_296	[p20l1426t121r1761b191],

1	N	NN	O	n	nn	3	SENT_297	[p20l154t207r205b255],
2	Engl	NNP	O	Engl	nn	3	SENT_297	[p20l224t202r344b272],
3	J	NNP	O	J	nsubj	4	SENT_297	[p20l355t207r390b272],
4	Med	VBD	O	med	_	0	SENT_297	[p20l409t202r529b255],
5	2007	CD	DATE	2007	dobj	4	SENT_297	[p20l549t205r695b263],
6	;	:	O	;	_	0	SENT_297	[p20l549t205r695b263],
7	357	CD	NUMBER	357	num	9	SENT_297	[p20l719t204r836b256],
8	:	:	O	:	_	0	SENT_297	[p20l719t204r836b256],
9	2001-15	CD	NUMBER	2001-15	dep	5	SENT_297	[p20l860t205r1104b255],
10	.	.	O	.	_	0	SENT_297	[p20l860t205r1104b255],

1	Trenk	NN	PERSON	trenk	nn	2	SENT_298	[p20l149t292r320b345],
2	D	NN	O	d	_	0	SENT_298	[p20l342t298r403b354],
3	,	,	O	,	_	0	SENT_298	[p20l342t298r403b354],
4	Hochholzer	NNP	PERSON	Hochholzer	nn	5	SENT_298	[p20l429t292r774b345],
5	W	NNP	PERSON	W	appos	2	SENT_298	[p20l791t298r864b354],
6	,	,	O	,	_	0	SENT_298	[p20l791t298r864b354],
7	Fromm	NNP	PERSON	Fromm	nn	8	SENT_298	[p20l889t295r1106b345],
8	MF	NN	O	mf	appos	2	SENT_298	[p20l1128t295r1242b354],
9	,	,	O	,	_	0	SENT_298	[p20l1128t295r1242b354],
10	et	FW	O	et	nn	11	SENT_298	[p20l1265t303r1317b345],
11	al.	FW	O	al.	appos	2	SENT_298	[p20l1336t292r1398b345],
12	.	.	O	.	_	0	SENT_298	[p20l1336t292r1398b345],

1	Cytochrome	NN	O	cytochrome	nn	3	SENT_299	[p20l1424t292r1777b362],
2	P450	NN	O	p450	nn	3	SENT_299	[p20l1801t295r1939b345],
3	2C19	NN	O	2c19	_	0	SENT_299	[p20l1961t296r2102b346],
4	681G	NN	O	681g	npadvmod	6	SENT_299	[p20l152t376r417b426],
5	—	CD	NUMBER	—	num	4	SENT_299	[p20l152t376r417b426],
6	>	JJR	O	>	dep	3	SENT_299	[p20l152t376r417b426],
7	A	DT	O	a	det	8	SENT_299	[p20l152t376r417b426],
8	polymorphism	NN	O	polymorphism	nsubj	14	SENT_299	[p20l436t373r870b443],
9	and	CC	O	and	_	0	SENT_299	[p20l891t373r999b426],
10	high	JJ	O	high	amod	13	SENT_299	[p20l1017t373r1151b443],
11	on-clopidogrel	JJ	O	on-clopidogrel	amod	13	SENT_299	[p20l1172t373r1592b443],
12	platelet	NN	O	platelet	nn	13	SENT_299	[p20l1612t373r1825b442],
13	reactivity	NN	O	reactivity	nsubj	14	SENT_299	[p20l1844t376r2108b443],
14	associated	VBN	O	associate	ccomp	6	SENT_299	[p20l151t453r448b506],
15	with	IN	O	with	_	0	SENT_299	[p20l466t453r596b506],
16	adverse	JJ	O	adverse	amod	19	SENT_299	[p20l617t453r834b506],
17	1-year	JJ	DURATION	1-year	amod	19	SENT_299	[p20l857t458r1024b522],
18	clinical	JJ	O	clinical	amod	19	SENT_299	[p20l1043t453r1251b506],
19	outcome	NN	O	outcome	prep_with	14	SENT_299	[p20l1271t463r1524b506],
20	of	IN	O	of	_	0	SENT_299	[p20l1546t452r1611b506],
21	elective	JJ	O	elective	amod	24	SENT_299	[p20l1621t453r1836b506],
22	percutaneous	JJ	O	percutaneous	amod	24	SENT_299	[p20l150t543r545b602],
23	coronary	JJ	O	coronary	amod	24	SENT_299	[p20l567t551r824b602],
24	intervention	NN	O	intervention	prep_of	19	SENT_299	[p20l842t536r1202b585],
25	with	IN	O	with	prep	6	SENT_299	[p20l1220t532r1350b585],
26	drug-eluting	NN	O	drug-eluting	dep	25	SENT_299	[p20l1371t532r1735b603],
27	or	CC	O	or	_	0	SENT_299	[p20l1756t551r1816b585],
28	bare-metal	JJ	O	bare-metal	amod	29	SENT_299	[p20l1834t532r2146b585],
29	stents	NNS	O	stent	conj_or	26	SENT_299	[p20l153t624r337b666],
30	.	.	O	.	_	0	SENT_299	[p20l153t624r337b666],
31	]	SYM	O	]	dep	3	SENT_299	[p20l353t618r388b683],

1	Am	VBP	O	be	dep	3	SENT_300	[p20l403t617r507b666],
2	Coll	NNP	O	Coll	nn	3	SENT_300	[p20l531t613r637b666],
3	Cardiol	NNP	O	Cardiol	_	0	SENT_300	[p20l661t613r861b666],
4	2008	CD	DATE	2008	num	3	SENT_300	[p20l882t618r1033b675],
5	;	:	O	;	_	0	SENT_300	[p20l882t618r1033b675],
6	51	CD	NUMBER	51	dep	3	SENT_300	[p20l1058t615r1134b666],
7	:	:	O	:	_	0	SENT_300	[p20l1058t615r1134b666],
8	1925-34	CD	NUMBER	1925-34	dep	6	SENT_300	[p20l1158t616r1404b666],
9	.	.	O	.	_	0	SENT_300	[p20l1158t616r1404b666],

1	Mega	JJ	O	mega	amod	2	SENT_301	[p20l153t708r306b773],
2	IL	NN	O	il	_	0	SENT_301	[p20l324t708r395b771],
3	,	,	O	,	_	0	SENT_301	[p20l324t708r395b771],
4	Close	NNP	O	Close	nn	5	SENT_301	[p20l417t702r570b756],
5	SL	NNP	O	SL	appos	2	SENT_301	[p20l591t707r674b764],
6	,	,	O	,	_	0	SENT_301	[p20l591t707r674b764],
7	Wiviott	NNP	PERSON	Wiviott	nn	8	SENT_301	[p20l692t706r895b756],
8	SD	NN	O	sd	appos	2	SENT_301	[p20l915t707r1012b764],
9	,	,	O	,	_	0	SENT_301	[p20l915t707r1012b764],
10	et	FW	O	et	nn	11	SENT_301	[p20l1033t713r1083b756],
11	al.	FW	O	al.	appos	2	SENT_301	[p20l1100t702r1159b756],
12	.	.	O	.	_	0	SENT_301	[p20l1100t702r1159b756],

1	Cytochrome	NN	O	cytochrome	nn	3	SENT_302	[p20l1181t702r1522b772],
2	p-450	NN	O	p-450	nn	3	SENT_302	[p20l1539t706r1690b772],
3	polymorphisms	NNS	O	polymorphism	_	0	SENT_302	[p20l1707t702r2153b772],
4	and	CC	O	and	_	0	SENT_302	[p20l151t783r256b836],
5	response	NN	O	response	conj_and	3	SENT_302	[p20l273t802r524b853],
6	to	TO	O	to	_	0	SENT_302	[p20l541t794r594b836],
7	clopidogrel	NN	O	clopidogrel	prep_to	3	SENT_302	[p20l613t783r937b853],
8	.	.	O	.	_	0	SENT_302	[p20l613t783r937b853],

1	N	NN	O	n	nn	3	SENT_303	[p20l961t788r1012b836],
2	Engl	NNP	O	Engl	nn	3	SENT_303	[p20l1028t783r1144b853],
3	]	NNP	O	]	nsubj	4	SENT_303	[p20l1152t788r1188b853],
4	Med	VBD	O	med	_	0	SENT_303	[p20l1204t783r1321b836],
5	2009	CD	DATE	2009	dobj	4	SENT_303	[p20l1338t788r1483b845],
6	;	:	O	;	_	0	SENT_303	[p20l1338t788r1483b845],
7	360	CD	NUMBER	360	num	9	SENT_303	[p20l1505t788r1617b836],
8	:	:	O	:	_	0	SENT_303	[p20l1505t788r1617b836],
9	354-62	CD	NUMBER	354-62	dep	5	SENT_303	[p20l1641t786r1847b836],
10	.	.	O	.	_	0	SENT_303	[p20l1641t786r1847b836],

1	Collet	NNP	PERSON	Collet	nn	4	SENT_304	[p20l153t874r321b927],
2	IP	NNP	O	IP	nn	4	SENT_304	[p20l341t879r419b942],
3	,	,	O	,	_	0	SENT_304	[p20l341t879r419b942],
4	I-Iulot	NNP	O	I-Iulot	nsubj	8	SENT_304	[p20l445t874r613b927],
5	IS	VBZ	O	be	cop	8	SENT_304	[p20l633t877r710b942],
6	,	,	O	,	_	0	SENT_304	[p20l633t877r710b942],
7	Pena	NNP	PERSON	Pena	nn	8	SENT_304	[p20l736t879r876b927],
8	A	NNP	O	A	_	0	SENT_304	[p20l894t877r955b935],
9	,	,	O	,	_	0	SENT_304	[p20l894t877r955b935],
10	et	FW	O	et	nn	11	SENT_304	[p20l978t884r1030b927],
11	al.	FW	O	al.	appos	8	SENT_304	[p20l1049t874r1112b927],
12	.	.	O	.	_	0	SENT_304	[p20l1049t874r1112b927],

1	Cytochrome	NN	O	cytochrome	nn	4	SENT_305	[p20l1137t874r1491b943],
2	P450	NN	O	p450	nn	4	SENT_305	[p20l1514t877r1652b927],
3	2C19	NN	O	2c19	nn	4	SENT_305	[p20l1675t877r1815b927],
4	polymorphism	NN	O	polymorphism	_	0	SENT_305	[p20l150t953r584b1023],
5	in	IN	O	in	_	0	SENT_305	[p20l604t957r663b1006],
6	young	JJ	O	young	amod	7	SENT_305	[p20l681t972r864b1023],
7	patients	NNS	O	patient	prep_in	4	SENT_305	[p20l883t957r1113b1023],
8	treated	VBN	O	treat	partmod	7	SENT_305	[p20l1135t953r1337b1006],
9	with	IN	O	with	_	0	SENT_305	[p20l1354t953r1484b1006],
10	clopidogrel	NN	O	clopidogrel	prep_with	8	SENT_305	[p20l1505t953r1830b1024],
11	after	IN	O	after	_	0	SENT_305	[p20l1851t953r1982b1006],
12	myocardial	JJ	O	myocardial	amod	13	SENT_305	[p20l150t1034r474b1104],
13	infarction	NN	O	infarction	prep_after	8	SENT_305	[p20l494t1034r795b1087],
14	:	:	O	:	_	0	SENT_305	[p20l494t1034r795b1087],
15	a	DT	O	a	det	16	SENT_305	[p20l819t1053r848b1087],
16	cohort	NN	O	cohort	dep	4	SENT_305	[p20l868t1034r1055b1087],
17	study	NN	O	study	dep	16	SENT_305	[p20l1076t1034r1240b1104],
18	.	.	O	.	_	0	SENT_305	[p20l1076t1034r1240b1104],

1	Lancet	NNP	O	Lancet	_	0	SENT_306	[p20l1266t1039r1446b1087],
2	2009	CD	DATE	2009	num	1	SENT_306	[p20l1466t1039r1617b1095],
3	;	:	O	;	_	0	SENT_306	[p20l1466t1039r1617b1095],
4	373	CD	NUMBER	373	num	6	SENT_306	[p20l1642t1037r1758b1088],
5	:	:	O	:	_	0	SENT_306	[p20l1642t1037r1758b1088],
6	309-17	CD	NUMBER	309-17	dep	1	SENT_306	[p20l1784t1037r1980b1089],
7	.	.	O	.	_	0	SENT_306	[p20l1784t1037r1980b1089],

1	Simon	NNP	PERSON	Simon	nn	2	SENT_307	[p20l155t1128r345b1178],
2	T	NN	PERSON	t	_	0	SENT_307	[p20l363t1128r411b1186],
3	,	,	O	,	_	0	SENT_307	[p20l363t1128r411b1186],
4	Verstuyft	NNP	O	Verstuyft	nn	5	SENT_307	[p20l433t1124r698b1194],
5	C	NNP	O	C	appos	2	SENT_307	[p20l719t1129r776b1186],
6	,	,	O	,	_	0	SENT_307	[p20l719t1129r776b1186],
7	Mary-Krause	NNP	O	Mary-Krause	nn	8	SENT_307	[p20l801t1130r1173b1194],
8	M	NNP	O	M	appos	2	SENT_307	[p20l1196t1130r1270b1186],
9	,	,	O	,	_	0	SENT_307	[p20l1196t1130r1270b1186],
10	et	FW	O	et	nn	11	SENT_307	[p20l1293t1135r1345b1178],
11	al.	FW	O	al.	appos	2	SENT_307	[p20l1364t1124r1426b1178],
12	.	.	O	.	_	0	SENT_307	[p20l1364t1124r1426b1178],

1	Genetic	JJ	O	genetic	amod	2	SENT_308	[p20l1451t1128r1675b1178],
2	determinants	NNS	O	determinant	_	0	SENT_308	[p20l1695t1124r2086b1178],
3	of	IN	O	of	_	0	SENT_308	[p20l151t1205r217b1258],
4	response	NN	O	response	prep_of	2	SENT_308	[p20l226t1224r488b1275],
5	to	TO	O	to	_	0	SENT_308	[p20l507t1216r562b1258],
6	clopidogrel	NN	O	clopidogrel	nn	9	SENT_308	[p20l583t1205r909b1275],
7	and	CC	O	and	_	0	SENT_308	[p20l930t1205r1037b1258],
8	cardiovascular	JJ	O	cardiovascular	nn	9	SENT_308	[p20l1057t1205r1477b1258],
9	events	NNS	O	event	prep_to	2	SENT_308	[p20l1496t1216r1695b1258],
10	.	.	O	.	_	0	SENT_308	[p20l1496t1216r1695b1258],

1	N	NN	O	n	nn	3	SENT_309	[p20l1722t1210r1773b1258],
2	Engl	NNP	O	Engl	nn	3	SENT_309	[p20l1792t1205r1912b1275],
3	]	NNP	O	]	nsubj	4	SENT_309	[p20l1923t1210r1958b1275],
4	Med	VBD	O	med	_	0	SENT_309	[p20l1978t1205r2098b1258],
5	2009	CD	DATE	2009	dobj	4	SENT_309	[p20l153t1290r303b1346],
6	;	:	O	;	_	0	SENT_309	[p20l153t1290r303b1346],
7	360	CD	NUMBER	360	num	9	SENT_309	[p20l327t1290r444b1339],
8	:	:	O	:	_	0	SENT_309	[p20l327t1290r444b1339],
9	363-75	CD	NUMBER	363-75	dep	5	SENT_309	[p20l470t1288r684b1340],
10	.	.	O	.	_	0	SENT_309	[p20l470t1288r684b1340],

1	wvvw	NN	O	wvvw	_	0	SENT_310	[p20l800t1528r1336b1579],
2	.	.	O	.	_	0	SENT_310	[p20l800t1528r1336b1579],

1	the	DT	O	the	det	2	SENT_311	[p20l800t1528r1336b1579],
2	|	NN	O	|	_	0	SENT_311	[p20l800t1528r1336b1579],
3	ancet.com	NNP	O	ancet.com	nn	4	SENT_311	[p20l800t1528r1336b1579],
4	Vol	NNP	O	Vol	dep	2	SENT_311	[p20l1379t1528r1467b1579],
5	376	CD	NUMBER	376	num	6	SENT_311	[p20l1487t1527r1591b1586],
6	October	NNP	DATE	October	dep	2	SENT_311	[p20l1637t1528r1863b1579],
7	16,2010	CD	DATE	16,2010	num	6	SENT_311	[p20l1879t1527r2125b1588],

1	Articles	NNPS	O	Articles	_	0	SENT_312	[p20l6t1826r156b1862],
2	I	PRP	O	I	dep	1	SENT_312	[p20l204t1663r252b1861],

1	Giusti	NNP	PERSON	Giusti	nn	2	SENT_313	[p20l140t2111r302b2157],
2	B	NNP	PERSON	B	_	0	SENT_313	[p20l323t2113r373b2164],
3	,	,	O	,	_	0	SENT_313	[p20l323t2113r373b2164],
4	Gori	NNP	ORGANIZATION	Gori	nn	5	SENT_313	[p20l396t2111r514b2157],
5	AM	NNP	ORGANIZATION	AM	appos	2	SENT_313	[p20l531t2112r646b2164],
6	,	,	O	,	_	0	SENT_313	[p20l531t2112r646b2164],
7	Marcucci	NNP	PERSON	Marcucci	nn	8	SENT_313	[p20l669t2111r914b2157],
8	R	NNP	PERSON	R	appos	2	SENT_313	[p20l935t2113r986b2164],
9	,	,	O	,	_	0	SENT_313	[p20l935t2113r986b2164],
10	et	FW	O	et	nn	11	SENT_313	[p20l1008t2118r1055b2157],
11	al.	FW	O	al.	appos	2	SENT_313	[p20l1073t2108r1131b2157],
12	.	.	O	.	_	0	SENT_313	[p20l1073t2108r1131b2157],

1	Relation	NN	O	relation	_	0	SENT_314	[p20l1155t2108r1375b2157],
2	of	IN	O	of	_	0	SENT_314	[p20l1394t2108r1454b2157],
3	cytochrome	NN	O	cytochrome	nn	4	SENT_314	[p20l1464t2108r1778b2172],
4	P450	NN	O	p450	prep_of	1	SENT_314	[p20l1800t2111r1927b2157],
5	22	CD	NUMBER	22	num	8	SENT_314	[p20l2094t2113r2153b2156],
6	2C19	NN	O	2c19	nn	8	SENT_314	[p20l140t2185r269b2231],
7	loss-of-function	NN	O	loss-of-function	nn	8	SENT_314	[p20l288t2182r710b2231],
8	polymorphism	NN	O	polymorphism	dep	1	SENT_314	[p20l728t2182r1128b2246],
9	to	TO	O	to	_	0	SENT_314	[p20l1146t2192r1195b2231],
10	occurrence	NN	O	occurrence	prep_to	8	SENT_314	[p20l1216t2199r1511b2231],
11	of	IN	O	of	_	0	SENT_314	[p20l1531t2182r1591b2231],
12	drug-eluting	JJ	O	drug-eluting	amod	15	SENT_314	[p20l1601t2182r1937b2246],
13	coronary	JJ	O	coronary	amod	15	SENT_314	[p20l139t2272r376b2319],
14	stent	NN	O	stent	nn	15	SENT_314	[p20l394t2264r525b2304],
15	thrombosis	NN	O	thrombosis	prep_of	10	SENT_314	[p20l541t2255r863b2304],
16	.	.	O	.	_	0	SENT_314	[p20l541t2255r863b2304],

1	Am	VBP	O	be	dep	3	SENT_315	[p20l883t2258r979b2303],
2	]	CD	NUMBER	]	num	3	SENT_315	[p20l988t2259r1021b2319],
3	Cardiol	NNP	O	Cardiol	_	0	SENT_315	[p20l1041t2255r1226b2304],
4	2009	CD	DATE	2009	num	3	SENT_315	[p20l1246t2259r1384b2311],
5	;	:	O	;	_	0	SENT_315	[p20l1246t2259r1384b2311],
6	103	CD	NUMBER	103	dep	3	SENT_315	[p20l1407t2259r1509b2304],
7	:	:	O	:	_	0	SENT_315	[p20l1407t2259r1509b2304],
8	806-11	CD	NUMBER	806-11	dep	6	SENT_315	[p20l1531t2259r1723b2304],
9	.	.	O	.	_	0	SENT_315	[p20l1531t2259r1723b2304],

1	Sibbing	VBG	O	sibb	_	0	SENT_316	[p20l142t2338r346b2402],
2	D	NN	O	d	dobj	1	SENT_316	[p20l367t2343r424b2394],
3	,	,	O	,	_	0	SENT_316	[p20l367t2343r424b2394],
4	Stegherr	NN	O	stegherr	nn	5	SENT_316	[p20l449t2338r678b2402],
5	I	NN	O	i	appos	2	SENT_316	[p20l696t2343r730b2400],
6	,	,	O	,	_	0	SENT_316	[p20l696t2343r730b2400],
7	Latz	NNP	PERSON	Latz	nn	8	SENT_316	[p20l753t2343r861b2387],
8	W	NNP	O	W	appos	2	SENT_316	[p20l880t2343r946b2394],
9	,	,	O	,	_	0	SENT_316	[p20l880t2343r946b2394],
10	et	FW	O	et	nn	11	SENT_316	[p20l967t2348r1015b2387],
11	al.	FW	O	al.	appos	2	SENT_316	[p20l1033t2338r1090b2387],
12	.	.	O	.	_	0	SENT_316	[p20l1033t2338r1090b2387],

1	Cytochrome	NN	O	cytochrome	nn	5	SENT_317	[p20l1114t2338r1440b2402],
2	P450	NN	O	p450	nn	5	SENT_317	[p20l1461t2341r1588b2387],
3	2C19	NN	O	2c19	nn	5	SENT_317	[p20l1609t2341r1738b2387],
4	lossoffunction	NN	O	lossoffunction	nn	5	SENT_317	[p20l1757t2338r1947b2387, p20l138t2411r368b2460],
5	polymorphism	NN	O	polymorphism	_	0	SENT_317	[p20l385t2411r786b2475],
6	and	CC	O	and	_	0	SENT_317	[p20l805t2411r904b2460],
7	stent	NN	O	stent	nn	8	SENT_317	[p20l924t2421r1054b2460],
8	thrombosis	NN	O	thrombosis	conj_and	5	SENT_317	[p20l1070t2411r1377b2460],
9	following	VBG	O	follow	_	0	SENT_317	[p20l1398t2411r1651b2475],
10	23	CD	NUMBER	23	num	13	SENT_317	[p20l2094t2415r2151b2460],
11	percutaneous	JJ	O	percutaneous	amod	13	SENT_317	[p20l138t2493r501b2547],
12	coronary	JJ	O	coronary	amod	13	SENT_317	[p20l522t2500r759b2547],
13	intervention	NN	O	intervention	prep_following	5	SENT_317	[p20l776t2486r1120b2532],
14	.	.	O	.	_	0	SENT_317	[p20l776t2486r1120b2532],

1	Ear	NN	O	ear	nn	2	SENT_318	[p20l1146t2486r1240b2532],
2	Heart	NNP	O	Heart	_	0	SENT_318	[p20l1258t2488r1447b2547],
3	]	CD	NUMBER	]	num	4	SENT_318	[p20l1258t2488r1447b2547],
4	2009	CD	DATE	2009	dep	2	SENT_318	[p20l1464t2487r1603b2539],
5	;	:	O	;	_	0	SENT_318	[p20l1464t2487r1603b2539],
6	30	CD	NUMBER	30	num	8	SENT_318	[p20l1625t2487r1700b2532],
7	:	:	O	:	_	0	SENT_318	[p20l1625t2487r1700b2532],
8	916-22	CD	NUMBER	916-22	dep	2	SENT_318	[p20l1722t2487r1920b2532],
9	.	.	O	.	_	0	SENT_318	[p20l1722t2487r1920b2532],

1	Shuldiner	NNP	PERSON	Shuldiner	nn	2	SENT_319	[p20l142t2566r409b2615],
2	AR	NNS	O	ar	_	0	SENT_319	[p20l425t2569r524b2622],
3	,	,	O	,	_	0	SENT_319	[p20l425t2569r524b2622],
4	O'Connell	NNP	PERSON	O'Connell	nn	5	SENT_319	[p20l546t2566r821b2615],
5	IR	NNP	O	IR	appos	2	SENT_319	[p20l840t2570r916b2628],
6	,	,	O	,	_	0	SENT_319	[p20l840t2570r916b2628],
7	Bliden	NNP	PERSON	Bliden	nn	8	SENT_319	[p20l940t2566r1112b2615],
8	KP	NNP	O	KP	appos	2	SENT_319	[p20l1134t2570r1223b2622],
9	,	,	O	,	_	0	SENT_319	[p20l1134t2570r1223b2622],
10	et	FW	O	et	nn	11	SENT_319	[p20l1245t2576r1292b2615],
11	al.	FW	O	al.	appos	2	SENT_319	[p20l1310t2566r1367b2615],
12	.	.	O	.	_	0	SENT_319	[p20l1310t2566r1367b2615],

1	Association	NNP	O	Association	_	0	SENT_320	[p20l1388t2569r1701b2615],
2	of	IN	O	of	_	0	SENT_320	[p20l1720t2566r1780b2615],
3	cytochrome	NN	O	cytochrome	nn	4	SENT_320	[p20l139t2640r453b2703],
4	P450	NN	O	p450	prep_of	1	SENT_320	[p20l475t2643r601b2689],
5	2C19	NN	O	2c19	nn	6	SENT_320	[p20l622t2643r751b2689],
6	genotype	NN	O	genotype	dep	1	SENT_320	[p20l772t2649r1014b2704],
7	with	IN	O	with	_	0	SENT_320	[p20l1032t2640r1151b2689],
8	the	DT	O	the	det	10	SENT_320	[p20l1168t2640r1253b2689],
9	antiplatelet	JJ	O	antiplatelet	amod	10	SENT_320	[p20l1272t2640r1573b2703],
10	effect	NN	O	effect	prep_with	6	SENT_320	[p20l1591t2640r1737b2689],
11	and	CC	O	and	_	0	SENT_320	[p20l1754t2640r1854b2689],
12	clinical	JJ	O	clinical	amod	13	SENT_320	[p20l139t2712r330b2761],
13	eﬂicacy	NN	O	eﬂicacy	conj_and	10	SENT_320	[p20l349t2712r549b2776],
14	of	IN	O	of	prep	13	SENT_320	[p20l567t2712r627b2761],
15	clopidogrel	NN	O	clopidogrel	nn	16	SENT_320	[p20l636t2712r936b2777],
16	therapy	NN	O	therapy	dep	14	SENT_320	[p20l954t2712r1164b2776],
17	.	.	O	.	_	0	SENT_320	[p20l954t2712r1164b2776],
18	]	SYM	O	]	dep	13	SENT_320	[p20l1178t2716r1354b2776],

1	AMA	NNP	O	AMA	_	0	SENT_321	[p20l1178t2716r1354b2776],
2	2009	CD	DATE	2009	num	1	SENT_321	[p20l1373t2716r1512b2768],
3	;	:	O	;	_	0	SENT_321	[p20l1373t2716r1512b2768],
4	302	CD	NUMBER	302	num	6	SENT_321	[p20l1534t2716r1642b2761],
5	:	:	O	:	_	0	SENT_321	[p20l1534t2716r1642b2761],
6	849-57	CD	NUMBER	849-57	dep	1	SENT_321	[p20l1663t2715r1849b2763],
7	.	.	O	.	_	0	SENT_321	[p20l1663t2715r1849b2763],

1	24	CD	NUMBER	24	num	3	SENT_322	[p20l2094t2717r2154b2760],
2	Anderson	NNP	PERSON	Anderson	nn	3	SENT_322	[p20l137t2796r404b2845],
3	IL	NN	PERSON	il	_	0	SENT_322	[p20l423t2800r491b2858],
4	,	,	O	,	_	0	SENT_322	[p20l423t2800r491b2858],
5	Mower	NNP	ORGANIZATION	Mower	nn	6	SENT_322	[p20l514t2800r701b2845],
6	CP	NNP	ORGANIZATION	CP	appos	3	SENT_322	[p20l720t2799r811b2852],
7	,	,	O	,	_	0	SENT_322	[p20l720t2799r811b2852],
8	Horne	NNP	PERSON	Horne	nn	9	SENT_322	[p20l835t2800r1007b2845],
9	BD	NNP	O	BD	appos	3	SENT_322	[p20l1029t2800r1126b2852],
10	,	,	O	,	_	0	SENT_322	[p20l1029t2800r1126b2852],
11	et	FW	O	et	nn	12	SENT_322	[p20l1148t2806r1195b2845],
12	al.	FW	O	al.	appos	3	SENT_322	[p20l1214t2796r1271b2845],
13	.	.	O	.	_	0	SENT_322	[p20l1214t2796r1271b2845],

1	Carriage	NN	O	carriage	_	0	SENT_323	[p20l1294t2799r1519b2860],
2	of	IN	O	of	dobj	9	SENT_323	[p20l1539t2796r1599b2845],
3	the	DT	O	the	det	6	SENT_323	[p20l1607t2796r1691b2845],
4	C	NN	O	c	nn	6	SENT_323	[p20l143t2872r182b2917],
5	YP2C19	NN	O	yp2c19	nn	6	SENT_323	[p20l187t2872r454b2918],
6	°	NN	O	°	rcmod	2	SENT_323	[p20l187t2872r454b2918],
7	'	''	O	'	_	0	SENT_323	[p20l187t2872r454b2918],
8	*	CD	NUMBER	*	num	9	SENT_323	[p20l187t2872r454b2918],
9	‘	NN	O	‘	dep	1	SENT_323	[p20l187t2872r454b2918],
10	2	CD	NUMBER	2	dep	9	SENT_323	[p20l187t2872r454b2918],
11	allele	NN	O	allele	nsubj	12	SENT_323	[p20l475t2868r613b2917],
12	increases	VBZ	O	increase	ccomp	9	SENT_323	[p20l632t2871r880b2917],
13	one-year	JJ	DURATION	one-year	amod	14	SENT_323	[p20l901t2886r1130b2932],
14	risk	NN	O	risk	dobj	12	SENT_323	[p20l1147t2868r1249b2917],
15	of	IN	O	of	_	0	SENT_323	[p20l1267t2868r1326b2917],
16	myocardial	JJ	O	myocardial	amod	17	SENT_323	[p20l1336t2868r1633b2932],
17	infarction	NN	O	infarction	prep_of	14	SENT_323	[p20l1651t2868r1916b2917],
18	among	IN	O	among	_	0	SENT_323	[p20l139t2959r326b3006],
19	recipients	NNS	O	recipient	prep_among	12	SENT_323	[p20l344t2945r608b3006],
20	of	IN	O	of	_	0	SENT_323	[p20l629t2942r689b2991],
21	drug-eluting	JJ	O	drug-eluting	amod	22	SENT_323	[p20l699t2942r1034b3006],
22	stents	NNS	O	stent	prep_of	19	SENT_323	[p20l1055t2952r1209b2991],
23	treated	VBN	O	treat	partmod	22	SENT_323	[p20l1228t2942r1415b2991],
24	with	IN	O	with	_	0	SENT_323	[p20l1431t2942r1550b2991],
25	clopidogrel	NN	O	clopidogrel	prep_with	23	SENT_323	[p20l1570t2942r1882b3006],
26	.	.	O	.	_	0	SENT_323	[p20l1570t2942r1882b3006],
27	]	SYM	O	]	dep	1	SENT_323	[p20l131t3019r164b3079],

1	Am	VBP	O	be	cop	3	SENT_324	[p20l178t3018r274b3063],
2	Coll	NNP	O	Coll	nn	3	SENT_324	[p20l295t3015r393b3064],
3	Cardiol	NNP	O	Cardiol	_	0	SENT_324	[p20l415t3015r600b3064],
4	2009	CD	DATE	2009	dep	3	SENT_324	[p20l619t3019r758b3071],
5	;	:	O	;	_	0	SENT_324	[p20l619t3019r758b3071],
6	53	CD	NUMBER	53	number	7	SENT_324	[p20l782t3017r840b3064],
7	(	CD	NUMBER	(	dep	3	SENT_324	[p20l864t3019r936b3079],
8	10	CD	NUMBER	10	num	9	SENT_324	[p20l864t3019r936b3079],
9	suppl	NN	O	suppl	dep	7	SENT_324	[p20l957t3015r1104b3078],
10	A	DT	O	a	det	11	SENT_324	[p20l1121t3018r1197b3079],
11	)	NN	O	)	dep	7	SENT_324	[p20l1121t3018r1197b3079],
12	:	:	O	:	_	0	SENT_324	[p20l1121t3018r1197b3079],
13	A27	NN	O	a27	dep	3	SENT_324	[p20l1217t3017r1322b3065],
14	.	.	O	.	_	0	SENT_324	[p20l1217t3017r1322b3065],

1	25	CD	NUMBER	25	num	3	SENT_325	[p20l2094t3018r2152b3063],
2	Mega	JJ	O	mega	amod	3	SENT_325	[p20l140t3102r285b3162],
3	IL	NN	O	il	_	0	SENT_325	[p20l305t3102r373b3160],
4	,	,	O	,	_	0	SENT_325	[p20l305t3102r373b3160],
5	Close	NNP	O	Close	nn	6	SENT_325	[p20l396t3097r541b3146],
6	SL	NNP	O	SL	appos	3	SENT_325	[p20l564t3101r642b3153],
7	,	,	O	,	_	0	SENT_325	[p20l564t3101r642b3153],
8	Wiviott	NNP	PERSON	Wiviott	nn	9	SENT_325	[p20l663t3100r857b3146],
9	SD	NN	O	sd	appos	3	SENT_325	[p20l878t3101r971b3153],
10	,	,	O	,	_	0	SENT_325	[p20l878t3101r971b3153],
11	et	FW	O	et	nn	12	SENT_325	[p20l992t3107r1040b3146],
12	al.	FW	O	al.	appos	3	SENT_325	[p20l1057t3097r1114b3146],
13	.	.	O	.	_	0	SENT_325	[p20l1057t3097r1114b3146],

1	Cytochrome	NN	O	cytochrome	nn	2	SENT_326	[p20l1138t3097r1464b3161],
2	P450	NN	O	p450	_	0	SENT_326	[p20l1486t3100r1613b3146],
3	genetic	JJ	O	genetic	amod	4	SENT_326	[p20l1633t3100r1825b3161],
4	polymorphisms	NNS	O	polymorphism	dep	2	SENT_326	[p20l138t3171r563b3235],
5	and	CC	O	and	_	0	SENT_326	[p20l585t3171r684b3220],
6	the	DT	O	the	det	7	SENT_326	[p20l701t3171r785b3220],
7	response	NN	O	response	conj_and	2	SENT_326	[p20l804t3188r1045b3234],
8	to	TO	O	to	_	0	SENT_326	[p20l1063t3181r1113b3220],
9	prasugrel	NN	O	prasugrel	prep_to	7	SENT_326	[p20l1132t3171r1400b3235],
10	:	:	O	:	_	0	SENT_326	[p20l1132t3171r1400b3235],
11	relationship	NN	O	relationship	dep	2	SENT_326	[p20l1422t3171r1745b3234],
12	to	TO	O	to	_	0	SENT_326	[p20l1763t3181r1813b3220],
13	pharmacokinetic	JJ	O	pharmacokinetic	prep_to	11	SENT_326	[p20l138t3243r607b3307],
14	,	,	O	,	_	0	SENT_326	[p20l138t3243r607b3307],
15	pharmacodynamic	JJ	O	pharmacodynamic	prep_to	11	SENT_326	[p20l627t3243r1146b3307],
16	,	,	O	,	_	0	SENT_326	[p20l627t3243r1146b3307],
17	and	CC	O	and	_	0	SENT_326	[p20l1167t3243r1267b3292],
18	clinical	JJ	O	clinical	amod	19	SENT_326	[p20l1285t3243r1476b3292],
19	outcomes	NNS	O	outcome	conj_and	13	SENT_326	[p20l1495t3253r1769b3292],
20	.	.	O	.	_	0	SENT_326	[p20l1495t3253r1769b3292],

1	Circulation	NN	O	circulation	_	0	SENT_327	[p20l143t3316r430b3365],
2	2009	CD	DATE	2009	num	1	SENT_327	[p20l449t3320r588b3373],
3	;	:	O	;	_	0	SENT_327	[p20l449t3320r588b3373],
4	119	CD	NUMBER	119	num	6	SENT_327	[p20l611t3320r709b3365],
5	:	:	O	:	_	0	SENT_327	[p20l611t3320r709b3365],
6	2553-60	CD	NUMBER	2553-60	dep	1	SENT_327	[p20l731t3319r967b3365],
7	.	.	O	.	_	0	SENT_327	[p20l731t3319r967b3365],

1	Taubert	NNP	PERSON	Taubert	nn	2	SENT_328	[p20l137t3401r344b3450],
2	D	NNP	PERSON	D	_	0	SENT_328	[p20l364t3405r420b3457],
3	,	,	O	,	_	0	SENT_328	[p20l364t3405r420b3457],
4	von	NNP	PERSON	von	nn	6	SENT_328	[p20l440t3418r538b3450],
5	Beckerath	NNP	PERSON	Beckerath	nn	6	SENT_328	[p20l559t3401r826b3450],
6	N	NNP	PERSON	N	appos	2	SENT_328	[p20l846t3405r903b3457],
7	,	,	O	,	_	0	SENT_328	[p20l846t3405r903b3457],
8	Grimberg	NNP	PERSON	Grimberg	nn	9	SENT_328	[p20l926t3401r1190b3466],
9	G	NNP	PERSON	G	appos	2	SENT_328	[p20l1209t3404r1267b3457],
10	,	,	O	,	_	0	SENT_328	[p20l1209t3404r1267b3457],
11	et	FW	O	et	nn	12	SENT_328	[p20l1289t3410r1337b3450],
12	al.	FW	O	al.	appos	2	SENT_328	[p20l1355t3401r1412b3450],
13	.	.	O	.	_	0	SENT_328	[p20l1355t3401r1412b3450],

1	Impact	NN	O	impact	_	0	SENT_329	[p20l1436t3405r1625b3465],
2	of	IN	O	of	_	0	SENT_329	[p20l1643t3401r1703b3450],
3	P-glycoprotein	NN	O	p-glycoprotein	prep_of	1	SENT_329	[p20l141t3475r529b3540],
4	on	IN	O	on	_	0	SENT_329	[p20l548t3492r616b3524],
5	clopidogrel	NN	O	clopidogrel	nn	6	SENT_329	[p20l635t3475r934b3540],
6	absorption	NN	O	absorption	prep_on	1	SENT_329	[p20l954t3475r1255b3539],
7	.	.	O	.	_	0	SENT_329	[p20l954t3475r1255b3539],

1	Clin	NNP	O	Clin	nn	3	SENT_330	[p20l1281t3475r1387b3524],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_330	[p20l1408t3475r1684b3524],
3	Ther	NNP	O	Ther	_	0	SENT_330	[p20l1706t3475r1823b3524],
4	2006	CD	DATE	2006	num	3	SENT_330	[p20l1839t3479r1978b3531],
5	;	:	O	;	_	0	SENT_330	[p20l1839t3479r1978b3531],
6	26	CD	NUMBER	26	num	7	SENT_330	[p20l2094t3466r2153b3511],
7	80	CD	NUMBER	80	dep	3	SENT_330	[p20l140t3553r215b3598],
8	:	:	O	:	_	0	SENT_330	[p20l140t3553r215b3598],
9	486-501	CD	NUMBER	486-501	dep	7	SENT_330	[p20l234t3552r464b3598],
10	.	.	O	.	_	0	SENT_330	[p20l234t3552r464b3598],

1	17	CD	NUMBER	17	num	3	SENT_331	[p21l9t27r60b76],
2	Wiviott	NNP	O	Wiviott	nn	3	SENT_331	[p21l137t28r332b74],
3	SD	NN	O	sd	_	0	SENT_331	[p21l353t28r445b81],
4	,	,	O	,	_	0	SENT_331	[p21l353t28r445b81],
5	Braunwald	NNP	PERSON	Braunwald	nn	6	SENT_331	[p21l469t24r761b74],
6	E	NNP	O	E	appos	3	SENT_331	[p21l782t27r828b81],
7	,	,	O	,	_	0	SENT_331	[p21l782t27r828b81],
8	McCabe	NNP	PERSON	McCabe	nn	9	SENT_331	[p21l851t24r1067b74],
9	CH	NN	O	ch	appos	3	SENT_331	[p21l1088t28r1195b81],
10	,	,	O	,	_	0	SENT_331	[p21l1088t28r1195b81],
11	et	FW	O	et	nn	12	SENT_331	[p21l1217t34r1264b74],
12	al	FW	O	al	appos	3	SENT_331	[p21l1282t24r1339b81],
13	,	,	O	,	_	0	SENT_331	[p21l1282t24r1339b81],
14	for	IN	O	for	_	0	SENT_331	[p21l1360t24r1437b74],
15	the	DT	O	the	det	16	SENT_331	[p21l1454t24r1538b74],
16	TRITON	NNP	ORGANIZATION	TRITON	prep_for	3	SENT_331	[p21l1556t27r1970b74],
17	.	.	O	.	_	0	SENT_331	[p21l1556t27r1970b74],

1	—	NN	O	—	_	0	SENT_332	[p21l1556t27r1970b74],
2	.	.	O	.	_	0	SENT_332	[p21l1556t27r1970b74],

1	TIMI	NNP	ORGANIZATION	TIMI	_	0	SENT_333	[p21l1556t27r1970b74],
2	38	CD	NUMBER	38	num	3	SENT_333	[p21l141t103r200b148],
3	Investigators	NNS	O	investigator	dep	1	SENT_333	[p21l222t102r581b163],
4	.	.	O	.	_	0	SENT_333	[p21l222t102r581b163],

1	Intensive	JJ	O	intensive	amod	4	SENT_334	[p21l605t102r852b148],
2	oral	JJ	O	oral	amod	4	SENT_334	[p21l872t99r973b148],
3	antiplatelet	JJ	O	antiplatelet	amod	4	SENT_334	[p21l993t99r1293b163],
4	therapy	NN	O	therapy	nsubj	19	SENT_334	[p21l1309t99r1513b163],
5	for	IN	O	for	_	0	SENT_334	[p21l1530t99r1607b148],
6	reduction	NN	O	reduction	prep_for	4	SENT_334	[p21l1624t99r1883b148],
7	of	IN	O	of	_	0	SENT_334	[p21l1903t99r1962b148],
8	ischaemic	JJ	O	ischaemic	amod	9	SENT_334	[p21l138t172r409b221],
9	events	NNS	O	event	prep_of	6	SENT_334	[p21l428t182r596b221],
10	including	VBG	O	include	_	0	SENT_334	[p21l616t172r875b236],
11	stent	JJ	O	stent	amod	12	SENT_334	[p21l895t182r1026b221],
12	thrombosis	NN	O	thrombosis	prep_including	9	SENT_334	[p21l1042t172r1349b221],
13	in	IN	O	in	_	0	SENT_334	[p21l1369t175r1423b220],
14	patients	NNS	O	patient	prep_in	12	SENT_334	[p21l1441t175r1653b235],
15	with	IN	O	with	_	0	SENT_334	[p21l1672t172r1791b221],
16	acute	JJ	O	acute	amod	18	SENT_334	[p21l1811t182r1951b221],
17	coronary	JJ	O	coronary	amod	18	SENT_334	[p21l139t263r376b309],
18	syndromes	NNS	O	syndrome	prep_with	14	SENT_334	[p21l394t245r688b309],
19	treated	VBN	O	treat	_	0	SENT_334	[p21l707t245r894b294],
20	with	IN	O	with	_	0	SENT_334	[p21l910t245r1029b294],
21	percutaneous	JJ	O	percutaneous	amod	23	SENT_334	[p21l1047t255r1410b309],
22	coronary	JJ	O	coronary	amod	23	SENT_334	[p21l1431t263r1668b309],
23	intervention	NN	O	intervention	prep_with	19	SENT_334	[p21l138t321r470b367],
24	and	CC	O	and	_	0	SENT_334	[p21l489t318r588b367],
25	stenting	VBG	O	stent	conj_and	19	SENT_334	[p21l608t321r826b383],
26	in	IN	O	in	_	0	SENT_334	[p21l844t321r898b366],
27	the	DT	O	the	det	30	SENT_334	[p21l915t318r1000b367],
28	TRITON-TIMI	NN	O	triton-timus	nn	30	SENT_334	[p21l1017t321r1417b367],
29	38	CD	NUMBER	38	num	30	SENT_334	[p21l1441t322r1499b367],
30	trial	NN	O	trial	prep_in	25	SENT_334	[p21l1518t318r1639b367],
31	:	:	O	:	_	0	SENT_334	[p21l1518t318r1639b367],
32	a	DT	O	a	det	33	SENT_334	[p21l1661t336r1688b367],
33	subanalysis	NN	O	subanalysis	dep	30	SENT_334	[p21l140t392r448b456],
34	of	IN	O	of	_	0	SENT_334	[p21l469t392r529b441],
35	a	DT	O	a	det	37	SENT_334	[p21l539t409r566b441],
36	randomised	JJ	O	randomised	amod	37	SENT_334	[p21l584t392r908b441],
37	trial	NN	O	trial	prep_of	33	SENT_334	[p21l925t392r1045b441],
38	.	.	O	.	_	0	SENT_334	[p21l925t392r1045b441],

1	Lancet	NNP	O	Lancet	_	0	SENT_335	[p21l1070t396r1236b441],
2	2008	CD	DATE	2008	num	1	SENT_335	[p21l1255t396r1394b448],
3	;	:	O	;	_	0	SENT_335	[p21l1255t396r1394b448],
4	371	CD	NUMBER	371	num	6	SENT_335	[p21l1416t395r1519b441],
5	:	:	O	:	_	0	SENT_335	[p21l1416t395r1519b441],
6	1353-63	CD	NUMBER	1353-63	dep	1	SENT_335	[p21l1542t395r1771b441],
7	.	.	O	.	_	0	SENT_335	[p21l1542t395r1771b441],

1	18	CD	NUMBER	18	num	3	SENT_336	[p21l9t478r63b523],
2	Farid	NNP	ORGANIZATION	Farid	nn	3	SENT_336	[p21l141t474r276b523],
3	NA	NNP	ORGANIZATION	NA	_	0	SENT_336	[p21l295t478r396b531],
4	,	,	O	,	_	0	SENT_336	[p21l295t478r396b531],
5	McIntosh	NNP	ORGANIZATION	McIntosh	nn	6	SENT_336	[p21l419t474r679b523],
6	M	NNP	ORGANIZATION	M	appos	3	SENT_336	[p21l700t479r767b531],
7	,	,	O	,	_	0	SENT_336	[p21l700t479r767b531],
8	Garofolo	NNP	PERSON	Garofolo	nn	9	SENT_336	[p21l790t474r1022b523],
9	E	NNP	O	E	appos	3	SENT_336	[p21l1044t477r1090b531],
10	,	,	O	,	_	0	SENT_336	[p21l1044t477r1090b531],
11	et	FW	O	et	nn	12	SENT_336	[p21l1111t484r1159b523],
12	al.	FW	O	al.	appos	3	SENT_336	[p21l1177t474r1234b523],
13	.	.	O	.	_	0	SENT_336	[p21l1177t474r1234b523],

1	Determination	NN	O	determination	_	0	SENT_337	[p21l1258t477r1656b523],
2	of	IN	O	of	_	0	SENT_337	[p21l1674t474r1734b523],
3	the	DT	O	the	det	7	SENT_337	[p21l1742t474r1827b523],
4	active	JJ	O	active	amod	7	SENT_337	[p21l139t552r289b598],
5	and	CC	O	and	_	0	SENT_337	[p21l309t549r408b598],
6	inactive	JJ	O	inactive	amod	7	SENT_337	[p21l425t552r632b598],
7	metabolites	NNS	O	metabolite	prep_of	1	SENT_337	[p21l651t549r962b598],
8	of	IN	O	of	_	0	SENT_337	[p21l983t549r1043b598],
9	prasugrel	NN	O	prasugrel	prep_of	7	SENT_337	[p21l1052t549r1307b613],
10	in	IN	O	in	_	0	SENT_337	[p21l1326t552r1379b597],
11	human	JJ	O	human	amod	12	SENT_337	[p21l1397t549r1594b598],
12	plasma	NN	O	plasma	prep_in	1	SENT_337	[p21l1612t549r1806b613],
13	by	IN	O	by	_	0	SENT_337	[p21l1823t549r1886b613],
14	liquid	JJ	O	liquid	amod	17	SENT_337	[p21l137t622r296b685],
15	chromatography/tandem	NN	O	chromatography/tandem	nn	17	SENT_337	[p21l314t622r993b686],
16	mass	NN	O	mass	nn	17	SENT_337	[p21l1012t639r1149b671],
17	spectrometry	NN	O	spectrometry	prep_by	1	SENT_337	[p21l1171t631r1531b686],
18	.	.	O	.	_	0	SENT_337	[p21l1171t631r1531b686],

1	Rapid	JJ	ORGANIZATION	rapid	amod	4	SENT_338	[p21l142t694r293b758],
2	Commun	NNP	ORGANIZATION	Commun	nn	4	SENT_338	[p21l315t698r554b743],
3	Mass	NNP	O	Mass	nn	4	SENT_338	[p21l574t699r702b743],
4	Spectrom	NNP	O	Spectrom	_	0	SENT_338	[p21l724t698r958b758],
5	2007	CD	DATE	2007	num	4	SENT_338	[p21l977t697r1111b750],
6	;	:	O	;	_	0	SENT_338	[p21l977t697r1111b750],
7	21	CD	NUMBER	21	num	9	SENT_338	[p21l1134t699r1204b743],
8	:	:	O	:	_	0	SENT_338	[p21l1134t699r1204b743],
9	169-79	CD	NUMBER	169-79	dep	4	SENT_338	[p21l1226t697r1419b745],
10	.	.	O	.	_	0	SENT_338	[p21l1226t697r1419b745],

1	19	CD	NUMBER	19	num	3	SENT_339	[p21l9t782r62b827],
2	Dumaual	JJ	O	dumaual	amod	3	SENT_339	[p21l141t778r391b827],
3	C	NN	O	c	_	0	SENT_339	[p21l412t781r464b834],
4	,	,	O	,	_	0	SENT_339	[p21l412t781r464b834],
5	Miao	NNP	PERSON	Miao	nn	6	SENT_339	[p21l487t781r620b827],
6	X	NNP	PERSON	X	appos	3	SENT_339	[p21l638t782r693b834],
7	,	,	O	,	_	0	SENT_339	[p21l638t782r693b834],
8	Daly	NNP	PERSON	Daly	nn	9	SENT_339	[p21l717t778r837b842],
9	TM	NNP	O	TM	appos	3	SENT_339	[p21l853t781r962b834],
10	,	,	O	,	_	0	SENT_339	[p21l853t781r962b834],
11	et	FW	O	et	nn	12	SENT_339	[p21l984t788r1032b827],
12	al.	FW	O	al.	appos	3	SENT_339	[p21l1049t778r1107b827],
13	.	.	O	.	_	0	SENT_339	[p21l1049t778r1107b827],

1	Comprehensive	NNP	O	Comprehensive	nn	2	SENT_340	[p21l1130t778r1554b841],
2	assessment	NN	O	assessment	nsubj	12	SENT_340	[p21l1574t788r1884b827],
3	of	IN	O	of	_	0	SENT_340	[p21l1903t778r1962b827],
4	metabolic	JJ	O	metabolic	amod	5	SENT_340	[p21l138t850r403b899],
5	enzyme	NN	O	enzyme	prep_of	2	SENT_340	[p21l421t867r631b914],
6	and	CC	O	and	_	0	SENT_340	[p21l651t850r751b899],
7	transporter	NN	O	transporter	nn	8	SENT_340	[p21l767t860r1071b914],
8	genes	NNS	O	gene	conj_and	5	SENT_340	[p21l1089t868r1242b915],
9	using	VBG	O	use	partmod	5	SENT_340	[p21l1261t854r1413b915],
10	the	DT	O	the	det	11	SENT_340	[p21l1430t850r1514b899],
11	Aﬁymetrix	NNP	O	Aﬁymetrix	dobj	9	SENT_340	[p21l1532t851r1823b914],
12	Targeted	VBN	O	target	_	0	SENT_340	[p21l137t924r370b988],
13	Genotyping	NNP	O	Genotyping	nn	14	SENT_340	[p21l389t927r704b988],
14	System	NNP	O	System	dobj	12	SENT_340	[p21l726t927r932b988],
15	.	.	O	.	_	0	SENT_340	[p21l726t927r932b988],

1	Pharmacogenomics	NNS	O	pharmacogenomic	_	0	SENT_341	[p21l957t924r1448b988],
2	2007	CD	DATE	2007	num	1	SENT_341	[p21l1467t927r1601b980],
3	;	:	O	;	_	0	SENT_341	[p21l1467t927r1601b980],
4	8	CD	NUMBER	8	num	6	SENT_341	[p21l1624t928r1666b973],
5	:	:	O	:	_	0	SENT_341	[p21l1624t928r1666b973],
6	293-305	CD	NUMBER	293-305	dep	1	SENT_341	[p21l1689t927r1924b973],
7	.	.	O	.	_	0	SENT_341	[p21l1689t927r1924b973],

1	20	CD	NUMBER	20	num	2	SENT_342	[p21l9t1011r69b1056],
2	Kimchi-Sarfaty	NN	O	kimchi-sarfaty	_	0	SENT_342	[p21l141t1007r543b1071],
3	C	NN	O	c	dep	2	SENT_342	[p21l562t1010r615b1063],
4	,	,	O	,	_	0	SENT_342	[p21l562t1010r615b1063],
5	Oh	UH	O	oh	dep	6	SENT_342	[p21l638t1007r719b1056],
6	IM	NN	O	im	dobj	3	SENT_342	[p21l738t1011r830b1069],
7	,	,	O	,	_	0	SENT_342	[p21l738t1011r830b1069],
8	Kim	NNP	PERSON	Kim	nn	9	SENT_342	[p21l854t1010r967b1055],
9	IW	NNP	O	IW	appos	2	SENT_342	[p21l988t1011r1074b1063],
10	,	,	O	,	_	0	SENT_342	[p21l988t1011r1074b1063],
11	et	FW	O	et	nn	12	SENT_342	[p21l1096t1016r1144b1056],
12	al.	FW	O	al.	appos	9	SENT_342	[p21l1162t1007r1219b1056],
13	.	.	O	.	_	0	SENT_342	[p21l1162t1007r1219b1056],

1	A	DT	O	a	det	2	SENT_343	[p21l1239t1010r1282b1055],
2	“	NN	O	“	_	0	SENT_343	[p21l1302t1007r1496b1056],
3	silent	JJ	O	silent	amod	5	SENT_343	[p21l1302t1007r1496b1056],
4	”	NN	O	”	nn	5	SENT_343	[p21l1302t1007r1496b1056],
5	polymorphism	NN	O	polymorphism	dep	2	SENT_343	[p21l1517t1007r1917b1071],
6	in	IN	O	in	_	0	SENT_343	[p21l138t1082r192b1127],
7	the	DT	O	the	det	9	SENT_343	[p21l209t1079r294b1128],
8	M	NN	O	m	nn	9	SENT_343	[p21l315t1084r371b1127],
9	DR1	NN	O	dr1	prep_in	5	SENT_343	[p21l375t1084r486b1127],
10	gene	NN	O	gene	nn	11	SENT_343	[p21l504t1097r630b1144],
11	changes	NNS	O	change	dep	2	SENT_343	[p21l650t1079r867b1144],
12	substrate	JJ	O	substrate	amod	13	SENT_343	[p21l889t1079r1133b1128],
13	speciﬁcity	NN	O	speciﬁcity	dep	11	SENT_343	[p21l1154t1079r1427b1143],
14	.	.	O	.	_	0	SENT_343	[p21l1154t1079r1427b1143],

1	Science	NNP	O	Science	_	0	SENT_344	[p21l1453t1081r1635b1128],
2	2007	CD	DATE	2007	num	1	SENT_344	[p21l1654t1082r1789b1135],
3	;	:	O	;	_	0	SENT_344	[p21l1654t1082r1789b1135],
4	315	CD	NUMBER	315	num	6	SENT_344	[p21l139t1155r242b1202],
5	:	:	O	:	_	0	SENT_344	[p21l139t1155r242b1202],
6	525-28	CD	NUMBER	525-28	dep	1	SENT_344	[p21l266t1156r468b1202],
7	.	.	O	.	_	0	SENT_344	[p21l266t1156r468b1202],

1	21	CD	NUMBER	21	num	2	SENT_345	[p21l9t1241r64b1285],
2	Hulot	NNP	PERSON	Hulot	nsubj	6	SENT_345	[p21l141t1236r296b1285],
3	IS	VBZ	O	be	cop	6	SENT_345	[p21l314t1240r385b1299],
4	,	,	O	,	_	0	SENT_345	[p21l314t1240r385b1299],
5	Bura	NNP	PERSON	Bura	nn	6	SENT_345	[p21l408t1241r534b1285],
6	A	NNP	O	A	_	0	SENT_345	[p21l551t1240r607b1293],
7	,	,	O	,	_	0	SENT_345	[p21l551t1240r607b1293],
8	Villard	NNP	O	Villard	nn	9	SENT_345	[p21l627t1236r808b1286],
9	E	NNP	O	E	appos	6	SENT_345	[p21l828t1239r874b1292],
10	,	,	O	,	_	0	SENT_345	[p21l828t1239r874b1292],
11	et	FW	O	et	nn	12	SENT_345	[p21l896t1246r943b1285],
12	al.	FW	O	al.	appos	9	SENT_345	[p21l962t1236r1019b1285],
13	.	.	O	.	_	0	SENT_345	[p21l962t1236r1019b1285],

1	Cytochrome	NN	O	cytochrome	nn	4	SENT_346	[p21l1042t1236r1368b1300],
2	P450	NN	O	p450	nn	4	SENT_346	[p21l1390t1239r1517b1285],
3	2C19	NN	O	2c19	nn	4	SENT_346	[p21l1538t1240r1667b1286],
4	lossoffunction	NN	O	lossoffunction	_	0	SENT_346	[p21l1685t1236r1875b1285, p21l138t1332r368b1381],

1	polymorphism	NN	O	polymorphism	nsubj	5	SENT_347	[p21l385t1332r786b1396],
2	is	VBZ	O	be	cop	5	SENT_347	[p21l804t1335r845b1381],
3	a	DT	O	a	det	5	SENT_347	[p21l866t1349r893b1381],
4	major	JJ	O	major	amod	5	SENT_347	[p21l911t1335r1072b1396],
5	determinant	NN	O	determinant	_	0	SENT_347	[p21l1090t1332r1426b1381],
6	of	IN	O	of	_	0	SENT_347	[p21l1444t1332r1504b1381],
7	clopidogrel	NN	O	clopidogrel	nn	8	SENT_347	[p21l1513t1332r1813b1396],
8	responsiveness	NN	O	responsiveness	prep_of	5	SENT_347	[p21l138t1408r547b1468],
9	in	IN	O	in	_	0	SENT_347	[p21l567t1408r621b1453],
10	healthy	JJ	O	healthy	amod	11	SENT_347	[p21l638t1405r837b1469],
11	subjects	NNS	O	subject	prep_in	8	SENT_347	[p21l855t1405r1085b1469],
12	.	.	O	.	_	0	SENT_347	[p21l855t1405r1085b1469],

1	Blood	NN	O	blood	_	0	SENT_348	[p21l1110t1405r1251b1454],
2	2006	CD	DATE	2006	num	1	SENT_348	[p21l1270t1409r1409b1461],
3	;	:	O	;	_	0	SENT_348	[p21l1270t1409r1409b1461],
4	108	CD	NUMBER	108	num	6	SENT_348	[p21l1431t1409r1534b1454],
5	:	:	O	:	_	0	SENT_348	[p21l1431t1409r1534b1454],
6	2244-47	CD	NUMBER	2244-47	dep	1	SENT_348	[p21l1557t1408r1767b1455],
7	.	.	O	.	_	0	SENT_348	[p21l1557t1408r1767b1455],

1	www	NN	O	www	_	0	SENT_349	[p21l6t1637r500b1684],
2	.	.	O	.	_	0	SENT_349	[p21l6t1637r500b1684],

1	the	DT	O	the	det	2	SENT_350	[p21l6t1637r500b1684],
2	|	NN	O	|	_	0	SENT_350	[p21l6t1637r500b1684],
3	ancet.com	NNP	O	ancet.com	nn	4	SENT_350	[p21l6t1637r500b1684],
4	Vol	NNP	O	Vol	dep	2	SENT_350	[p21l540t1637r621b1684],
5	376	CD	NUMBER	376	num	6	SENT_350	[p21l639t1636r735b1691],
6	October	NNP	DATE	October	dep	2	SENT_350	[p21l778t1637r985b1684],
7	16,2010	CD	DATE	16,2010	num	6	SENT_350	[p21l1001t1636r1227b1693],

1	Fontana	NNP	ORGANIZATION	Fontana	nn	2	SENT_351	[p21l14t1830r188b1867],
2	P	NN	ORGANIZATION	p	nsubj	9	SENT_351	[p21l205t1831r243b1873],
3	,	,	O	,	_	0	SENT_351	[p21l205t1831r243b1873],
4	Hulot	NNP	PERSON	Hulot	appos	2	SENT_351	[p21l262t1827r387b1867],
5	IS	VBZ	O	be	cop	9	SENT_351	[p21l402t1830r458b1878],
6	,	,	O	,	_	0	SENT_351	[p21l402t1830r458b1878],
7	De	NNP	PERSON	De	nn	9	SENT_351	[p21l477t1831r536b1867],
8	Moerloose	NNP	PERSON	Moerloose	nn	9	SENT_351	[p21l553t1827r778b1867],
9	P	NN	PERSON	p	_	0	SENT_351	[p21l795t1831r833b1873],
10	,	,	O	,	_	0	SENT_351	[p21l795t1831r833b1873],
11	Gaussem	NNP	PERSON	Gaussem	nn	13	SENT_351	[p21l852t1830r1054b1867],
12	P.	NNP	PERSON	P.	nn	13	SENT_351	[p21l1071t1831r1109b1867],
13	Inﬂuence	NNP	PERSON	Inﬂuence	appos	9	SENT_351	[p21l1128t1827r1335b1867],
14	of	IN	O	of	_	0	SENT_351	[p21l1350t1827r1399b1867],
15	C	NNP	O	C	nn	16	SENT_351	[p21l15t1889r47b1926],
16	YPZC	NNP	O	YPZC	prep_of	13	SENT_351	[p21l51t1889r171b1926],
17	19	CD	NUMBER	19	nn	21	SENT_351	[p21l174t1890r218b1926],
18	and	CC	O	and	_	0	SENT_351	[p21l231t1886r311b1926],
19	CYP3A4	NN	O	cyp3a4	conj_and	17	SENT_351	[p21l329t1889r510b1926],
20	gene	NN	O	gene	nn	21	SENT_351	[p21l522t1900r624b1938],
21	polymorphisms	NNS	O	polymorphism	dep	24	SENT_351	[p21l639t1886r982b1938],
22	on	IN	O	on	_	0	SENT_351	[p21l999t1900r1053b1926],
23	clopidogrel	NN	O	clopidogrel	prep_on	21	SENT_351	[p21l1068t1886r1310b1938],
24	responsiveness	NN	O	responsiveness	dep	13	SENT_351	[p21l11t1947r341b1996],
25	in	IN	O	in	_	0	SENT_351	[p21l357t1947r401b1984],
26	healthy	JJ	O	healthy	amod	27	SENT_351	[p21l415t1945r575b1997],
27	subjects	NNS	O	subject	prep_in	24	SENT_351	[p21l590t1945r775b1997],
28	.	.	O	.	_	0	SENT_351	[p21l590t1945r775b1997],
29	]	SYM	O	]	dep	9	SENT_351	[p21l786t1948r813b1997],

1	Thromb	NNP	O	Thromb	nn	2	SENT_352	[p21l829t1945r989b1984],
2	Haemost	NNP	O	Haemost	_	0	SENT_352	[p21l1007t1948r1189b1984],
3	2007	CD	DATE	2007	num	2	SENT_352	[p21l1204t1947r1312b1990],
4	;	:	O	;	_	0	SENT_352	[p21l1204t1947r1312b1990],
5	5	CD	NUMBER	5	num	7	SENT_352	[p21l13t2007r47b2045],
6	:	:	O	:	_	0	SENT_352	[p21l13t2007r47b2045],
7	2153-55	CD	NUMBER	2153-55	dep	2	SENT_352	[p21l65t2007r250b2045],
8	.	.	O	.	_	0	SENT_352	[p21l65t2007r250b2045],

1	Brandt	NNP	PERSON	Brandt	nn	2	SENT_353	[p21l14t2072r161b2112],
2	IT	NNP	O	IT	_	0	SENT_353	[p21l176t2074r229b2123],
3	,	,	O	,	_	0	SENT_353	[p21l176t2074r229b2123],
4	Close	NNP	O	Close	nn	5	SENT_353	[p21l247t2072r364b2112],
5	SL	NNP	O	SL	appos	2	SENT_353	[p21l383t2075r446b2117],
6	,	,	O	,	_	0	SENT_353	[p21l383t2075r446b2117],
7	Iturria	NNP	ORGANIZATION	Iturria	nn	8	SENT_353	[p21l465t2074r604b2112],
8	SI	NNP	ORGANIZATION	SI	appos	2	SENT_353	[p21l622t2075r676b2123],
9	,	,	O	,	_	0	SENT_353	[p21l622t2075r676b2123],
10	et	FW	O	et	nn	11	SENT_353	[p21l694t2080r732b2112],
11	al.	FW	O	al.	appos	2	SENT_353	[p21l747t2072r793b2112],
12	.	.	O	.	_	0	SENT_353	[p21l747t2072r793b2112],

1	Common	JJ	O	common	amod	2	SENT_354	[p21l811t2075r1017b2112],
2	polymorphisms	NNS	O	polymorphism	nsubj	11	SENT_354	[p21l1031t2072r1375b2124],
3	of	IN	O	of	_	0	SENT_354	[p21l1391t2072r1440b2112],
4	C	NN	O	c	nn	5	SENT_354	[p21l15t2133r47b2170],
5	YPZC	NN	O	ypzc	prep_of	2	SENT_354	[p21l51t2133r171b2170],
6	19	CD	NUMBER	19	num	5	SENT_354	[p21l174t2134r218b2170],
7	and	CC	O	and	_	0	SENT_354	[p21l231t2130r311b2170],
8	C	NN	O	c	nn	9	SENT_354	[p21l329t2133r361b2170],
9	YPZC	NN	O	ypzc	conj_and	2	SENT_354	[p21l365t2133r485b2170],
10	9	CD	NUMBER	9	dep	9	SENT_354	[p21l489t2134r511b2170],
11	affect	VBP	O	affect	_	0	SENT_354	[p21l524t2131r642b2170],
12	the	DT	O	the	det	16	SENT_354	[p21l655t2130r722b2170],
13	pharmacokinetic	JJ	O	pharmacokinetic	amod	16	SENT_354	[p21l737t2130r1105b2182],
14	and	CC	O	and	_	0	SENT_354	[p21l1120t2130r1200b2170],
15	pharmacodynamic	JJ	O	pharmacodynamic	conj_and	13	SENT_354	[p21l11t2189r418b2241],
16	response	NN	O	response	dobj	11	SENT_354	[p21l433t2203r627b2241],
17	to	TO	O	to	dep	16	SENT_354	[p21l642t2197r682b2229],
18	clopidogrel	NN	O	clopidogrel	dep	16	SENT_354	[p21l698t2189r940b2242],
19	but	CC	O	but	_	0	SENT_354	[p21l954t2189r1026b2229],
20	not	RB	O	not	neg	21	SENT_354	[p21l1040t2197r1112b2229],
21	prasugrel	NN	O	prasugrel	dep	16	SENT_354	[p21l1125t2189r1342b2242],
22	.	.	O	.	_	0	SENT_354	[p21l1125t2189r1342b2242],
23	]	SYM	O	]	dep	16	SENT_354	[p21l6t2253r32b2301],

1	Thromb	NNP	O	Thromb	nn	2	SENT_355	[p21l49t2249r209b2289],
2	Haemost	NNP	O	Haemost	_	0	SENT_355	[p21l227t2253r409b2289],
3	2007	CD	DATE	2007	num	2	SENT_355	[p21l424t2251r532b2294],
4	;	:	O	;	_	0	SENT_355	[p21l424t2251r532b2294],
5	5	CD	NUMBER	5	num	7	SENT_355	[p21l551t2251r584b2288],
6	:	:	O	:	_	0	SENT_355	[p21l551t2251r584b2288],
7	2429-36	CD	NUMBER	2429-36	dep	2	SENT_355	[p21l602t2252r790b2289],
8	.	.	O	.	_	0	SENT_355	[p21l602t2252r790b2289],

1	Gladding	VBG	PERSON	gladd	_	0	SENT_356	[p21l13t2315r214b2368],
2	P	NN	PERSON	p	dep	1	SENT_356	[p21l230t2319r269b2361],
3	,	,	O	,	_	0	SENT_356	[p21l230t2319r269b2361],
4	Webster	NNP	PERSON	Webster	nn	5	SENT_356	[p21l285t2315r464b2355],
5	M	NNP	O	M	appos	2	SENT_356	[p21l479t2319r534b2361],
6	,	,	O	,	_	0	SENT_356	[p21l479t2319r534b2361],
7	Zeng	NNP	O	Zeng	appos	2	SENT_356	[p21l553t2318r664b2368],
8	I	PRP	O	I	dep	7	SENT_356	[p21l681t2319r707b2361],
9	,	,	O	,	_	0	SENT_356	[p21l681t2319r707b2361],
10	et	FW	O	et	nn	11	SENT_356	[p21l725t2323r763b2355],
11	al.	FW	O	al.	appos	2	SENT_356	[p21l777t2315r823b2355],
12	.	.	O	.	_	0	SENT_356	[p21l777t2315r823b2355],

1	The	DT	O	the	det	2	SENT_357	[p21l840t2315r923b2355],
2	pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_357	[p21l938t2315r1335b2368],
3	and	CC	O	and	_	0	SENT_357	[p21l1352t2315r1432b2355],
4	pharmacodynamics	NNS	O	pharmacodynamic	conj_and	2	SENT_357	[p21l11t2393r438b2445],
5	of	IN	O	of	_	0	SENT_357	[p21l455t2393r504b2433],
6	clopidogrel	NN	O	clopidogrel	nn	7	SENT_357	[p21l512t2393r754b2445],
7	response	NN	O	response	prep_of	2	SENT_357	[p21l768t2407r974b2445],
8	:	:	O	:	_	0	SENT_357	[p21l768t2407r974b2445],
9	an	DT	O	a	det	10	SENT_357	[p21l991t2407r1043b2433],
10	analysis	NN	O	analysis	dep	2	SENT_357	[p21l1058t2393r1229b2445],
11	from	IN	O	from	_	0	SENT_357	[p21l1245t2393r1352b2433],
12	the	DT	O	the	det	15	SENT_357	[p21l1366t2393r1434b2433],
13	PRINC	NNP	O	PRINC	nn	15	SENT_357	[p21l14t2455r166b2491],
14	(	CD	NUMBER	(	num	15	SENT_357	[p21l186t2452r325b2504],
15	plavix	NN	O	plavix	prep_from	10	SENT_357	[p21l186t2452r325b2504],
16	response	NN	O	response	dep	10	SENT_357	[p21l338t2466r533b2503],
17	in	IN	O	in	prep	16	SENT_357	[p21l548t2454r591b2491],
18	coronary	JJ	O	coronary	amod	20	SENT_357	[p21l606t2466r797b2504],
19	intervention	NN	O	intervention	nn	20	SENT_357	[p21l811t2454r1091b2504],
20	)	NN	O	)	dep	17	SENT_357	[p21l811t2454r1091b2504],
21	trial	NN	O	trial	dep	20	SENT_357	[p21l1108t2452r1206b2491],
22	.	.	O	.	_	0	SENT_357	[p21l1108t2452r1206b2491],
23	]	SYM	O	]	dep	16	SENT_357	[p21l6t2513r137b2562],

1	ACC	NNP	O	ACC	nn	3	SENT_358	[p21l6t2513r137b2562],
2	Cardiovasc	NNP	O	Cardiovasc	nn	3	SENT_358	[p21l153t2510r375b2550],
3	Interv	NNP	O	Interv	_	0	SENT_358	[p21l391t2514r512b2550],
4	2008	CD	DATE	2008	num	3	SENT_358	[p21l527t2514r639b2556],
5	;	:	O	;	_	0	SENT_358	[p21l527t2514r639b2556],
6	1	CD	NUMBER	1	num	8	SENT_358	[p21l656t2514r687b2550],
7	:	:	O	:	_	0	SENT_358	[p21l656t2514r687b2550],
8	620-27	CD	NUMBER	620-27	dep	3	SENT_358	[p21l705t2513r857b2551],
9	.	.	O	.	_	0	SENT_358	[p21l705t2513r857b2551],

1	Wiviott	NNP	PERSON	Wiviott	nn	2	SENT_359	[p21l11t2580r167b2618],
2	SD	NN	O	sd	_	0	SENT_359	[p21l185t2580r259b2623],
3	,	,	O	,	_	0	SENT_359	[p21l185t2580r259b2623],
4	Antman	NNP	ORGANIZATION	Antman	nn	5	SENT_359	[p21l275t2580r455b2617],
5	EM	NNP	ORGANIZATION	EM	appos	2	SENT_359	[p21l472t2580r557b2623],
6	,	,	O	,	_	0	SENT_359	[p21l472t2580r557b2623],
7	Gibson	NNP	PERSON	Gibson	nn	8	SENT_359	[p21l575t2578r730b2617],
8	CM	NN	O	cm	appos	2	SENT_359	[p21l746t2580r836b2623],
9	,	,	O	,	_	0	SENT_359	[p21l746t2580r836b2623],
10	et	FW	O	et	nn	11	SENT_359	[p21l853t2586r891b2617],
11	al.	FW	O	al.	appos	2	SENT_359	[p21l906t2578r952b2617],
12	.	.	O	.	_	0	SENT_359	[p21l906t2578r952b2617],

1	Evaluation	NN	O	evaluation	_	0	SENT_360	[p21l972t2578r1198b2617],
2	of	IN	O	of	_	0	SENT_360	[p21l1213t2577r1262b2617],
3	prasugrel	NN	O	prasugrel	prep_of	1	SENT_360	[p21l1269t2578r1475b2630],
4	compared	VBN	O	compare	_	0	SENT_360	[p21l12t2636r229b2688],
5	with	IN	O	with	prepc_compared_with	3	SENT_360	[p21l241t2636r338b2676],
6	clopidogrel	NN	O	clopidogrel	pobj	3	SENT_360	[p21l353t2636r595b2689],
7	in	IN	O	in	_	0	SENT_360	[p21l609t2639r653b2676],
8	patients	NNS	O	patient	prep_in	1	SENT_360	[p21l667t2639r839b2688],
9	with	IN	O	with	_	0	SENT_360	[p21l854t2636r950b2676],
10	acute	JJ	O	acute	amod	12	SENT_360	[p21l965t2644r1078b2676],
11	coronary	JJ	O	coronary	amod	12	SENT_360	[p21l1094t2650r1285b2689],
12	syndromes	NNS	O	syndrome	prep_with	1	SENT_360	[p21l13t2696r262b2748],
13	:	:	O	:	_	0	SENT_360	[p21l13t2696r262b2748],
14	design	NN	O	design	dep	12	SENT_360	[p21l279t2696r423b2748],
15	and	CC	O	and	_	0	SENT_360	[p21l438t2696r518b2736],
16	rationale	NN	O	rationale	conj_and	14	SENT_360	[p21l532t2696r722b2736],
17	for	IN	O	for	_	0	SENT_360	[p21l738t2696r800b2736],
18	the	DT	O	the	det	19	SENT_360	[p21l813t2696r881b2736],
19	TRial	NN	O	trial	prep_for	14	SENT_360	[p21l895t2696r1012b2736],
20	to	TO	O	to	aux	21	SENT_360	[p21l1026t2704r1067b2736],
21	assess	VB	O	assess	infmod	19	SENT_360	[p21l1083t2710r1215b2736],
22	Improvement	NN	O	improvement	nsubj	32	SENT_360	[p21l14t2758r313b2806],
23	in	IN	O	in	_	0	SENT_360	[p21l327t2757r371b2794],
24	Therapeutic	JJ	O	therapeutic	amod	25	SENT_360	[p21l385t2755r647b2806],
25	Outcomes	NNS	O	outcome	prep_in	22	SENT_360	[p21l663t2758r883b2794],
26	by	IN	O	by	_	0	SENT_360	[p21l899t2755r950b2807],
27	optimizing	VBG	O	optimize	prepc_by	25	SENT_360	[p21l964t2757r1204b2807],
28	platelet	NN	O	platelet	nn	29	SENT_360	[p21l1218t2755r1376b2806],
29	InhibitioN	NN	O	inhibition	dobj	27	SENT_360	[p21l14t2813r240b2853],
30	with	IN	O	with	_	0	SENT_360	[p21l255t2813r351b2853],
31	prasugrel	NN	O	prasugrel	prep_with	27	SENT_360	[p21l366t2813r572b2866],
32	Thrombolysis	NNP	O	Thrombolysis	xcomp	21	SENT_360	[p21l586t2813r886b2865],
33	In	IN	O	in	dep	32	SENT_360	[p21l904t2817r950b2853],
34	Myocardial	JJ	O	myocardial	amod	35	SENT_360	[p21l966t2813r1206b2865],
35	Infarction	NN	O	infarction	pobj	33	SENT_360	[p21l1223t2813r1439b2853],
36	38	CD	NUMBER	38	number	37	SENT_360	[p21l14t2877r61b2913],
37	(	CD	NUMBER	(	num	38	SENT_360	[p21l80t2876r414b2925],
38	TRITON-TIMI	NN	O	triton-timus	dep	35	SENT_360	[p21l80t2876r414b2925],
39	38	CD	NUMBER	38	num	40	SENT_360	[p21l433t2877r508b2925],
40	)	NN	O	)	dep	38	SENT_360	[p21l433t2877r508b2925],
41	.	.	O	.	_	0	SENT_360	[p21l433t2877r508b2925],

1	Am	VBP	O	be	dep	2	SENT_361	[p21l525t2876r601b2912],
2	Heart	NNP	O	Heart	_	0	SENT_361	[p21l618t2877r771b2925],
3	]	CD	NUMBER	]	num	2	SENT_361	[p21l618t2877r771b2925],
4	2006	CD	DATE	2006	dep	2	SENT_361	[p21l784t2877r897b2919],
5	;	:	O	;	_	0	SENT_361	[p21l784t2877r897b2919],
6	152	CD	NUMBER	152	dep	4	SENT_361	[p21l914t2875r998b2913],
7	:	:	O	:	_	0	SENT_361	[p21l914t2875r998b2913],
8	627-35	CD	NUMBER	627-35	dep	6	SENT_361	[p21l1015t2876r1176b2914],
9	.	.	O	.	_	0	SENT_361	[p21l1015t2876r1176b2914],

1	Zhou	NNP	PERSON	Zhou	nn	2	SENT_362	[p21l13t2939r131b2979],
2	SF	NNP	O	SF	_	0	SENT_362	[p21l148t2942r214b2985],
3	,	,	O	,	_	0	SENT_362	[p21l148t2942r214b2985],
4	Di	NNP	ORGANIZATION	Di	nn	5	SENT_362	[p21l233t2942r282b2979],
5	YM	NNP	ORGANIZATION	YM	appos	2	SENT_362	[p21l296t2943r385b2985],
6	,	,	O	,	_	0	SENT_362	[p21l296t2943r385b2985],
7	Chan	NNP	PERSON	Chan	nn	8	SENT_362	[p21l403t2939r519b2979],
8	E	NNP	PERSON	E	appos	2	SENT_362	[p21l536t2942r573b2985],
9	,	,	O	,	_	0	SENT_362	[p21l536t2942r573b2985],
10	et	FW	O	et	nn	11	SENT_362	[p21l591t2947r629b2979],
11	al.	FW	O	al.	appos	2	SENT_362	[p21l643t2939r690b2979],
12	.	.	O	.	_	0	SENT_362	[p21l643t2939r690b2979],

1	Clinical	JJ	O	clinical	amod	2	SENT_363	[p21l708t2939r874b2979],
2	pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_363	[p21l888t2939r1285b2992],
3	and	CC	O	and	_	0	SENT_363	[p21l1302t2939r1382b2979],
4	potential	JJ	O	potential	amod	5	SENT_363	[p21l11t2998r202b3050],
5	application	NN	O	application	conj_and	2	SENT_363	[p21l218t2998r457b3050],
6	in	IN	O	in	_	0	SENT_363	[p21l472t3001r516b3037],
7	personalized	JJ	O	personalized	amod	8	SENT_363	[p21l530t2998r809b3050],
8	medicine	NN	O	medicine	prep_in	2	SENT_363	[p21l823t2998r1036b3038],
9	.	.	O	.	_	0	SENT_363	[p21l823t2998r1036b3038],

1	Curr	NNP	MISC	Curr	nn	3	SENT_364	[p21l1057t3001r1155b3038],
2	Drug	NNP	MISC	Drug	nn	3	SENT_364	[p21l1169t3002r1276b3051],
3	Metab	NNP	MISC	Metab	_	0	SENT_364	[p21l1289t2998r1416b3038],
4	2008	CD	DATE	2008	num	3	SENT_364	[p21l13t3062r125b3104],
5	;	:	O	;	_	0	SENT_364	[p21l13t3062r125b3104],
6	9	CD	NUMBER	9	num	8	SENT_364	[p21l143t3062r177b3098],
7	:	:	O	:	_	0	SENT_364	[p21l143t3062r177b3098],
8	738-84	CD	NUMBER	738-84	dep	3	SENT_364	[p21l194t3061r353b3099],
9	.	.	O	.	_	0	SENT_364	[p21l194t3061r353b3099],

1	Moriya	NNP	PERSON	Moriya	nn	2	SENT_365	[p21l13t3127r163b3176],
2	Y	NN	PERSON	y	_	0	SENT_365	[p21l177t3128r213b3170],
3	,	,	O	,	_	0	SENT_365	[p21l177t3128r213b3170],
4	Nakamura	NNP	PERSON	Nakamura	nn	5	SENT_365	[p21l231t3124r459b3164],
5	T	NN	O	t	appos	2	SENT_365	[p21l473t3127r508b3170],
6	,	,	O	,	_	0	SENT_365	[p21l473t3127r508b3170],
7	I-Iorinouchi	NN	O	i-iorinouchus	nn	8	SENT_365	[p21l527t3124r780b3164],
8	M	NN	O	m	appos	2	SENT_365	[p21l796t3128r851b3170],
9	,	,	O	,	_	0	SENT_365	[p21l796t3128r851b3170],
10	et	FW	O	et	nn	11	SENT_365	[p21l869t3132r907b3164],
11	al.	FW	O	al.	appos	2	SENT_365	[p21l921t3124r967b3164],
12	.	.	O	.	_	0	SENT_365	[p21l921t3124r967b3164],

1	Elfects	NNS	O	elfect	_	0	SENT_366	[p21l987t3124r1129b3164],
2	of	IN	O	of	_	0	SENT_366	[p21l1145t3124r1194b3164],
3	polymorphisms	NNS	O	polymorphism	prep_of	1	SENT_366	[p21l11t3184r354b3236],
4	of	IN	O	of	_	0	SENT_366	[p21l371t3184r420b3224],
5	MDR1	NN	O	mdr1	prep_of	3	SENT_366	[p21l429t3188r577b3229],
6	,	,	O	,	_	0	SENT_366	[p21l429t3188r577b3229],
7	M	NN	O	m	nn	8	SENT_366	[p21l595t3188r641b3223],
8	RP1	NN	O	rp1	prep_of	3	SENT_366	[p21l644t3188r736b3230],
9	,	,	O	,	_	0	SENT_366	[p21l644t3188r736b3230],
10	and	CC	O	and	_	0	SENT_366	[p21l753t3184r834b3224],
11	M	NN	O	m	nn	13	SENT_366	[p21l850t3188r895b3223],
12	RP2	NN	O	rp2	nn	13	SENT_366	[p21l898t3188r987b3223],
13	genes	NNS	O	gene	conj_and	5	SENT_366	[p21l1000t3198r1123b3236],
14	on	IN	O	on	_	0	SENT_366	[p21l1140t3198r1195b3224],
15	their	PRP$	O	they	poss	18	SENT_366	[p21l1209t3184r1312b3224],
16	mRNA	NN	O	mrna	nn	18	SENT_366	[p21l1326t3187r1479b3224],
17	expression	NN	O	expression	nn	18	SENT_366	[p21l12t3245r244b3294],
18	levels	NNS	O	level	prep_on	1	SENT_366	[p21l258t3243r377b3282],
19	in	IN	O	in	_	0	SENT_366	[p21l392t3245r436b3282],
20	duodenal	JJ	O	duodenal	amod	21	SENT_366	[p21l451t3243r653b3282],
21	enterocytes	NNS	O	enterocyte	prep_in	1	SENT_366	[p21l668t3250r912b3295],
22	of	IN	O	of	_	0	SENT_366	[p21l929t3242r977b3282],
23	healthy	JJ	O	healthy	amod	25	SENT_366	[p21l984t3242r1144b3295],
24	Iapanese	JJ	MISC	iapanese	amod	25	SENT_366	[p21l1158t3246r1349b3294],
25	subjects	NNS	O	subject	prep_of	21	SENT_366	[p21l13t3301r198b3353],
26	.	.	O	.	_	0	SENT_366	[p21l13t3301r198b3353],

1	Biol	NNP	O	Biol	nn	3	SENT_367	[p21l218t3301r298b3341],
2	Pharm	NNP	O	Pharm	nn	3	SENT_367	[p21l315t3301r456b3341],
3	Bull	NNP	O	Bull	_	0	SENT_367	[p21l473t3301r555b3341],
4	2002	CD	DATE	2002	num	3	SENT_367	[p21l570t3305r682b3347],
5	;	:	O	;	_	0	SENT_367	[p21l570t3305r682b3347],
6	25	CD	NUMBER	25	num	8	SENT_367	[p21l700t3303r761b3341],
7	:	:	O	:	_	0	SENT_367	[p21l700t3303r761b3341],
8	1356-59	CD	NUMBER	1356-59	dep	3	SENT_367	[p21l779t3304r964b3341],
9	.	.	O	.	_	0	SENT_367	[p21l779t3304r964b3341],

1	Nakamura	NNP	PERSON	Nakamura	nn	2	SENT_368	[p21l13t3370r241b3410],
2	T	NN	O	t	_	0	SENT_368	[p21l255t3372r290b3416],
3	,	,	O	,	_	0	SENT_368	[p21l255t3372r290b3416],
4	Sakaeda	FW	ORGANIZATION	sakaeda	appos	2	SENT_368	[p21l310t3370r483b3410],
5	T	NN	ORGANIZATION	t	dep	4	SENT_368	[p21l497t3372r533b3416],
6	,	,	O	,	_	0	SENT_368	[p21l497t3372r533b3416],
7	Horinouchi	NNP	PERSON	Horinouchi	nn	8	SENT_368	[p21l552t3370r805b3410],
8	M	NNP	O	M	appos	2	SENT_368	[p21l821t3374r876b3416],
9	,	,	O	,	_	0	SENT_368	[p21l821t3374r876b3416],
10	et	FW	O	et	nn	11	SENT_368	[p21l893t3378r932b3410],
11	al.	FW	O	al.	appos	2	SENT_368	[p21l946t3370r992b3410],
12	.	.	O	.	_	0	SENT_368	[p21l946t3370r992b3410],

1	Effect	NN	O	effect	_	0	SENT_369	[p21l1012t3370r1134b3410],
2	of	IN	O	of	_	0	SENT_369	[p21l1148t3370r1197b3410],
3	the	DT	O	the	det	7	SENT_369	[p21l1203t3370r1271b3410],
4	mutation	NN	O	mutation	nn	7	SENT_369	[p21l1286t3372r1487b3410],
5	(	CD	NUMBER	(	num	7	SENT_369	[p21l15t3431r206b3481],
6	C3435T	NN	O	c3435t	nn	7	SENT_369	[p21l15t3431r206b3481],
7	)	NN	O	)	prep_of	1	SENT_369	[p21l15t3431r206b3481],
8	at	IN	O	at	_	0	SENT_369	[p21l225t3436r263b3468],
9	exon	NN	O	exon	prep_at	7	SENT_369	[p21l278t3442r379b3468],
10	26	CD	NUMBER	26	num	9	SENT_369	[p21l395t3432r443b3468],
11	of	IN	O	of	_	0	SENT_369	[p21l460t3428r508b3468],
12	the	DT	O	the	det	15	SENT_369	[p21l514t3428r582b3468],
13	M	NN	O	m	nn	15	SENT_369	[p21l599t3432r645b3468],
14	DR1	NN	O	dr1	nn	15	SENT_369	[p21l648t3432r737b3468],
15	gene	NN	O	gene	prep_of	1	SENT_369	[p21l752t3442r854b3481],
16	on	IN	O	on	_	0	SENT_369	[p21l870t3442r924b3468],
17	expression	NN	O	expression	nn	18	SENT_369	[p21l939t3431r1171b3480],
18	level	NN	O	level	prep_on	1	SENT_369	[p21l1185t3428r1283b3468],
19	of	IN	O	of	_	0	SENT_369	[p21l1299t3428r1347b3468],
20	MDR1	NN	O	mdr1	nn	23	SENT_369	[p21l1356t3432r1494b3468],
21	messenger	NN	O	messenger	nn	23	SENT_369	[p21l11t3502r249b3540],
22	ribonucleic	JJ	O	ribonucleic	amod	23	SENT_369	[p21l263t3488r508b3528],
23	acid	NN	O	acid	prep_of	1	SENT_369	[p21l523t3488r610b3528],
24	in	IN	O	in	_	0	SENT_369	[p21l624t3491r668b3527],
25	duodenal	JJ	O	duodenal	amod	26	SENT_369	[p21l683t3488r884b3528],
26	enterocytes	NNS	O	enterocyte	prep_in	1	SENT_369	[p21l900t3496r1143b3540],
27	of	IN	O	of	_	0	SENT_369	[p21l1160t3488r1209b3528],
28	healthy	JJ	O	healthy	amod	30	SENT_369	[p21l1215t3488r1375b3540],
29	Iapanese	JJ	MISC	iapanese	amod	30	SENT_369	[p21l13t3551r203b3598],
30	subjects	NNS	O	subject	prep_of	1	SENT_369	[p21l220t3547r405b3599],
31	.	.	O	.	_	0	SENT_369	[p21l220t3547r405b3599],

1	Clin	NNP	O	Clin	nn	3	SENT_370	[p21l426t3547r512b3587],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_370	[p21l529t3547r751b3587],
3	Ther	NNP	O	Ther	_	0	SENT_370	[p21l769t3547r864b3586],
4	2002	CD	DATE	2002	num	3	SENT_370	[p21l876t3550r988b3592],
5	;	:	O	;	_	0	SENT_370	[p21l876t3550r988b3592],
6	71	CD	NUMBER	71	num	8	SENT_370	[p21l1007t3549r1063b3587],
7	:	:	O	:	_	0	SENT_370	[p21l1007t3549r1063b3587],
8	297-303	CD	NUMBER	297-303	dep	3	SENT_370	[p21l1081t3549r1268b3588],
9	.	.	O	.	_	0	SENT_370	[p21l1081t3549r1268b3588],

1	I-Ioffmeyer	NN	O	i-ioffmeyer	nn	2	SENT_371	[p21l14t3613r250b3665],
2	S	NN	O	s	_	0	SENT_371	[p21l267t3616r302b3659],
3	,	,	O	,	_	0	SENT_371	[p21l267t3616r302b3659],
4	Burk	NNP	PERSON	Burk	nn	5	SENT_371	[p21l321t3613r426b3653],
5	o	NN	O	o	appos	2	SENT_371	[p21l441t3616r488b3659],
6	,	,	O	,	_	0	SENT_371	[p21l441t3616r488b3659],
7	Von	NNP	PERSON	Von	nn	9	SENT_371	[p21l503t3627r583b3653],
8	Richter	NNP	PERSON	Richter	nn	9	SENT_371	[p21l600t3613r757b3653],
9	O	NNP	PERSON	O	appos	2	SENT_371	[p21l772t3616r819b3659],
10	,	,	O	,	_	0	SENT_371	[p21l772t3616r819b3659],
11	et	FW	O	et	nn	12	SENT_371	[p21l836t3621r875b3653],
12	al.	FW	O	al.	appos	2	SENT_371	[p21l889t3613r935b3653],
13	.	.	O	.	_	0	SENT_371	[p21l889t3613r935b3653],

1	Functional	JJ	O	functional	amod	2	SENT_372	[p21l955t3613r1185b3653],
2	polymorphisms	NNS	O	polymorphism	_	0	SENT_372	[p21l11t3673r354b3725],
3	of	IN	O	of	_	0	SENT_372	[p21l371t3673r420b3713],
4	the	DT	O	the	det	7	SENT_372	[p21l426t3673r494b3713],
5	human	JJ	O	human	amod	7	SENT_372	[p21l509t3673r668b3713],
6	multidrug-resistance	JJ	O	multidrug-resistance	amod	7	SENT_372	[p21l682t3673r1137b3725],
7	gene	NN	O	gene	prep_of	2	SENT_372	[p21l1153t3687r1266b3725],
8	:	:	O	:	_	0	SENT_372	[p21l1153t3687r1266b3725],
9	multiple	JJ	O	multiple	amod	11	SENT_372	[p21l1283t3673r1467b3725],
10	sequence	NN	O	sequence	nn	11	SENT_372	[p21l13t3745r213b3783],
11	variations	NNS	O	variation	dep	2	SENT_372	[p21l227t3734r439b3771],
12	and	CC	O	and	_	0	SENT_372	[p21l455t3732r536b3771],
13	correlation	NN	O	correlation	conj_and	11	SENT_372	[p21l550t3732r785b3771],
14	of	IN	O	of	_	0	SENT_372	[p21l800t3731r848b3771],
15	one	CD	NUMBER	one	num	16	SENT_372	[p21l856t3746r934b3771],
16	allele	NN	O	allele	prep_of	13	SENT_372	[p21l950t3732r1060b3771],
17	With	IN	O	with	_	0	SENT_372	[p21l1074t3732r1171b3771],
18	P-glycoprotein	NN	O	p-glycoprotein	nn	19	SENT_372	[p21l1187t3732r1500b3784],
19	expression	NN	O	expression	prep_with	16	SENT_372	[p22l12t13r244b62],
20	and	CC	O	and	_	0	SENT_372	[p22l259t10r339b50],
21	activity	NN	O	activity	conj_and	19	SENT_372	[p22l354t13r506b62],
22	in	FW	O	in	prep	13	SENT_372	[p22l520t13r563b49],
23	vivo	FW	O	vivo	pobj	22	SENT_372	[p22l577t13r674b50],
24	.	.	O	.	_	0	SENT_372	[p22l577t13r674b50],

1	Proc	NNP	ORGANIZATION	Proc	nn	5	SENT_373	[p22l694t14r784b50],
2	Natl	NNP	ORGANIZATION	Natl	nn	5	SENT_373	[p22l800t10r889b50],
3	Acad	NNP	ORGANIZATION	Acad	nn	5	SENT_373	[p22l902t10r1007b50],
4	Sci	NNP	ORGANIZATION	Sci	nn	5	SENT_373	[p22l1024t12r1084b50],
5	USA	NNP	ORGANIZATION	USA	_	0	SENT_373	[p22l1106t13r1202b50],
6	2000	CD	DATE	2000	num	5	SENT_373	[p22l1217t14r1329b56],
7	;	:	O	;	_	0	SENT_373	[p22l1217t14r1329b56],
8	97:3473	CD	NUMBER	97:3473	num	9	SENT_373	[p22l12t73r271b111],
9	—	NN	O	—	dep	5	SENT_373	[p22l12t73r271b111],
10	78	CD	NUMBER	78	dep	9	SENT_373	[p22l12t73r271b111],
11	.	.	O	.	_	0	SENT_373	[p22l12t73r271b111],

